BERBERINE

1. 11-Hydroxylation of ProtoBerberine by the Novel Berberine -Utilizing Aerobic Bacterium Sphingobium sp. Strain BD3100
2. 12-Oxo-phytodienoic acid induces accumulation of Berberine bridge enzyme transcript in a manner analogous to methyl jasmonate
3. 13-(2-Methylbenzyl) Berberine Is a More Potent Inhibitor of MexXY-Dependent Aminoglycoside Resistance than Berberine
4. 13-[CH2CO-Cys-(Bzl)-OBzl]-Berberine : Exploring The Correlation Of Anti-Tumor Efficacy With ROS And Apoptosis Protein
5. 13-MethylBerberine , a Berberine analogue with stronger anti-adipogenic effects on mouse 3T3-L1 cells
6. 146. Synthetical experiments on protopine and allied alkaloids. Part II. New synthesis of the Berberine ring-system, and of a ring-homologue of the aporphine alkaloids
7. 166. The isomerization of Berberine and cotarnine bases in presence of alkali
8. 18F-Berberine Derivatives: a Potential Molecular Imaging Agent for Tumor Targeting by PET/CT Tumor
9. 1H NMR investigation of the interaction of Berberine and sanguinarine with DNA.
10. 1H-NMR-based metabonomics of the protective effect of Coptis chinensis and Berberine on cinnabar-induced hepatotoxicity and nephrotoxicity in rats
11. 2 new fluorochromation methods for blood smears and chromosomes using Berberine sulfate following deoxyribonucleoprotein denaturation
12. 2469-PUB: Exploring the Mechanisms of Berberine against Type 2 Diabetes Mellitus and Its Complications by Network Pharmacology
13. 5′-Methoxyhydnocarpin-D and Pheophorbide A: Berberis Species Components that Potentiate Berberine Growth Inhibition of Resistant Staphylococcus aureus
14. 6. Berberine -INDUCED UPREGULATION OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS IMPROVES ENDOTHELIAL FUNCTION AND …
15. 611-P: Berberine Prevented High-Fat Diet-Induced Metabolic Disorders via Inhibition of Whole Lipid Metabolism
16. 62 Cases child bronchneumonia treated by the union of the ion transmission of rhizome of Berberine and ultraviolet radiation
17. 6-S-cysteinylation of bi-covalently attached FAD in Berberine bridge enzyme tunes the redox potential for optimal activity
18. 9-N-Substituted Berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc
19. 9-O-benzoyl-substituted Berberine exerts a triglyceride-lowering effect through AMPK signaling pathway in human hepatoma HepG2 cells
20. 9-O-Butyl-13-(4-isopropylbenzyl) Berberine , KR-72, is a potent antifungal agent that inhibits the growth of Cryptococcus neoformans by regulating gene …
21. 9-ON-aryl/arylalkyl amino carbonyl methyl substituted Berberine analogues induce self-structure in polyadenylic acid
22. 9-Substituted Berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA
23. A 42-markers pharmacokinetic study reveals interactions of Berberine and glycyrrhizic acid in the anti-diabetic Chinese medicine formula Gegen-Qinlian decoction
24. A Berberine group, the 13-methyl derivatives
25. A Berberine -aniline blue fluorescent staining procedure for suberin, lignin, and callose in plant tissue
26. A Berberine -Bridge enzyme-like protein is a specific oxidase that modifies cellulose oligomers and plays a role in Arabidopsis immunity and development
27. A Berberine -loaded electrospun poly-(ε-caprolactone) nanofibrous membrane with hemostatic potential and antimicrobial property for wound dressing
28. A biomimetic conversion of Berberine into chelerythrine and dihydrochelerythrine
29. A biotechnological production of Berberine from Thalictrum minus L. cell culture.
30. A Clinical Examination on Effectiveness of Berberine in 89 Premature Beat Cases
31. A clinical study on the short-term effect of Berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
32. A combination of Berberine and-oryzanol for hyperlipidemia therapy: An hypothesis
33. A combination of metabolomics and metallomics studies of urine and serum from hypercholesterolaemic rats after Berberine injection
34. A combination of sulfadimidine, neomycin and Berberine in the treatment of infectious diarrhoea
35. A common and general access to Berberine and benzo [c] phenanthridine alkaloids
36. A comparative study of nine Berberine salts in the solid state: optimization of the photoluminescence and self-association properties through the choice of the anion
37. A concerted mechanism for Berberine bridge enzyme
38. A Contribution to the Pharmacology of Berberine .
39. A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine Berberine
40. A highly fluorescent lanthanide metal-organic framework as dual-mode visual sensor for Berberine hydrochloride and tetracycline
41. A highly sensitive and widely adaptable plasmonic aptasensor using Berberine for small-molecule detection
42. A improvement assay for the content datermination of Berberine Hydrochloride tablets
43. A mass spectrometric investigation of novel quadruplex DNA-selective Berberine derivatives
44. A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered Berberine
45. A Mixed Micelle Formulation Strategy for Enhancing Oral Bioavailability of Berberine by Modulating P-glycoprotein
46. A multicenter study effect of Berberine hydrochloride on serum HIF-1αand Caspase-3 levels in patients with acute cerebral infarction
47. A multidrug and toxic compound extrusion transporter mediates Berberine accumulation into vacuoles in Coptis japonica
48. A natural alkaloid, Berberine , as a novel transcriptional repressor of RET proto-oncogene in medullary thyroid carcinoma
49. A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine .
50. A New Berberine -selective Liquid Membrane Electrode [J]
51. A new bioassay system for screening high Berberine -producing cell colonies of Thalictrum minus
52. A New Fluorescence Method for the Determination Trace Amounts of Berberine Using KAuI2
53. A New Method for Improving Detection Limit of Berberine Polyvinyl Chloride Ion Selective Electrode [J]
54. A new triple system DNA-Nanosilver-Berberine for cancer therapy
55. A newly identified Berberine derivative induces cancer cell senescence by stabilizing endogenous G-quadruplexes and sparking a DNA damage response at …
56. A novel Berberine ‐metformin hybrid compound exerts therapeutic effects on obese type 2 diabetic rats
57. A novel injectable in situ forming gel based on carboxymethyl hexanoyl chitosan/hyaluronic acid polymer blending for sustained release of Berberine
58. A novel method to mask the bitter taste of Berberine hydrochloride: Powder surface modification
59. A NOVEL RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF Berberine , QUERCETIN, AND PIPERINE IN AN AYURVEDIC FORMULATION
60. A novel UPLC–MS/MS method for simultaneous quantification of rhein, emodin, Berberine and baicalin in rat plasma and its application in a pharmacokinetic study
61. A paradoxical stimulatory effect of Berberine on guinea-pig ileum contractility: Possible involvement of acetylcholine release from the postganglionic parasympathetic …
62. A Phase I Trial of Berberine in Chinese with Ulcerative Colitis
63. A photochemical approach to the fully functionalized ring system of chilinene, a key alkaloid of the Berberine family
64. A Piezoelectric Sensing Technology for the Determination of Berberine Hydrochloride (BHC)
65. A Possible Cannizzaro’s Reaction of Berberine In Vivo
66. A preliminary investigation of the mechanisms underlying the effect of Berberine in preventing high-fat diet-induced insulin resistance in rats
67. A randomized clinical trial of Berberine hydrochloride in patients with diarrhea‐predominant irritable bowel syndrome
68. A RAPID DETERMINATION OF THE TWO COMPONENTS IN SYNERGIC Berberine CAPSULE
69. A review of the effects of Berberis vulgaris and its major component, Berberine , in metabolic syndrome
70. A review on analytical methods for natural Berberine alkaloids
71. A review on Pharmacological potential of Berberine ; an active component of Himalayan Berberis aristata
72. A room-temperature protocol to access isoquinolines through Ag(i) catalysed annulation of o-(1-alkynyl)arylaldehydes and ketones with NH4OAc: elaboration to Berberine and palmatine†
73. A safer hypoglycemic agent for type 2 diabetes—Berberine organic acid salt
74. A selective and sensitive assay of Berberine using total internal reflected resonance light scattering technique with fluorescein at the water/1, 2-dichloroethane …
75. A sensitive and specific liquid chromatography mass spectrometry method for simultaneous determination of Berberine , palmatine, coptisine, epiBerberine and …
76. A sensitive optode membrane for Berberine using conjugated polymer as sensing material
77. A Sensitive Resonance Scattering Method for the Determination of Trace Berberine Based on Formation of Particles
78. A sensitive spectrofluorometric method for detection of Berberine hydrochloride using Ag nanoclusters directed by natural fish sperm DNA
79. A simple fluorescence quenching method for Berberine determination using water-soluble CdTe quantum dots as probes
80. A Simple Phosphorescent Method for Berberine Detection Using 3-Mercaptopropionic Acid-capped Manganese-doped ZnS Quantum Dots
81. A simple, fast, and sensitive colorimetric assay for visual detection of Berberine in human plasma by NaHSO 4-optimized gold nanoparticles
82. A single arm pilot study of effects of Berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory Chinese women with …
83. A stereospecific conversion of Berberine into (±)-β-hydrastine
84. A Study for the isolation of the Berberine -type Alkaloid from Coptidis Rhizoma and for their Antitumor Activities
85. A study of chemiluminescence characteristics of a novel peroxyoxalate system using Berberine as the fluorophore
86. A study of the antiarrhythmic mechanism of Berberine on delayed activation potassium current by voltage clamp
87. A study on antioxidant activity of Berberine [J]
88. A Study on Compound Berberine Colon-Specific Tablets’ Preparation and Their Release Characteristics in Vitro and in Vivo.
89. A study on mechanism underlying the inhibition of Berberine on proliferation of human melanoma A375 cells
90. A study on natural dyeing (5)-Adsorption properties of Berberine for silk fabrics
91. A study on the extraction efficiency of Berberine in Coptidis rhizoma
92. A study on the synergism antifungal activity of clotrimazole in combination with Berberine hydrochloride against Candida albicans in vitro
93. A systematic review of the anticancer properties of Berberine , a natural product from Chinese herbs
94. A systematic review of the Berberine in protecting kidneys of diabetic rats [J]
95. A Unified Strategy for the Syntheses of the Isoquinolinium Alkaloids Berberine , Coptisine, and Jatrorrhizine
96. Berberine _on.203.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/jhypertension/Abstract/2018/10003/A7643_Inhibitory_Impacts_of_Berberine _on.203.aspx&source=gmail&ust=1581476863113000&usg=AFQjCNGu_T_oLJvsJjPoLgYIdGH8qGmr6A”>A7643 Inhibitory Impacts of Berberine on Catecholamine Secretion from the Adrenal Medulla
97. AB229. Effect of Berberine on human sperm parameters in vitro
98. Abilities of Berberine and chemically modified Berberine s to inhibit proliferation of pancreatic cancer cells
99. Abilities of Berberine and chemically modified Berberine s to interact with metformin and inhibit proliferation of pancreatic cancer cells
100. Absorption spectra study of the association nanoparticle system of Berberine -[AuI4]-and its analytical application
101. Absorption, distribution and excretion of Berberine .
102. Abstract A45: Berberine acts as an antagonist to estradiol-induced proliferation by inducing apoptosis in cervical cancer cells
103. Abstract B70: Berberine , a putative bioactive compound from traditional herbal plant, induces apoptosis in MCF‐7 breast cancer cells through p53 activation and …
104. Abstract C38: Berberine /cisplatin-based radiotherapy for cervical cancer: The new and effective method to treat cervical cancer
105. Abstracts: The effects of Coptis japonica root extract and its key component, Berberine , on human subcutaneous adipocytes
106. Berberine -in-the-medicinal-plant-of-tali-kuning-tin” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.neliti.com/publications/291688/abundance-of-yellow-alkaloid-Berberine -in-the-medicinal-plant-of-tali-kuning-tin&source=gmail&ust=1581476863114000&usg=AFQjCNGM6CL4faXT0Sp61_jltXX7U_VNJA”>Abundance of Yellow Alkaloid ‘Berberine ‘in the Medicinal Plant of Tali Kuning (Tinospora Dissitiflora Diels.) Collected From Manokwari–West Papua
107. Acetaldehyde-induced interleukin-1β and tumor necrosis factor-α production is inhibited by Berberine through nuclear factor-κB signaling pathway in HepG2 cells
108. Achyranthis bidentatae radix enhanced articular distribution and anti-inflammatory effect of Berberine in Sanmiao Wan using an acute gouty arthritis rat model
109. Activation of a refolded, Berberine -specific, single-chain Fv fragment by addition of free Berberine
110. Activation of AMP-activated protein kinase is required for Berberine -induced reduction of atherosclerosis in mice: the role of uncoupling protein 2
111. Activation of AMPK by Berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice
112. Activation of AMPK by Berberine promotes adiponectin multimerization in 3T3-L1 adipocytes
113. Activation of IGF-1/IGFBP-3 signaling by Berberine improves intestinal mucosal barrier of rats with acute endotoxemia
114. Activation of peritoneal macrophages by Berberine -type alkaloids in terms of induction of cytostatic activity
115. Activation of the aryl hydrocarbon receptor by Berberine in HepG2 and H4IIE cells: Biphasic effect on CYP1A1
116. Activity of Berberine on Shigella dysenteriae investigated by microcalorimetry and multivariate analysis
117. Activity of isoflavones and Berberine on vasomotor symptoms and lipid profile in menopausal women
118. Acute toxicity of Berberine and its correlation with the blood concentration in mice
119. Addition of Berberine to 5-aminosalicylic acid for treatment of dextran sulfate sodium-induced chronic colitis in C57BL/6 mice
120. Addition of Berberine to preservation solution in an animal model of ex vivo liver transplant preserves mitochondrial function and bioenergetics from the damage …
121. Addition of dichlorocarbene to oxyBerberine and Berberine
122. Adenosine monophosphate-activated protein kinase modulation by Berberine attenuates mitochondrial deficits and redox imbalance in experimental diabetic …
123. Adsorption and reduction of Berberine at a mercury electrode
124. Adsorption characteristics of proteins on membrane surface and effect of protein solution environment on permeation behavior of Berberine
125. Adsorption Effects in Polarography of Berberine
126. Adsorption kinetics and isotherms of Berberine by ZSM-5 molecular sieves from Cortex Phellodendron
127. Adsorption kinetics of Berberine hydrochloride on AB-8 resin [J]
128. Adsorption of Berberine by polymeric resin H103: kinetics and thermodynamics
129. Adsorption of Berberine hydrochloride onto mesoporous carbons with tunable pore size
130. Adsorption of Berberine hydrochloride, ligustrazine hydrochloride, colchicine, and matrine alkaloids on macroporous resins
131. Adsorption of Berberine on commercial minerals
132. Adsorption of penicillin–Berberine ion associates at a water/tetrachloromethane interface and determination of penicillin based on total internal-reflected resonance …
133. Advance in Antimicrobial Activities of Berberine [J]
134. Advance of studies on anti-atherosclerosis mechanism of Berberine
135. Advance on study in anti-atherosclerosis mechanism of Berberine
136. Advances in research of Berberine hydrochloride wastewater treatment technologies
137. Advances in structural modifications and biological activities of Berberine : an active compound in traditional Chinese medicine.
138. Advances in the study of Berberine and its derivatives
139. Advances of the mechanism study on Berberine in the control of blood glucose and lipid as well as metabolism disorders
140. Aggregation of DNA enhanced by the protoBerberine alkaloids, coralyne and Berberine
141. Agonist‐dependent differential effects of Berberine in human platelet aggregation
142. Agonistic effects of Berberine hydrochloride on muscarinic receptors 1
143. Aiming to understand the mechanisms underlying the different responses to Berberine among different cell lines
144. Akt signaling is associated with the Berberine -induced apoptosis of human gastric cancer cells
145. ALA/Berberine Complex
146. Alkaloids as aldose reductase inhibitors, with special reference to Berberine
147. Alkaloids in the nature: pharmacological applications in clinical practice of Berberine and mate tea
148. Alkaloids of the Papaveraceae V. Muramine and Berberine from Argemone squarrosa
149. Allelopathic Effects of Berberine , a Plant Alkaloid, on the Algae, Microcystis aeruginosa (FACHB-905), at Different Initial Densities
150. Allelopathic potential of Berberine from Coptis chinensis Franch on invasive weeds.
151. Allergic Rhinitis: 239 Berberine Inhibits Myofibroblast Differentiation in Nasal Polyp-deroved Fibroblast via P-38 Pathway
152. Allosteric Effect of Cu~(2+)/Zn~(2+) on Binding Process of Bovine Serum Albumin-Berberine Chloride [J]
153. Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by Berberine
154. Alternative final steps in Berberine biosynthesis in Coptis japonica cell cultures
155. Altitudinal variation of Berberine , total phenolics and flavonoid content in Thalictrum foliolosum and their correlation with antimicrobial and antioxidant …
156. Ameliorating effects of Berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia
157. Amelioration effects of Berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro
158. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by Berberine via suppression of MLCK-MLC phosphorylation signaling …
159. Amelioration of intestinal barrier dysfunction by Berberine in the treatment of nonalcoholic fatty liver disease in rats
160. Amelioration of testicular damages in renal ischemia/reperfusion by Berberine : An experimental study
161. Ameliorative effect of Berberine coated bio-active nanoparticles in acetaminophen induced hepato-renal damage in diabetic rats
162. Ameliorative effect of Berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin
163. Ameliorative effect of Berberine on functional disorders and histological damages of pancreas in renal ischemia/reperfusion
164. Ameliorative Effect of Berberine on Neonatally Induced Type 2 Diabetic Neuropathy via Modulation of BDNF, IGF-1, PPAR-γ, and AMPK Expressions
165. Ameliorative effect of Berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin
166. AMELIORATIVE POTENTIAL OF QUERCETIN AND Berberine ON EXPERIMENTALLY INDUCED NEPHROTOXICITY IN RATS
167. Amino-Modified Hydrogen-Bonding Resin and its Adsorption on Berberine
168. Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA2β/Cardiolipin/Opa1 pathwayin db/db mice and in Palmitate-treated MIN6 β-cells
169. Amorphous solid dispersion of Berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability
170. An Analytical Study of Berberine
171. An ancient Chinese herb Berberine : new research in Diabetes Mellitus
172. An ATR–FTIR Sensor Unraveling the Drug Intervention of Methylene Blue, Congo Red, and Berberine on Human Tau and Aβ
173. An efficient conversion of Berberine into a rhoeadine via an indenobenzazepine
174. An Experimental Study of Extracting Berberine Hydrochloride from Medicinal Herbs of Barberry and Coptis Root
175. AN EXPERIMENTAL STUDY ON THE PHOTODYNAMIC ACTIVITY OF Berberine IN VITRO OF CANCER CELLS
176. An immobilized cell culture system for Berberine production by Thalictrum minus cells
177. An Infrared Spectroscopy Analysis of Extracting Berberine from Cortex Phallodendri
178. An insight into the molecular mechanism of Berberine towards multiple cancer types through systems pharmacology
179. An Investigation on Extraction of Berberine Hydrochlride from Rhizoma Copidis by Liquid Membrane [J]
180. AN ION-SELECTIVE ELECTRODE USING CHLOROPHYLL AS ELECTROACTIVE MATERIAL-DETERMINATION OF Berberine
181. An isoquinoline alkaloid, Berberine , can inhibit fungal alpha amylase: enzyme kinetic and molecular modeling studies
182. An Observation of Oral Berberine on 36 Children with Ventricular Premature Beats [J]
183. An observational study of the antidiabetic activity of Berberine in newly diagnosed type 2 diabetes mellitus patients
184. An optical fiber sensor for Berberine based on immobilized 1, 4-bis (naphth [2, 1-d] oxazole-2-yl) benzene in a new copolymer
185. An oral cocktail study on potential drug interactions of a proprietary nutraceutical combination containing Berberine and monacolin in healthy volunteers
186. Analysis of Berberine and total alkaloid content in Cortex Phellodendri by near infrared spectroscopy (NIRS) compared with high-performance liquid chromatography …
187. Analysis of Berberine by a Sensitive High Performance Liquid Chromatographic (HPLC) Method
188. Analysis of Berberine content using HPTLC fingerprinting of root and bark of three Himalayan Berberis species
189. Analysis of Content Determination of Berberine Hydrochloride and Emodin and Chrysophanol of Sanhuang Tablets by HPLC [J]
190. Analysis of contents of Berberine in Coptis chinensis of Lichuan
191. Analysis of coptisine, Berberine and palmatine in adulterated Chinese medicine by capillary electrophoresis–electrospray ion trap mass spectrometry
192. Analysis of Curative Effect of Triple Viable Bifidobacterium combined with Berberine in Treatment of Chronic Diarrhea
193. Analysis of Effects of Berberine on the Photosynthesis of Microcystis aeruginosa at Gene Transcriptional Level
194. Analysis of Fibrauretin and Its Adulterant Berberine Hydrochloride by HPLC [J]
195. Analysis of promoters from tyrosine/dihydroxyphenylalanine decarboxylase and Berberine bridge enzyme genes involved in benzylisoquinoline alkaloid biosynthesis …
196. Analysis on Related Factors of Anti-fatigue Effect of Berberine
197. Angiogenic pathway inhibition of Corydalis yanhusuo and Berberine in human umbilical vein endothelial cells
198. Animal experimental study on the mechanism of Berberine in treating chronic heart failure
199. Ann Allergy Asthma Immunol. 2014: Berberine and limonin suppress IgE production by human b cells and peripheral blood mononuclear cells from food-allergic …
200. Antagonism of cholera toxin by Berberine in the gastrointestinal tract of adult rats.
201. Anti-adipogenic activity of Berberine in 3T3-L1 pre-adipocytes cultured in high-glucose medium
202. Anti‐Adipogenic Activity of Berberine is Not Mediated by the WNT/β‐Catenin Pathway
203. Anti-Alzheimer’s potential of Berberine using surface decorated multi-walled carbon nanotubes: a preclinical evidence
204. Anti-amoebic value of Berberine and kurchi alkaloids.
205. Antiangiogenic activity of Berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators
206. Antiangiogenic and antitumor activities of Berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma
207. Anti-apoptotic and moderate anti-inflammatory effects of Berberine in sulfur mustard exposed keratinocytes
208. Anti-arthritic effect of Berberine on adjuvant-induced rheumatoid arthritis in rats
209. Anti‐atherogenic effect of Berberine on LXRα‐ABCA1‐dependent cholesterol efflux in macrophages
210. Anti-atherogenic mechanisms of Berberine
211. Antibacterial activity and mechanism of Berberine against Streptococcus agalactiae
212. Antibacterial activity and mechanism of Berberine on avian Pasteurella multocida
213. Antibacterial activity and structure-activity relationships of Berberine analogs
214. Antibacterial activity of Berberine -NorA pump inhibitor hybrids with a methylene ether linking group
215. Antibacterial Activity of Prulifloxacin Combined with Berberine Chloride in Vitro [J]
216. Antibacterial effects of Berberine on antibiotic-resistant staphylococcus aureus
217. Antibacterial effects of Berberine on three aquatic pathogens in vitro.
218. Antibacterial mechanisms of Berberine and reasons for little resistance of bacteria
219. Antibiotic delivery system using nano‐hydroxyapatite/chitosan bone cement consisting of Berberine
220. Anticachectic effects of the natural herb Coptidis rhizoma and Berberine on mice bearing colon 26/clone 20 adenocarcinoma
221. Anticancer activity of Mahonia leschenaultii methanolic root extract and Berberine on Dalton’s ascitic lymphoma in mice
222. Anticancer Efficacy of the Combination of Berberine and PEGylated Liposomal Doxorubicin in Meth A Sarcoma-Bearing Mice
223. Anti‐cancer Herbal Drug Berberine –Sensitive Determination Using Boron‐doped Diamond Electrode
224. Anti‐Clastogenic Effect of Berberine against DMBA‐Induced Clastogenesis
225. Anticomplement activity of Mahonia aquifolium bisbenzylisoquinoline alkaloids and Berberine extract
226. Anticonvulsant activity of Berberine , an isoquinoline alkaloid in mice
227. Antidiabetic activity of benzyl tetra isoquinoline alkaloid Berberine in streptozotocin-nicotinamide induced type 2 diabetic rats
228. Anti-diabetic effects of cinnamaldehyde and Berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus
229. Antidiabetic properties of Berberine : from cellular pharmacology to clinical effects
230. Antidiarrheal and anti-inflammatory effects of Berberine
231. Anti-Eimeria activity of Berberine and identification of associated gene expression changes in the mouse jejunum infected with Eimeria papillata
232. Antifibrotic cardioprotection of Berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats
233. Antifungal activity of aqueous extracts and of Berberine isolated from Berberis heterophylla
234. Antifungal activity of Berberine hydrochloride and palmatine hydrochloride against Microsporum canis in rabbits and underlying mechanism
235. Antifungal activity of Berberine hydrochloride and palmatine hydrochloride against Microsporum canis-induced dermatitis in rabbits and underlying …
236. Antifungal activity of Berberine iodide, a constituent ofFumaria indica
237. Antifungal Activity of Chaerophylline and Berberine Hydroxide Isolated from Corydalis Species
238. Anti-fungal effect of Berberine on Candida albicans by microcalorimetry with correspondence analysis
239. Antifungal susceptibility analysis of Berberine , baicalin, eugenol and curcumin on Candida albicans
240. Antifungal, Antileishmanial, and Cytotoxicity Activities of Various Extracts of Berberis vulgaris (Berberidaceae) and Its Active Principle Berberine
241. Anti-Helicobacter pylori activity and structure-activity relationships of Berberine derivatives
242. Berberine -nanosuspension-against-human-HepG2-and/10.1117/12.2067978.short” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.spiedigitallibrary.org/conference-proceedings-of-spie/9230/923003/Anti-hepatocarcinoma-effects-of-Berberine -nanosuspension-against-human-HepG2-and/10.1117/12.2067978.short&source=gmail&ust=1581476863127000&usg=AFQjCNE_ZI3droOmm7kPhmrgvZz4TxE_Ng”>Anti-hepatocarcinoma effects of Berberine nanosuspension against human HepG2 and Huh7 cells as well as H22 tumor bearing mice
243. Berberine -nanostructured-lipid-carriers-against-human/10.1117/12.2245514.short” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.spiedigitallibrary.org/conference-proceedings-of-spie/10024/1002417/Anti-hepatocarcinoma-effects-of-Berberine -nanostructured-lipid-carriers-against-human/10.1117/12.2245514.short&source=gmail&ust=1581476863127000&usg=AFQjCNGPY2vVqYEgJ3wLs-7ljACG6LbjVQ”>Anti-hepatocarcinoma effects of Berberine -nanostructured lipid carriers against human HepG2, Huh7, and EC9706 cancer cell lines
244. Anti-herpes simplex virus effects of Berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San
245. Anti-hyperglycemic effect of the compatibility of ginsenoside Re and Berberine in different ratio on type 2 diabetes
246. Anti-hypertensive and renoprotective effects of Berberine in spontaneously hypertensive rats
247. Anti-inflammatory activities of pentaherbs formula, Berberine , gallic acid and chlorogenic acid in atopic dermatitis-like skin inflammation
248. ANTI-INFLAMMATORY AND ANALGESIC ACTIONS OF Berberine [J]
249. Anti-Inflammatory and Barrier-Protective Effects of Berberine
250. Berberine ” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://research.nu.edu.kz/en/publications/anti-inflammatory-effects-and-mechanism-of-Berberine &source=gmail&ust=1581476863127000&usg=AFQjCNHY049pFO25fm4ME8epnQovUB6OsQ”>Anti-inflammatory effects and mechanism of Berberine
251. Anti-inflammatory Effects of Berberine [J]
252. Anti-inflammatory effects of Berberine hydrochloride in an LPS-induced murine model of mastitis
253. Anti‐influenza activity of Berberine improves prognosis by reducing viral replication in mice
254. Anti-Leishmanial Effects of Chitosan-Polyethylene Oxide Nanofibers Containing Berberine : An Applied Model for Leishmania Wound Dressing
255. Antilipemic Effect of Berberine Combined with Atorvastatin on Rats with Hypelipemia
256. Anti-malarial Berberine Alkaloids from Corydalis yanhusuo WT Wang
257. Antimicrobial Activity of Berberine Alone and in Combination with Ampicillin or Oxacillin Against Methicillin-Resistant Staphylococcus aureus
258. Antimicrobial activity of Berberine —a constituent ofMahonia aquifolium
259. Antimicrobial characteristics of Berberine against prosthetic joint infection-related Staphylococcus aureus of different multi-locus sequence types
260. Antimicrobial Natural Product Berberine Is Efficacious for the Treatment of Atrial Fibrillation
261. Antimicrobial Profile of Antidiabetic Drug: Berberine
262. Antimycotic activity of Berberine sulphate: an alkaloid from an Indian medicinal herb
263. Antineoplastic mechanism research progress of Berberine
264. Antinociceptive effect of Berberine on visceral hypersensitivity in rats
265. Anti-obesity effect of Berberine in mice fed a high fat diet
266. Antioxidant activities of Berberine hydrochloride
267. Antioxidant activity of Berberine on benzo (A) pyrene induced experimental lung carcinogenesis in mice
268. Antioxidant activity studies in several system of Berberine and NAC.
269. Anti-Oxidant and Anti-Apoptotic Effects of Berberine in Pentylenetetrazole-Induced Kindling Model in Rat
270. Antioxidant and anti-inflammatory activities of Berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats
271. Antioxidant and anti-inflammatory activities of Berberine in the treatment of diabetes mellitus
272. Antioxidant effect of Berberine and its phenolic derivatives against human fibrosarcoma cells
273. Antioxidant properties of Berberine on cultured rabbit corpus cavernosum smooth muscle cells injured by hydrogen peroxide1
274. Antioxidation of Berberine Hydrochloride to Oils and Fat [J]
275. Berberine -pre-treatment/5/01300535″ target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://insights.ovid.com/neural-regeneration-research/nrgr/2010/09/280/antioxidative-effects-Berberine -pre-treatment/5/01300535&source=gmail&ust=1581476863130000&usg=AFQjCNFrCZjO8wYfUaOTq1jfWPsO51t2UQ”>Antioxidative effects of Berberine pre-treatment on hydrogen peroxide-induced PC12 cell toxicity*☆
276. Antiproliferation of Berberine in combination with fluconazole from the perspectives of reactive oxygen species, ergosterol and drug efflux in a fluconazole …
277. Antiproliferation of Berberine is mediated by epigenetic modification of constitutive androstane receptor (CAR) metabolic pathway in hepatoma cells
278. Anti-proliferation of Berberine on human breast cancer cell line MDA-MB-231 and its relationship to PPARγ
279. Antiproliferative activity of Berberine from Coscinium fenestratum on NCI-H838 cell line
280. Antiproliferative activity of Berberine in vitro and in vivo
281. Anti-Proliferative Activity of Standardized Methanol Extract of Coscinium fenestratum and Its Major Constituent, Berberine , Against Nasopharyngeal Carcinoma Cells
282. ANTISECRETORY EFFECTS OF Berberine [J]
283. Anti-secretory effects of Berberine in human colonic epithelium
284. Antisecretory effects of Berberine in rat ileum
285. Antisecretory effects of Berberine with morphine, clonidine, L-phenylephrine, yohimbrine or neostigmine in pig jejunum
286. Antitubercular Natural Products: Berberine from the Roots of Commercial Hydrastis canadensis Powder. Isolation of Inactive 8-Oxotetrahydrothalifendine …
287. Antitumor Ability of Berberine Accompanied by Modulation of Gut Microbiome in Sarcoma-180 Tumor-bearing Mice
288. Antitumor activity of NAX060: A novel semisynthetic Berberine derivative in breast cancer cells
289. Antitumor effect of Berberine against primary effusion lymphoma via inhibition of NF‐κ B pathway
290. Antitumor effect of Berberine hydrochloride in the serum and plasma on nasopharyngeal carcinoma CNE-1 cell: A comparative study
291. Antitumor effect of novel Berberine derivatives in breast cancer cells
292. Antitumor effects of Berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study
293. Antitumor Effects of Berberine on Gliomas via Inactivation of Caspase-1-Mediated IL-1β and IL-18 Release
294. Antitumor effects of Berberine α-hydroxy β-decanoylethyl sulfonate in vitro [J]
295. Antitumor potential of Berberine and cinnamic acid against solid Ehrlich carcinoma in mice
296. Antiurolithic effect of Berberine is mediated through multiple pathways
297. Antiviral activity of Berberine and related compounds against human cytomegalovirus
298. Anxiolytic effect of Berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors
299. Apoptosis of B16 melanoma cells induced by Berberine α-hydroxy-β-decanoylethyl sulfonate [J]
300. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by Berberine through the activation of caspase-3
301. Apoptosis of MDA-MB-231 cells induced by Berberine alpha-hydroxy beta-decanoylethyl sulfonate
302. Application of 1H-NMR spectroscopy to validation of Berberine alkaloid reagents and to chemical evaluation of Coptidis Rhizoma
303. Application of Berberine on treating type 2 diabetes mellitus
304. Application of metabolomics in treating polycystic ovary syndrome with Berberine based on ultra high performance liquid chromatography-mass spectrometry
305. Application of Orthogonal Test to the Experiment for the Students of the Extraction of Berberine in the Rhizoma Coptidis
306. Application of Thermal Analysis Technology for Berberine Hydrochloride
307. Application of thermochromism in spectrophotometric analysis: Selective determination of Berberine in pharmaceuticals by solvent extraction
308. Application of uniform design for preparation of Berberine hydrochloride liposomes
309. Application of xanthene derivatives for analytical chemistry. Part 44. Spectrophotometric determination of Berberine chloride in pharmaceutical preparations.
310. Berberine _for_removal_of_bioaerosols/links/55ab746b08aea994672425b2/Applied-the-filter-pretreated-with-Berberine -for-removal-of-bioaerosols.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Chin-Hsiang_Luo/publication/237505345_Applied_the_filter_pretreated_with_Berberine _for_removal_of_bioaerosols/links/55ab746b08aea994672425b2/Applied-the-filter-pretreated-with-Berberine -for-removal-of-bioaerosols.pdf&source=gmail&ust=1581476863133000&usg=AFQjCNHwA1eouCKliW554I_o2pH05ew2FA”>Applied the filter pretreated with Berberine for removal of bioaerosols
311. Applying the Berberine -Pretreated Filter for Inactivating Bioaerosols
312. Approaches to improve the oral bioavailability and effects of novel anticancer drugs Berberine and betulinic acid
313. Aptamer‐functionalized Fe3O4 magnetic nanoparticles as a solid‐phase extraction adsorbent for the selective extraction of Berberine from Cortex phellodendri
314. Aromatization within the putative bio-medical action mechanism of Berberine and related cationic alkaloids with double iso-quinolinoid skeleton. A theoretical study
315. ART. LXVI.–ON Berberine
316. ART. LXVIII.–ON THE OCCURRENCE OF Berberine IN THE ROOT OF THE BARBERRY AND COLUMBO
317. Article Details Development and Validation of Stability Indicating RP-HPLC Method for the Simultaneous Determination of Berberine and Curcumin in an Ayurvedic …
318. Assay of Berberine Hydrochloride in Huanglian Xiaoke Capsules by HPLC
319. Assay of Berberine hydrochloride in Sanhuang Tablets by HPLC
320. Assessing the impact on aqueous solubility of Berberine chloride via co-crystallization with different stoichiometric ratios of pyromellitic dianhydride
321. Assessment of Berberine as a multi-target antimicrobial: a multi-omics study for drug discovery and repositioning
322. ASSESSMENT OF LEARNING AND MEMORY IN INTRAHIPPOCAMPAL KAINATE EPILEPTIC RATS FOLLOWING Berberine ADMINISTRATION
323. Assimilation of Berberine and chelidoxanthine by bacteria
324. Assimilation of Berberine by bacteria
325. Association of Berberine into hydrogel as drug delivery system
326. Astaxanthin plus Berberine : a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome
327. Astaxanthin/Berberine /folic acid/monascus/policosanol/ubidecarenone/rosuvastatin/sertraline interaction
328. Atherosclerotic Rat Model After a High-Fat, High-Sucrose Diet: Protective Role of Quercetin, O-Coumaric, and Berberine
329. Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug Berberine
330. Attenuation of Berberine on lipopolysaccharide-induced inflammatory and apoptosis responses in β-cells via TLR4-independent JNK/NF-κB pathway
331. Automated Online-SPE-HPLC for Rapid Determination of the Content of Berberine in the Chinese Traditional Medicine Compound [J]
332. B-125, a novel Berberine derivative, acts as a better retinoid X receptor a agonist with stronger anti-tumor activity in colon cancer
333. Bacteriostasis test of Berberine and compound Rhizoma coptidis injection on mastitis
334. Bacteriostatic effect of Berberine on rabbit mastitis pathogens
335. Bacterium endotoxin test of medical macrogol 400 Berberine hydrochloride
336. Bacterium endotoxin test of medical macrogol 400 Berberine hydrochloride [J]
337. Baekjeolyusin‐tang and its active component Berberine block the release of collagen and proteoglycan from IL‐1β‐stimulated rabbit cartilage and down‐regulate …
338. Baicalin and Berberine ultradeformable vesicles as potential adjuvant in vitiligo therapy
339. Batch Time Course Behaviors of Growth and Berberine Production in Plant Cell Suspension Cultures of Tlurlictrum rugosum.
340. Behavioral pharmacology of Berberine -type alkaloids.(1) Central depressive action of Coptidis rhizoma and its constituents
341. Behavioral pharmacology of Berberine -type alkaloids.(2) Central depressant effects of tetrahydroBerberine (THB) and related compounds
342. Beneficial effect of Berberine on atherosclerosis based on attenuating vascular inflammation and calcification
343. Beneficial effect of Berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXRα and PPARα transcriptional programs
344. Beneficial effects of Berberine on hemodynamics during acute ischemic left ventricular failure in dogs.
345. Beneficial Effects of Berberine on Nonalcoholic Fatty Liver Disease (NAFLD)
346. Beneficial effects of Berberine on oxidized LDL-induced cytotoxicity to human retinal Müller cells
347. Benzenediol-Berberine hybrids: Multifunctional agents for Alzheimer’s disease
348. Berberine
349. Berberine – a novel approach to cholesterol lowering: KONG W, WEI J, ABIDI P et al.: Berberine is a novel cholesterol-lowering drug working through a unique mechanism …
350. Berberine (BBR) Attenuated Palmitic Acid (PA)-Induced Lipotoxicity in Human HK-2 Cells by Promoting Peroxisome Proliferator-Activated Receptor a (PPAR …
351. Berberine _A_POTENT_SUBSTANCE_FOR_RESEARCHER_A_REVIEW/links/559a66aa08ae21086d25fa3b/Berberine -A-POTENT-SUBSTANCE-FOR-RESEARCHER-A-REVIEW.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Shardendu_Mishra/publication/279763833_Berberine _A_POTENT_SUBSTANCE_FOR_RESEARCHER_A_REVIEW/links/559a66aa08ae21086d25fa3b/Berberine -A-POTENT-SUBSTANCE-FOR-RESEARCHER-A-REVIEW.pdf&source=gmail&ust=1581476863137000&usg=AFQjCNHKeLXRM5FtOeEf0Se23yRfB6FPmQ”>Berberine A POTENT SUBSTANCE FOR RESEARCHER: A
352. Berberine Accelerates Odontoblast Differentiation by Wnt/β-Catenin Activation
353. Berberine action targets and its absorption behavior: how to use old drug for new mechanisms
354. Berberine Activates AMPK and Inhibits 3T3-L1 Adipocyte Differentiation
355. Berberine Activates AMPK in L6 Myotubes by a Mechanism Other Than Via Changes in ATP Levels.
356. Berberine activates AMPK to suppress proteolytic processing, nuclear translocation and target DNA binding of SREBP-1c in 3T3-L1 adipocytes
357. Berberine activates aryl hydrocarbon receptor but suppresses CYP1A1 induction through miR-21-3p stimulation in MCF-7 breast cancer cells
358. Berberine activates bitter taste responses of enteroendocrine STC-1 cells
359. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo
360. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes
361. Berberine activates Nrf2 nuclear translocation and inhibits apoptosis induced by high glucose in renal tubular epithelial cells through a phosphatidylinositol 3-kinase …
362. Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor …
363. Berberine activates peroxisome proliferator‐activated receptor gamma to increase atherosclerotic plaque stability in Apoe−/− mice with hyperhomocysteinemia
364. Berberine activates thermogenesis in white and brown adipose tissue
365. Berberine activates volume-sensitive chloride channel in human colorectal carcinoma cells
366. Berberine acts as a natural inhibitor of Wnt/β‐catenin signaling—Identification of more active 13‐arylalkyl derivatives
367. Berberine Acts As A Novel Autophagy Blocker To Protect Human müLler Cell From 4-hne Induced Cell Death
368. Berberine acts as a putative epigenetic modulator by affecting the histone code
369. Berberine acutely activates the glucose transport activity of GLUT1
370. Berberine acutely inhibits insulin secretion from β-cells through 3′, 5′-cyclic adenosine 5′-monophosphate signaling pathway
371. Berberine acutely inhibits the digestion of maltose in the intestine
372. Berberine adsorption at a mercury electrode
373. Berberine affects osteosarcoma via downregulating the caspase-1/IL-1β signaling axis
374. Berberine against gastrointestinal peptides elevation and mucous secretion in hyperthyroid diarrheic rats
375. Berberine Alkaloid as a Medicament for Prophylaxis and Treatment of Alzheimer’s Disease
376. Berberine alkaloid as a sensitive fluorescent probe for bile salt aggregates
377. Berberine alkaloid: Quantum chemical study of different forms by the DFT and MP2 methods
378. Berberine Alkaloids via 6, 7-Dimethoxy iso quinoline-l-aldoxime
379. Berberine alleviates adipose tissue fibrosis by inducing AMP-activated kinase signaling in high-fat diet-induced obese mice
380. Berberine alleviates amyloid beta-induced injury in Alzheimer’s disease by miR-107/ZNF217
381. Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors
382. Berberine Alleviates Amyloid β-Induced Mitochondrial Dysfunction and Synaptic Loss
383. Berberine Alleviates Amyloid-beta Pathogenesis Via Activating LKB1/AMPK Signaling in the Brain of APP/PS1 Transgenic Mice
384. Berberine alleviates amyloid-beta pathology in the brain of APP/PS1 transgenic mice via inhibiting β/γ-secretases activity and enhancing α-secretases
385. Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes
386. Berberine alleviates chronic inflammation of mouse model of type 2 diabetes by adjusting intestinal microbes and inhibiting TLR4 signaling pathway
387. Berberine alleviates dextran sodium sulfate‑induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress
388. Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS
389. Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C δ pathway
390. Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice
391. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids
392. Berberine alleviates ischemic arrhythmias via recovering depressed Ito and ICa currents in diabetic rats
393. Berberine alleviates ischemic arrhythmias via recovering depressed Iₜₒ and ICₐ currents in diabetic rats
394. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3
395. Berberine Alleviates Olanzapine-Induced Adipogenesis via the AMPKα–SREBP Pathway in 3T3-L1 Cells
396. Berberine alleviates oxidative stress in islets of diabetic mice by inhibiting mir‐106b expression and up‐regulating sirt1
397. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK …
398. Berberine alleviates oxidized low‐density lipoprotein‐induced macrophage activation by downregulating galectin‐3 via the NF‐κB and AMPK signaling pathways
399. Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway
400. Berberine alleviates paclitaxel-induced neuropathy
401. Berberine alleviates preeclampsia possibly by regulating the expression of interleukin-2/interleukin-10 and Bcl-2/Bax
402. Berberine _alleviates_rotenone_induced_cytotoxicity.7.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/neuroreport/Fulltext/2020/01010/Berberine _alleviates_rotenone_induced_cytotoxicity.7.aspx&source=gmail&ust=1581476863141000&usg=AFQjCNFob7BYoMCZGFVMTBK-8_vuxpuB9g”>Berberine alleviates rotenone-induced cytotoxicity by antioxidation and activation of PI3K/Akt signaling pathway in SH-SY5Y cells
403. Berberine alleviates symptoms of anxiety by enhancing dopamine expression in rats with post-traumatic stress disorder
404. Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3 β Pathway
405. Berberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca 2+ handling in smooth …
406. Berberine Alone and in Conjunction With Immunomodulators Down-regulates Pro-inflammatory CD4+ T-Cells: Implications for a Combined Treatment of Inflammatory …
407. Berberine alters epigenetic modifications, disrupts microtubule network, and modulates HPV-18 E6–E7 oncoproteins by targeting p53 in cervical cancer cell HeLa: a …
408. Berberine alters the processing of Alzheimer’s amyloid precursor protein to decrease Aβ secretion
409. Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats
410. Berberine ameliorates allodynia induced by chronic constriction injury of the sciatic nerve in rats
411. Berberine ameliorates blockade of autophagic flux in the liver by regulating cholesterol metabolism and inhibiting COX2-prostaglandin synthesis
412. Berberine ameliorates brain inflammation in poloxamer 407-induced hyperlipidemic rats
413. Berberine ameliorates cartilage degeneration in interleukin‐1β‐stimulated rat chondrocytes and in a rat model of osteoarthritis via Akt signalling
414. Berberine ameliorates cellular senescence and extends the lifespan of mice via regulating p16 and cyclin protein expression
415. Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NFκB signaling pathway in rats
416. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses
417. Berberine Ameliorates Chronic Ulcerative Colitis Through Suppressing Oncostatin M-Driven Mucosal Inflammation
418. Berberine ameliorates chronic unpredictable mild stress induced depression like behaviors and elevating kelch-like erythroid cell-derived protein with CNC …
419. Berberine ameliorates chronic unpredictable mild stress induced depressive like behaviors and elevating Keap1-Nrf2 antioxidant signaling pathways
420. Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy
421. Berberine ameliorates collagen-induced arthritis in rats associated with anti-inflammatory and anti-angiogenic effects
422. Berberine ameliorates collagen‐induced arthritis in rats by suppressing Th17 cell responses via inducing cortistatin in the gut
423. Berberine ameliorates colonic damage accompanied with the modulation of dysfunctional bacteria and functions in ulcerative colitis rats
424. Berberine ameliorates COX-2 expression in rat small intestinal mucosa partially through PPARγ pathway during acute endotoxemia
425. Berberine ameliorates diabetes-associated cognitive decline through modulation of aberrant inflammation response and insulin signaling pathway in DM rats
426. Berberine ameliorates diabetic mouse renal injury through inhibition of SphK1-S1P signaling pathway
427. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway
428. Berberine ameliorates diabetic neuropathic pain in a rat model: involvement of oxidative stress, inflammation, and μ-opioid receptors
429. Berberine ameliorates diabetic neuropathy: TRPV1 modulation by PKC pathway
430. Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway
431. Berberine ameliorates experimental autoimmune neuritis by suppressing both cellular and humoral immunity
432. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling
433. Berberine ameliorates experimental varicocele‐induced damages at testis and sperm levels; evidences for oxidative stress and inflammation
434. Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells
435. Berberine ameliorates hepatic steatosis and suppresses liver and adipose tissue inflammation in obesity mice independent of AMPK
436. Berberine ameliorates high glucose-induced cardiomyocyte injury via AMPK signaling activation to stimulate mitochondrial biogenesis and restore autophagic flux
437. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway
438. Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway
439. Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention
440. Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia
441. Berberine ameliorates intestinal mucosal barrier damage induced by peritoneal air exposure
442. Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: Underlying mechanisms
443. Berberine ameliorates lipid accumulation of mouse primary hepatocytes by decreasing fatty acids uptake
444. Berberine ameliorates lipopolysaccharide‐induced acute lung injury via the PERK‐mediated Nrf2/HO‐1 signaling axis
445. Berberine ameliorates lipopolysaccharide‑induced inflammatory responses in mouse inner medullary collecting duct‑3 cells by downregulation of NF‑κB …
446. Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms
447. Berberine Ameliorates MCAO Induced Cerebral Ischemia/Reperfusion Injury via Activation of the BDNF–TrkB–PI3K/Akt Signaling Pathway
448. Berberine ameliorates methotrexate-induced liver injury by activating Nrf2/HO-1 pathway and PPARγ, and suppressing oxidative stress and apoptosis in rats
449. Berberine ameliorates neonatal necrotizing enterocolitis by activating the phosphoinositide 3-kinase/protein kinase B signaling pathway
450. Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
451. Berberine ameliorates non‑alcoholic steatohepatitis in ApoE-/-mice
452. Berberine ameliorates nonbacterial prostatitis via multi-target metabolic network regulation
453. Berberine ameliorates non‐steroidal anti‐inflammatory drugs‐induced intestinal injury by the repair of enteric nervous system
454. Berberine ameliorates oxidative stress-induced apoptosis by modulating ER stress and autophagy in human nucleus pulposus cells
455. Berberine ameliorates periodontal bone loss by regulating gut microbiota
456. Berberine Ameliorates Pro-inflammatory Cytokine-Induced Endoplasmic Reticulum Stress in Human Intestinal Epithelial Cells In Vitro
457. Berberine AMELIORATES PULMONARY INJURY INDUCED BY ISCHEMIC ACUTE RENAL FAILURE IN RAT
458. Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3‐kinase–protein kinase B pathway in diabetic rats
459. Berberine ameliorates renal injury by regulating G proteins-AC-cAMP signaling in diabetic rats with nephropathy
460. Berberine ameliorates renal injury in a rat model of D‐galactose-induced aging through a PTEN/Akt-dependent mechanism
461. Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK–S1P signaling pathway
462. Berberine Ameliorates Renal injury in Diabetic Nephropathy Rats
463. Berberine _ameliorates_renal_injury_in.9.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/cmj/Fulltext/2008/04020/Berberine _ameliorates_renal_injury_in.9.aspx&source=gmail&ust=1581476863146000&usg=AFQjCNHBooAAxCFNNukTZ0yOOw0_VnyHPw”>Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase
464. Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats
465. Berberine AMELIORATES RENAL ISCHEMIA/REPERFUSION INJURY IN RATS
466. Berberine ameliorates severe acute pancreatitis‑induced intestinal barrier dysfunction via a myosin light chain phosphorylation‑dependent pathway
467. Berberine ameliorates spatial learning memory impairment and modulates cholinergic anti-inflammatory pathway in diabetic rats
468. Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation
469. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation
470. Berberine ameliorates type 2 diabetes via modulation of Bifidobacterium species, tumor necrosis factor‐alpha, and lipopolysaccharide
471. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer’s disease transgenic mouse model
472. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux
473. Berberine Analogue Y53 has Improved Antioxidant and Anti-Inflammatory Activities in Diabetic C57BL/6J Mice with Liver Steatosis
474. Berberine Analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure− activity relationships, and cholesterol-lowering …
475. Berberine and a Berberis lycium extract inactivate Cdc25A and induce α-tubulin acetylation that correlate with HL-60 cell cycle inhibition and apoptosis
476. Berberine and amitozine binding with calf thymus DNA
477. Berberine and barberry (Berberis vulgaris): A clinical review
478. Berberine and Berberine -Containing Plants in Pharmacology and Therapeutics
479. Berberine and chemotherapeutic drugs synergistically inhibits cell proliferation and migration of breast cancer cells
480. Berberine and chloramphenicol in the treatment of cholera and severe diarrhoea.
481. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations
482. Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives
483. Berberine and coptisine free bases
484. Berberine and coptisine in liquid ammonia
485. Berberine and Dyslipidemia: Different Applications and Biopharmaceutical Formulations Without Statin-Like Molecules—A Meta-Analysis
486. Berberine and evodiamine act synergistically against human breast cancer MCF-7 cells by inducing cell cycle arrest and apoptosis
487. Berberine and evodiamine influence serotonin transporter (5-HTT) expression via the 5-HTT-linked polymorphic region
488. Berberine and inflammatory bowel disease: A concise review
489. Berberine and itraconazole are not synergistic in vitro against Aspergillus fumigatus isolated from clinical patients
490. Berberine and its derivatives: a patent review (2009–2012)
491. Berberine and its metabolites: relationship between physicochemical properties and plasma levels after administration to human subjects
492. Berberine and its molecular mechanisms in inhibiting the growth of renal carcinoma cell line ACHN.
493. Berberine and its more biologically available derivative, dihydroBerberine , inhibit mitochondrial respiratory complex I: a mechanism for the action of Berberine to …
494. Berberine and its role in chronic disease
495. Berberine and limonin suppress IgE production by human B cells and peripheral blood mononuclear cells from food-allergic patients
496. Berberine and lycopene profiling during the ontogeny of Tinospora cordifolia (Willd.) Miers ex Hook. F. & Thoms fruit
497. Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia
498. Berberine and musculoskeletal disorders: the therapeutic potential and underlying molecular mechanisms
499. Berberine and neurodegeneration: A review of literature
500. Berberine and palmatine inhibit the growth of human rhabdomyosarcoma cells
501. Berberine and Pentoxifylline: A novel combination in amelioration of acute kidney injury
502. Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters
503. Berberine and S allyl cysteine mediated amelioration of DEN+ CCl4 induced hepatocarcinoma
504. Berberine and Sanguinarine quantitation in Argemone mexicana L. (Papaveraceae) tissues by TLC-in situ fluorography
505. Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific pathways
506. Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease
507. Berberine and zinc oxide-based nanoparticles for the chemo-photothermal therapy of lung adenocarcinoma
508. Berberine antifungal activity in fluconazole-resistant pathogenic yeasts: action mechanism evaluated by flow cytometry and biofilm growth inhibition in Candida spp.
509. Berberine as a chemical and pharmacokinetic marker of the butanol-extracted food allergy herbal formula-2
510. Berberine as a factor in the resistance of Mahonia trifoliolata and M. swaseyi to Phymatotrichum root rot
511. Berberine as a natural compound inhibits the development of brown rot fungus Monilinia fructicola
512. Berberine as a natural source inhibitor for mild steel in 1 M H2SO4
513. Berberine as a natural source inhibitor for mild steel in 1 MH {sub 2} SO {sub 4}
514. Berberine as a novel light-up i-motif fluorescence ligand and its application in designing molecular logic systems
515. Berberine as a Photosensitizing Agent for Antitumoral
516. Berberine as a photosensitizing agent for antitumoral photodynamic therapy: Insights into its association to low density lipoproteins
517. Berberine as a potential autophagy modulator
518. Berberine as a potential therapeutic agent in the treatment of acute pancreatitis
519. Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms
520. Berberine as a promising safe anti-cancer agent-is there a role for mitochondria?
521. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies
522. Berberine as an Adjuvant and Sensitizer to Current Chemotherapy
523. Berberine as an Environmental-Friendly Inhibitor for Hot-Dip Coated Steels in Diluted Hydrochloric Acid
524. Berberine -as-source-of-antiproliferative-hybrid-compounds-in-vitr” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://investigadores.unison.mx/en/publications/Berberine -as-source-of-antiproliferative-hybrid-compounds-in-vitr&source=gmail&ust=1581476863149000&usg=AFQjCNEutU2t3gl61Ppt232DAdSIqcTuiA”>Berberine as Source of Antiproliferative Hybrid Compounds: In vitro Antiproliferative Activity and Quantitative Structure-Activity Relationship. Anticancer Agents. Med …
525. Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells
526. Berberine attenuate staphylococcal enterotoxin B-mediated acute liver injury via regulating HDAC expression
527. Berberine attenuated aging-accelerating effect of high temperature in Drosophila model
528. Berberine Attenuated Oxidative Stress Induced by Sodium Nitrite in Rat Liver
529. Berberine attenuated pro-inflammatory factors and protect against neuronal damage via triggering oligodendrocyte autophagy in spinal cord injury
530. Berberine attenuated proliferation, invasion and migration by targeting the AMPK/HNF4α/WNT5A pathway in gastric carcinoma
531. Berberine attenuated the cytotoxicity induced by t-BHP via inhibiting oxidative stress and mitochondria dysfunction in PC-12 cells
532. Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy
533. Berberine attenuates apoptosis in rat retinal Müller cells stimulated with high glucose via enhancing autophagy and the AMPK/mTOR signaling
534. Berberine attenuates arthritis in adjuvant-induced arthritic rats associated with regulating polarization of macrophages through AMPK/NF-кB pathway
535. Berberine attenuates autophagy in adipocytes by targeting BECN1
536. Berberine attenuates axonal transport impairment and axonopathy induced by calyculin a in N2a cells
537. Berberine attenuates Aβ25-35-induced apoptosis in primary cultured hippocampal neurons.
538. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study
539. Berberine attenuates calyculin A-induced cytotoxicity and Tau hyperphosphorylation in HEK293 cells
540. Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes
541. Berberine -attenuates-cancer-cell-growth-via-modulating-the-cell-cycle-dynamics-but-not-apoptosis-in-human-colorectal-HCT-116-3D-spheroid-model-converted.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://jbaar.org/wp-content/uploads/2019/07/Berberine -attenuates-cancer-cell-growth-via-modulating-the-cell-cycle-dynamics-but-not-apoptosis-in-human-colorectal-HCT-116-3D-spheroid-model-converted.pdf&source=gmail&ust=1581476863150000&usg=AFQjCNHBrQ6x6VbkE2s_vM_gHIkEIbVVMQ”>Berberine attenuates cancer cell growth via modulating the cell cycle dynamics but not apoptosis in human colorectal HCT-116 3D spheroid model
542. Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats
543. Berberine attenuates CCN2-induced IL-1β expression and prevents cartilage degradation in a rat model of osteoarthritis
544. Berberine attenuates cerebral ischemia-reperfusion injury via activating PI3K-Akt signaling in a rat model of type 2 diabetes
545. Berberine _Attenuates_Cholesterol_Accumulation_in.98488.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/cardiovascularpharm/Abstract/publishahead/Berberine _Attenuates_Cholesterol_Accumulation_in.98488.aspx&source=gmail&ust=1581476863151000&usg=AFQjCNFSw-6_OdDeOG7LJCrQa629SxcEPQ”>Berberine Attenuates Cholesterol Accumulation in Macrophage Foam Cells via Suppressing AP-1 Activity and Activation of Nrf2/HO-1 Pathway
546. Berberine Attenuates Cigarette Smoke Extract-induced Airway Inflammation in Mice: Involvement of TGF-β1/Smads Signaling Pathway
547. Berberine attenuates cigarette smoke-induced acute lung inflammation
548. Berberine attenuates cigarette smoke-induced airway inflammation and mucus hypersecretion in mice
549. Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling …
550. Berberine attenuates convulsing behavior and extracellular glutamate and aspartate changes in 4-aminopyridine treated rats
551. Berberine attenuates depressive-like behaviors by suppressing neuro-inflammation in stressed mice
552. Berberine attenuates development of the hepatic gluconeogenesis and lipid metabolism disorder in type 2 diabetic mice and in palmitate-incubated HepG2 …
553. Berberine attenuates doxorubicin-induced cardiotoxicity in mice
554. Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice
555. Berberine attenuates hepatic oxidative stress in rats with non‑alcoholic fatty liver disease via the Nrf2/ARE signalling pathway
556. Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21
557. Berberine attenuates high glucose-induced fibrosis by activating the G protein-coupled bile acid receptor TGR5 and repressing the S1P2/MAPK signaling pathway in …
558. Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression …
559. Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice
560. Berberine Attenuates Hyperlipidemia in Mice by a Novel Underlying Mechanism Involving Trib1
561. Berberine attenuates hypoxia‐induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor‐β signaling
562. Berberine attenuates impairment of intestinal glutamine transport in sepsis
563. Berberine attenuates intestinal disaccharidases in streptozotocin-induced diabetic rats
564. Berberine attenuates intestinal mucosal barrier dysfunction in type 2 diabetic rats
565. Berberine attenuates ischemia–reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation
566. Berberine attenuates ischemia-reperfusion injury via regulation of adenosine-5′-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat …
567. Berberine attenuates isoniazid-induced hepatotoxicity by modulating peroxisome proliferator-activated receptor gamma, oxidative stress and inflammation
568. Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway
569. Berberine attenuates lipopolysaccharide-induced impairments of intestinal glutamine transport and glutaminase activity in rat
570. Berberine attenuates macrophages infiltration in intracranial aneurysms potentially through FAK/Grp78/UPR axis
571. Berberine attenuates myocardial ischemia reperfusion injury by suppressing the activation of PI3K/AKT signaling
572. Berberine attenuates myocardial ischemia/reperfusion injury by reducing oxidative stress and inflammation response: role of silent information regulator 1
573. Berberine Attenuates NLRP3 Inflammasome Activation in Macrophages to Reduce the Secretion of Interleukin-1β
574. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway
575. Berberine _attenuates_olanzapine_induced-metabolic_syndrome/links/5d9b92cd92851c2f70f3fd1f/Berberine -attenuates-olanzapine-induced-metabolic-syndrome.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Hayder_Al-Kuraishy/publication/336315641_Berberine _attenuates_olanzapine_induced-metabolic_syndrome/links/5d9b92cd92851c2f70f3fd1f/Berberine -attenuates-olanzapine-induced-metabolic-syndrome.pdf&source=gmail&ust=1581476863152000&usg=AFQjCNEpkcZ700LoPaLjXZeZIOnKuNVvEw”>Berberine attenuates olanzapine induced-metabolic syndrome
576. Berberine attenuates oxidative stress and hepatocytes apoptosis via protecting mitochondria in blunt snout bream Megalobrama amblycephala fed high-fat diets
577. Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway
578. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cells
579. Berberine attenuates pulmonary arterial hypertension via protein phosphatase 2A signaling pathway both in vivo and in vitro
580. Berberine attenuates sodium palmitate-induced lipid accumulation, oxidative stress and apoptosis in grass carp (Ctenopharyngodon idella) hepatocyte in vitro
581. Berberine attenuates the acute pancreatitis induced by Dibutyltin dichloride (DBTC) in albino Wistar rats
582. Berberine attenuates vascular remodeling and inflammation in a rat model of metabolic syndrome
583. Berberine attenuates XRCC1‐mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs
584. Berberine augments ATP-induced inflammasome activation in macrophages by enhancing AMPK signaling
585. Berberine augments for TRAIL-induced apoptosis of leukemic cells
586. Berberine Averts Formation of Azoxymethane Induced Colonic Preneoplastic Lesions in Rats
587. Berberine azoles as antimicrobial agents: synthesis, biological evaluation and their interactions with human serum albumin
588. Berberine behind the thriller of marked symptomatic bradycardia
589. Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells
590. Berberine bioisostere Q8 compound stimulates osteoblast differentiation and function in vitro
591. Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment
592. Berberine _bridge_enzyme_and_the_family_of_bicovalent_flavoenzymes/links/57c5a22808ae6db2cc769e24/Berberine -bridge-enzyme-and-the-family-of-bicovalent-flavoenzymes.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Peter_Macheroux/publication/285740438_Berberine _bridge_enzyme_and_the_family_of_bicovalent_flavoenzymes/links/57c5a22808ae6db2cc769e24/Berberine -bridge-enzyme-and-the-family-of-bicovalent-flavoenzymes.pdf&source=gmail&ust=1581476863154000&usg=AFQjCNHEPuH-vWUelmYbRw4neqAkawAqDQ”>Berberine bridge enzyme and the family of bicovalent flavoenzymes
593. Berberine bridge enzyme catalyzes the six electron oxidation of (S)-reticuline to dehydroscoulerine
594. Berberine bridge enzyme, a key branch-point enzyme in benzylisoquinoline alkaloid biosynthesis, contains a vacuolar sorting determinant
595. Berberine -bridge-enzyme-like-proteins-a-multi-gene-family-from-va” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://graz.pure.elsevier.com/en/publications/Berberine -bridge-enzyme-like-proteins-a-multi-gene-family-from-va&source=gmail&ust=1581476863154000&usg=AFQjCNFxGIQO5qw8SBlI-EGmziU_Zhx_zQ”>Berberine bridge enzyme-like proteins: a multi-gene family from vascular plants
596. Berberine can reduce calyculin A-induced tau hyperphosphorylation by inhibiting GSK-3β in HEK293/tau cell
597. Berberine cation: A fluorescent chemosensor for alkanes and other low-polarity compounds. An explanation of this phenomenon
598. Berberine chloride ameliorated PI3K/Akt‐p/SIRT‐1/PTEN signaling pathway in insulin resistance syndrome induced in rats
599. Berberine chloride ameliorates oxidative stress, inflammation and apoptosis in the pancreas of Streptozotocin induced diabetic rats
600. Berberine chloride an isoquinoline alkaloid induces cytotoxicity in cultured HeLa Cells
601. Berberine Chloride and Hyperthermia Promote Osterix Expression and Suppress Cell Cycle Genes in Osteosarcoma Cells
602. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the …
603. Berberine chloride causes a caspase-independent, apoptotic-like death in Leishmania donovani promastigotes
604. Berberine chloride improved synaptic plasticity in STZ induced diabetic rats
605. Berberine -chloride-induced-apoptosis-in-hepg2-cancer-cell-line-via-ppar-gamma-activation-and-cox2-inhibition-by-regulating-prostaglandin-e2-pge2-signalling-pathway/?view=fulltext” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://ijpsr.com/bft-article/Berberine -chloride-induced-apoptosis-in-hepg2-cancer-cell-line-via-ppar-gamma-activation-and-cox2-inhibition-by-regulating-prostaglandin-e2-pge2-signalling-pathway/?view%3Dfulltext&source=gmail&ust=1581476863154000&usg=AFQjCNEWxabvZkM7yEvtXJ3IrohetLQpzg”>Berberine CHLORIDE INDUCED APOPTOSIS IN HEPG2 CANCER CELL LINE VIA PPAR GAMMA ACTIVATION AND COX2 INHIBITION BY REGULATING …
606. Berberine chloride mediates its antileishmanial activity by inhibiting Leishmania mitochondria
607. Berberine chloride mediates its anti-leishmanial activity via differential regulation of the mitogen activated protein kinase pathway in macrophages
608. Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat
609. Berberine coated mannosylated liposomes curtail RANKL stimulated osteoclastogenesis through the modulation of GSK3β pathway via upregulating miR-23a
610. Berberine combined with 2-deoxy-d-glucose synergistically enhances cancer cell proliferation inhibition via energy depletion and unfolded protein response …
611. Berberine combined with atorvastatin downregulates LOX‑1 expression through the ET‑1 receptor in monocyte/macrophages
612. Berberine combined with stachyose induces better glycometabolism than Berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice
613. Berberine Combined with Triple Therapy versus Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials
614. Berberine complexes with DNA in the Berberine -induced apoptosis in human leukemic HL-60 cells
615. Berberine confers neuroprotection in coping with focal cerebral ischemia by targeting inflammatory cytokines
616. Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial.
617. Berberine content in Coscinium fenestratum (Gaertn.) Colebr grown in Sri Lanka
618. Berberine contents and alkaloid profile of Berberis species from different altitudes
619. Berberine Contents from Different Parts of five Barberry (Berberis L.)[J]
620. Berberine Contents in Coptis chinensis and Phellodenron chinense before and after Processing Tested with Capillary Zone Electrophoresis [J]
621. Berberine cooperates with adrenal androgen dehydroepiandrosterone sulfate to attenuate PDGF-induced proliferation of vascular smooth muscle cell A7r5 through …
622. Berberine could ameliorate cardiac dysfunction via interfering myocardial lipidomic profiles in the rat model of diabetic cardiomyopathy
623. Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK …
624. Berberine counteracts enhanced IL-8 expression of AGS cells induced by evodiamine
625. Berberine decelerates glucose metabolism via suppression of mTOR‑dependent HIF‑1α protein synthesis in colon cancer cells
626. Berberine decreased inducible nitric oxide synthase mRNA stability through negative regulation of human antigen R in lipopolysaccharide-induced macrophages
627. Berberine decreased iNOS mRNA stability through negative regulation of HuR in LPS-induced macrophages
628. Berberine decreased N-acetylation of 2-aminofluorene through inhibition of N-acetyltransferase gene expression in human leukemia HL-60 cells
629. Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption
630. Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways
631. Berberine decreases PCSK9 expression in HepG2 cells
632. Berberine Decreases Plasma Lipids and Liver Weight in Hypercholesterolemic Rats
633. Berberine decreases plasma triglyceride levels and upregulates hepatic TRIB1 in LDLR wild type mice and in LDLR deficient mice
634. Berberine delays onset of collagen induced arthritis through T cell suppression
635. Berberine demonstrates anti‐inflammatory properties in Helicobacter pylori‐infected mice with chronic gastritis by attenuating the Th17 response triggered by the B …
636. Berberine depresses contraction of smooth muscle via inhibiting myosin light-chain kinase
637. Berberine derivative, Q8, stimulates osteogenic differentiation
638. Berberine derivatives as antileishmanial drugs.
639. Berberine derivatives as cationic fluorescent probes for the investigation of the energized state of mitochondria
640. Berberine derivatives as heteroatom induced hydrophobic sensor: An analytical approach for the selective and sensitive fluorometric detection and discrimination of …
641. Berberine Derivatives as Multi-Kinase Inhibitors of MAP Kinase and PI3K Pathways: Molecular Modelling, Molecular Dynamics Simulations, and in vitro Evaluation
642. Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE−/− mice
643. Berberine derivatives with different pharmacological activities via structural modifications
644. Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase
645. Berberine detection based on a fluorescent conjugated polyelectrolyte
646. Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice
647. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2
648. Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells
649. Berberine directly affects the gut microbiota to promote intestinal farnesoid x receptor activation
650. Berberine displays antitumor activity in esophageal cancer cells in vitro
651. Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes
652. Berberine down-regulates cellular JNK and NF-κB activation and this may result in an inhibition of HSV replication
653. Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells
654. Berberine down-regulates the Th1/Th2 cytokine gene expression ratio in mouse primary splenocytes in the absence or presence of lipopolysaccharide in a preventive …
655. Berberine dyeing of acrylic fibers [J]
656. Berberine Effect of Anti-microbiota-Possibility and Clinical Significance on Gut Microbiota and Metabolism: A Review
657. Berberine Effects on NFΚB, HIF1A and NFE2L2/AP-1 Pathways in HeLa Cells
658. Berberine elicits anti‐arrhythmic effects via IK1/Kir2. 1 in the rat type 2 diabetic myocardial infarction model
659. Berberine encapsulated PLGA-PEG nanoparticles modulate PCSK-9 in HepG2 Cells
660. Berberine enhances antidiabetic effects and attenuates untoward effects of canagliflozin in streptozotocin-induced diabetic mice
661. Berberine enhances chemosensitivity and induces apoptosis through dose-orchestrated AMPK signaling in breast cancer
662. Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NF‑κB
663. Berberine enhances defects in the establishment of leaf polarity in asymmetric leaves1 and asymmetric leaves2 of Arabidopsis thaliana
664. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide
665. Berberine enhances mitomycin C-induced cell cycle arrest and apoptosis of T24 bladder cancer cells
666. Berberine enhances posttranslational protein stability of p21/cip1 in breast cancer cells via down-regulation of Akt
667. Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo
668. Berberine enhances the antibacterial activity of selected antibiotics against coagulase-negative Staphylococcus strains in vitro
669. Berberine enhances the anti‑tumor activity of tamoxifen in drug‑sensitive MCF‑7 and drug‑resistant MCF‑7/TAM cells
670. Berberine enhances the radiosensitivity of hepatoma cells by Nrf2 pathway.
671. Berberine enhances tumor necrosis factor‑related apoptosis‑inducing ligand‑mediated apoptosis in breast cancer
672. Berberine -enhances-ucp1-expression-via-modulating-the-nfe2-respon” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://mdanderson.elsevierpure.com/en/publications/Berberine -enhances-ucp1-expression-via-modulating-the-nfe2-respon&source=gmail&ust=1581476863158000&usg=AFQjCNGjfUhqepIiaAi8yFHEJJp05mmUug”>Berberine enhances Ucp1 expression via modulating the NFE2 response element in cold environments: New perspectives on the thermogenesis in brown adipose …
673. Berberine Exerts a Protective Effect on Gut-Vascular Barrier via the Modulation of the Wnt/Beta-Catenin Signaling Pathway During Sepsis
674. Berberine exerts an anticonvulsant effect and ameliorates memory impairment and oxidative stress in a pilocarpine-induced epilepsy model in the rat
675. Berberine exerts anti-adipogenic activity through up-regulation of C/EBP inhibitors, CHOP and DEC2
676. Berberine exerts antioxidant effects via protection of spiral ganglion cells against cytomegalovirus-induced apoptosis
677. Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and …
678. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: involvement of B-cell …
679. Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy
680. Berberine exhibits antioxidative effects and reduces apoptosis of the vaginal epithelium in bacterial vaginosis
681. Berberine exhibits antitumor effects in human ovarian cancer cells
682. Berberine exposure triggers developmental effects on planarian regeneration
683. Berberine EXTRACTION FROM BARBERRY ROOT: A COMPARISON STUDY BETWEEN SCW AND SCF EXTRACTION TECHNIQUES
684. Berberine Facilitates Angiogenesis Against Ischemic Stroke Through Modulating Microglial Polarization via AMPK Signaling
685. Berberine finishing for developing antimicrobial nylon 66 fibers:% exhaustion, colorimetric analysis, antimicrobial study, and empirical modeling
686. Berberine _for_Diabetes.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://www.tahomaclinic.com/Research/PDFs/Berberine _for_Diabetes.pdf&source=gmail&ust=1581476863159000&usg=AFQjCNHOvrKWMf_YFMvk3O5W-ukVN0JZCw”>Berberine for diabetes mellitus type 2
687. Berberine formate–succinic acid (1/1)
688. Berberine from Argemone mexicana L exhibits broadspectrum antibacterial activity
689. Berberine from roots of Berberis aristata prevents cataract formation in isolated goat eye lens: An In-vitro Study
690. Berberine gel in periodontal inflammation: clinical and histological effects
691. Berberine -one-herb-works-in-many-ways/” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://healthesolutions.com/Berberine -one-herb-works-in-many-ways/&source=gmail&ust=1581476863160000&usg=AFQjCNFebn_rFHgxiM0NZU4bfJ34tNgcxQ”>Berberine Herb Works in Many Ways
692. Berberine hydrochloride as a treatment of oriental sore (a preliminary report).
693. Berberine hydrochloride attenuates cyclooxygenase-2 expression in rat small intestinal mucosa during acute endotoxemia
694. Berberine hydrochloride attenuates lipopolysaccharide-induced endometritis in mice by suppressing activation of NF-κB signal pathway
695. Berberine hydrochloride counteracts enhanced IL-8 expression induced by SN 38 in AGS cells
696. Berberine Hydrochloride for the Prevention of Colorectal Adenomas: A Double-Blind, Randomised Controlled Multicenter Clinical Trial
697. Berberine %20hydrochloride%20hydrate.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://www.kimnfriends.co.kr/pop/0804/Berberine %2520hydrochloride%2520hydrate.pdf&source=gmail&ust=1581476863160000&usg=AFQjCNFPYqliOzz6KPXTrdNDAOmK2MFJlw”>Berberine hydrochloride hydrate
698. Berberine hydrochloride IL-8 dependently inhibits invasion and IL-8-independently promotes cell apoptosis in MDA-MB-231 cells
699. Berberine hydrochloride impact on physiological processes and modulation of twist levels in nasopharyngeal carcinoma CNE-1 cells
700. Berberine hydrochloride improves symptoms in diarrhoea predominant irritable bowel syndrome
701. Berberine hydrochloride in inhibiting expression of proteome of Staphylococcus epidermidis
702. Berberine hydrochloride induces brown adipogenesis
703. Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax …
704. Berberine hydrochloride inhibits formation of Staphylococcus epidermidis biofilm: relative gene expressions
705. Berberine hydrochloride on G6PD enzyme defects in red blood cells of patients [J]
706. Berberine hydrochloride prevents postsurgery intestinal adhesion and inflammation in rats
707. Berberine hydrochloride protects against cytokine-induced inflammation through multiple pathways in undifferentiated C2C12 myoblast cells
708. Berberine hydrochloride protects C2C12 myoblast cells against oxidative stress‐induced damage via induction of Nrf‐2‐mediated HO‐1 expression
709. Berberine Hydrochloride Protects Cytokine-Induced Inflammation through Multiple Pathways
710. Berberine Hydrochloride Reference Standard (Control 001) of National Institute of Health Sciences
711. Berberine hydrochloride reference standard (Control 941) of the National Institute of Health Sciences
712. Berberine hydrochloride: anticancer activity and nanoparticulate delivery system
713. Berberine Hydrochloride-chitosan Slow Releasing Microspheres
714. Berberine hydrochloride-loaded chitosan nanoparticles effectively targets and suppresses human nasopharyngeal carcinoma
715. Berberine impairs embryonic development in vitro and in vivo through oxidative stress‐mediated apoptotic processes
716. Berberine improved Aldo-induced podocyte injury via inhibiting oxidative stress and endoplasmic reticulum stress pathways both in vivo and in vitro
717. Berberine improved experimental chronic colitis by regulating interferon-γ-and IL-17A-producing lamina propria CD4+ T cells through AMPK activation
718. Berberine improves advanced glycation end products‑induced osteogenic differentiation responses in human periodontal ligament stem cells through the …
719. Berberine improves airway inflammation and inhibits NF-κB signaling pathway in an ovalbumin-induced rat model of asthma
720. Berberine improves benign prostatic hyperplasia via suppression of 5 alpha reductase and extracellular signal-regulated kinase in vivo and in vitro
721. Berberine improves cognitive deficiency and muscular dysfunction via activation of the AMPK/SIRT1/PGC-1a pathway in skeletal muscle from naturally aging rats
722. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer’s …
723. Berberine Improves Diabetic Encephalopathy Through the SIRT1/ER Stress Pathway in db/db Mice
724. Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans
725. Berberine improves free-fatty-acid–induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator–activated receptor γ and fatty acid transferase …
726. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
727. Berberine improves glucose homeostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistance
728. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis
729. Berberine improves glucose metabolism through induction of glycolysis
730. Berberine Improves High Glucose-induced Damage to Vascular Endothelial Cells and Microvascular Endothelial Cells
731. Berberine improves insulin resistance in adipocyte models by regulating the methylation of hypoxia-inducible factor-3α
732. Berberine improves insulin resistance in cardiomyocytes via activation of 5′-adenosine monophosphate-activated protein kinase
733. Berberine improves insulin resistance induced by high fat diet in rats
734. Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients
735. Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice
736. Berberine improves intestinal motility and visceral pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms in …
737. Berberine improves kidney function in diabetic mice via AMPK activation
738. Berberine Improves Kidney Injure Following Renal Ischemia Reperfusion in Rats
739. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity
740. Berberine IMPROVES LIVER FAILURE INDUCED BY FERROUS SULFATE IN RAT
741. Berberine improves liver injury following renal ischemia reperfusion in rats
742. Berberine IMPROVES LIVER INJURY FOLLOWING RENAL ISCHEMIA/REPERFUSION IN RATS
743. Berberine improves mesenteric artery insulin sensitivity through up‐regulating insulin receptor‐mediated signalling in diabetic rats
744. Berberine improves metabolic syndrome insulin resistance by inducing macrophage M2 polarization
745. Berberine improves motor function recovery by inhibiting endoplasmic reticulum stress-induced neuronal apoptosis via AMPK activation in rats with spinal cord …
746. Berberine improves neurogenic contractile response of bladder detrusor muscle in streptozotocin-induced diabetic rats
747. Berberine Improves Plasma Glucose Control and Lipid Profiles in Streptozotocin-Induced Diabetic Rats
748. Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy
749. Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity
750. Berberine improves the intestinal antioxidant status of laboratory mice, Mus musculus
751. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
752. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
753. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis
754. Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft
755. Berberine in combination with insulin has additive effects on titanium implants osseointegration in diabetes mellitus rats
756. Berberine in combination with yohimbine attenuates sepsis-induced neutrophil tissue infiltration and multiorgan dysfunction partly via IL-10-mediated inhibition of …
757. Berberine in Malaria. A Preliminary Note
758. Berberine in the treatment of childhood diarrhoea
759. Berberine in the Treatment of Malaria.
760. Berberine in the treatment of oriental sore
761. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis
762. Berberine in toxin-induced experimental cholera
763. Berberine in trachoma
764. Berberine in type 2 diabetes therapy: a new perspective for an old antidiarrheal drug?
765. Berberine increases adipose triglyceride lipase in 3T3-L1 adipocytes through the AMPK pathway
766. Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation
767. Berberine increases glucose uptake and intracellular ROS levels by promoting Sirtuin 3 ubiquitination
768. Berberine increases glucose uptake in 3T3-L1 adipocytes by enhancing GLUT1 activity
769. Berberine Increases the Expression of ATP-Binding Cassette Transporter A1 and Cholesterol Efflux in THP-1 Macrophages via Deacetylation of Liver X Receptor-α
770. Berberine increases the expression of NHE3 and AQP4 in sennosideA-induced diarrhoea model
771. Berberine increasing the expression of adipophilin in macrophage
772. Berberine induced apoptosis of human osteosarcoma cells by inhibiting phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signal pathway activation
773. Berberine induced apoptosis via promoting the expression of caspase-8,-9 and-3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous …
774. Berberine induced down-regulation of matrix metalloproteinase-1,-2 and-9 in human gastric cancer cells (SNU-5) in vitro
775. Berberine induced down-regulation of matrix metalloproteinases-1-2 and-7 expressions were associated with levels of reactive oxygen species in human gastric …
776. Berberine INDUCED IMPROVEMENT IN HEPATIC STEATOSIS INDEX IN OVERWEIGHT DYSLIPIDAEMIC PATIENTS TREATED WITH LIPID-LOWERING …
777. Berberine induced modulation of PHLPP2-Akt-MST1 kinase signaling is coupled with mitochondrial impairment and hepatoma cell death
778. Berberine induces apoptosis and DNA damage in MG‑63 human osteosarcoma cells
779. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma
780. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway
781. Berberine induces apoptosis in hormone refractory human prostate carcinoma DU145 cells through activation of caspase 3 accompanied with disruption of …
782. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway
783. Berberine induces apoptosis in human multiple myeloma cell line U266 through hypomethylation of p53 promoter
784. Berberine induces apoptosis in non-small-cell lung cancer cells by upregulating miR-19a targeting tissue factor
785. Berberine induces apoptosis in p53-null leukemia cells by down-regulating XIAP at the post-transcriptional level
786. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL
787. Berberine induces apoptosis of breast cancer MCF-7 cells: Its related oxidative stress mechanism [J]
788. Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells
789. Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells
790. Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines
791. Berberine induces apoptosis via the mitochondrial pathway in liver cancer cells
792. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism
793. Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor
794. Berberine induces cell apoptosis through cytochrome C/apoptotic protease-activating factor 1/caspase-3 and apoptosis inducing factor pathway in mouse insulinoma …
795. Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line
796. Berberine induces cell cycle arrest and apoptosis in human HSC-3 oral cancer cells
797. Berberine induces cell cycle arrest in cholangiocarcinoma cell lines via inhibition of NF-κB and STAT3 pathways
798. Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147
799. Berberine Induces CYP2J2 Expression in Human U251 Glioma Cells via Regulation of Peroxisome Proliferator-Activated Receptor Alpha
800. Berberine induces dedifferentiation by actin cytoskeleton reorganization via phosphoinositide 3-kinase/Akt and p38 kinase pathways in rabbit articular chondrocytes
801. Berberine induces dendritic cell apoptosis and has therapeutic potential for rheumatoid arthritis
802. Berberine induces double-strand DNA breaks in Rev3 deficient cells
803. Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells
804. Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway
805. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways
806. Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase/AKT and NF-E2-related factor-2 signaling pathway in astrocytes
807. Berberine induces hERG channel deficiency through trafficking inhibition
808. Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway
809. Berberine induces mitochondrial apoptosis of EBV-transformed B cells through p53-mediated regulation of XAF1 and GADD45α
810. Berberine induces mitochondrial‑mediated apoptosis and protective autophagy in human malignant pleural mesothelioma NCI‑H2452 cells
811. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells
812. Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP …
813. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage
814. Berberine induces pacemaker potential inhibition via cGMP-dependent ATP-sensitive K+ channels by stimulating mu/delta opioid receptors in cultured …
815. Berberine induces resistance against tobacco mosaic virus in tobacco
816. Berberine induces selective apoptosis through the AMPK‑mediated mitochondrial/caspase pathway in hepatocellular carcinoma
817. Berberine induces senescence of human glioblastoma cells by downregulating the EGFR–MEK–ERK signaling pathway
818. Berberine induces toxicity in HeLa cells through perturbation of microtubule polymerization by binding to tubulin at a unique site
819. Berberine induces ZIP14 expression and modulates zinc redistribution to protect intestinal mucosal barrier during polymicrobial sepsis
820. Berberine influences blood glucose via modulating the gut microbiome in grass carp
821. Berberine inhibited apoptosis of human umbilical vein endothelial cells induced by Staphylocoocus aureus: an experimental research
822. Berberine Inhibited Arylamine N-Acetyltransferase Activity and Gene Expression and DNA Adduct Formation in Human Malignant Astrocytoma (G9T/VGH) and Brain …
823. Berberine inhibited radioresistant effects and enhanced anti-tumor effects in the irradiated-human prostate cancer cells
824. Berberine inhibited the growth of thyroid cancer cell lines 8505C and TPC1
825. Berberine Inhibited the Proliferation of Cancer Cells by Suppressing the Activity of Tumor Pyruvate Kinase M2
826. Berberine inhibition of electrogenic ion transport in rat colon
827. Berberine Inhibition of Fibrogenesis in a Rat Model of Liver
828. Berberine inhibition of fibrogenesis in a rat model of liver fibrosis and in hepatic stellate cells
829. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway
830. Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy
831. Berberine inhibits adipocyte differentiation, proliferation and adiposity through down-regulating galectin-3
832. Berberine inhibits adipogenesis in high-fat diet-induced obesity mice
833. Berberine Inhibits Adipogenesis in Porcine Adipocytes via AMP‐Activated Protein Kinase‐Dependent and ‐Independent Mechanisms
834. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose
835. Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells
836. Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2/ERK pathway
837. Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down‐regulation in vitro
838. Berberine inhibits arylamine N-acetyltransferase activity and gene expression in mouse leukemia L 1210 cells
839. Berberine Inhibits Arylamine N-Acetyltransferase Activity and Gene Expression in Salmonella Typhi
840. Berberine inhibits cardiac fibrosis of diabetic rats
841. Berberine inhibits cardiac remodeling of heart failure after myocardial infarction by reducing myocardial cell apoptosis in rats
842. Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells
843. Berberine inhibits cell growth via Wnt/beta-catenin signaling in glioma
844. Berberine inhibits Chlamydia pneumoniae infection-induced vascular smooth muscle cell migration through downregulating MMP3 and MMP9 via PI3K
845. Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth
846. Berberine -inhibits-cyclin-d1-expression-via/14/00145742″ target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://insights.ovid.com/acta-pharmacologica-sinica/aphsa/2008/05/000/Berberine -inhibits-cyclin-d1-expression-via/14/00145742&source=gmail&ust=1581476863169000&usg=AFQjCNEqx4mqbBIc9-h_O4YU_x9apjUe4Q”>Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif1
847. Berberine inhibits cyclin D1 expression via suppressed binding of AP‐1 transcription factors to CCND1 AP‐1 motif1
848. Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the α2-adrenergic receptor in mice
849. Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression
850. Berberine inhibits dyslipidemia in C57BL/6 mice with lipopolysaccharide induced inflammation
851. Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer
852. Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy
853. Berberine inhibits epithelial-mesenchymal transition and promotes apoptosis of tumour-associated fibroblast-induced colonic epithelial cells through regulation of TGF …
854. Berberine inhibits experimental varicocele‐induced cell cycle arrest via regulating cyclin D1, cdk4 and p21 proteins expression in rat testicles
855. Berberine inhibits fluphenazine-induced up-regulation of CDR1 in Candida albicans
856. Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages
857. Berberine inhibits glucose oxidation and insulin secretion in rat islets
858. Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma QBC939 cells
859. Berberine inhibits growth and inflammatory invasive phenotypes of ectopic stromal cells: Imply the possible treatment of adenomyosis
860. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231
861. Berberine inhibits HEp-2 cell invasion induced by Chlamydophila pneumoniae infection
862. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats
863. Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis
864. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein
865. Berberine inhibits HIF-1α expression via enhanced proteolysis
866. Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages
867. Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin β1 signaling
868. Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes
869. Berberine inhibits human melanoma A375. S2 cell migration and invasion via affecting the FAK, uPA, and NF-κB signaling pathways and inhibits PLX4032 resistant …
870. Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis
871. Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model
872. Berberine inhibits IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K/Akt signaling pathway and …
873. Berberine inhibits inflammatory activation of rat brain microglia*⋆
874. Berberine inhibits inflammatory mediators and attenuates acute pancreatitis through deactivation of JNK signaling pathways
875. Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes
876. Berberine Inhibits Intestinal Polyps Growth in Apc (min
877. Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins.
878. Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway
879. Berberine inhibits ion transport in human colonic epithelia
880. Berberine inhibits lipopolysaccharide-and polyethylene particle-induced mouse calvarial osteolysis in vivo
881. Berberine inhibits low shear stress-induced glycocalyx degradation via modulating AMPK and p47phox/Hyal2 signal pathway
882. Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-κB/p65, Akt and MAPK pathway in THP-1 cells
883. Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-κB signaling pathway to protect against DSS-induced colitis
884. Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567
885. Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic β-cell
886. Berberine -inhibits-mrna-degradation-by-promoting-the-interaction-” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://mdanderson.elsevierpure.com/en/publications/Berberine -inhibits-mrna-degradation-by-promoting-the-interaction-&source=gmail&ust=1581476863171000&usg=AFQjCNFyuOL-5x_bRy-IKulHzj7pbyDD7A”>Berberine inhibits mRNA degradation by promoting the interaction between the poly A tail and its binding protein PABP
887. Berberine inhibits myocardial inflammation in rat with chronic heart failure
888. Berberine Inhibits Myofibroblast Differentiation in Nasal Polyp‐Derived Fibroblasts via the p38 Pathway
889. Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages
890. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell
891. Berberine inhibits norepinephrine-induced apoptosis in neonatal rat cardiomyocytes via inhibiting ROS-TNF-α-caspase signaling pathway
892. Berberine inhibits oxygen consumption rate independent of alteration in cardiolipin levels in H9c2 cells
893. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells
894. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking Berberine to insulin …
895. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells
896. Berberine inhibits proliferation and down-regulates epidermal growth factor receptor through activation of Cbl in colon tumor cells
897. Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78.
898. Berberine Inhibits Proliferative Ability of Breast Cancer Cells by Reducing Metadherin
899. Berberine inhibits PTP1B activity and mimics insulin action
900. Berberine inhibits pulmonary metastasis through down‐regulation of MMP in metastatic B16F‐10 melanoma cells
901. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-κB and Akt pathways
902. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo: Berberine improves …
903. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells
904. Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells
905. Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis
906. Berberine inhibits SREBP‐1‐related clozapine and risperidone induced adipogenesis in 3T3‐L1 cells
907. Berberine inhibits Staphylococcus Epidermidis adhesion and biofilm formation on the surface of titanium alloy
908. Berberine inhibits the chemotherapy‐induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer
909. Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer
910. Berberine inhibits the expression of TNFα, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARγ pathway
911. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo
912. Berberine inhibits the interleukin‐1 beta‐induced inflammatory response via MAPK downregulation in rat articular chondrocytes
913. Berberine inhibits the invasion and metastasis of nasopharyngeal carcinoma cells through Ezrin phosphorylation.
914. Berberine inhibits the ischemia-reperfusion induced testicular injury through decreasing oxidative stress
915. Berberine inhibits the ischemia‑reperfusion injury induced inflammatory response and apoptosis of myocardial cells through the phosphoinositide 3‑kinase/RAC‑α …
916. Berberine inhibits the LPS‑induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling …
917. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive …
918. Berberine inhibits the MexXY‑OprM efflux pump to reverse imipenem resistance in a clinical carbapenem‑resistant Pseudomonas aeruginosa isolate in a …
919. Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase
920. Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells
921. Berberine inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-κB pathway in mast cells
922. Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2
923. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling
924. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism
925. Berberine inhibits the proliferation of human uterine leiomyoma cells
926. Berberine inhibits the proliferation of prostate cancer cells and induces G0/G1 or G2/M phase arrest at different concentrations
927. Berberine inhibits the release of glutamate in nerve terminals from rat cerebral cortex
928. Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes
929. Berberine inhibits tumor necrosis factor‑α‑induced expression of inflammatory molecules and activation of nuclear factor‑κB via the activation of AMPK in …
930. Berberine inhibits tumor-associated macrophages in subcutaneous tumor of mice [J]
931. Berberine inhibits uterine leiomyoma cell proliferation via downregulation of cyclooxygenase 2 and pituitary tumor-transforming gene 1
932. Berberine Inhibits WEHI-3 Leukemia Cells in Balb/C Mice In Vivo
933. Berberine inhibits WEHI-3 leukemia cells in vivo
934. Berberine inhibits Wilms’ tumor cell progression through upregulation of Wilms’ tumor gene on the X chromosome
935. Berberine interfered with breast cancer cells metabolism, balancing energy homeostasis
936. Berberine is a dopamine D1-and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses
937. Berberine is a new mechanism drug against energy metabolic disorder
938. Berberine is a new medicine for energy-related metabolic disorders
939. Berberine is a new medicine for energy–related metabolic disorders
940. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
941. Berberine is a novel type efflux inhibitor which attenuates the MexXY-mediated aminoglycoside resistance in Pseudomonas aeruginosa
942. Berberine is a potent agonist of peroxisome proliferator activated receptor alpha
943. Berberine is a potential therapeutic agent for metabolic syndrome via brown adipose tissue activation and metabolism regulation
944. Berberine is multi-targets therapeutic weapon; medical biotechnology resolves the mystery
945. Berberine -is-superior-to-metformin” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://old.life-enhancement.com/magazine/article/2439-Berberine -is-superior-to-metformin&source=gmail&ust=1581476863175000&usg=AFQjCNGH2h0B-N95qkQFqT8XzBrVnagXtA”>Berberine is superior to Metformin
946. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
947. Berberine Maintains Gut Microbiota Homeostasis and Ameliorates Liver Inflammation in Experimental Non-alcoholic Fatty Liver Disease
948. Berberine may be a promising botanical for glycemic control
949. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells
950. Berberine metabolites exhibit triglyceride-lowering effects via activation of AMP-activated protein kinase in Hep G2 cells
951. Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines
952. Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity
953. Berberine mitigates IL-21/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17/Treg imbalance in rheumatoid arthritis
954. Berberine mitigates methotrexate-induced oxidative stress and inflammation in the cerebrum of rats
955. Berberine moderates glucose and lipid metabolism through multipathway mechanism
956. Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine
957. Berberine modifies cysteine 179 of IκBα kinase, suppresses nuclear factor-κB–regulated antiapoptotic gene products, and potentiates apoptosis
958. Berberine modulates amyloid-β peptide generation by activating AMP-activated protein kinase
959. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells
960. Berberine modulates ASK1 signaling mediated through TLR4/TRAF2 via upregulation of miR-23a
961. Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203
962. Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203 Animal
963. Berberine Modulates Epigenetics via Inhibition of Hypoxia‐Induced Histone Lysine Demethylases Expression
964. Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel
965. Berberine modulates gut microbiota and reduces insulin resistance via the TLR4 signaling pathway
966. Berberine modulates insulin signaling transduction in insulin-resistant cells
967. Berberine Modulates LPA Function to Inhibit the Proliferation and Inflammation of FLS-RA via p38/ERK MAPK Pathway Mediated by LPA1
968. Berberine modulation on doxorubicin-induced cell death and auto phagy
969. Berberine nanoparticles for promising sonodynamic therapy of a HeLa xenograft tumour
970. Berberine nanoparticles protects tubular epithelial cells from renal ischemia-reperfusion injury
971. Berberine nanoparticles with enhanced in vitro bioavailability: characterization and antimicrobial activity
972. Berberine nanosuspension enhances hypoglycemic efficacy on streptozotocin induced diabetic C57BL/6 mice
973. Berberine on Inducing HL-60 Cells Differentiation and Cytostatic Effect
974. Berberine on LPS-induced COX-2 expression: p38 mitogen-activated protein kinase and extracellular signal-regulated kinase signaling pathway comparision
975. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials
976. Berberine Overcome the Drug Resistance of Leukemic K562/A02 Cells
977. Berberine Plus
978. Berberine possesses muscarinic agonist-like properties in cultured rodent cardiomyocytes
979. Berberine _potentizes_apoptosis_induced_by_X_rays.19.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/cmj/Fulltext/2011/04020/Berberine _potentizes_apoptosis_induced_by_X_rays.19.aspx&source=gmail&ust=1581476863177000&usg=AFQjCNGEb_DqMdx7XAgQ-po_oLDnnva89w”>Berberine potentizes apoptosis induced by X-rays irradiation probably through modulation of gap junctions
980. Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling
981. Berberine potently inhibits protein tyrosine phosphatase 1B: investigation by docking simulation and experimental validation
982. Berberine Preconditioning Protects Neurons Against Ischemia via Sphingosine-1-Phosphate and Hypoxia-Inducible Factor-1
983. Berberine Pretreatment Confers Cardioprotection Against Ischemia–Reperfusion Injury in a Rat Model of Type 2 Diabetes
984. Berberine _prevents.10.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/eurjcancerprev/fulltext/2012/03000/Berberine _prevents.10.aspx&source=gmail&ust=1581476863177000&usg=AFQjCNGA5UYqYSkCidM7z8pgU4P7UT9G5A”>Berberine prevents 7, 12-dimethylbenz [a] anthracene-induced hamster buccal pouch carcinogenesis: a biochemical approach
985. Berberine Prevents Bone and Cartilage Destruction and Influences Cell Senescence in Experimental Arthritis
986. Berberine prevents cardiac dysfunction and myocardial neutrophil accumulation independent of α_2 adrenoceptor in endotoxemic mice
987. Berberine -prevents-cognitive-disorders-induced-by-sepsis-by-regulating-the-inflammatory-cytokines-oxidative-stress-and-neuronal-ap-12309.html” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://www.jneuropsychiatry.org/peer-review/Berberine -prevents-cognitive-disorders-induced-by-sepsis-by-regulating-the-inflammatory-cytokines-oxidative-stress-and-neuronal-ap-12309.html&source=gmail&ust=1581476863177000&usg=AFQjCNHXjKOohgJUcNxNCeTofTeUIRZt8g”>Berberine Prevents Cognitive Disorders Induced by Sepsis by Regulating the Inflammatory Cytokines, Oxidative Stress and Neuronal Apoptosis in Rat Brain
988. Berberine prevents damage to the intestinal mucosal barrier during early phase of sepsis in rat through mechanisms independent of the NOD-like receptors signaling …
989. Berberine prevents free fatty acid-induced lipid accumulation by activating ERK through sphingosine-1-phosphate receptor 2 in hepatocytes
990. Berberine prevents high glucose-induced cell viability inhibition and apoptosis in podocytes
991. Berberine prevents human nucleus pulposus cells from IL‑1β‑induced extracellular matrix degradation and apoptosis by inhibiting the NF‑κB pathway
992. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial …
993. Berberine prevents intestinal mucosal barrier damage during early phase of sepsis in rat through the toll-like receptors signaling pathway
994. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson’s disease
995. Berberine prevents nitric oxide-induced rat chondrocyte apoptosis and cartilage degeneration in a rat osteoarthritis model via AMPK and p38 MAPK signaling
996. Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice
997. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress
998. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats
999. Berberine prevents the apoptosis of mouse podocytes induced by TRAF5 overexpression by suppressing NF-κB activation
1000. Berberine prevents UV-induced MMP-1 and reduction of type I procollagen expression in human dermal fibroblasts
1001. Berberine produces antidepressant-like effects in ovariectomized mice
1002. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice
1003. Berberine production by batch and semi-continuous cultures of immobilized Thalictrum cells in an improved bioreactor
1004. Berberine production by cultured Coptis japonica cells in a one-stage culture using medium with a high copper concentration
1005. Berberine prolongs life span and stimulates locomotor activity of Drosophila melanogaster
1006. Berberine promoted myocardial protection of postoperative patients through regulating myocardial autophagy
1007. Berberine promotes antiproliferative effects of epirubicin in T24 bladder cancer cells by enhancing apoptosis and cell cycle arrest
1008. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU …
1009. Berberine promotes axonal regeneration in injured nerves of the peripheral nervous system
1010. Berberine Promotes Beige Adipogenic Signatures of 3T3-L1 Cells by Regulating Post-transcriptional Events
1011. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway
1012. Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats
1013. Berberine promotes glucose consumption independently of AMP-activated protein kinase activation
1014. Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3
1015. Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b
1016. Berberine promotes nerve regeneration through IGFR‑mediated JNK‑AKT signal pathway
1017. Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK
1018. Berberine Promotes Osteogenic Differentiation of Human Dental Pulp Stem Cells Through Activating EGFR-MAPK-Runx2 Pathways
1019. Berberine promotes osteogenic differentiation of mesenchymal stem cells with therapeutic potential in periodontal regeneration
1020. Berberine promotes proliferation of sodium nitroprusside-stimulated rat chondrocytes and osteoarthritic rat cartilage via Wnt/β-catenin pathway
1021. Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice
1022. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage
1023. Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans
1024. Berberine protected rats against adiposity induced by high-fat diets
1025. Berberine protects 6-hydroxydopamine-induced human dopaminergic neuronal cell death through the induction of heme oxygenase-1
1026. Berberine protects acute liver failure in mice through inhibiting inflammation and mitochondria-dependent apoptosis
1027. Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 …
1028. Berberine protects against chronic social defeat stress-induced depressive-like behaviors with upregulation of neuronal PAS domain protein 4/brain-derived …
1029. Berberine protects against cytokine-induced inflammation through multiple pathways in undifferentiated C2C12 myoblast cells
1030. Berberine protects against diabetic kidney disease via promoting PGC‐1α‐regulated mitochondrial energy homeostasis
1031. Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels
1032. Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines
1033. Berberine protects against glutamate-induced oxidative stress and apoptosis in PC12 and N2a cells
1034. Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis
1035. Berberine protects against ischemia/reperfusion injury after orthotopic liver transplantation via activating Sirt1/FoxO3α induced autophagy
1036. Berberine protects against ischemia-reperfusion injury: a review of evidence from animal models and clinical studies
1037. Berberine protects against light-induced photoreceptor degeneration in the mouse retina
1038. Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms
1039. Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer’s-like dementia: Involvement of …
1040. Berberine protects against metformin-associated lactic acidosis in induced diabetes mellitus
1041. Berberine -protects-against-murine-malariainduced-spleen-tissue-damage.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://www.biomedres.info/biomedical-research/Berberine -protects-against-murine-malariainduced-spleen-tissue-damage.pdf&source=gmail&ust=1581476863181000&usg=AFQjCNFBWlJnRtvz6-4cJ5RxeTFMxnF3kQ”>Berberine Protects Against murine malaria-Induced Spleen Tissue Damage.
1042. Berberine Protects against NEFA-Induced Impairment of Mitochondrial Respiratory Chain Function and Insulin Signaling in Bovine Hepatocytes
1043. Berberine protects against neuronal damage via suppression of glia-mediated inflammation in traumatic brain injury
1044. Berberine protects against palmitate-induced apoptosis in tubular epithelial cells by promoting fatty acid oxidation
1045. Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4
1046. Berberine _Protects_Against_Schistosoma_mansoni-Induced_Oxidative_Damage_in_Renal_and_Testicular_Tissues_of_Mice/links/56b3762b08ae5deb2657d498.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Ahmed_Abdel_Moneim/publication/287897266_Berberine _Protects_Against_Schistosoma_mansoni-Induced_Oxidative_Damage_in_Renal_and_Testicular_Tissues_of_Mice/links/56b3762b08ae5deb2657d498.pdf&source=gmail&ust=1581476863181000&usg=AFQjCNEeASEXaPFxD0V_NxM_K2oeKf58vg”>Berberine protects against Schistosoma mansoni-induced oxidative damage in renal and testicular tissues of mice
1047. Berberine protects C17. 2 neural stem cells from oxidative damage followed by inducing neuronal differentiation
1048. Berberine protects C57BL/6J mice against ethanol withdrawal‐induced hyperexcitability
1049. Berberine PROTECTS CELLULAR INTEGRITY DURING 7, 12-DIMETHYLBENZ [A] ANTHRACENE-INDUCED ORAL CARCINOGENESIS IN GOLDEN SYRIAN …
1050. Berberine protects endothelial progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS signaling pathway
1051. Berberine Protects Glomerular Podocytes via Inhibiting Drp1-Mediated Mitochondrial Fission and Dysfunction
1052. Berberine protects HK-2 cells from hypoxia/reoxygenation induced apoptosis via inhibiting SPHK1 expression
1053. Berberine protects homocysteic acid-induced HT-22 cell death: involvement of Akt pathway
1054. Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress …
1055. Berberine protects human retinal pigment epithelial cells from hydrogen peroxide-induced oxidative damage through activation of AMPK
1056. Berberine protects human umbilical vein endothelial cells against LPS-induced apoptosis by blocking JNK-mediated signaling
1057. Berberine protects immortalized line of human melanocytes from H2O2-induced oxidative stress via activation of Nrf2 and Mitf signaling pathway
1058. Berberine protects liver from ethanol-induced oxidative stress and steatosis in mice
1059. Berberine protects mesenchymal stem cells against hypoxia-induced apoptosis in vitro
1060. Berberine Protects Mice Against Dextran Sulfate Sodium-Induced Colitis by Activating mTORC1 Pathway
1061. Berberine protects myocardial cells against anoxia‑reoxygenation injury via p38 MAPK‑mediated NF‑κB signaling pathways
1062. Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress
1063. Berberine protects renal tubular cells against hypoxia/reoxygenation injury via the Sirt1/p53 pathway
1064. Berberine protects secondary injury in mice with traumatic brain injury through anti-oxidative and anti-inflammatory modulation
1065. Berberine protects steatotic donor undergoing liver transplantation via inhibiting endoplasmic reticulum stress-mediated reticulophagy
1066. Berberine protects the liver and kidney against functional disorders and histological damages induced by ferrous sulfate
1067. Berberine protects vascular endothelial cells in hypertensive rats
1068. Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51
1069. Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1α expression
1070. Berberine reduce allergic inflammation in a house dust mite allergic rhinitis mouse model
1071. Berberine reduced blood pressure and improved vasodilation in diabetic rats
1072. Berberine Reduced Lipopolysaccharide-Mediated Macrophage Migration By Suppression Of Src Enhancement
1073. Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages
1074. Berberine reduces cAMP-induced chloride secretion in T84 human colonic carcinoma cells through inhibition of basolateral KCNQ1 channels
1075. Berberine reduces endoplasmic reticulum stress and improves insulin signal transduction in Hep G2 cells
1076. Berberine reduces endothelial injury and arterial stiffness in spontaneously hypertensive rats
1077. Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition
1078. Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models
1079. Berberine reduces inflammation of human dental pulp fibroblast via miR-21/KBTBD7 axis
1080. Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro
1081. Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
1082. Berberine _reduces_insulin_resistance_induced_by_dexamethasone_in_theca_cells_in_vitro/links/5644910808ae451880a8356e.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Xiao-Ke_Wu/publication/283718304_390-2011Berberine _reduces_insulin_resistance_induced_by_dexamethasone_in_theca_cells_in_vitro/links/5644910808ae451880a8356e.pdf&source=gmail&ust=1581476863183000&usg=AFQjCNFxVmcvs_zK6Tv9evcnR__A9R732Q”>Berberine reduces insulin resistance: the roles for glucocorticoid receptor and aryl hydrocarbon receptor
1083. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K–Akt signaling in diabetic rats
1084. Berberine Reduces Leukocyte Adhesion to Lps-Stimulated Endothelial Cells and Vcam-1 Expression Both In Vivo and In Vitro
1085. Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats
1086. Berberine reduces neuroglia activation and inflammation in streptozotocin-induced diabetic mice
1087. Berberine reduces neurotoxicity related to nonalcoholic steatohepatitis in rats
1088. Berberine reduces pyruvate-driven hepatic glucose production by limiting mitochondrial import of pyruvate through mitochondrial pyruvate carrier 1
1089. Berberine reduces rat intestinal tight junction injury induced by ischemia–reperfusion associated with the suppression of inducible nitric oxide synthesis
1090. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte
1091. Berberine reduces the hypoxic-ischemic insult in rat pup brain
1092. Berberine reduces the metastasis of chondrosarcoma by modulating the αvβ3 integrin and the PKCδ, c-Src, and AP-1 signaling pathways
1093. Berberine reduces the metastasis of chondrosarcoma by modulating the 𝛼v𝛽3 integrin and the PKC𝛿, c-Src, and AP-1 signaling pathways
1094. Berberine reduces the occurrence of neonatal necrotizing enterocolitis by reducing the inflammatory response
1095. Berberine reduces Toll-like receptor-mediated macrophage migration by suppression of Src enhancement
1096. Berberine reduces uremia-associated intestinal mucosal barrier damage
1097. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver
1098. Berberine regulated Gck, G6pc, Pck1 and Srebp-1c expression and activated AMP-activated protein kinase in primary rat hepatocytes
1099. Berberine regulated lipid metabolism in the presence of C75, compound C, and TOFA in breast cancer cell line MCF-7
1100. Berberine regulates AMP‐activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice
1101. Berberine regulates glycemia via local inhibition of intestinal dipeptidyl peptidase-Ⅳ
1102. Berberine regulates melanin synthesis by activating PI3K/AKT, ERK and GSK3β in B16F10 melanoma cells
1103. Berberine regulates neurite outgrowth through AMPK-dependent pathways by lowering energy status
1104. Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes
1105. Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway
1106. Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy
1107. Berberine regulates the microRNA‑21‑ITGΒ4‑PDCD4 axis and inhibits colon cancer viability
1108. Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines
1109. Berberine regulates Treg/Th17 balance to treat ulcerative colitis through modulating the gut microbiota in the colon
1110. Berberine regulates type 2 diabetes mellitus related with insulin resistance
1111. Berberine reinforces Sertoli cells niche and accelerates spermatogonial stem cells renewal in experimentally-induced varicocele condition in rats
1112. Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells
1113. Berberine represses DAXX gene transcription and induces cancer cell apoptosis
1114. Berberine rescues D-galactose-induced synaptic/memory impairment by regulating the levels of Arc
1115. Berberine restored nitrergic and adrenergic function in mesenteric and iliac arteries from streptozotocin-induced diabetic rats
1116. Berberine restricts coxsackievirus B type 3 replication via inhibition of c-Jun N-Terminal Kinase (JNK) and p38 MAPK Activation in vitro
1117. Berberine reversed the epithelial‐mesenchymal transition of normal colonic epithelial cells induced by SW480 cells through regulating the important components in …
1118. Berberine reverses abnormal expression of L-type pyruvate kinase by DNA demethylation and histone acetylation in the livers of the non-alcoholic fatty …
1119. Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells
1120. Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKβ
1121. Berberine reverses hypoxia-induced chemoresistance in breast cancer through the inhibition of AMPK-HIF-1α
1122. Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS
1123. Berberine reverses LPS-induced repression of CYP7A1 through an anti-inflammatory effect
1124. Berberine Reverses the Chemoresistance of Breast Cancer to 5-Fluorouracil by Downregulating Metadherin
1125. Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: a possible role for SirT3 activation
1126. Berberine salts on the basis of some aminoacids
1127. Berberine salts on the basis of some aminoacids; Soli berberina na osnove nekotorikh aminokislot
1128. Berberine selectively inhibits human monoamine oxidase B: kinetics and mechanism of inhibition
1129. Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro.
1130. Berberine sensitizes human ovarian cancer cells to cisplatin through miR-93/PTEN/Akt signaling pathway
1131. Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro
1132. Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis
1133. Berberine sensitizes rapamycin‑mediated human hepatoma cell death in vitro
1134. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins
1135. Berberine significantly reduces plasma total cholesterol and nonhigh density lipoprotein cholesterol levels in Golden Syrian hamsters
1136. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells
1137. Berberine stimulates fibroblast growth factor 21 by modulating the molecular clock component brain and muscle Arnt-like 1 in brown adipose tissue
1138. Berberine stimulates glucose transport through a mechanism distinct from insulin
1139. Berberine substance groups obtained from HPLC have affects on the content of IL-1β, IL-6, IL-8 and TNF-α of the excessive heat syndrome model rats
1140. Berberine sulfate attenuates osteoclast differentiation through RANKL induced NF-κB and NFAT pathways
1141. Berberine sulfate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane.
1142. Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin
1143. Berberine sulfate: antimicrobial activity, bioassay, and mode of action
1144. Berberine sulphate binding to mast cell polyanions: a cytofluorometric method for the quantitation of heparin
1145. Berberine sulphate in chronic trachoma
1146. Berberine sulphate in oriental sore
1147. Berberine suppress the colon cancer proliferation through activating AMPK.
1148. Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells
1149. Berberine suppresses adipocyte differentiation via decreasing CREB transcriptional activity
1150. Berberine suppresses amyloid‐beta‐induced inflammatory response in microglia by inhibiting nuclear factor‐kappaB and mitogen‐activated protein kinase signalling …
1151. Berberine suppresses androgen receptor signaling in prostate cancer
1152. Berberine SUPPRESSES ANDROGEN RECEPTOR SIGNALING IN PROSTATE CANCER CELLS.
1153. Berberine suppresses apoptosis and extracellular matrix (ECM) degradation in nucleus pulposus cells and ameliorates disc degeneration in a rodent model
1154. Berberine suppresses cell motility through downregulation of TGF-β1 in triple negative breast cancer cells
1155. Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis
1156. Berberine suppresses fibronectin expression through inhibition of c-Jun phosphorylation in breast cancer cells
1157. Berberine suppresses gero-conversion from cell cycle arrest to senescence
1158. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2
1159. Berberine Suppresses Hepatic Glucose Output and Improves Insulin Signaling in Hepatocytes.
1160. Berberine suppresses high glucose-induced TGF-β1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway
1161. Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling
1162. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-κB, u-PA and MMP-2 and …
1163. Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB
1164. Berberine suppresses inflammatory agents-induced interleukin-1β and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells
1165. Berberine Suppresses Interleukin-1β-Induced MUC5AC Gene Expression in Human Airway Epithelial Cells
1166. Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study
1167. Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264. 7 cells
1168. Berberine suppresses mast cell-mediated allergic responses via regulating FcɛRI-mediated and MAPK signaling
1169. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury
1170. Berberine suppresses migration of MCF-7 breast cancer cells through down-regulation of chemokine receptors
1171. Berberine suppresses neuroinflammatory responses through AMP‐activated protein kinase activation in BV‐2 microglia
1172. Berberine suppresses osteoclastogenesis and osteolysis in a mouse model
1173. Berberine suppresses proinflammatory responses through AMPK activation in macrophages
1174. Berberine Suppresses RANKL-Induced Osteoclast Differentiation by Inhibiting c-Fos and NFATc1 Expression
1175. Berberine suppresses Th17 and dendritic cell responses
1176. Berberine suppresses the ectopic expression of miR-133a in endothelial cells to improve vascular dementia in diabetic rats
1177. Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells
1178. Berberine suppresses TNF-α-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells
1179. Berberine suppresses TPA-induced fibronectin expression through the inhibition of VEGF secretion in breast cancer cells
1180. Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts
1181. Berberine synergy with amphotericin B against disseminated candidiasis in mice
1182. Berberine synthase, the methylenedioxy group forming enzyme inBerberine synthesis
1183. Berberine synthesis by callus and cell suspension cultures of Coscinium fenestratum
1184. Berberine target key enzymes and amino acid inibitiors in AD treatment—–creation from Berberine -based structure screening
1185. Berberine targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and cytochrome-c/caspase signaling to suppress human cancer cell growth
1186. Berberine targets assembly of Escherichia coli cell division protein FtsZ
1187. Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro
1188. Berberine therapy of hypertyraminemia in patients with liver cirrhosis.
1189. Berberine treatment attenuates the palmitate-mediated inhibition of glucose uptake and consumption through increased 1, 2, 3-triacyl-sn-glycerol synthesis and …
1190. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe−/− mice
1191. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5′-adenosine monophosphate-activated protein kinase in type 2 diabetic rats …
1192. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/-mice
1193. Berberine treatment-emergent mild diarrhea associated with gut microbiota dysbiosis
1194. Berberine upregulates hepatic low-density lipoprotein receptor through ras-independent but AMP-activated protein kinase-dependent Raf-1 activation
1195. Berberine upregulates miR-22-3p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1
1196. Berberine upregulates P-glycoprotein in human Caco-2 cells and in an experimental model of colitis in the rat via activation of Nrf2-dependent mechanisms
1197. Berberine up-regulates the BDNF expression in hippocampus and attenuates corticosterone-induced depressive-like behavior in mice
1198. Berberine Uptake in HepG2 Cells
1199. Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice
1200. Berberine vs. nifedipine in treating essential hypertension
1201. Berberine was neuroprotective against an in vitro model of brain ischemia: survival and apoptosis pathways involved
1202. Berberine wastewater treatment test using Fenton oxidation.
1203. Berberine , a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells
1204. Berberine , a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth
1205. Berberine , a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway
1206. Berberine , a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth
1207. Berberine , a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells
1208. Berberine , a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells
1209. Berberine , a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib
1210. Berberine , a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
1211. Berberine , a natural plant product, activates AMPK with beneficial metabolic effects in diabetic and insulin resistant states
1212. Berberine , a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase-mediated pathway in HeLa cells
1213. Berberine , a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells
1214. Berberine , a natural product, inhibits growth and induces G1 arrest and caspase-3-dependent apoptosis accompanied with loss of mitochondrial membrane potential …
1215. Berberine , a plant alkaloid with lipid-and glucose-lowering properties: from in vitro evidence to clinical studies
1216. Berberine , a potential drug for trachoma.
1217. Berberine , a strong polyriboadenylic acid binding plant alkaloid: spectroscopic, viscometric, and thermodynamic study
1218. Berberine , a Traditional Chinese Medicine, Reduces Inflammation in Adipose Tissue, Polarizes M2 Macrophages, and Increases Energy Expenditure in Mice …
1219. Berberine , an epiphany against cancer
1220. Berberine , an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice
1221. Berberine , an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the …
1222. Berberine , an isoquinoline alkaloid, inhibits streptozotocin-induced apoptosis in mouse pancreatic islets through down-regulating Bax/Bcl-2 gene expression ratio
1223. Berberine , an isoquinoline alkaloid, inhibits the metastatic potential of breast cancer cells via Akt pathway modulation
1224. Berberine , and quina in large doses. Lime juice was also given
1225. Berberine , COPTIDIS RHIZOMA AND DIOSPYRIN AS NOVEL ANTINEOPLASTIC AGENTS: A REVIEW ON TRADITIONAL USE AND BIOMEDICAL …
1226. Berberine , Quercetin and O-Coumaric Acid Phytochemicals Ameliorate the Impact of Experimentally Fed High-Fat/High-Sucrose Diet on Pancreas Β-Cells and …
1227. Berberine /tacrolimus interaction
1228. Berberine /γ‐Cyclodextrin Inclusion Structure Studied by 1H‐NMR Spectroscopy and Molecular‐Dynamics Calculations
1229. Berberine : a fluorescent alkaloid with a variety of applications from medicine to chemistry
1230. Berberine : A multipotent remedy with unknown cellular target?
1231. Berberine : a naturally occurring phototoxic alkaloid
1232. Berberine : A pioneer remedy for various Ailments
1233. Berberine : a plant alkaloid with therapeutic potential for central nervous system disorders
1234. Berberine : A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease
1235. Berberine : A potential adjunct for the treatment of gastrointestinal cancers?
1236. Berberine : a potential multipotent natural product to combat Alzheimer’s disease
1237. Berberine : a potential phytochemical with multispectrum therapeutic activities
1238. Berberine _A_POTENTIAL_THERAPEUTIC_CANDIDATE_FOR_BREAST_CANCER/links/543bb3fe0cf2d6698be31595.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Akm_Mahmudul_Haque/publication/264552752_Berberine _A_POTENTIAL_THERAPEUTIC_CANDIDATE_FOR_BREAST_CANCER/links/543bb3fe0cf2d6698be31595.pdf&source=gmail&ust=1581476863192000&usg=AFQjCNH1egJ5rUJWynVBNR3KrKdNsJsC7A”>Berberine : a potential therapeutic candidate for breast cancer
1239. Berberine : A Traditional Natural Product With Novel Biological Activities.
1240. Berberine : alkaloid with wide spectrum of pharmacological activities.
1241. Berberine : An Antihypoglycemic Alkaloid
1242. Berberine : an indigenous drug in experimental herpetic uveitis
1243. Berberine : An old drug but new use for liver diseases
1244. Berberine : As a therapeutic target for treating obese diabetes
1245. Berberine : Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders
1246. Berberine : Chemistry and biological activity
1247. Berberine : complex with DNA
1248. Berberine : metabolic and cardiovascular effects in preclinical and clinical trials
1249. Berberine : new insights from pharmacological aspects to clinical evidences in the management of metabolic disorders
1250. Berberine : new perspectives for old remedies
1251. Berberine : Pathways to protect neurons
1252. Berberine : Production Through Plant (Thalictrum spp.) Cell Cultures
1253. Berberine 8998, a new derivative of Berberine , improves hyperlipidemia through additional mechanisms
1254. Berberine -A Neuropsychiatric Pharmacotherapy
1255. Berberine —antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells
1256. Berberine ‑attenuated monocyte adhesion to endothelial cells induced by oxidized low‑density lipoprotein via inhibition of adhesion molecule expression
1257. Berberine -based carbon dots for selective and safe cancer theranostics
1258. Berberine -containing herbs and pregnancy
1259. Berberine –DNA complexation: New insights into the cooperative binding and energetic aspects
1260. Berberine -electrochemical detector for the determination of Berberine -type alkaloids in various Chinese patent medicines by flow injection analysis
1261. Berberine -improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver X receptors, and …
1262. Berberine -incorporated shape memory fiber applied as a novel surgical suture
1263. Berberine -induced activation of 5′-adenosine monophosphate–activated protein kinase and glucose transport in rat skeletal muscles
1264. Berberine -induced activation of AMPK increases hepatic FGF21 expression via NUR77
1265. Berberine -Induced Amelioration of the Pathological Changes in Nutrients Homeostasis During Murine Intestinal Eimeria papillata Infection
1266. Berberine -induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression
1267. Berberine -induced anticancer activities in FaDu head and neck squamous cell carcinoma cells
1268. Berberine -induced-anticancer-effects-in-squamous-cell-carcinoma-of-oral-tongue-cells” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://cyberleninka.ru/article/n/Berberine -induced-anticancer-effects-in-squamous-cell-carcinoma-of-oral-tongue-cells&source=gmail&ust=1581476863193000&usg=AFQjCNHwMxdVrqpFzOPhH9Ir91_PHtbNUw”>Berberine -INDUCED ANTICANCER EFFECTS IN SQUAMOUS CELL CARCINOMA OF ORAL TONGUE CELLS
1269. Berberine -induced apoptosis in human breast cancer cells is mediated by reactive oxygen species generation and mitochondrial-related apoptotic pathway
1270. Berberine -induced apoptosis in human glioblastoma T98G cells is mediated by endoplasmic reticulum stress accompanying reactive oxygen species and …
1271. Berberine -induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation
1272. Berberine -induced apoptosis in leukemia Molt-4 cell line and expression of NF-κB/p65 and Caspase-3
1273. Berberine ‐induced apoptosis of human leukemia HL‐60 cells is associated with down‐regulation of nucleophosmin/B23 and telomerase activity
1274. Berberine -induced apoptosis via decreasing the survivin protein in K562 cell line
1275. Berberine -induced apoptotic and autophagic death of HepG2 cells requires AMPK activation
1276. Berberine -induced autophagic cell death by elevating GRP78 levels in cancer cells
1277. Berberine -induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts
1278. Berberine -induced changes in protein expression and antioxidant enzymes in melanoma cells
1279. Berberine -induced changes of mitochondria membrane potential and free intracellular calcium of HaCaT cells
1280. Berberine -induced decline in circulating CD31+/CD42− microparticles is associated with improvement of endothelial function in humans
1281. Berberine ‐induced growth inhibition of epithelial ovarian carcinoma cell lines
1282. Berberine ‐induced Haemolysis Revisited: Safety of Rhizoma coptidis and Cortex phellodendri in Chronic Haematological Diseases
1283. Berberine -induced Inactivation of signal transducer and activator of transcription 5 signaling promotes male-specific expression of a bile acid uptake transporter
1284. Berberine -induced inhibition of adipocyte enhancer-binding protein 1 attenuates oxidized low-density lipoprotein accumulation and foam cell formation in phorbol 12 …
1285. Berberine -induced LDLR up-regulation involves JNK pathway
1286. Berberine -induced mobilization of circulating endothelial progenitor cells improves human small artery elasticity
1287. Berberine -induced morphologic differentiation and down-regulation of c-Ki-ras2 protooncogene expression in human teratocarcinoma cells
1288. Berberine -induced pigment dispersion in Bufo melanostictus melanophores by stimulation of beta-2 adrenergic receptors
1289. Berberine -induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma
1290. Berberine -induced upregulation of circulating endothelial progenitor cells is related to nitric oxide production in healthy subjects
1291. Berberine -INF55 (5-nitro-2-phenylindole) hybrid antimicrobials: effects of varying the relative orientation of the Berberine and INF55 components
1292. Berberine –INF55 Hybrid Antimicrobials: Effects of Varying the Relative Orientation of the Berberine and INF55 Components
1293. Berberine -loaded Janus gold mesoporous silica nanocarriers for chemo/radio/photothermal therapy of liver cancer and radiation-induced injury inhibition
1294. Berberine ‐loaded Janus nanocarriers for magnetic field‐enhanced therapy against hepatocellular carcinoma
1295. Berberine -loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice
1296. Berberine -loaded solid proliposomes prepared using solution enhanced dispersion by supercritical CO2: Sustained release and bioavailability enhancement
1297. Berberine -loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study
1298. Berberine -piperazine conjugates as potent influenza neuraminidase blocker
1299. Berberine -Promoted CXCR4 Expression Accelerates Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Persons with Prehypertension
1300. Berberine -sonodynamic therapy induces autophagy and lipid unloading in macrophage
1301. Berberine -stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK
1302. Berberine -targeted miR-21 chemosensitizes oral carcinomas stem cells
1303. Berberis ceylanica Schneider Stems: A Rich Source of Berberine with Antimicrobial Properties
1304. Berberis Vulgaris and Berberine : An Update Review
1305. Berberis vulgaris and its constituent Berberine as antidotes and protective agents against natural or chemical toxicities
1306. Bidirectional regulation of adenosine 5′‐monophosphate–activated protein kinase activity by Berberine and metformin in response to changes in ambient glucose …
1307. Biliverdin/Phycocyanobilin, Glycine, High-Dose Folate, and Metformin/Berberine as Antidotes to Endotoxin
1308. Binding of 9-O-(ω-amino) alkyl ether analogues of the plant alkaloid Berberine to poly (A): Insights into self-structure induction
1309. Binding of alkaloids Berberine , palmatine and coralyne to lysozyme: a combined structural and thermodynamic study
1310. Binding of Berberine to a membrane fraction from Coptis cells
1311. Binding of Berberine to bovine serum albumin: spectroscopic approach
1312. Binding of Berberine to human telomeric quadruplex–spectroscopic, calorimetric and molecular modeling studies
1313. Binding of DNA-binding alkaloids Berberine and palmatine to tRNA and comparison to ethidium: spectroscopic and molecular modeling studies
1314. Binding of isoquinoline alkaloids Berberine , palmatine and coralyne to hemoglobin: structural and thermodynamic characterization studies
1315. Binding of novel 9-O–N-aryl/arylalkyl amino carbonyl methyl Berberine analogs to poly(U)-poly(A)·poly(U) triplex and comparison to the duplex poly(A)-poly(U)
1316. Binding of plant alkaloids Berberine and palmatine to serum albumins: a thermodynamic investigation
1317. Binding of the 9-ON-aryl/arylalkyl amino carbonyl methyl substituted Berberine analogs to tRNAphe
1318. Binding parameters of alkaloids Berberine and sanguinarine with DNA
1319. Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models
1320. Bioactivities of Berberine metabolites after transformation through CYP450 isoenzymes
1321. Bioactivities of Berberine , palmatine, and jatrorrhizine isolated from food allergy herbal formula 2 (FAHF-2)
1322. Berberine _An_Update/links/56d524a608ae9e9dea65bfc8.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Ren_You_Gan/publication/296384677_Bioactivities_of_Berberine _An_Update/links/56d524a608ae9e9dea65bfc8.pdf&source=gmail&ust=1581476863197000&usg=AFQjCNEifbSIca4H1YxoQpQtfSvsN50ilw”>Bioactivities of Berberine : an update
1323. Bioactivity evaluation of Berberine Sulfate on Microcystis aeruginosa
1324. Bioactivity of Berberine hydrochloride to brevicoryne brassicae (L.)
1325. BIOACTIVITY OF Berberine HYDROCHLORIDE TO BREVICORYNE BRASSICAE (L.)[J]
1326. Bioavailability of Berberine and monacolin after oral administration of a proprietary nutraceutical combination in healthy male volunteers
1327. Bioavailability study of Berberine and the enhancing effects of TPGS on intestinal absorption in rats
1328. Biocatalytic Oxidative C C Bond Formation Catalysed by the Berberine Bridge Enzyme: Optimal Reaction Conditions
1329. Biochemical activities of Berberine , palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores
1330. Biochemical characterisation of Berberine bridge enzyme (BBE), a covalently flavinylated oxidase involved in benzophenanthridine alkaloid biosynthesis
1331. Biochemical effects of Berberine
1332. Biochemical evidence that Berberine bridge enzyme belongs to a novel family of flavoproteins containing a bi-covalently attached FAD cofactor
1333. Biochemical pathways in the antiatherosclerotic effect of Berberine
1334. Bioformulation of silver nanoparticles as Berberine carrier cum anticancer agent against breast cancer
1335. Biogenic gold nanoparticles as fotillas to fire Berberine hydrochloride using folic acid as molecular road map
1336. Bioinformatics Analysis of Berberine Bridge Enzyme in Papaver somniferum L.[J]
1337. Bioinformatics analysis of endophytic bacteria related to Berberine in the Chinese medicinal plant Coptis teeta Wall.
1338. Biological and molecular evaluation of accessions of Coscinium fenestratum Gaertn Colebr in vitro synthesis of Berberine and its antibacterial and cytotoxic evaluation
1339. Biological function of Berberine and its effects on growth and immune functions of broilers.
1340. Biomass and Berberine Content in Mixed Forest of Phellodendron amurense and Cunninghamia lanceolata [J]
1341. Biopharmaceutics classification system of Chinese materia medica of Berberine in Gegen Qinlian decoction
1342. Biophysical characterization of the strong stabilization of the RNA triplex poly (U)• poly (A)* poly (U) by 9-O-(ω-amino) alkyl ether Berberine analogs
1343. Biophysical studies on the effect of the 13 position substitution of the anticancer alkaloid Berberine on its DNA binding
1344. Bioreactor operating strategy inThalictrum rugosum plant cell culture for the production of Berberine
1345. Biosynthesis of a Tricyclo[6.2.2.02,7]dodecane System by a Berberine Bridge Enzyme‐Like Aldolase
1346. BIOSYNTHESIS OF Berberine AND BERBERASTINE INCORPORATION OF CATECHOLAMINES
1347. Biosynthetic Incorporation of One-Carbon Units into Berberine and Hydrastine
1348. Biotechnology; Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes
1349. Biotransformation of tetrahydroBerberine to Berberine by enzymes prepared from cultured Coptis japonica cells
1350. Bitterness intensity prediction of Berberine hydrochloride using an electronic tongue and a GA‑BP neural network
1351. Block of HERG channels by Berberine : mechanisms of voltage-and state-dependence probed with site-directed mutant channels
1352. Blocking action of Berberine on various receptors in rat anococcygeus muscle
1353. Blocking action of Berberine on various receptors in the rat anococoygeus muscle
1354. Blocking action of Berberine on α2- and α1-adrenoceptors in rat vas deferens and anococcygeus muscle
1355. BMD-TLC—the useful technique for quantitative analysis of chelidonine, chelerithrine and Berberine in herbal drugs
1356. Butanol fraction containing Berberine or related compound from Nexrutine® inhibits NFκB signaling and induces apoptosis in prostate cancer cells
1357. C34 INSIGHTS INTO COPD PATHOGENESIS FROM PRE-CLINICAL STUDIES: Berberine Attenuates Airway Inflammation And Mucus Production Induced By …
1358. C60 Fullerene as an Effective Nanoplatform of Alkaloid Berberine Delivery into Leukemic Cells
1359. Calmodulin as a Potential Target by Which Berberine Induces Cell Cycle Arrest in Human Hepatoma B el7402 Cells
1360. Calorimetric study and thermal analysis of Berberine sulphate
1361. Canadine synthase from Thalictrum tuberosum cell cultures catalyses the formation of the methylenedioxy bridge in Berberine synthesis
1362. Cancer cell membrane-modified biodegradable mesoporous silica nanocarriers for Berberine therapy of liver cancer
1363. Capillary Electrophoresis Determination of Berberine in Pharmaceuticals with End‐Column Electrochemiluminescence Detection
1364. Capsaicin and Berberine inhibit the production of TNF-α, IL-1β and nitric oxide on LPS-stimulated mice
1365. Cardiometabolic Efficacy and Mechanisms of Berberine in Experimentally Induced Changes in Diabetes and Metabolic Syndrome Rats
1366. Cardiovascular actions of Berberine
1367. Cardiovascular and metabolic effects of Berberine
1368. Cardiovascular aspects of pharmacology of Berberine : I. α-adrenoceptor blocking action of Berberine in isolated rat anococcygeus muscle and rabbit aortic strip
1369. Cardiovascular Effects Circular Training (Resistance-Interval) Combined with Berberine in Overweight Elderly Men
1370. Cardiovascular effects of Berberine in patients with severe congestive heart failure
1371. Cardiovascular effects of Berberine : a review of the literature
1372. Catalytic and structural role of a conserved active site histidine in Berberine bridge enzyme
1373. Cause Analysis of Low Diversion Rate of Berberine Hydrochloride in Caulis Mahoniae of Xiaojie’an Capsule [J]
1374. CCXIX.—ψ-Berberine
1375. Cell-specific pattern of Berberine pleiotropic effects on different human cell lines
1376. Cellular delivery and enhanced anticancer activity of Berberine complexed with a cationic derivative of γ–cyclodextrin
1377. Cetyltrimethylammonium assay using fluorescence probe Berberine and a competitive host–guest complexation with butylated β-cyclodextrin
1378. Changes in Fingerprint Pattern of Compound Granatum Berberine Capsules before and after Irradiation
1379. Changes of the Physiological and Berberine Content in Phellodendron amurense Seedlings under Drought Stress
1380. Characterisation of the selectivity and binding interactions of Berberine derivatives with G-quadruplex DNA and a DNA/RNA hybrid
1381. Characteristics of the Combination of Hesperidin-Berberine , and Hesperidin-synephrine on Myosin Activities [J]
1382. Characterization and assessment of antifungal activity of chemically modified Berberine
1383. Characterization and mechanism of the Berberine bridge enzyme, a covalently flavinylated oxidase of benzophenanthridine alkaloid biosynthesis in plants
1384. Characterization of bacterial communities in hybrid upflow anaerobic sludge blanket (UASB)–membrane bioreactor (MBR) process for Berberine antibiotic wastewater treatment
1385. Characterization of Berberine transport into Coptis japonica cells and the involvement of ABC protein
1386. CHARACTERIZATION OF CdS-TiO_2 COMPOSITE PHOTOCATALYST AND PHOTOCATALYTIC ACTIVITY FOR Berberine UNDER VISIBLE LIGHT [J]
1387. Characterization of encapsulated Berberine in yeast cells of Saccharomyces cerevisiae
1388. Characterization of the promoter region of biosynthetic enzyme genes involved in Berberine biosynthesis in Coptis japonica
1389. Characterization of the transient species generated by the photoionization of Berberine : A laser flash photolysis study
1390. Characterization of the transportation of Berberine in Coptidis rhizoma extract through rat primary cultured cortical neurons
1391. Characterization of tinospora cordifolia willd miers germplasm using molecular marker and Berberine content
1392. Characterization of vacuolar transport of the endogenous alkaloid Berberine in Coptis japonica
1393. Characterization, pharmacokinetics, and hypoglycemic effect of Berberine loaded solid lipid nanoparticles
1394. Chemical Transformation of ProtoBerberine s. III. Convenient Synthesis of 8-MethoxyBerberine phenolbetaine by Photooxygenation of Berberine . A Novel Conversion of Berberine into (±)-Ophiocarpine, (±)-Epiophiocarpine, (±)-α-Hydrastine, and (±)-β-Hydrastine
1395. Chemical Transformation of ProtoBerberine s. IV. A Novel, Simple Synthesis of (±)-Canadaline and a Retroproto-Berberine from TetrahydroBerberine
1396. Chemical transformation of protoBerberine s. Part 9. A biomimetic synthesis of oxychelerythrine, dihydrochelerythrine, and chelerythrine from Berberine
1397. Chemical Transformation of ProtoBerberine s. VI. Ring D Inversion of ProtoBerberine Alkaloids. Conversion of Berberine into Non-naturally Occurring 11, 12 …
1398. Chemical transformation of protoBerberine s. VI. Ring D inversion of protoBerberine alkaloids. Conversion of Berberine into non-naturally occurring 11, 12-oxygenated …
1399. Chemiluminescence flow sensor for Berberine with immobilized reagents
1400. Chemiluminescence recognition of Berberine triggered by biomimetically synthesized silver nanoparticles
1401. Berberine &ots=UwjdxruGwp&sig=C0wc0OpsJiY_nJSXdUaldAHcago” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://books.google.com/books?hl%3Den%26lr%3Dlang_en%26id%3D0k6rBAAAQBAJ%26oi%3Dfnd%26pg%3DPA129%26dq%3D%2BBerberine %26ots%3DUwjdxruGwp%26sig%3DC0wc0OpsJiY_nJSXdUaldAHcago&source=gmail&ust=1581476863208000&usg=AFQjCNF0958ZbosVhVoaO0K7Oyw9iZF1mA”>Chemo-enzymatic access to novel berbine derivatives employing the Berberine bridge enzyme
1402. Chemopreventive effects of Berberine on intestinal tumor development in Apc min/+ mice
1403. Chemopreventive efficacy of Berberine in 7, 12-dimethylbenz [a] anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice
1404. Chitosan hydrogel as a base for transdermal delivery of Berberine and its evaluation in rat skin
1405. Chitosan sponge matrices with β-cyclodextrin for Berberine loadinging
1406. Chitosan-coated nano-liposomes for the oral delivery of Berberine hydrochloride
1407. Chronic administration of Berberine inhibits Aβ production, plaque formation, gliosis and cognitive deterioration in a transgenic mouse model of alzheimer’s
1408. Chronic effects of Berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats
1409. Chronic infusion of Berberine into the hypothalamic paraventricular nucleus attenuates hypertension and sympathoexcitation via the ROS/Erk1/2/iNOS pathway
1410. Circadian Pharmacological Effects of Berberine on Chronic Colitis in Mice: Role of the Clock Component Rev-erbα
1411. Circular dichroism studies of the structure of DNA complex with Berberine
1412. CL.—The constitution of Berberine
1413. Claudin-1-and-2-based cytokine-induced paracellular barrier impairment: prevention by the plant alkaloide, Berberine
1414. Clinic and pharmacological effect of Berberine on cardiovascular system [J]
1415. Clinic observation of Metronidazole and Berberine clyster therapy for chronic colitis 26 cases [J]
1416. CLINICAL ACTIVITY OF ISOFLAVONES+ Berberine IN MENOPAUSAL PATIENTS WITH BORDERLINE DYSLIPIDAEMIA: PREVENTION IN THE MENOPAUSE.
1417. Clinical Application of Berberine in the Treatment of Diabetes
1418. Clinical Curative Effect of all kinds of Arrhythmia Treated with the Combination of Berberine Hydrochtoride. Oryzanol and Coenzyme Q_10
1419. Clinical Curative effect of Compound Berberine Hydrochloride Soluble Power on Colibacillosis of Chickling [J]
1420. Clinical Effects of Sucralfate and Berberine in Treating 94 Cases of Chronic Refractory Gastritis
1421. Clinical evidence of efficacy of red yeast rice and Berberine in a large controlled study versus diet
1422. Clinical observation about wash and drainage of deep abscess by Berberine [J]
1423. Clinical Observation of Adjuvant Therapy of Berberine on Type 2 Diabetes plus Peptic Ulcer with HP Infection [J]
1424. Clinical Observation of Berberine Combined With Nitrendipine on Essential Hypertension and Cardia Insufficiency
1425. Clinical Observation of Berberine in Intervening Insulin Resistance of Polycystic Ovary Syndrome
1426. Clinical Observation of Berberine in Treatment of Non-Gonococcal Urethritis and Cervicitis Due to Chlamydia Trachomatis
1427. Clinical observation on Berberine treating non-alcoholic fatty liver disease.
1428. Clinical Observation on Compound Berberine in Treatment of Irritable Bowel Syndrome
1429. Clinical observation on the therapeutic effect of Berberine in thetreatment of type 2 diabetes [J]
1430. Clinical Observation on the Therapeutic Effect of Berberine plus Ciprofloxacin Hydrochloride on Bedsore
1431. Clinical observe of effect of regulating hyperlipidemia and weight reduction by Berberine and oryzanol [J]
1432. Clinical pharmacokinetics and metabolism of Berberine and hydrastine following an oral dose of goldenseal supplement
1433. Clinical Research on Combining Berberine and Bifico of Diarrhea in Patients after Esophageal Cancer Surgery
1434. Clinical Research on the Changes in Activation, Release and Ultrastructure of Platelet and the Protective Function of Berberine on Platelet During Cardiopulmonary …
1435. Clinical study on Berberine , amoxicillin, lansoprazole, bismuth quadruple therapy for Helicobacter pylori eradication in 283 patients
1436. Clinical study on improvement of typeⅡdiabetes mellitus complicated with fatty liver treated by Berberine
1437. Clinical Study: Berberine Treats the Insulin Resistance in Patients with Polycystic Ovarian Syndrome (PCOS)
1438. Clinical trial of Berberine in acute watery diarrhoea
1439. Clinical trial of Berberine in acute watery diarrhoea.
1440. Clinical trial of high-dose Berberine and tetracycline in cholera
1441. Cloning, expression and immunological characterization of full‐length timothy grass pollen allergen Phl p 4, a Berberine bridge enzyme‐like protein with homology to …
1442. CLVIII.—The constitution of sinactine (1-tetrahydro epi Berberine )
1443. Co-administration of Berberine and plant stanols synergistically reduces plasma cholesterol in rats
1444. Co-Existent Biphasic Region of Nematic and Columnar Smectic Phases in Binary Mixture of Berberine and Alizarin Dye
1445. CO-EXTRACTION-SPECTROPHOTOMETRIC DETERMINATION OF Berberine WITH QUININE AND BROMOPHENOL BLUE
1446. Cognitive impairments induced by severe acute pancreatitis are attenuated by Berberine treatment in rats
1447. Combating drug resistance-Comparison of the antibiotic effect of Hydrastis canadensis extract and pure Berberine via Minimum Inhibitory Concentration assay
1448. Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine : Molecular Mechanisms and Therapeutic Potential
1449. Combination of Berberine and ciprofloxacin reduces multi-resistant Salmonella strain biofilm formation by depressing mRNA expressions of luxS, rpoE, and …
1450. Combination of Berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats
1451. Combination of Berberine and Plant Stanols Significantly Reduce Plasma Cholesterol and Triacylglyceride Concentrations in Golden Syrian Hamsters
1452. Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy
1453. Combination of simvastatin with Berberine improves the lipid-lowering efficacy
1454. Combination of upflow anaerobic sludge blanket (UASB) and membrane bioreactor (MBR) for Berberine reduction from wastewater and the effects of Berberine on bacterial community dynamics
1455. Combination Therapy of Amlodipine with Berberine for Hypertensive with Arthrolithiasis [J]
1456. Combination treatment of Berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured …
1457. Combined analytical approaches to define biodistribution and biological activity of semi-synthetic berberrubine, the active metabolite of natural Berberine
1458. Combined use of astragalus polysaccharide and Berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway
1459. Combining effects of probiotics, oligosaccharides and Berberine on production performance of pigs
1460. Combining effects of probiotics, oligosaccharides and Berberine on production performance of pigs.
1461. Comment on “Berberine and its emerging benefits in psychiatric conditions especially Alzheimer’s disease”
1462. Comparation of the Berberine Content in the Roots of Thalictrum from Gansu
1463. Comparative effect of Berberine and its derivative 8-cetylBerberine on attenuating atherosclerosis in ApoE−/− mice
1464. Comparative inhibitory effects of sanhuang, Berberine and gentamicin against E. coli
1465. Comparative pharmacokinetics and safety assessment of transdermal Berberine and dihydroBerberine
1466. Comparative pharmacokinetics of Berberine after oral administration of pure Berberine , coptidis rhizoma extract, and decoctions of two different complex herbal …
1467. Comparative pharmacokinetics of Berberine and salvianolic acid B in single herb and traditional herbal medicine
1468. Comparative pharmacokinetics of Berberine , palmatine and jatrorrhizine in rat plasma after oral administration of Rhizoma coptidis and Zuojinwan using liquid …
1469. Comparative pharmacokinetics of puerarin, daidzin, baicalin, glycyrrhizic acid, liquiritin, Berberine , palmatine and jateorhizine by liquid chromatography–mass …
1470. Comparative studies on concentration of Berberine in plasma after oral administration of coptidis rhizoma extract, its cultured cells extract, and combined use of these …
1471. Comparative study of Berberine in various organs of three kinds of Berberis in different areas of Qinghai province.
1472. Comparative study of Berberis vulgaris fruit extract and Berberine chloride effects on acetic acid-induced colitis in rats
1473. Comparative study of pharmacokinetics and tissue distribution of 8-cetylBerberine and Berberine in rats
1474. Comparative study of single/combination use of Huang-Lian-Jie-Du decoction and Berberine on their protection on sepsis induced acute liver injury by NMR metabolic …
1475. Comparative study of transport character of jatrorrhizine, coptisine, palmatine and Berberine in Zuojin Wan and its similar formulae in Caco-2 cells
1476. Comparative study on purification of Berberine in rhizoma of Coptis chinensis Franch by different ways
1477. Comparative study on the ACTH-releasing activities of Berberine , palmatine and tetrahydropalmatine (Corydalis B) in the rat
1478. Comparative study on the antimicrobial activity of Berberis aristata from different regions and Berberine in vitro
1479. Comparative Study on the Dissolution Character between Berberine and 8-hydroxy DihydroBerberine
1480. Comparative study on the effects of huanglianjiedu decoction and Berberine on glucose and lipid metabolisms in type 2 diabetic rats
1481. Comparative study on the treatment of Berberine wastewater by chemical-and electro-coagulation processes: zeta potential analysis
1482. Comparing effects of Berberine on the growth and photosynthetic activities of Microcystis aeruginosa and Chlorella pyrenoidosa
1483. Comparision of Dissolution Rates of Berberine Hydrochloride in Sanhuang Tablets Produced by Different Factories
1484. Comparison of anti-inflammatory effects of Berberine , and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo
1485. Comparison of Antimicrobial Effect of Berberine as an Endodontic Irrigant with that of Other Common Root Canal Irrigants on Three Microorganisms Involved in …
1486. Comparison of Antimicrobial Potency between Berberine Hydrochloride and Drug Material Coptis Chinensis on Staphyloccocus Aureus by Cup-Plate Method [J]
1487. Comparison of Berberine Hydrochloride Content in Single Medicine Decoction and Mixed Medicine Decoction of Sanhuangxiexin Decoction [J]
1488. Comparison of Berberine hydrochloride, palmtine hydrochloride and jatrorrhizinehydrochloride in dispensing granule of Coptis produced by different factories [J]
1489. Comparison of Changes of Content of Berberine Hydrochloride and Yield of Dry Extract from Pieces and Powder of Phellodendri chinense in Different Boiling Time [J]
1490. Comparison of Content of Berberine Hydrochloride in Dispensing Granules and Slice Decoctions of Rhizoma Coptidis and Cortex Phellodendri [J]
1491. Comparison of Contents of Berberine Hydrochloride, Jatrorrhizine Hydrochloride and Palmatine Hydrochloride in Phellodendri Chinensis Cortex of Different Extract by …
1492. Comparison of Contents of Kakonein, Baicalin and Berberine Hydrochloride by HPLC in Gegen Qinlian Decoctions with Different Compatibility [J]
1493. Comparison of extraction rate of Berberine with ultrasonic extraction and alkaline immersion method
1494. Comparison of Helicobacter pylori urease inhibition by Rhizoma Coptidis, cortex phellodendri and Berberine : mechanisms of interaction with the sulfhydryl group
1495. Comparison of the antidiabetic activity of Berberis lyceum root extract and Berberine in alloxan‐induced diabetic rats
1496. Comparison of the contents of Berberine and baicalin in three preparation methods for San huang Xiexin decoction.
1497. Comparison of the Contents of Berberine Hydrochloride in Traditional Decoctions vs. TCM Formula Granules of Lianpu Drink
1498. Comparison of the Contents of Ferulic Acid, Berberine , Baicalin in Single Medicine Decoction and Mixed Medicine Decoction of Dangguiliuhang Decoction [J]
1499. Comparison of Three Traditional Methods to Extract Berberine from Coptis chinensis in Laboratory
1500. Comparison of total alkaloids from Coptis Root and Berberine for ulcerative colitis treatment [J]
1501. Comparison on the Content of Berberine between Granule and Traditional Decoction of Traditional Chinese Medicine of TangKuei Six Yellow Decoction
1502. Comparison on the dissolution rate of Berberine between granule and traditional decoction of traditional Chinese medicine of Jiaotai pill [J]
1503. Competition of Berberine with pyridoxal phosphate in the tryptophanase system of Escherichia coli
1504. Competitive supramolecular interaction of carbachol and Berberine with cucurbit [7] uril and its analytical application
1505. Comprehensive evaluation of SCFA production in the intestinal bacteria regulated by Berberine using gas-chromatography combined with polymerase chain reaction
1506. Comprehensive study in the inhibitory effect of Berberine on gene transcription, including TATA box
1507. Computational and experimental prediction of molecules involved in the anti-melanoma action of Berberine
1508. Concurrent acetylation of FoxO1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in Berberine -treated HepG2 cells
1509. Conformation-activity studies on the interaction of Berberine with acetylcholinesterase: Physical chemistry approach
1510. Conformational aspects of poly (dI-dC). poly (dI-dC) and poly (dG-dC). poly (dG-dC) on binding of the alkaloid, Berberine chloride.
1511. Conjugating Berberine to a multidrug resistance pump inhibitor creates an effective antimicrobial
1512. Considerable fluorescence enhancement upon supramolecular complex formation between Berberine and p-sulfonated calixarenes
1513. Construction and expression of a single-chain Fv fragment against Berberine in Escherichia coli
1514. Content and Dissolution Determination of Berberine Hydrochloride in Fengshi Qutong Capsule by HPLC
1515. Content comparison of Berberine hydrochloride in ultramicro and conventional Wuji Pills
1516. Content Determinate of Berberine Hydrochloride in Sifangwei Capsules by HPLC
1517. Content determination of Berberine hydrochloride and palmatine hydrochloride in Haemorrhoid Lotion by HPLC.
1518. Content Determination of Berberine Hydrochloride in Bai Qing Gel by HPLC
1519. Content Determination of Berberine Hydrochloride in Biantong Pills by RP-HPLC
1520. Content Determination of Berberine Hydrochloride in Canghuang Tablet by High Performance Liquid Chromatography
1521. Content determination of Berberine hydrochloride in Chunyu Burn Ointment by HPLC [J]
1522. Content determination of Berberine hydrochloride in coptis chinensis franch by RP-HPLC with the quantification of Triethylamine
1523. Content determination of Berberine Hydrochloride in Duodongning Capsules by HPLC [J]
1524. Content determination of Berberine hydrochloride in Fuke Zhidai tablets by HPLC
1525. Content Determination of Berberine Hydrochloride in Huanglian Shangqing Water Pills by HPLC [J]
1526. Content Determination of Berberine Hydrochloride in Jiawei Xianglian Water Pills by HPLC [J]
1527. Content Determination of Berberine Hydrochloride in Kangfu Films by HPLC [J]
1528. Content Determination of Berberine Hydrochloride in Lianzhen Pill by HPLC [J]
1529. Content determination of Berberine hydrochloride in Li’ermian Tablets by HPLC
1530. Content Determination of Berberine Hydrochloride in Prossing Calamina by Sanhuang Tang [J]
1531. Content Determination of Berberine Hydrochloride in Qianlietong Soft Capsules by High Performance Liquid Chromatography
1532. Content Determination of Berberine Hydrochloride in Qingrejiedu Granule by HPLC
1533. Content determination of Berberine Hydrochloride in Shirebi Granules by HPLC [J]
1534. Content Determination of Berberine Hydrochloride in Sifangwei Capsule
1535. Content determination of Berberine hydrochloride in Wubaishen Cleaning Solution by HPLC
1536. Content Determination of Berberine in Compound Sophorae Raidix Lotion
1537. Content Determination of Berberine in Double Yellow Antiinflammatory Tablets
1538. Content Determination of Berberine in Fujie Lotion by RP-HPLC
1539. Content determination of Berberine in Huangju Detoxication Tablets.
1540. Content Determination of Berberine in Lomatogonium rotatum Soup-4 by HPLC [J]
1541. Content Determination of Berberine in Rhizoma Coptidis and Zuojin Pills by Macroporous Adsorptive Resin-RP-HPLC [J]
1542. Content determination of Berberine in Yiqing soft capsule by HPCE
1543. Content Determination of Oryzanol and Berberine in Sanhe Pingzhi Capsules by Microemulsion Liquid Chromatography [J]
1544. Contents determination of Berberine , palmatine and jatrorrhizine of Phellodendren amurense bark by HPLC
1545. Contractile effect of Berberine on isolated antral smooth muscle-cells in rat stomach
1546. Contribution to the study on quantitation dosage of Berberine hydrochloride by potentio-titration method in dry medium
1547. Control Effectiveness of 95% Berberine on Two Pepper Anthracnose Fungi [J]
1548. Controlled release of Berberine hydrochloride from alginate microspheres embedded within carboxymethyl chitosan hydrogels
1549. Controlling effect of Berberine on in vitro synthesis and metabolism of steroid hormones in insulin resistant ovary
1550. Conversion of Berberine into berberrubine by selective demethylation under microwave irradiation
1551. Conversion of Berberine into phthalideisoquinolines
1552. Conversion of Hydrastine into Berberine , and an Instance of the Asymmetrical Quaternization of a Tertiary Base
1553. Coptis rhizome and Phellodendron bark extracts and Berberine inhibit the development of mouse embryos
1554. Coptis: In Vitro Regeneration of Plants and the Production of Berberine
1555. Correction: A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered Berberine
1556. Correction: Berberine attenuates axonal transport impairment and axonopathy induced by calyculin a in N2a cells
1557. Correction: Berberine Reduces Fibronectin Expression by Suppressing the S1P-S1P2 Receptor Pathway in Experimental Diabetic Nephropathy Models
1558. Correction: Berberine -targeted miR-21 chemosensitizes oral carcinomas stem cells
1559. Correction: Design, synthesis and anti-inflammatory effects of novel 9-O-substituted-Berberine derivatives electronic supplementary information
1560. Correlation between antitumor activity of Berberine and the inhibition of Wnt/?-catenin signal pathway
1561. Correlation between the amelioration of insulin resistance and protein expression of PI-3K and GLUT4 in type 2 diabetic rats treated with Berberine
1562. Corrigendum to” Activation of AMPK by Berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice”[Toxicol. Appl. Pharmacol …
1563. Corrigendum to” Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice”[Biomed. Pharmacother. 118 (2019) 109206].
1564. Corrigendum: Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro
1565. Cortex Phellodendron (huang bai) but not its major ingredient Berberine blocks anaphylactic reactions in a murine model of peanut allergy
1566. COX-2 and survivin reduction may play a role in Berberine -induced apoptosis in human ductal breast epithelial tumor cell line
1567. CPU86017, a Berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting …
1568. Croatian barberry (Berberis croatica Horvat): a new source of Berberine —analysis and antimicrobial activity
1569. Cryptic stereochemistry of Berberine alkaloid biosynthesis
1570. Curing Elderly Person’s Chronic Bacterial Dysentery with Transnormal Dosages of Berberine Associated with TMP
1571. Current knowledge and pharmacological profile of Berberine : an update
1572. Cyclizing-Berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127)
1573. CYP2D plays a major role in Berberine metabolism in liver of mice and humans
1574. CYP450 enzyme inhibition of Berberine in pooled human liver microsomes by cocktail probe drugs
1575. Cytological effects of Berberine sulphate onChironomus salivary gland nuclei
1576. Cytotoxic and Proapoptotic Activity of Sanguinarine, Berberine , and Extracts of Chelidonium majus L. and Berberis thunbergii DC. toward Hematopoietic Cancer Cell …
1577. Cytotoxic Benzophenanthridine and Berberine Alkaloids from Argemone mexicana
1578. Cytotoxic Effect of Coscinium Fenestratrum (Gaertn.) Colebr. and its Active Principle Berberine on L929 Cells
1579. Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (Berberine , coptisine and icariin) on hepatoma and leukaemia …
1580. Cytotoxicity enhancement in MDA-MB-231 cells by the combination treatment of tetrahydropalmatine and Berberine derived from Corydalis yanhusuo WT …
1581. Cytotoxicity evaluation of natural coptisine and synthesis of coptisine from Berberine
1582. Cytotoxicity of Berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction
1583. Cytotoxicity of the natural herbicidal chemical, Berberine , on Nicotiana tabacum Bright yellow-2 cells
1584. Cytotoxicity testing of a polyurethane nanofiber membrane modified with chitosan/β-cyclodextrin/Berberine suitable for wound dressing application: evaluation of …
1585. D and BP. Antibacterial Activity of Berberine against Methicillin-Resistant Staphylococcus Aureus Planktonic and Biofilm Cells
1586. Deciphering the positional impact of chlorine in new series of Berberine analogues towards superb-selective “turn-on” hydrophobic signaling of bovine serum albumin …
1587. Decrease in the production of beta-amyloid by Berberine inhibition of the expression of beta-secretase in HEK293 cells
1588. Decreased Levels of Spleen Tissue CD4+ CD25+ Foxp3+ Regulatory T Lymphocytes in Mice Exposed to Berberine
1589. Degradation of Berberine in Fe (Ⅲ)-fumarate system under ultraviolet radiation
1590. Degradation of MDM2 by the interaction between Berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells
1591. Degradative study in the Berberine series—I
1592. Berberine /10.1117/1.JBO.19.11.117005.short” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics/volume-19/issue-11/117005/Delayed-luminescence-to-monitor-programmed-cell-death-induced-by-Berberine /10.1117/1.JBO.19.11.117005.short&source=gmail&ust=1581476863225000&usg=AFQjCNH4363_4bB4T0O_YEQrOcF2AtHeVg”>Delayed luminescence to monitor programmed cell death induced by Berberine on thyroid cancer cells
1593. Delivery of Berberine using chitosan/fucoidan-taurine conjugate nanoparticles for treatment of defective intestinal epithelial tight junction barrier
1594. Delivery system for Berberine chloride based on the nanocarrier ZnAl-layered double hydroxide: physicochemical characterization, release behavior and evaluation of …
1595. Dendrimer encapsulated and conjugated delivery of Berberine : A novel approach mitigating toxicity and improving in vivo pharmacokinetics
1596. Dendritic effect of ligand-coated nanoparticles: enhanced apoptotic activity of silica− Berberine nanoconjugates
1597. Dentin Matrix Metalloprotease Inhibition by Berberine
1598. Derivatives of the cationic plant alkaloids Berberine and palmatine amplify protonophorous activity of fatty acids in model membranes and mitochondria
1599. Derivatization of Berberine based on its synergistic antifungal activity with fluconazole against fluconazole-resistant Candida albicans
1600. Design and Evalution of Liposomal Formulation for Topical Delivery of Curcumin and Berberine
1601. Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery
1602. Design and Synthesis of a Berberine Dimer: A Fluorescent Ligand with High Affinity towards G‐Quadruplexes
1603. Design of experiments for the optimization and statistical analysis of Berberine finishing of polyamide substrates
1604. Design, synthesis and anti-inflammatory effects of novel 9-O-substituted-Berberine derivatives
1605. Design, synthesis and biological evaluation of a hybrid compound of Berberine and magnolol for improvement of glucose and lipid metabolism
1606. Design, synthesis, and anticancer activity of novel Berberine derivatives prepared via CuAAC “click” chemistry as potential anticancer agents
1607. Design-of-experiment approach for the development and validation of a high-performance thin-layer chromatography method for the simultaneous estimation of Berberine chloride and galangin in Tinospora cordifolia M. and Alpinia galanga L. and their herbal formulations
1608. Detection of antibacterial activity of Berberine hydrochloride by multiwalled carbon nanotubes
1609. Detection of Berberine Hydrochloride in Jin Weng Zhili Particle Using TLC and HPLC.
1610. DETECTION OF Berberine , HYDRASTINE AND OXYACANTHINE.
1611. Detection of DNA in agarose gels using Berberine and mordant yellow 3R
1612. Determinatin of Berberine hydrochloride in Mongolia Medicine Huchun Pill by HPLC
1613. Determination and correlation of the solubility for Berberine chloride in pure imidazolium-based ionic liquids
1614. Determination and preliminary studies of metabolism of Berberine in human urine after oral administration
1615. Determination Berberine in Coptis Chinensis Franch by High Performance Liquid Chromatography-tandem Mass Spectrometry [J]
1616. Determination for Berberine in Huanglian Jiedu Decoction by HPLC [J]
1617. Determination of (+)-catechin and (-)-epicatechin and Berberine hydrochloride in Wangying Capsule by RP-HPLC
1618. Determination of Aesculin and Berberine Hydrochloride in Enema of Pulsatillae Decoction by HPLC [J]
1619. Determination of Baicalin and Berberine Hydrochloride in Angong Niuhuang Capsules by HPLC
1620. Determination of baicalin and Berberine hydrochloride in Xiaoyanshuan by HPLC.
1621. Determination of Baicalin and Berberine Hydrochloride in Yigan Jiedu Capsules by HPLC [J]
1622. Determination of baicalin and Berberine in Ganmao Yixiaoshi Capsule by HPLC [J]
1623. Determination of Baicalin and Berberine in Lianmeiyin preparation
1624. Determination of Baicalin, Berberine Hydrochloride, Prim-o-glucosylcimifugin and Liquiritin in Mingmu Jili Pill by HPLC at the Same Time
1625. Determination of baicalin, rhein and Berberine in Yiqing Capsule by HPLC
1626. Determination of Berberine and berberrubine in rabbit plasma by capillary electrophoresis with amperometric detection and its application to pharmacokinetic study
1627. Determination of Berberine and palmatine in Cortex phellodendron and Chinese patent medicines by HPLC
1628. Determination of Berberine and palmatine in Phellodendri Cortex using ion-pair supercritical fluid chromatography on-line coupled with ion-pair supercritical fluid …
1629. Determination of Berberine and phellodendrine in Cortex Phellodendri by HPLC
1630. Determination of Berberine and Phellodendrine in Cortex Phellodendri of Enshi by HPLC
1631. Determination of Berberine and Scutellarin in Yankening Tablets by RP-HPLC [J]
1632. Determination of Berberine and strychnine in medicinal plants and herbal preparations by pressurized liquid extraction with capillary zone electrophoresis
1633. Determination of Berberine and the study of fluorescence quenching mechanism between Berberine and enzyme-catalyzed product
1634. Determination of Berberine and trimethoprim in compound Berberine in-jection by HPLC [J]
1635. Determination of Berberine by Its Polarographic Catalytic Wave [J]
1636. Determination of Berberine by measuring the enhanced total internal reflected fluorescence at water/tetrachloromethane interface in the presence of sodium dodecyl …
1637. Determination of Berberine by RP-HPLC-FLDC [J]
1638. Determination of Berberine bydrochloride in sanbuan tablets by selective electrode method
1639. Determination of Berberine chloride in mouse plasma after intragastric administration of Lianxiang microemulsion
1640. Determination of Berberine content in the stem extracts of Coscinium fenestratum by TLC densitometry
1641. Determination of Berberine from Daochi pills by HPCE and HPLC
1642. Determination of Berberine hydrochlodride in Rupi Anxiao Granules by HPLC
1643. Determination of Berberine hydrochlodride in Rupi’anxiao soft capsule by HPLC
1644. Determination of Berberine hydrochlorde in Shirebi Tablets by HPLC [J]
1645. Determination of Berberine hydrochlorid in Kangli ointment by TLC-scanning
1646. Determination of Berberine hydrochloride and ammonium glycyrrhizinate in ganhuan zaoshi lotion by HPLC
1647. Determination of Berberine hydrochloride and baicalin in Compound Kushen Lotions by HPLC [J]
1648. Determination of Berberine Hydrochloride and Baicalin in Qingxinling Pellets by HPLC [J]
1649. Determination of Berberine hydrochloride and baicalin in the Gegen Qinlian mini-pill by second order derivative spectrophotometry [J]
1650. Determination of Berberine hydrochloride and Baicalin in Wefushu Capsules by HPLC [J]
1651. Determination of Berberine Hydrochloride and Baicalin in Yankening Tablet by HPLC [J]
1652. Determination of Berberine hydrochloride and Baicalin in Yiqing Granules by HPLC [J]
1653. Determination of Berberine Hydrochloride and Chlorogenic Acid in Zhizi Jinhuawan by Capillary Electrophoresis [J]
1654. Determination of Berberine Hydrochloride and Curcumine in Shangke Dieda Paste by HPLC
1655. Determination of Berberine hydrochloride and gallic acid in Suxiao Zhixie capsules by HPLC [J]
1656. Determination of Berberine hydrochloride and jatrorrhizine hydrochlo ride in different parts of Cortex Phellodendri Chinensis by HPLC
1657. Determination of Berberine Hydrochloride and Palmatine Hydrochloride in Coptis omeiensis and Coptis deltoidea
1658. Determination of Berberine hydrochloride and palmatine hydrochloride in different processing products of phellodendri amurensis cortex
1659. Determination of Berberine Hydrochloride and Phellodendrine in Lishukang Capsules by HPLC
1660. Determination of Berberine hydrochloride and total alkaloids in compound Er-xian decoction
1661. Determination of Berberine Hydrochloride and Total Alkaloids in Thalictrum [J]
1662. Determination of Berberine hydrochloride based on the interaction of perfluorooctanesulfonate with Berberine hydrochlo-ride by the resonance light scattering method.
1663. Determination of Berberine Hydrochloride by Fluorescent Spectrometry with Sodium Dodecyl Sulfate as Sensitizer
1664. Determination of Berberine hydrochloride by light-emitting diode induced fluorescence microplate analyzer with surfactant sensitization
1665. Determination of Berberine hydrochloride content in Phellodendri Chinensis Cortex decoction of different comminution degree by HPLC
1666. Determination of Berberine Hydrochloride Content in Qingwen Baidu Granule by HPLC
1667. Determination of Berberine hydrochloride contents in its tablets by HPLC
1668. Determination of Berberine hydrochloride contents of RU AN membrane by HPLC
1669. Determination of Berberine hydrochloride contents of RU AN membrane with thin layer scanning
1670. Determination of Berberine hydrochloride from Cortex Phellodendri in Sichuan and its genuineness
1671. Determination of Berberine Hydrochloride in Berberine Prickly-heat Powder by UV Spectrophotometry [J]
1672. Determination of Berberine Hydrochloride in Berberis Nummularia Bge. By HPLC [J]
1673. Determination of Berberine hydrochloride in Changershu Capsules by RP-HPLC
1674. Determination of Berberine Hydrochloride in Changkang Tablets by HPLC
1675. Determination of Berberine hydrochloride in Changshuling Capsules by HPLC [J]
1676. Determination of Berberine hydrochloride in changyan enema by UV spectrophotometry [J]
1677. Determination of Berberine Hydrochloride in Child Changweikang Granules by HPLC
1678. Determination of Berberine Hydrochloride in Ciprofloxacin Hydrochloride and Berberine Hydrochloride Premix by UV Spectrophotometry [J]
1679. Determination of Berberine hydrochloride in compound huang lian granules by TLCS [J]
1680. Determination of Berberine Hydrochloride in Compound Huangsong Lotion by HPLC
1681. Determination of Berberine Hydrochloride in Compound Jinhuang Hemorrhoids Ointment by RP-HPLC [J]
1682. Determination of Berberine Hydrochloride in Compound Kushenzi Lotion by HPLC
1683. Determination of Berberine hydrochloride in compound mingmu soap by HPLC
1684. Determination of Berberine Hydrochloride in Compound Zinc Sulfate Eye Drops by HPLC
1685. Determination of Berberine hydrochloride in Coptis deltoidea CY Cheng et Hsiao in Sichuan by HPLC
1686. Determination of Berberine hydrochloride in Cortex Phellodendri Chinensis with direct potential method based on molecularly imprinted polymers
1687. Determination of Berberine Hydrochloride in Danwei Capsules by HPLC
1688. Determination of Berberine hydrochloride in Diyu Pills by HPLC
1689. Determination of Berberine Hydrochloride in Duxiekang Granules by HPLC [J]
1690. Determination of Berberine hydrochloride in Erlongtongqiao Pills by RP-HPLC
1691. Determination of Berberine Hydrochloride in Ermiao Wan by HPLC [J]
1692. Determination of Berberine Hydrochloride in Fat-Soluble Qianlie’an Suppositories by HPLC
1693. Determination of Berberine Hydrochloride in Fluorescent Spectrophotometry
1694. Determination of Berberine Hydrochloride in Fukang Xiji by TLCF [J]
1695. Determination of Berberine Hydrochloride in Fulexiaoyan Wan by HPLC [J]
1696. Determination of Berberine Hydrochloride in Fuyanpin Paoteng Pian by HPLC [J]
1697. Determination of Berberine hydrochloride in fuyanpin powder by HPLC
1698. Determination of Berberine Hydrochloride in Fuyanping Effervescent Tablets Using Reversed-Phase High Performance Liquid Chromatography
1699. Determination of Berberine Hydrochloride in Gandouling Tablets by TLC-scanning
1700. Determination of Berberine hydrochloride in Gangtai suppositories by HPLC [J]
1701. Determination of Berberine Hydrochloride in Ge Gen Qin Lian Capsules By RP-HPLC
1702. Determination of Berberine Hydrochloride in Gegen Qinlian Tablets by HPLC
1703. Determination of Berberine Hydrochloride in Gegen Qinlian Tablets by RP-HPLC [J]
1704. Determination of Berberine Hydrochloride in Gengnian ningxin tablets by HPLC
1705. Determination of Berberine hydrochloride in Habudari-16 pill by HPLC
1706. Determination of Berberine hydrochloride in Huangbai capsules by HPLC
1707. Determination of Berberine Hydrochloride in Huangbaidiy (?) Capsules by HPLC [J]
1708. Determination of Berberine hydrochloride in huangbo qingye oral solution by high performance liquid chromatography.
1709. Determination of Berberine Hydrochloride in Huanglian Jiangtang Pill by HPLC
1710. Determination of Berberine hydrochloride in Huanglian Shangqing pills by HPLC
1711. Determination of Berberine Hydrochloride in Huanglian Shangqing Tablets by RP-HPLC [J]
1712. Determination of Berberine hydrochloride in Huanglian Zhixie Pills by HPLC [J]
1713. Determination of Berberine hydrochloride in Huanglianshangqing Tablets by HPLC
1714. Determination of Berberine hydrochloride in Huanglianshangqing Tablets by HPLC [J]
1715. Determination of Berberine Hydrochloride in Huangzhulishi Granules by HPLC [J]
1716. Determination of Berberine Hydrochloride in Huashe Jieyang Tablets by HPLC [J]
1717. Determination of Berberine Hydrochloride in Jianglianzhixie Tablets by HPLC [J]
1718. Determination of Berberine hydrochloride in Jianpi Zengshi Pill by HPLC
1719. Determination of Berberine hydrochloride in Jiaotongxinshen capsules by HPLC
1720. Determination of Berberine hydrochloride in Jieyinjing suppositories by HPLC [J]
1721. Determination of Berberine Hydrochloride in Jieze Lotion by HPLC [J]
1722. Determination of Berberine Hydrochloride in Jin Ji Capsule by RP-HPLC [J]
1723. Determination of Berberine Hydrochloride in Jinhuaxiaocuo Pills by HPLC
1724. Determination of Berberine hydrochloride in JinYuan Capsules by HPLC
1725. Determination of Berberine hydrochloride in Kangfuling dropping pills by HPLC [J]
1726. Determination of Berberine Hydrochloride in Kanji Xiaoke Tablets by HPLC
1727. Determination of Berberine Hydrochloride in Keyangmin Tincture by RP-HPLC
1728. Determination of Berberine Hydrochloride in Liangan granules by HPLC [J]
1729. Determination of Berberine Hydrochloride in Lianpu Shuangqing Tablets by HPLC
1730. Determination of Berberine Hydrochloride in Lishukang Capsules by HPLC [J]
1731. Determination of Berberine Hydrochloride in Mixture for Burn and Scald by HPLC
1732. Determination of Berberine hydrochloride in Mongolia Medicine Maidong-18 Powder by HPLC
1733. Determination of Berberine hydrochloride in Naotongling Granules by TLCS [J]
1734. Determination of Berberine hydrochloride in Niantongwan by HPLC [J]
1735. Determination of Berberine Hydrochloride in Ninbitai Capsules by HPLC
1736. Determination of Berberine hydrochloride in Ningxinanshen Capsules by HPLC [J]
1737. Determination of Berberine Hydrochloride in Phellodendron amurense Rupr by RRLC
1738. Determination of Berberine hydrochloride in Pifu pills by HPLC
1739. Determination of Berberine Hydrochloride in Qianlie Shutong Tablets by RP-HPLC
1740. Determination of Berberine Hydrochloride in Qianlieshutong Tablets by HPLC [J]
1741. Determination of Berberine Hydrochloride in Qianlieshutong Troche by RP-HPLC [J]
1742. Determination of Berberine Hydrochloride in Qingfei Yihuowan by HPLC [J]
1743. Determination of Berberine Hydrochloride in Qinggan Granules by HPLC
1744. Determination of Berberine hydrochloride in Qingre Huadu Pill by HPLC [J]
1745. Determination of Berberine hydrochloride in Quyou ointment by RP-HPLC [J]
1746. Determination of Berberine Hydrochloride in Rhizoma Coptidis and its Concentrated Granule for Prescription by HPLC
1747. Determination of Berberine hydrochloride in Ruyi Jinhuang Powder with scanning method of two-wavelengths thin layer chramography [J]
1748. Determination of Berberine hydrochloride in Sambucus williamsti Hance by RP-HPLC.
1749. Determination of Berberine Hydrochloride in San Yu Ointment by HPLC
1750. Determination of Berberine Hydrochloride in Sanhao Shedan Chuanbei Tablets by HPLC [J]
1751. Determination of Berberine hydrochloride in Sanhuang decoction for purging stomach-fire by HPLC
1752. Determination of Berberine Hydrochloride in Sanhuang Sanyu Cataplasm by HPLC [J]
1753. Determination of Berberine Hydrochloride in Sanhuang series by HPLC
1754. Determination of Berberine hydrochloride in sanhuang tablets by HPLC
1755. Determination of Berberine Hydrochloride in Sanhuang Tablets by HPLC [J]
1756. Determination of Berberine hydrochloride in sanhuangpian by HPLC
1757. Determination of Berberine Hydrochloride in Sanmiao Pills by HPLC
1758. Determination of Berberine Hydrochloride in Sanmiao Pills by HPLC [J]
1759. Determination of Berberine hydrochloride in Shangqing pills by HPLC
1760. Determination of Berberine Hydrochloride in Shangtongning plaster by HPLC
1761. Determination of Berberine Hydrochloride in Shaoshang Ⅱ Tincture by HPLC [J]
1762. Determination of Berberine hydrochloride in Shaoyao decoction by HPLC.
1763. Determination of Berberine Hydrochloride in Shenshe Ointments by HPLC
1764. Determination of Berberine hydrochloride in Shihu Yeguang pills by HPLC.
1765. Determination of Berberine hydrochloride in Shuanghuang Xiaoyan capsule by HPLC.
1766. DETERMINATION OF Berberine HYDROCHLORIDE IN SHUANGHUANGBUSUSTAINED RELEASE MEDICINAL STRIPS BY RP-HPLC [J]
1767. Determination of Berberine Hydrochloride in Shuanghuangxiaoyan Tablets by HPLC [J]
1768. Determination of Berberine Hydrochloride in Shuiniujiao Detoxicating Pill by HPLC
1769. Determination of Berberine Hydrochloride in Sifangwei Capsule by HPLC
1770. Determination of Berberine Hydrochloride in Siji Sanhuang Capsules
1771. Determination of Berberine Hydrochloride in Sijisanhuang Capsules by TLC-Scanning
1772. Determination of Berberine Hydrochloride in Smilax Glabra Roxby Capsules by RP-HPLC [J]
1773. Determination of Berberine hydrochloride in Suniaozhixie Capsules by HPLC
1774. Determination of Berberine Hydrochloride in the Changzhong Capusules by RP-HPLC [J]
1775. Determination of Berberine Hydrochloride in the Fufanglingxiao Capusules by RP-HPLC
1776. Determination of Berberine hydrochloride in the Miniaoning tablets by HPLC [J]
1777. Determination of Berberine Hydrochloride in Three fellows Lotion co. by RP-HPLC
1778. Determination of Berberine hydrochloride in Tibetan medicine Bangbei Kangyan suppository by RP-HPLC
1779. Determination of Berberine hydrochloride in Tongluo Jiedu liniment with Thin Layer Chromatography-Ultraviolet Spectrophotometry [J]
1780. Determination of Berberine hydrochloride in Tongmai Jiangtang granules by HPLC [J]
1781. Determination of Berberine hydrochloride in traditional Chinese medicines containing Coptis chinensis Franch by reversed phase high performance liquid …
1782. Determination of Berberine Hydrochloride in Weian Capsule by HPLC
1783. Determination of Berberine Hydrochloride in Weichangning Granules by HPLC
1784. Determination of Berberine hydrochloride in weidean capsule [J]
1785. Determination of Berberine hydrochloride in Weitai capsule by RP-HPLC [J]
1786. Determination of Berberine Hydrochloride in Weiwei Granules by TLC-Fluorometry
1787. Determination of Berberine hydrochloride in Weiyankang Capsule by RP-HPLC
1788. Determination of Berberine hydrochloride in Wuji Pills by HPLC
1789. Determination of Berberine Hydrochloride in Wuji Pills by HPLC [J]
1790. Determination of Berberine Hydrochloride in Xianglian Capsules by HPLC [J]
1791. Determination of Berberine Hydrochloride in Xianglian Pills by TLC scanning [J]
1792. Determination of Berberine Hydrochloride in Xiao A Lotion by HPLC
1793. Determination of Berberine Hydrochloride in Xiaoerxiaoke Tablets by HPLC
1794. Determination of Berberine Hydrochloride in Xiaokeling Tablets by HPLC [J]
1795. Determination of Berberine Hydrochloride in Xiaomi Effervescent Tablets by RP-HPLC
1796. Determination of Berberine Hydrochloride in Xiaotangling Capsule by HPLC
1797. Determination of Berberine Hydrochloride in XiaoYan Paste by HPLC
1798. Determination of Berberine Hydrochloride in Xiaoyan Pills by HPLC
1799. Determination of Berberine Hydrochloride in Xiaoyanjing Capsules by HPLC [J]
1800. Determination of Berberine Hydrochloride in Xiaoyanliniao Mixture by RP-HPLC
1801. Determination of Berberine Hydrochloride in Xiaozhi Granule by HPLC
1802. Determination of Berberine Hydrochloride in Xingnao Zaizao Jiaonang Capsule by HPLC [J]
1803. Determination of Berberine Hydrochloride in Xueqing Two Number Granule by HPLC [J]
1804. Determination of Berberine Hydrochloride in Yangxianfeng Wan by HPLC
1805. Determination of Berberine Hydrochloride in Yinghuang Capsule by HPLC
1806. Determination of Berberine Hydrochloride in Zhikang Jiaonang by RP-HPLC
1807. Determination of Berberine hydrochloride in Zhike complex granules by RP-HPLC [J]
1808. Determination of Berberine Hydrochloride in Zhimei Miedi Capsules by RP-HPLC
1809. Determination of Berberine Hydrochloride in Zhimiling Effervescent Tablets by HPLC
1810. Determination of Berberine Hydrochloride in Zhixiebaotong Granule by HPLC
1811. Determination of Berberine hydrochloride in Zhongweikang capsules by convolution spectrometry method
1812. Determination of Berberine Hydrochloride in Zuning Granules by HPLC
1813. Determination of Berberine Hydrochloride in Zuojin Dispersible Tablets by HPLC
1814. Determination of Berberine Hydrochloride of Fuke Zhidai Tablets [J]
1815. Determination of Berberine hydrochloride of Yankening tablets by HPLC
1816. Determination of Berberine Hydrochloride Premix Content by HPLC
1817. Determination of Berberine hydrochloride using a fluorimetric method with silica nanoparticles as a probe
1818. Determination of Berberine Hydrochloride Using Flow Injection Chemiluminescence
1819. Determination of Berberine Hydrochloride with Reverse Flow Injection Chemiluminescence [J]
1820. Determination of Berberine Hydrochloride, Baicalin and Wogonin in Yankening Pian by HPLC
1821. Determination of Berberine hydrochloride, chlorogenic acid and phillyrin in Compound prescription cortex phellodendri chinensis fluid by RP-HPLC [J]
1822. Determination of Berberine hydrochloride, palmatine hydrochloride and jatrorrhizine hydrochloride in Cortex Phellodendri Chinensis by HPLC
1823. Determination of Berberine Hydrochloridein Compound Fuxikang Lotion by HPLC [J]
1824. Determination of Berberine hydrochlorie in Bozhiqianlietong Granules by HPLC [J]
1825. Determination of Berberine in Angong Niuhuang Wan by HPLC
1826. Determination of Berberine in Baidai Wan by HPLC
1827. Determination of Berberine in Bianyan Oral Solution by HPLC
1828. DETERMINATION OF Berberine IN BIOLOGICAL SPECIMEN BY HIGH PERFORMANCE TLC AND [J]
1829. Determination of Berberine in biological specimen by high performance TLC and fluoro-densitometric method
1830. Determination of Berberine in Changyanxiao Solution by HPLC
1831. Determination of Berberine in Compound Huangbai Tincture by RP-HPLC [J]
1832. DETERMINATION OF Berberine IN COPTIS [J]
1833. Determination of Berberine in Cortex Phellodendri with Different Processing Methods by HPLC
1834. Determination of Berberine in decocted liquid from shenshu granules with water by reversed-phase liquid chromatography
1835. Determination of Berberine in Guilinxiguashuang Spray by HPLC [J]
1836. Determination of Berberine in Guzhining Liniment by RP-HPLC
1837. Determination of Berberine in human plasma by liquid chromatography–electrospray ionization–mass spectrometry
1838. Determination of Berberine in Human Serum by Reversed Phase High Performance Liquid Chromatography [J]
1839. Determination of Berberine in human serum by reversed-phase high performance liquid chromatography
1840. Determination of Berberine in kangjixiaoke tablet by HPLC [J]
1841. Determination of Berberine in lianpushuangqing tablets by HPLC [J]
1842. Determination of Berberine in pharmaceutical preparations using acidic hydrogen peroxide–nitrite chemiluminescence system
1843. Determination of Berberine in Phellodendron amurense from different sites of Changbai Mountain
1844. Determination of Berberine in Phellodendron chinense Schneid and its processed products by TLC (thin layer chromatography) densitometry
1845. Determination of Berberine in plasma, urine and bile by high-performance liquid chromatography
1846. Determination of Berberine in Processed Amur Corktree (Phellodendron amurense) by HPLC [J]
1847. DETERMINATION OF Berberine IN QINGJING CAPSULES BY HPLC [J]
1848. Determination of Berberine in Rhizoma coptidis and its preparations by non‐aqueous capillary electrophoresis
1849. Determination of Berberine in Shanhuang Tablets by HPLC
1850. Determination of Berberine in shuanghuangxiaoyan tablets by HPLC [J]
1851. Determination of Berberine in Siji Sanhuang Soft Capsules by HPLC [J]
1852. Determination of Berberine in Taxilli Herba and Its Host Plants-Clausena lansium by RP-HPLC
1853. Determination of Berberine in the callus of the Berberis lycium.
1854. Determination of Berberine in Tongdadibiji by TLC-scanning
1855. Determination of Berberine in xiancaihuangliansu Capsule by HPLC [J]
1856. Determination of Berberine in Xiaotangling Capsules by HPLC [J]
1857. Determination of Berberine in yankening tablets by HPLC [J]
1858. Determination of Berberine Sulfate Injection by HPLC
1859. Determination of Berberine sulphate in sompound solanum lyratum injection by UV
1860. Determination of Berberine , palmatine and jatrorrhizine in rabbit plasma by liquid chromatography–electrospray ionization-mass spectrometry
1861. Determination of Berberine , Palmatine and Jatrorrhizine in Tangkeqing Tablet
1862. Determination of Berberine -type Alkaloids in Wanshi Niuhuang Qingxin Wan by HPLC [J]
1863. Determination of Berberine -upregulated endogenous short-chain fatty acids through derivatization by 2-bromoacetophenone
1864. Determination of Caffeic Acid and Berberine Hydrochlcride in Lianpu Shuangqing Pian by HPLC [J]
1865. Determination of Chlorogenic Acid and Berberine Hydrochloride in Yiqi Decoction by HPLC [J]
1866. Determination of content of Berberine chloride in Dabaidu capsule by HPLC
1867. Determination of Content of Berberine Hydrochloride and Phellodendrine in Manpenyihao Power by RP-HPLC [J]
1868. Determination of Content of Berberine Hydrochloride in Coptis chinensis Franch. by RP-HPLC [J]
1869. Determination of Content of Berberine Hydrochloride in Sanhuang Qinghuo Capsules by HPLC [J]
1870. Determination of Content of Berberine Hydrochloride in Shuitiao Powders by HPLC [J]
1871. Determination of Content of Berberine Hydrochloride in the Mongolian Medicine Leizhuhua by RP-HPLC
1872. Determination of Content of Berberine Hydrochloride in the Mongolian Medicine Tufuling Qiwei Powder by RP-HPLC
1873. Determination of contents of Berberine type alkaloids in Huanglian Shangqing Pills (Tablets)
1874. Determination of coptisine, Berberine and palmatine in traditional Chinese medicinal preparations by capillary electrophoresis
1875. Determination of Dehydrocavidine, Palmatine Hydrochloride and Berberine Hydrochloride in Total Alkaloids of Corydalis saxicola Bunting [J]
1876. Determination of emodin and Berberine hydrochloride in Wangshibaochi Pills by HPLC
1877. Determination of furazolidone, carbenoxolone sodium and Berberine hydrochloride in wei kang tablets by reversed-phase high performance liquid chromatography …
1878. Determination of Gallic Acid and Berberine Hydrochloride in Fukang Vaginal Effervescent Tablets by HPLC [J]
1879. Determination of genpioside, baicalin and Berberine hydrochloride in Gonglao Quhuo Tablets simultaneously by RP-HPLC [J]
1880. Determination of gentiopicroside, mangiferin, palmatine, Berberine , baicalin, wogonin and glycyrrhizin in the traditional Chinese medicinal preparation Sann-Joong …
1881. Determination of Glycyrrhizic Acid and Berberine in Xiancaihuangliansu Capsules by HPLC
1882. Determination of hydrastine and Berberine in goldenseal raw materials, extracts, and dietary supplements by high-performance liquid chromatography with UV …
1883. Determination of hydrochloric acid Berberine in kangfuyan capsules by high performance liquid chromatography
1884. Determination of Hydrochloric Berberine in Burn Ⅱ Medicine by RP-HPLC [J]
1885. Determination of hydrochloric Berberine in Quban powder by HPLC [J]
1886. Determination of jatrorrhizine hydrochloride, palmatine hydrochloride and Berberine hydrochloride in compound Kushen lotion by HPLC
1887. Determination of jatrorrhizine, palmatine and Berberine in Cortex phellodendron by HPLC
1888. Determination of mangiferin, jateorrhizine, palmatine, Berberine , cinnamic acid, and cinnamaldehyde in the traditional Chinese medicinal preparation Zi-Shen pill by …
1889. Determination of muriatic acid Berberine by microscale chemical experiment [J]
1890. Determination of Norfloxacin and Berberine Hydrochloride by HPLC [J]
1891. Determination of paeoniflorin, palmatine hydrochloride and Berberine hydrochloride in Changji’an Preparation by HPLC [J]
1892. Determination of Palmatine and Berberine in the Coptis chinensisFranch by High Performance Liquid Chromatography [J]
1893. Determination of Palmatine Hydrochloride and Berberine Hydrochloride in Baishi Shuitiao Powder by HPLC
1894. Determination of palmatine hydrochloride and Berberine hydrochloride in Jinji capsules by RP-HPLC [J]
1895. Determination of palmatine hydrochloride and Berberine hydrochloride in phellodendron and gypsum powder by HPLC
1896. Determination of palmatine hydrochloride and Berberine hydrochloride in traditional Chinese patent medicine Qinlian tablets by HPLC [J]
1897. Determination of Palmatine Hydrochloride and Berberine Hydrochloride in Zhizi Huangbai Oral Solutions by HPLC
1898. Determination of Penicillamine Using Fluorescence Probe of Complexation Between Berberine and Cucurbit [7] uril [J]
1899. Determination of Plasma Protein Binding Rate of Berberine Hydrochloride
1900. Determination of propafenone and Berberine in serum by HPLC [J]
1901. Determination of rhein, baicalin and Berberine in traditional Chinese medicinal preparations by capillary electrophoresis with two‐marker technique
1902. Determination of Scutellarin and Berberine Hydrochloride in Jiawei Weiyanxiao Tablets by HPLC [J]
1903. Determination of the Antineoplastic Activivity of Berberine Isolated from Tinospora cordifolia in Swiss Albino Mice Transplanted with Ehrlich Ascites Carcinoma
1904. Determination of the Berberine Hydrochloride and Jatrorrhizine Hydrochlorid in Huanglian by HPLC
1905. Determination of the concentration of Berberine in rats plasma by HPLC
1906. Determination of the content of Berberine Hydrochloride by HPLC in Zuojin Capsule
1907. Determination of the Content of Berberine Hydrochloride in Baitouweng Powder by HPLC
1908. Determination of the content of Berberine hydrochloride in Fengtongding Capsules by HPLC [J]
1909. Determination of the Content of Berberine Hydrochloride in Fukezhidai Capsules by HPLC
1910. Determination of the Content of Berberine Hydrochloride in Fukezhidai Tablets by HPLC
1911. Determination of the content of Berberine Hydrochloride in Nanyanxiao Granu by TLC-Scanning
1912. Determination of the Content of Berberine Hydrochloride in Qinhuang Houzheng Capsule by HPLC
1913. Determination of the content of Berberine hydrochloride in Sanmiao Pills by HPLC
1914. Determination of the Content of Berberine Hydrochloride in Shentekang Capsule by HPLC
1915. Determination of the Content of Berberine Hydrochloride in the Fukezhidai Tablets by RP-HPLC
1916. Determination of the Content of Berberine Hydrochloride in Tibetan Medicine Bawei Zhangyacai Pills by HPLC
1917. Determination of the Content of Berberine Hydrochloride in Weining capsule by HPLC
1918. Determination of the content of Berberine hydrochloride of lianpu shuangqing tablets by UV Spectrophotometry [J]
1919. Determination of the content of Berberine hydrochloride of weikangning tablets by UV spectrophotometry
1920. Determination of the content of Berberine hydrochloride tablets by potassium dichromate colormetric method
1921. Determination of the contents of Berberine hydrochloride in Biyan Jiedu capsules by HPLC [J]
1922. Determination of the Contents of Berberine Hydrochloride in Spring Rain Burns Gels
1923. Determination of the Contents of Berberine in Huanglian Shangqing Pills [J]
1924. Determination of three kinds of Berberine type alkaloids in Rhizoma coptidis and Jinqi Jiangtang Tablet by RP-HPLC
1925. Determination of Trimethoprim in Berberine Hydrochloride and Trimethoprim Capsules by HPLC [J]
1926. Determination of Two Active Constituents in Enrofloxacin and Berberine Hydrochloride Powder by HPLC
1927. Determination of ZhangYe FangJijian Hydrochloride and Berberine Hydrochloride by HPLC
1928. Determination on Berberine of Huangbo in Shenkang oral liquid by RP—HPLC [J]
1929. Determination on the Content of Berberine Bydrochloride in Rhizoma Coptidis by HPLC [J]
1930. Determination the Content of Berberine Hydrochloride in Fuke Zhidai Tablets by HPLC [J]
1931. Determination the Content of Berberine Hydrochloride in Lianpushuangqing Tablets by HPLC [J]
1932. DETERMINATION THE CONTENT OF COSTUNOLIDE AND DEHYDROCOSTUSLACTONE IN THE Berberine COMPOUND TABLETS BY UPLC
1933. Determination the Contents of Berberine Hydrochloride in Jieyinshu Lotions by HPLC [J]
1934. Determination the contents of hydrochloric Berberine in Ermiao capsule by HPLC [J]
1935. Determinaton of Berberine hydrochloride in Linghuangbaoer Pellets by HPLC
1936. Determine of Berberine hydrochloride in luji kechuan keli by HPLC [J]
1937. Determining the Content of Berberine Hydrochloride in Weiyan kang Capsule by High Pressure Liquid Chromatography (HPLC)
1938. Determining the interaction behavior of calf thymus DNA with Berberine hydrochloride in the presence of linker histone: a biophysical study
1939. Deternination of Berberine in Shujing Tongluo Pill by HPLC
1940. Development and application of a UPLC‐MS/MS method for simultaneous determination of fenofibric acid and Berberine in rat plasma: application to the drug–drug pharmacokinetic interaction study of fenofibrate combined with Berberine after oral administration in rats
1941. Development and Application of Berberine Chemical Sensor [J]
1942. Development and Application of Silicotungstic Acid-Berberine Field Effect Transistor [J]
1943. Development and factorial design of glyceryl tristearate based solid lipid nanoparticles (SLNs) containing Berberine
1944. Development and in vitro evaluation of linear PEI-shelled heparin/Berberine nanoparticles in human osteosarcoma U-2 OS cells
1945. Development and Percutaneous Permeation Study of Escinosomes, Escin-Based Nanovesicles Loaded with Berberine Chloride
1946. Development and validation of a method for densitometric analysis of Berberine in herbal extract and polyherbal formulation
1947. DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD OF Berberine AND ITS QUANTIFICATION IN MULTICOMPONENT HOMEOPATHIC …
1948. Development and Validation of High-Performance Thin-layer Chromatographic Method for Quantification of Berberine in Rhizomes of Coptis teeta Wall, an …
1949. Development and Validation of RP-HPLC Method for Quantification of Berberine in Ethanol Fraction of Methanol Extract and Developed Formulation of …
1950. Development and Validation of UV-Spectrophotometric Methods for the Determination of Berberine in Polymeric Nanoparticles
1951. Development of a Berberine Loaded Multifunctional Design for the Treatment of Helicobacter pylori Induced Gastric Ulcer
1952. Development of a High Sensitive Assay for Determination of Berberine in Rat Plasma by LC-MS and its Application to a Pharmacokinetic Study
1953. Development of a new, rapid, and sensitive validated high-performance thin-layer chromatographic method for the estimation of Berberine in Tinospora cordifolia
1954. Development of a novel Berberine -mediated mitochondria-targeting nano-platform for drug-resistant cancer therapy
1955. Development of a novel quality control method for estimation of Berberine in Tinospora cordifolia by HPTLC fingerprint approach
1956. DEVELOPMENT OF ANTIBACTERIAL AND ANTIFUNGAL Berberine -PVA GEL PATCH AND ITS IN-VIVO ASSAY AGAINST STAPHYLOCOCCUS AUREUS …
1957. Development of Berberine attraction sites onto cellulosic substrates modified by reactive bridging agent: statistical optimization and analysis
1958. Development of Berberine -based derivatives as novel antimicrobial agents
1959. Development of bioadhesive microspheres for oral bioavailability enhancement of Berberine hydrochloride
1960. Development of botanical fungicide on japanese apple canker. 2. Synthesis and antifungal activity of Berberine derivatives.
1961. Development of botanical fungicide on japanese apple canker. 3. Control effect of Berberine derivatives on japanese apple canker
1962. Development of BSA gel/Pectin/Chitosan polyelectrolyte complex microcapsules for Berberine delivery and evaluation of their inhibitory effect on Cutibacterium acnes
1963. Development of Capsules Filled with Phenytoin and Berberine Loaded Nanoparticles-A New Approach to Improve Anticonvulsant Efficacy
1964. Development of escin-based nanovesicles loaded with Berberine chloride and percutaneous permeation study
1965. Development of formaldehyde-free agar/gelatin microcapsules containing Berberine HCl and gallic acid and their topical and oral applications
1966. Development of Nanoformulations for Enhancement in the Bioavailability of P-gp Substrate–Berberine Chloride
1967. Development of nano-scaled Silibinin and Berberine formulations to enhance their bioavailability for hepatoprotective and anticancer activities
1968. Development of novel nanoparticles shelled with heparin for Berberine delivery to treat Helicobacter pylori
1969. Development of poly(N-isopropylacrylamide)/alginate copolymer hydrogel-grafted fabrics embedding of Berberine nanosuspension for the infected wound treatment
1970. Development of process strategies for Berberine production in plant cell suspension cultures
1971. Development of self-microemulsifying drug delivery system for oral bioavailability enhancement of Berberine hydrochloride
1972. Developmental toxicity evaluation of Berberine in rats and mice
1973. Dexamethasone combined with Berberine is an effective therapy for bleomycin‑induced pulmonary fibrosis in rats
1974. Dietary administration of Berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis
1975. Differences Between the Concentrations in Rabbit Body Fluid of Berberine Hydrochloride, Chlorogenic Acid, Baicalin, and Their Minimal Inhibitory Concentrations
1976. Differences of the Contents of Berberine for Three Preparation Methods in Sanhuang Xiexin Decoction by High Performance Capillary Electrophoresis with Internal …
1977. Differences of the contents of Berberine hydrochloride by three preparation methods in Sanhuang Xiexin decoction by HPCE Internal Standard Method.
1978. Different concentrations of Berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line
1979. Different mechanisms involved in the Berberine ‐induced antiproliferation effects in triple‐negative breast cancer cell lines
1980. Different regulation of Berberine via regulation of adenosine-5′-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart
1981. Different salinity influenced the percutaneous absorption of Berberine in washout application of traditional Chinese medicine in vitro [J]
1982. Different structures of Berberine and five other protoBerberine alkaloids that affect P-glycoprotein-mediated efflux capacity
1983. Differential effect of Rhizoma coptidis and its main alkaloid compound Berberine on TNF-α induced NFκB translocation in human keratinocytes
1984. Differential effects of Berberine , baicalein, and triptolide on cytokine production from IL-1β-activated mast cells (95.28)
1985. Differential inhibition of CYP1-catalyzed regioselective hydroxylation of estradiol by Berberine and its oxidative metabolites
1986. Differential interaction behaviors of an alkaloid drug Berberine with various bile salts
1987. Differential modes of photosensitisation in cancer cells by Berberine and coralyne
1988. Differential pulse anodic stripping voltammetric determination of Berberine using nano-Na-montmorillonite clay modifiedcarbon paste electrode
1989. Differentiated hypoglycemic effects of baicalin, Berberine and puerarin on insulin-resistance HepG2 cells
1990. Differentiation of B16 Melanoma Induced by Berberine Hydrochloride
1991. Digital gene expression analysis of Microsporum canis exposed to Berberine chloride
1992. DihydroBerberine , a hydrogenated derivative of Berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB …
1993. Direct fluorometric determination of liver alcohol dehydrogenase with Berberine
1994. Discovery and characterization of Berberine derivatives as stimulators of osteoblast differentiation
1995. Discovery of 2-aminothiazolyl Berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumanii
1996. Discovery of Berberine based derivatives as anti-influenza agent through blocking of neuraminidase
1997. Discovery of Berberine , abamectin and ivermectin as antivirals against chikungunya and other alphaviruses
1998. Discovery of mitochondria-targeting Berberine derivatives as the inhibitors of proliferation, invasion and migration against rat C6 and human U87 glioma cells
1999. Discovery of natural Berberine -derived nitroimidazoles as potentially multi-targeting agents against drug-resistant Escherichia coli
2000. Discovery of novel Berberine imidazoles as safe antimicrobial agents by down regulating ROS generation
2001. Discussion about Determination of Berberine Hydrochloride Tablets by HPLC [J]
2002. Discussion on Methods of Content Determination in Berberine Hydrocloride Tablets
2003. Berberine chitosan-composite-membrane/44ED1C0599AE1FC30EF7807183F5E848″ target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.cambridge.org/core/journals/fruits/article/disease-control-during-peach-preservation-with-a-Berberine chitosan-composite-membrane/44ED1C0599AE1FC30EF7807183F5E848&source=gmail&ust=1581476863256000&usg=AFQjCNGJlqGR6UkrNVDbFjjoSUg29ctvdg”>Disease control during peach preservation with a Berberine -chitosan composite membrane
2004. Displacement of bilirubin from albumin by Berberine
2005. Dissolution Determination of Berberine Hydrochloride in Compound Berberine Tablets by HPLC
2006. Dissolution of Baicalin and Berberine Hydrochloride in Sanhuang Tablets from Different Pharmaceutical Factories
2007. Dissolution properties of salt forms of Berberine
2008. Dissolution rate of Berberine in ermiao pills
2009. Dissolution Test in Vitro of Weiyoujing Tablets of Hydrodynamic Balance System (HBS (Berberine Hydrochloride)[J]
2010. Distribution in vivo of colon-oriented Berberine hydrochloride-carboxymethyl konjac glucomannan pellets in rats
2011. Berberine _re20151023-22093-gy95od.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.academia.edu/download/39384941/Different_concentrations_of_Berberine _re20151023-22093-gy95od.pdf&source=gmail&ust=1581476863256000&usg=AFQjCNFX0xNfzCSnkmmdGTIJ5BRSdFT9VA”>DiVerent concentrations of Berberine result in distinct cellular localization patterns and cell cycle eVects in a melanoma cell line
2012. Diversity of the Gut Microbiota in Dihydrotestosterone-induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine
2013. DNA Binding Mode of the Isoquinoline Alkaloid Berberine with the Deoxyoligonucleotide d(GCCGTCGTTTTACA)2
2014. DNA Damage and Oxidation Damage of Berberine Hydrochloride on Spleen of Mice
2015. DNA Logic Gate Based on the Competitive Reaction Between Hemin and G-Quadruplex/Berberine Composite
2016. DNA-binding cytotoxic alkaloids: comparative study of the energetics of binding of Berberine , palmatine, and coralyne
2017. Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine )
2018. Dose-dependent AMPK-dependent and independent mechanisms of Berberine and metformin inhibition of mTORC1, ERK, DNA synthesis and proliferation in …
2019. Dose-dependent effects of Berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells
2020. Dose-dependent effects of Berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells.
2021. Dose-effect relationship of Berberine and analogues on antibacterial metabolism of Bacillus shigae by microcalorimetry
2022. Dose-effect relationship of Berberine and analogues on antibacterial metabolism of Bacillus shigae by microcalorimetry.
2023. Dose-response effect of Berberine on bile acid profile and gut microbiota in mice
2024. Dose–response of Berberine on hepatic cytochromes P450 mRNA expression and activities in mice
2025. Downregulation of cellular c-Jun N-terminal protein kinase and NF-κB activation by Berberine may result in inhibition of herpes simplex virus replication
2026. Down-regulation of c-Ki-ras2 gene expression associated with morphologic differentiation in human embryonal carcinoma cells treated with Berberine .
2027. Down-regulation of cyclin B1 and up-regulation of Wee1 by Berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle
2028. Down-regulation of cyclin B1 expression by Berberine promotes leukemia cells entry into G2/M phase of cell cycle
2029. Downregulation of inflammatory cytokines by Berberine attenuates Riemerella anatipestifer infection in ducks
2030. Berberine &ots=a_RIvdZWA8&sig=4vwQf9atSulUJNOfS3PDbfpO7lU” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://books.google.com/books?hl%3Den%26lr%3Dlang_en%26id%3DnzSoDwAAQBAJ%26oi%3Dfnd%26pg%3DPA283%26dq%3D%2BBerberine %26ots%3Da_RIvdZWA8%26sig%3D4vwQf9atSulUJNOfS3PDbfpO7lU&source=gmail&ust=1581476863259000&usg=AFQjCNFaZdrwyLBSL5OaPY31tfHOONfPcQ”>Drug Delivery Systems for the Controlled Delivery of Berberine
2031. Drug-carrying capacity and anticancer effect of the folic acid-and Berberine -loaded silver nanomaterial to regulate the AKT-ERK pathway in breast cancer
2032. Drug–drug interactions between Ketoconazole and Berberine in rats: pharmacokinetic effects benefit pharmacodynamic synergism
2033. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of Berberine
2034. Dual-functionalised shellac nanocarriers give a super-boost of the antimicrobial action of Berberine
2035. Dual‐Stimuli‐Responsive Gut Microbiota‐Targeting Berberine ‐CS/PT‐NPs Improved Metabolic Status in Obese Hamsters
2036. Dual-Targeting of AR and Akt Pathways by Berberine in Castration-Resistant Prostate Cancer
2037. Dyed fabrics modified via assembly with phytic acid/Berberine for antibacterial, UV resistance, and self-cleaning applications
2038. Dyeing behaviors of Berberine , palmatine, and dye extracted from Phellodendron bark on silk fabric
2039. Dyeing of anionic modified cotton fabric with natural dye Berberine
2040. Dyeing of anionic modified cotton fabric with natural dyes extracted from Berberine
2041. Dyeing of soybean protein fibers with Berberine [J]
2042. Dyeing Properties of Berberine on Cationic Dyeable Polyester
2043. Dynamic intracellular localization of natural alkaloids in different human tumor cell lines: a case study with Berberine
2044. E. coli QS inhibition by TCM Inhibitory effect of two traditional Chinese medicine monomers, Berberine and matrine, on the quorum sensing system of antimicrobial …
2045. Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product Berberine
2046. Effect and mechanism of Berberine inhibiting cardiac fibroblasts proliferation and collagen protein synthesis induced by AngⅡ [J]
2047. Effect and mechanism of EGFR expression in macrophages on the anti-cancer effect of Berberine on colorectal cancer
2048. Effect and mechanisms of Berberine on hyperlipidemic and insulin resistant rats
2049. Effect and Mechanisms of Berberine on Proliferation of Ehrlich Ascites Tumor Cell in Mice [J]
2050. Effect of a combination of Berberine and monacolin on CYP enzymes: an oral cocktail interaction study in healthy volunteers
2051. Effect of a food supplement containing Berberine , monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: a randomized, double-blind, placebo …
2052. Effect of Alstonia scholaris in Enhancing the Anticancer Activity of Berberine in the Ehrlich Ascites Carcinoma-Bearing Mice
2053. Effect of anemonin and Berberine on E-selectin expression in rat intestinal microvascular endothelial cells
2054. Effect of Antibacterial Activities of Berberine by Introduction of Lipophilic Aryl in its 9-position [J]
2055. Effect of Astragalus polysaccharides and Berberine on carbohydrate metabolism and cell differentiation in 3T3-L1 adipocytes
2056. Effect of auxins on Berberine synthesis in cell suspension culture of Coscinium fenestratum (Gaertn.) Colebr—A critically endangered medicinal liana of Western …
2057. Effect of Baicalin and Berberine Against Ureaplasma Urealyticum in Vitro
2058. Effect of baicalin and Berberine on transport of nimodipine on primary‐cultured, rat brain microvascular endothelial cells1
2059. Effect of benzyl alcohol on Berberine dyeing of acrylic fibers
2060. Effect of Berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion
2061. Berberine -against-cerebral-ischemia-and-reperfusion-inv” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://mdanderson.elsevierpure.com/en/publications/effect-of-Berberine -against-cerebral-ischemia-and-reperfusion-inv&source=gmail&ust=1581476863261000&usg=AFQjCNH8kpw67Czoan_eaHx_jY8d7iq88A”>Effect of Berberine against cerebral ischemia and reperfusion involving in the methylation of PPARγ promoter
2062. Effect of Berberine alkaloid on cholera vibrio and its endotoxin.
2063. Effect of Berberine alkaloids on Bifidobacterium adolescentis growth by microcalorimetry
2064. EFFECT OF Berberine ALONE OR IN COMBINATION WITH ARGON ION LASER TREATMENT ON 9L RAT GLIOMA CELL LINE
2065. Effect of Berberine alone or in combination with argon ion laser treatment on 9L rat glioma cell line.
2066. Effect of Berberine and (±)-bicuculline isolated fromCorydalis chaerophylla on spore germination of some fungi
2067. Effect of Berberine and Berberis aetnensis C. Presl. alkaloid extract on glutamate‐evoked tissue transglutaminase up‐regulation in astroglial cell cultures
2068. Effect of Berberine and Berberis aetnensis C. Presl. alkaloid extract on tissue transglutaminase in primary astroglial cell cultures
2069. Effect of Berberine and Dioscin on Expression of Saccharometabolism Disorders Trophocyte MLN64 mRNA and Placental Hormone Secretion
2070. Effect of Berberine and some antibiotics on the growth of microorganisms
2071. Effect of Berberine bisulfate on platelet hemostasis in thrombocytopenia patients
2072. Effect of Berberine Chloride on Absorption Rate of Cyclosporin A by Small Intestine in Rat
2073. Effect of Berberine chloride on caspase-3 dependent apoptosis and antioxidant capacity in the hippocampus of the chronic cerebral hypoperfusion rat model
2074. Effect of Berberine chloride on long term potentiation (ltp) at dentate gyrus in streptozotocin-induced diabetic rats
2075. Effect of Berberine combined with bone marrow mesenchymal stem cells on energy metabolism of HUVECs damaged by high glucose
2076. Effect of Berberine combined with risperidone therapy on endocrine hormones and oxidative stress in patients with schizophrenia
2077. Effect of Berberine derivative HB-13 on IFN-γ secretion in cultured HaCaT cells
2078. Berberine _Gel_on_Periodontal_Inflammation_Clinical_and_Histological/links/0046352d01c4f29413000000.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Iman_Parisay2/publication/259640580_Effect_of_Berberine _Gel_on_Periodontal_Inflammation_Clinical_and_Histological/links/0046352d01c4f29413000000.pdf&source=gmail&ust=1581476863262000&usg=AFQjCNHUHCjsvh0xIgAeCGa2ne6LocV7UA”>Effect of Berberine Gel on Periodontal Inflammation: Clinical and Histological
2079. Effect of Berberine HCl on pharmacokinetics of cyclosporine A in human
2080. Effect of Berberine Hydrochloride and Vitamin E on Learning and Memory in Streptozotocin-Induced Diabetes in Rats
2081. Effect of Berberine hydrochloride from coptis Chinensis franch on the proliferation of three kinds of carcinoma cell lines [J]
2082. Effect of Berberine hydrochloride on grass carp Ctenopharyngodon idella serum bactericidal activity against Edwardsiella ictaluri
2083. Effect of Berberine Hydrochloride on Lipid Metabolism, Endocrine and Antioxidan Function of Meat Rabbit
2084. Effect of Berberine hydrochloride on muscarinic receptors
2085. Effect of Berberine Hydrochloride on Ornithine Decarboxylase Expression in Colon Cancer HT29 cells
2086. Effect of Berberine Hydrochloride on Slaughter Performance and Meat Quality of Rabbit
2087. Effect of Berberine Hydrochloride on the Expression of Bone Gla Protein and Interleukin-6 in the Periodontal Tissues of Rats
2088. Effect of Berberine hydrochloride on the expression of interleukin-1beta and tumor necrosis factor-alpha in periodontal tissues in rats
2089. Effect of Berberine hydrochloride on the proliferation, apoptosis and cytokine secretion of splenocytes in mice
2090. Effect of Berberine hydrochloride on the secretion of monocyte chemoattractant protein-1 from human periodontal ligament cells in vitro
2091. Effect of Berberine hydrochloride-functionalized gold nanoparticles on calf thymus DNA: a biophysical study
2092. Effect of Berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms
2093. Effect of Berberine in Tumor Necrosis Factor-α Induced Inflammation
2094. Effect of Berberine on a cellular model of non-alcoholic fatty liver disease
2095. Effect of Berberine on acetylcholine-induced atrial fibrillation in rabbit
2096. Effect of Berberine on adhesion characteristic of PG cell line from highly metastatic human giant cell lung carcinoma
2097. Effect of Berberine on airway inflammation and mucus hypersecretion in mice with chronic obstructive pulmonary disease and its molecular mechanism
2098. Effect of Berberine on Angiogenesis and HIF-1α/VEGF Signal Transduction Pathway in Rats with Cerebral Ischemia-Reperfusion Injury
2099. Effect of Berberine on apoptosis and expression of Bax and Bcl-2 proteins in HeLa cells
2100. Effect of Berberine on AQP4 Expression in Focal Cerebral Ischemia Area in Diabetic Rats
2101. Effect of Berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells
2102. Effect of Berberine on barrier function in a human retinal pigment epithelial cell line
2103. Effect of Berberine on Blood Glucose and Peripheral Neuropathy in Type 2 Diabetes Patients
2104. Effect of Berberine on bone mineral density in SAMP6 as a senile osteoporosis model
2105. Effect of Berberine on cardiac arrhythmia following coronary artery occlusion and its mechanism
2106. Effect of Berberine on Cardiac Function and Plasma Inflammatory Factors in Chronic Heart Failure
2107. Effect of Berberine on cardiac hypertrophy induced by isoproterenol in rats [J]
2108. Effect of Berberine on catecholamine levels in rats with experimental cardiac hypertrophy
2109. Effect of Berberine on CDK9 and cyclin T1 expression in skeletal muscle of diabetic rats induced by streptozotocin and a high-carbohydrate/high-fat diet
2110. Effect of Berberine on Cdk9 and cyclin T1 expressions in myocardium of diabetic rats
2111. Effect of Berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with p53/cyclin D1 and PI3K/Akt
2112. Effect of Berberine on cell survival in the developing rat brain damaged by MK-801
2113. Effect of Berberine on Cerebral Pial Microcirculation in Cerebral Ischemic Rats [J]
2114. Effect of Berberine on Cognitive Impairment and Hippocampal Lesion in Diabetic Rats
2115. Effect of Berberine on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials
2116. Effect of Berberine on cytosolic free Ca~(2+) concentration in cultured myocardial cells of neonatal rat
2117. Effect of Berberine on cytosolic free calcium concentration in isolated ventricular myocytes of adult rats
2118. Effect of Berberine on cytosolic free calcium of rat myocardial cells in vitro
2119. Effect of Berberine on D-dimer, fibrinogen and interleukin-6 in peripheral blood of ovarian cancer patients
2120. Effect of Berberine on depression-and anxiety-like behaviors and activation of the noradrenergic system induced by development of morphine dependence in …
2121. Effect of Berberine on Electrolyte in Renal Transplanted Recipients Taking Cyclosporin A
2122. Effect of Berberine on enterotoxin-induced intestinal fluid accumulation in rats
2123. Effect Of Berberine On Epigenetic Regulation Mediated By Histone Deacetylases Targeted Chromatin Remodeling In A549 Human Nonsmall Cell Lung Cancer …
2124. Effect of Berberine on Escherichia coli, Bacillus subtilis, and their mixtures as determined by isothermal microcalorimetry
2125. Effect of Berberine on expression of Bcl-2, Caspase-3 in cerebral ischemia reperfusion in rats
2126. Effect of Berberine on expression of fibronectin and connective tissue growth factor in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats [J]
2127. Effect of Berberine on expression of hepatocyte nuclear factor-4α in rats with fructose-induced insulin resistance
2128. Effect of Berberine on expression of transforming growth factor-beta1 and type IV collagen proteins in mesangial cells of diabetic rats with nephropathy
2129. Effect of Berberine on Expressions of Cell Adhesion Molecules in Rats with Middle Cerebral Artery Occlusion [J]
2130. Effect of Berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats
2131. Effect of Berberine on extracellular release of HMGB1.
2132. Effect of Berberine on fructose-induced insulin resistance and expression of tumor necrosis factor-alpha in liver of rats
2133. EFFECT OF Berberine ON FUNCTION OF MEMORY AND LEARN IN MICE [J]
2134. Effect of Berberine on gastric precancerous lesions in rats and its mechanism
2135. Effect of Berberine on Gene Expression of Adiponectin by IL-6 Induced Insulin Resistance in 3T3-L1 Adipocyte
2136. Effect of Berberine on gene expression of adiponectin in type 2 diabetic mellitus rats
2137. Effect of Berberine on glucokinase and its related glucose metabolism in rats with insulin-secretion deficiency [J]
2138. EFFECT OF Berberine ON GLUTAMATE-INDUCED CYTOTOXICITY IN PC12 AND N2A CELLS
2139. Effect of Berberine on growth of the callus cultures of several species
2140. Effect of Berberine on Helicobacter pylori-induced human gastric epithe-lial cells injury
2141. Effect of Berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine-and …
2142. Effect of Berberine on Hepatocytes of Obstructive Jaundice Rats
2143. Effect of Berberine on hippocampal tissue oxidative stress levels and BDNF expression in diabetic encephalopathy rats
2144. Effect of Berberine on HL-60 cell proliferation, apoptosis and vascular endothelial growth factor receptor 2 expression
2145. Effect of Berberine on HMGB1 Release from Macrophages and its Mechanism
2146. Effect of Berberine on human endometrial carcinoma cell line Ishikawa co-cultured with TAM [J]
2147. Effect of Berberine on human lung carcinoma cell line A549 and experimental lung cancer
2148. Effect of Berberine on HuR accumulation in necleus in macrophages.
2149. EFFECT OF Berberine ON HYDROGEN PEROXIDE INDUCED ALTERATIONS OF ELECTRICAL ACTIVITY OF GUINEA PIG PAPILARY MUSCLES
2150. Effect of Berberine on In Vitro Metabolism of Sulfonylureas: A herb‐drug interactions study
2151. Effect of Berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial
2152. Effect of Berberine on insulin secretion and glucokinase activity of NIT-1 cells
2153. Effect of Berberine on Insulin, GLP-1R and DPP4 Gene Expression Levels in Streptozotocin Induced Diabetic Rats
2154. Effect of Berberine on interleukin 8 and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line
2155. Effect of Berberine on intestinal secretion mediated by Escherichia coli heat-stable enterotoxin in jejunum of pigs.
2156. Effect of Berberine on Intimal Hyperplasia and Vascular Remodeling After Balloon Withdrawal Injury of Rabbit Carotid artery
2157. Effect of Berberine on intracellular free CA2+ concentration in cultured brain cells
2158. Effect of Berberine on invasion and migration of PG cells from a high metastatic human giant lung carcinoma cell line
2159. Effect of Berberine on islet β-cell function in type 2 diabetes mellitus (damp-heat type)
2160. Effect of Berberine on Islet?-cell Function in Type 2 Diabetes Mellitus (Damp-Heat Type)
2161. Effect of Berberine on left ventricular remodeling in renovascular hypertensive rats
2162. Effect of Berberine on lipid metabolism and atherosclerosis of atherosclerotic rabbits
2163. Effect of Berberine on lipid metabolism and expressions of low density lipoprotein receptor and scavenger receptor class‐B type 1 genes in livers of hyperlipidemic …
2164. Effect of Berberine on lipopolysaccharide-induced monocyte chemotactic protein-1 and interleukin-8 expression in a human retinal pigment epithelial cell line
2165. Effect of Berberine on Liver Fibrosis in Mice
2166. Effect of Berberine on LPS-induced tranendothelial migration of leukocytes [J]
2167. Effect of Berberine on membrane fluidity and membrane protein fluorescence of rabbit red-blood cells.
2168. Effect of Berberine on monocyte chemotactic protein-1 and cytokine-induced neutrophil chemoattractant-1 expression in rat lipopolysaccharide-induced uveitis
2169. Effect of Berberine on mRNA expression levels of hepatic glucokinase, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase in type 2 diabetic Chinese …
2170. Effect of Berberine on MUC5AC Mucin Gene Expression and Mucin Production from Human Airway Epithelial Cells
2171. Effect of Berberine on myoelectric activity and transit of the small intestine in rats
2172. Effect of Berberine on Nasal Polyp-derived Fibroblast
2173. Effect of Berberine on nitric oxide production during oxygen-glucose deprivation/reperfusion in OLN-93 oligodendrocytes.
2174. Effect of Berberine on nitric oxide release of rat intestinal mucous microvascular endothelial cells
2175. Effect of Berberine on p53 expression by TPA in breast cancer cells
2176. Effect of Berberine on pentylenetetrazol-induced seizures in rats
2177. Effect of Berberine on peripheral neuropathy of type 2 diabetic model rats
2178. Effect of Berberine on pharmacokinetics of digoxin after oral administration to rats
2179. Effect of Berberine on positive transcription elongation factor b expression in diabetic rat retinas [J]
2180. Effect of Berberine on PPARalpha/delta/gamma expression in type 2 diabetic rat retinae.
2181. Effect of Berberine on PPARs expression in myocardium of diabetic rats
2182. Effect of Berberine on PPARα/NO activation in high glucose-and insulin-induced cardiomyocyte hypertrophy
2183. Effect of Berberine on PPARα/δ/γexpression in type 2 diabetic rat kidney
2184. Effect of Berberine on PPARα-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV
2185. Effect of Berberine on Prevention of 7, 12 Dimethylbenz (α) Anthracene Induced Mammary Carcinogenesis in Rats
2186. Effect of Berberine on proinflammatory cytokine production by ARPE-19 cells following stimulation with tumor necrosis factor-α
2187. Effect of Berberine on proliferation and apoptosis of gastric adenocarcinoma cells AGS
2188. Effect of Berberine on proliferation and apoptosis of MCF-7 cells
2189. Effect of Berberine on proliferation and secretion of transforming growth factor-β_1 of glomerular mesangial cells from diabetic nephropathy rats
2190. Effect of Berberine on Proliferation of Pulmonary Artery Smooth Muscle Cells in Rats [J]
2191. Effect of Berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich …
2192. Effect of Berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells
2193. Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters
2194. Effect of Berberine on proto-oncogene c-fos expression inducedby focal cerebral ischemia in rats
2195. Effect of Berberine on radiosensitivity of cervical cancer cells
2196. Effect of Berberine on regression of pressure-overload induced cardiac hypertrophy in rats
2197. Effect of Berberine on Restenosis after Percutaneous Transluminal Angioplasty of carotid artery in rabbits [J]
2198. Effect of Berberine on Sensitivity Enhances of K562/DOX Cells to Doxorubicin [J]
2199. Effect of Berberine on serum C-reactive protein in obese patients
2200. Effect of Berberine on serum inflammatory mediators and patho-morphology of beta cells in rats with type 2 diabetes [J]
2201. Effect of Berberine on serum retinol-binding protein4 contents in patients with type 2 diabetes mellitus [J]
2202. Effect of Berberine on serum superoxide dismutase activity, MDA content and neural function in rats after cerebral ischemia reperfusion [J]
2203. Effect of Berberine on slow inward ionic current in guinea pig ventricular papillary muscle
2204. Effect of Berberine on spatial learning and memory impairment in Alzheimer’s disease model rats with okadaic acid and its mechanism
2205. Effect of Berberine on Staphylococcus epidermidis biofilm formation
2206. Effect of Berberine on Testosterone secretion from Testicular TM3 cell lines in hypoxia condition.
2207. Effect of Berberine on the antioxidant status, ultrastructural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats
2208. Effect of Berberine on the atrial natriuretic peptide secretion in cardiac atria (1150.9)
2209. Effect of Berberine on the autolytic enzyme system of methicillin-resistant Staphylococcus aureus [J]
2210. Effect of Berberine on the blood concentration of cyclosporine A in the renal transplant recipients
2211. Effect of Berberine on the brain damage of glycated rats induced by D-galactose
2212. Effect of Berberine on the cytosolic calcium concentration in the single ventricular cell of guinea pig
2213. Effect of Berberine on the cytosolic calcium concentration in the single ventricular cell of guinea pig [J]
2214. Effect of Berberine on the diaphragm in rabbits
2215. Effect of Berberine on the differentiation and apoptosis of K562 cell line
2216. Effect of Berberine on the differentiation of adipocyte
2217. Effect of Berberine on the endoplasmic reticulum stress-related apoptosis in pancreatic β cells
2218. Effect of Berberine on the expression of lipid metabolism-associated gene PPARα and CPTIA
2219. Effect of Berberine on the expression of nephrin, podocin and intergrin α3β1 in diabetic nephropathy rats
2220. Effect of Berberine on the Expression of Nuclear Factor Kappa B, Vascular Cell Adhesion Molecule-1 and Monocyte Chemoattractant Protein-1 in Carotid Artery …
2221. Effect of Berberine on the expression of P-glycoprotein in the epileptic rat’s brain tissue
2222. Effect of Berberine on the expression of phosphorylation tau proteins in frontal cortex of rats with Alzheimer’s disease induced by okadaic acid [J]
2223. Effect of Berberine on the fatty acid composition of Vibrio cholerae and Vibrio cholerae biotype eltor.
2224. Effect of Berberine on the function of myosin and on the contractility of intestinal and gastric smooth muscle [J]
2225. Effect of Berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats
2226. Effect of Berberine on the insulin resistance and TLR4/IKKbeta/NF-kappaB signaling pathways in skeletal muscle of obese rats with insulin resistance
2227. Effect of Berberine on the levels of endothelium-1, nitric oxide, platelet derived growth factor and transfer growth factor-β1 in rabbit carotid artery injured by balloon
2228. Effect of Berberine on the Levels of Nitric Oxide and Endothelin-1 after Balloon Withdrawal Injury of Rabbit Carotid Artery
2229. Effect of Berberine on the MMP-9 and TIMP-1 gene expression of alveolar and peritoneal macrophages from diabetic rats [J]
2230. Effect of Berberine on the mRNA expression of nitric oxide synthase (NOS) in rat corpus cavernosum
2231. Effect of Berberine on the mRNA expression of phosphodiesterase type 5 (PDE5) in rat corpus cavernosum</li
2232. Effect of Berberine on the osteogenic differentiation of bone marrow mesenchymal cells [J]
2233. Effect of Berberine on the peristalsis of cavy small intestine [J]
2234. Effect of Berberine on the pharmacokinetics of carbamazepine and its metabolism in rats [J]
2235. Effect of Berberine on the pharmacokinetics of substrates of CYP3A and P‐gp
2236. Effect of Berberine on the proinflammatory cytokines production in mice
2237. Effect of Berberine on the proliferation and apoptosis of a human skin squamous cell carcinoma cell line A431
2238. Effect of Berberine on the proliferation and apoptosis of lung cancer stem cells and the possible mechanism
2239. Effect of Berberine on the ratio of high-molecular weight adiponectin to total adiponectin and adiponectin receptors expressions in high-fat diet fed rats
2240. Effect of Berberine on the viability of adipose tissue-derived mesenchymal stem cells in nutrients deficient condition
2241. Effect of Berberine on the yield of pyrimidine dimers in uv-irradiated DNA
2242. Effect of Berberine on TNF-α-induced VEGF Expression via NF-κB Signaling Pathway
2243. Effect of Berberine on Toll-like Receptor 2 Signaling Pathway and Inflammatory Cytokines
2244. Effect of Berberine on transit time of human small intestine
2245. Effect of Berberine on Transit Time of Human Small Intestine [J]
2246. Effect of Berberine on Tyrosine Decarboxylase Activity of Streptococcus faeclis
2247. Effect of Berberine on visfatin expression in 3T3-L1 adipocytes
2248. Effect of Berberine preconditioning on intestinal injury caused by liver cold ischemia/reperfusion in rats
2249. Effect of Berberine pretreatment on hypoxia/reoxygenation-induced apoptosis in human renal tubular epithelial cells
2250. Effect of Berberine sulphate on Entamoeba histolytica
2251. Effect of Berberine treatment on the expressions of oxLDL, CD36 and PPAR? of macrophages from diabetic rats
2252. Effect of Berberine , glaucine, stephaglabrine and sanguiritrine on neuromuscular transmission
2253. Effect of Berberine , liensinine and neferine on HERG channel expression
2254. Effect of Berberine , liensinine and neferine on HERG channel expression [J]
2255. Effect of carbon dioxide and ethylene on Berberine production and cell browning in Thalictrum minus cell cultures
2256. Effect of catalpol, Berberine , and their combination on expression of Glut4 protein and C-Cb1 associated protein in insulin resistant 3T3-L1 adipocytes [J]
2257. Effect of catapol, Berberine , and their combination on insulin resistant 3T3-L1 adipocytes
2258. Effect of Compatible Compound Metformin and Berberine on Neural System of Diabetic Rats
2259. Effect of curcumin, Berberine and its compatibility on glucose and lipid metabolism in db/db mice
2260. Effect of Denuding and Undenuding the Sugarcoat on The Determination of Berberine in Sanhuang Tablets
2261. Effect of Different Extracting Methods on the Content of Berberine Hydrochloride in Rhizoma Coptis
2262. Effect of different nitrogen concentrations on the growth and contents of Berberine in rhizome of Coptis chinensis Franch
2263. Effect of Different Ultrasonic Frequencies on Extraction Rate of Berberine Chloride from Phellodendron chinese Schneid [J]
2264. Effect of enhanced UV-B radiation on metabolism and Berberine content of Coptis chinensis
2265. Effect of environmental factors on allelopathic inhibition of Microcystis aeruginosa by Berberine
2266. Effect of evodiamine and Berberine on miR-429 as an oncogene in human colorectal cancer
2267. Effect of evodiamine and Berberine on the interaction between DNMTs and target microRNAs during malignant transformation of the colon by TGF-β1
2268. Effect of extract method on pharmacokinetics of baicalin and Berberine in dogs
2269. Effect of Extracting Temperature to Microwave Irradiation of Berberine
2270. Effect of Extraction on Berberine Hydrochloride Transfer Rate for Lianxie Capsules Decomposed Recipes
2271. Effect of food on the oral bioavailability of Berberine and monacolin administered in combination in healthy male volunteers
2272. Effect of gibberellic acid on Berberine and tyrosine accumulation in Coptis japonica
2273. Effect of Glucosidorum Tripterygll Totorum, Berberine and Daunorubicin on Acute Lymphocyte Leukemia Cells and Comparison of Different Tetrazolium Salt Assays
2274. Effect of growth regulators, carbon source and cell aggregate size on Berberine production from cell cultures of Tinospora cordifolia Miers
2275. Effect of Host Trees on Berberine Content in Stem of Tinospora cordifolia Climber: A Preliminary Study
2276. Effect of Hydrochloric Acid-methyl Alcohol on Extraction Rate of Berberine Chloride from Berberis tsienii Ying
2277. Effect of inhibitor Berberine of the morphology on Human tongue cancer Tca8113 cell pine
2278. Effect of ion pairing on the fluorescence of Berberine , a natural isoquinoline alkaloid
2279. Effect of ion-pair formation with bile salts on the in vitro cellular transport of Berberine
2280. Effect of jatrorrhizine, Berberine , Huanglian Decoction and compound-mimic prescription on blood glucose in mice
2281. Effect of long-term administration of Berberine on scopolamine-induced amnesia in rats
2282. EFFECT OF L-TYROSINE ON Berberine SYNTHESIS IN COPT1S CHINENSIS CELLS CULTURED
2283. Effect of metal ions on the interaction between bovine serum albumin and Berberine chloride extracted from a traditional Chinese Herb coptis chinensis franch
2284. Effect of new Berberine derivatives on colon cancer cells
2285. Effect of new nutraceutical formulation with policosanol, Berberine , red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate …
2286. Effect of nitrogen, phosphorus and potassium on the growth of rhizome of Coptis chinensis Franch and its contents of Berberine
2287. Effect of oxygen supply on Berberine production in cell suspension cultures and immobilized cells ofThalictrum minus
2288. Effect of Puerarin, Baicalin and Berberine Hydrochloride on the Regulation of IPEC-J2 Cells Infected with Enterotoxigenic Escherichia coli
2289. Effect of reactive anionic agent on dyeing of cellulosic fibers with a Berberine colorant
2290. Effect of reactive anionic agent on dyeing of cellulosic fibers with a Berberine colorant—part 2: anionic agent treatment and antimicrobial activity of a Berberine dyeing
2291. Effect of Resistance Training and Berberine Chloride Supplementation on IGF-1, PDGF, and VEGF Gene Expression in Hippocampal Tissue of Diazinon …
2292. Effect of Rhizoma Coptidis and Radix Rehmanniae with different ratio on pharmacokinetics of Berberine in rats
2293. Effect of Rhizoma Coptidis coadministration with Cortex Cinnamomi on tissue distribution of Berberine in rats
2294. Effect of traditional Chinese medicine Berberine on type 2 diabetes based on comprehensive metabonomics
2295. Effect of ultrasonic extraction on extraction rate of Berberine
2296. Effectiveness and safety of bifidobacteria and Berberine in people with hyperglycemia: study protocol for a randomized controlled trial
2297. Effectiveness Evaluation Analysis on Berberine Tablets Combination with Metformin Treating Type 2 Diabetes
2298. Effects and action mechanisms of Berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice
2299. Effects and interaction of icariin, curculigoside, and Berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption
2300. Effects and mechanism of Berberine on the hypertensive renal injury rats induced by enriched high fat-salt-fructose diet
2301. Effects and mechanisms of Berberine in diabetes treatment
2302. Effects and underlying mechanism of Berberine on renal tubulointerstitial injury in diabetic rats
2303. Effects of 13-alkyl-substituted Berberine alkaloids on the expression of COX-II, TNF-α, iNOS, and IL-12 production in LPS-stimulated macrophages
2304. Effects of 13-hexyl-Berberine hydrochloride and 13-hexyl-palmatine hydrochloride on the activation of nuclear factor-kappa B and phosphorylation of p38 mitogen …
2305. Effects of a combination of puerarin, baicalin and Berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of …
2306. Effects of a new nutraceutical formulation (Berberine , red yeast rice and chitosan) on non-HDL cholesterol levels in individuals with dyslipidemia: results from a …
2307. Effects of a nutraceutical combination (Berberine , red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo …
2308. Effects of a nutraceutical combination containing Berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: a meta …
2309. Effects of a nutraceutical combination of Berberine , policosanol, red yeast rice and antioxidants, on lipid profile in hypercholesterolemic patients: A meta-analysis
2310. Effects of a nutraceutical combination of fermented red rice, liposomal Berberine , and curcumin on lipid and inflammatory parameters in patients with mild-to …
2311. Effects of AM fungi on the Berberine content in Phellodendron chinense seedlings [J]
2312. Effects of Andrographis Paniculata and Berberine Injected to Houhai Point on Anti-diarrhea of Mice
2313. Effects of baicalein, Berberine , curcumin and hesperidin on mucin release from airway goblet cells
2314. Effects of Berberine against radiation-induced intestinal injury in mice
2315. Effects of Berberine and 8-hydroxy dihydroBerberine on vascular endothelial function in type 2 diabetic rats
2316. Effects of Berberine and Atorvastatin on Circulating Endothelial Progenitor Cells in Patients with Acute Coronary Syndrome
2317. Effects of Berberine and cinnamic acid on palmitic acid-induced intracellular triglyceride accumulation in NIT-1 pancreatic β cells
2318. Effects of Berberine and Cortex Moutan Compatible with Dachengqi Decoction on IL-6 and NO of Rats with Intestine-heat and Fu-organ Excess Syndrome
2319. Effects of Berberine and hwangryunhaedok-tang on oral bioavailability and pharmacokinetics of ciprofloxacin in rats
2320. Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
2321. Effects of Berberine and its derivatives on the expression of PTP1B protein in skeletal tissues of type 2 diabetic rats
2322. Effects of Berberine and mangiferin and their combination on glucose uptake in L6 myotubes and the mechanism
2323. Effects of Berberine and Matrine against Formation of Mixed Biofilms of Vulvovaginal Candidiasis [J]
2324. Effects of Berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice
2325. Effects of Berberine and pioglitazone on type 2 diabetes acute insulin secretion and adiponectin [J]
2326. Effects of Berberine and pomegranate seed oil on plasma phospholipid metabolites associated with risks of type 2 diabetes mellitus by U-HPLC/Q-TOF-MS
2327. Effects of Berberine and red yeast on proinflammatory cytokines IL-6 and TNF-α in peripheral blood mononuclear cells (PBMCs) of human subjects
2328. Effects of Berberine and yohimbine on splenocyte apoptosis in septic mice
2329. Effects of Berberine chloride and coadministration with cyclo sporin on liver and small intestine microsomal cytochrome P450 isoenzyme in rat [J]
2330. Effects of Berberine chloride on secondary brain injury in contralateral parietal lobe cortex of TBI model mice
2331. Effects of Berberine chloride on the liver of streptozotocin-induced diabetes in albino Wistar rats
2332. Effects of Berberine Chloride or Bifendate and Coadministration with Cyclosporin on the Movement of Small Intestine in Mice
2333. Effects of Berberine combined with evodiamine on liver HMG-CoA reductase and L-FABP mRNA expression levels in a rat model of hyperlipidemia
2334. Effects of Berberine Combined with Magnolol and Honokiol on the Formation of THP-1 Macrophage-derived Foam Cells
2335. Effects of Berberine derivate CPU 86017 on IKur currents and experimental atrial fibrillation
2336. Effects of Berberine from Cortex Phellodendri Chinensis on osteoporosis in ovariectomized rats
2337. Effects of Berberine gelatin on recurrent aphthous stomatitis: a randomized, placebo-controlled, double-blind trial in a Chinese cohort
2338. Effects of Berberine Hydrochloride and 8-hydroxy DihydroBerberine on the Activity of Acetylcholinesterase (AChE) in the Cerebral Tissue and Serum of Rats
2339. Effects of Berberine hydrochloride on alphar_1-adrenoceptor and voltage dependent calcium channel in vas-cular smooth muscle
2340. Effects of Berberine hydrochloride on nonalcoholic fatty liver disease in rats [J]
2341. Effects of Berberine hydrochloride on periodontal tissues and cytokine expression in rats with experimental periodontitis☆
2342. Effects of Berberine hydrochloride on secretion of interleukin-6 from human periodontal ligament cells cultured in vitro
2343. Effects of Berberine in the gastrointestinal tract—a review of actions and therapeutic implications
2344. Effects of Berberine of L-and T-type calcium channels in guinea pig ventricular myocytes.
2345. Effects of Berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson’s disease
2346. Effects of Berberine on a rat model of chronic stress and depression via gastrointestinal tract pathology and gastrointestinal flora profile assays
2347. Effects of Berberine on acquisition and reinstatement of morphine-induced conditioned place preference
2348. Effects of Berberine on acquisition and reinstatement of morphine-induced conditioned place preference in mice
2349. Berberine _on_Acute_Necrotizing.12.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/pancreasjournal/Fulltext/2017/09000/Effects_of_Berberine _on_Acute_Necrotizing.12.aspx&source=gmail&ust=1581476879648000&usg=AFQjCNGhTmDBEth_-ARSfCtNlJYLqWm-gQ”>Effects of Berberine on acute necrotizing pancreatitis and associated lung injury
2350. Effects of Berberine on adiponectin mRNA expression in 3T3-L1 adipocyte
2351. Effects of Berberine on adipose tissues and kidney function in 3T3-L1 cells and spontaneously hypertensive rats
2352. Effects of Berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo
2353. Effects of Berberine on amelioration of renal artery damage caused by atherosclerosis [J]
2354. Effects of Berberine on angiotensin-converting enzyme and NO/cGMP system in vessels
2355. EFFECTS OF Berberine ON APOPTOSIS AND SURVIVIN GENE IN EXPERIMENTALLY INDUCED DYSPHASIA OF GASTRIC EPITHELIA CELL [J]
2356. Effects of Berberine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells
2357. Effects of Berberine on arylamine N-acetyltransferase activity in human bladder tumour cells
2358. Effects of Berberine on arylamine N-acetyltransferase activity in human colon tumor cells
2359. Effects of Berberine on Atherosclerosis and vulnerable plaque and Serum Levels of Lipid in Atherosclerotic Rabbits [J]
2360. Effects of Berberine on basal and secretagogue-modified ion transport in the rabbit ileum in vitro.
2361. Effects of Berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis
2362. Effects of Berberine on blood glucose regulation of normal mice
2363. Effects of Berberine on cell cycle, DNA, reactive oxygen species, and apoptosis in L929 murine fibroblast cells
2364. Effects of Berberine on cell proliferation, peroxisome proliferation activated receptor gamma, CAAT/enhancer binding protein mRNA and protein expression in 3T3-L1 …
2365. Effects of Berberine on cholesterol efflux in THP-1 macrophage derived foam cells
2366. Effects of Berberine on cholesterol metabolism and Insig-2 gene expression of hyperlipidemic rats
2367. Effects of Berberine on conductivity of heart
2368. Effects of Berberine on Contractile Activity of Circular Muscle in Rat Gastric Body Under High Glucose and Insulin Conditions [J]
2369. Effects of Berberine on C-reactive protein expression in diabetic nephropathy rats
2370. Effects of Berberine on C-type inactivation of Kv1. 4 channel using Xenopus oocytes as carriers
2371. Effects of Berberine on cyclic GMP and cyclic AMP levels in rabbit corpus cavernosum in vitro
2372. Effects of Berberine on Cytoskeleton and Permeability of HUVEC Cells Infected with Influenza Virus
2373. Effects of Berberine on Cytosolic cAMP and Calcium Influx of Rabbit Platelets
2374. Effects of Berberine on delayed afterdepolarizations in ventricular muscles in vitro and in vivo.
2375. Effects of Berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats
2376. Effects of Berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
2377. Effects of Berberine on Digestion and Metabolism of Meat Rabbits
2378. Effects of Berberine on digestion and metabolism of meat rabbits.
2379. Effects of Berberine on DNFB-induced delayed type hypersensitivity in mice
2380. Effects of Berberine on EEG and EEG power spectrum recorded in conscious rabbits
2381. Effects of Berberine on EEG and EEG power spectrum recorded in conscious rabbits [J]
2382. Effects of Berberine on epithelial endoplasmic reticulum stress in a mouse model of dextran sulfate sodium-induced colitis
2383. Effects of Berberine on expression of hepatic sterol regulatory element-binding protein, its control and target genes in type 2 diabetic Chinese hamsters
2384. Effects of Berberine on expression of hepatocyte nuclear factor 4alpha and glucokinase activity in mouse primary hepatocytes
2385. Effects of Berberine on expression of LOX-1 and SR-BI in human macrophage-derived foam cells induced by ox-LDL
2386. Effects of Berberine on fibronectin and p38MAPK signal pathway in rat glomerular mesangial cells cultured under high glucose condition
2387. Effects of Berberine on glucose and lipid metabolism in animal experiment
2388. Effects of Berberine on glucose metabolism in vitro
2389. Effects of Berberine on Glucose Stimulated Glucokinase Translation in NIT-1 Cells
2390. Effects of Berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome
2391. Effects of Berberine on Growth Development and Blood Parameters of Meat Rabbits
2392. Effects of Berberine on growth development and blood parameters of meat rabbits.
2393. Effects of Berberine on growth, liver histology, and expression of lipid-related genes in blunt snout bream (Megalobrama amblycephala) fed high-fat diets
2394. Effects of Berberine on Hemodynamics in Guinea Pigs
2395. Effects of Berberine on Hepatic Sirtuin 1-uncoupling Protein 2 Pathway in Non-alcoholic Fatty Liver Disease Rats Induced by High-fat Diet
2396. Effects of Berberine on Hepatocarcinoma Cell Lines
2397. Effects of Berberine on hippocampal neuronal damage and matrix metalloproteinase‐9 activity following transient global cerebral ischemia
2398. Effects of Berberine on human omental preadipocyte proliferation and differentiation
2399. Effects of Berberine on human rheumatoid arthritis fibroblast-like synoviocytes
2400. Effects of Berberine on IL-1 or tumour necrosis factor induced polymorphonuclear leucocyte-endothelium adhesion
2401. Effects of Berberine on In Vivo Pharmacokinetics of Midazolam and Its Metabolite in Rats
2402. Effects of Berberine on Induced Resistance and Development of Wheat and Preparation of Mixture
2403. Effects of Berberine on Insig-2 and VDR gene expression of HepG2 cell line
2404. Effects of Berberine on intracellular calcium concentration in smooth muscle cells of guinea pig colon
2405. Effects of Berberine on intracellular free calcium in smooth muscle cells of Guinea pig colon
2406. Effects of Berberine on ischemic ventricular arrhythmia
2407. Effects of Berberine on L-DOPA Therapy in 6-Hydroxydopamine-induced Rat Models of Parkinsonism
2408. Effects of Berberine on learning and memory ability in vascular cognitive impairment rats
2409. Effects of Berberine on Learning and Memory of Mice
2410. Effects of Berberine on left atria and trachea in guinea pigs
2411. Effects of Berberine on lipid and glucose metabolism in rats [J]
2412. Effects of Berberine on lipid metabolism and atherosclerosis in hyperlipidemic rabbits and its mechanism
2413. Effects of Berberine on lipid metabolism and PPARγ, INSIG-2 gene expression in adipose tissue of hyperlipidemic rabbits.
2414. Effects of Berberine on lipid metabolism in rats
2415. Effects of Berberine on lipid profile in subjects with low cardiovascular risk
2416. Effects of Berberine on Lymphocyte Proliferation and GM-CSF Production in Mice.
2417. Effects of Berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury
2418. EFFECTS OF Berberine ON MEMBRANE POTENTIAL AND CONTRACTION ACTIVITY OF SMOOTH MUSCLE IN GUINEA PIG PORTAL VEIN [J]
2419. Effects of Berberine on morphological changes of mesenteric vessels in diabetic rats
2420. Effects of Berberine on mRNA expression levels of PPARγ and adipocytokines in insulin-resistant adipocytes
2421. Effects of Berberine on mRNA expression of 11β-Hydroxysteroid dehydrogenase type Ⅰ in insulin-resistant HepG2 cells
2422. Effects of Berberine on Myoelectric Activity and Contractility of Rat Colonic Smooth Muscle
2423. Effects of Berberine on neurological effect and inflammatory factor in diabetes rats
2424. Effects of Berberine on neuronal apoptosis after global cerebral ischemia in mice [J]
2425. Effects of Berberine on neuronal apoptosis related gene after global cerebral ischemia in mice
2426. Effects of Berberine on neurotransmitter induced intracellular free Ca 2+ elevation in isolated brain cells of neonatal rat 1
2427. Effects of Berberine on neurotransmitter-induced intracellular free Ca~(2+) elevation in isolated brain cells of neonatal rat
2428. Effects of Berberine on NLRP3 and IL-1β expressions in monocytic THP-1 cells with monosodium urate crystals-induced inflammation
2429. Effects of Berberine on ovalbumin sensitized ileum smooth muscle strips of guinea pig
2430. Effects of Berberine on oxidative stress and endoplasmic reticulum stress in insulin resistance rats [J]
2431. Effects of Berberine on peripheral nerve function and neuropathic pain in diabetes rats
2432. Effects of Berberine on pharmacokinetics of amlodipine in rats and its potential mechanism
2433. Effects of Berberine on pharmacokinetics of midazolam and rhodamine 123 in rats in vivo
2434. Effects of Berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1 alpha in rats with reversible middle cerebral artery occlusion
2435. EFFECTS OF Berberine ON PLATELET AGGREGATION AND PLASMA LEVELS OF TXB2 AND6-KETO-PGFla IN RATS WITH REVEKSIBLE MIDDLE CEREBRAL …
2436. Effects of Berberine on platelet aggregation and release
2437. Effects of Berberine on Potassium Current in Myocardial Cells of Cardiomyopathic Rats Induced by Abdominal Aorta Constriction
2438. Effects of Berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus
2439. Effects of Berberine on proliferation and apoptosis of human hepatoma Bel-7402 cell line
2440. Effects of Berberine on proliferation and apoptosis of human ovarian cancer cell line SKOV-3 in vitro
2441. Effects of Berberine on Proliferation and Metastasis of Human Endometrial Carcinoma Cell Line Ishikawa [J]
2442. Effects of Berberine on proliferation, cell cycle distribution and apoptosis of human breast cancer T47D and MCF7 cell lines
2443. Effects of Berberine on proliferation, migration and adhesion of lung adenocarcinoma cell line A549
2444. Effects of Berberine on Proto-oncogene c-fos Expression Induced by Global Cerebral Ischemia in Rats
2445. Effects of Berberine on rat jejunal motility
2446. Effects of Berberine on renal function, oxidative stress and renal aldose reductase in rats with diabetic nephropathy [J]
2447. Effects of Berberine on renal tubular of type 2 diabetic rats [J]
2448. Effects of Berberine on serum inflammatory factors and carotid atherosclerotic plaques in patients with acute cerebral ischemic stroke
2449. Effects of Berberine on serum levels of inflammatory factors and inflammatory signaling pathway in obese mice induced by high fat diet
2450. Effects of Berberine on single Ca2+ channel current in cultured embryonic chick ventricular myocytes
2451. Effects of Berberine on skeletal muscle protein metabolism in db/db mice and study of its mechanism
2452. Effects of Berberine on synthesis of platelet TXA2 and plasma PGI2 in rabbits
2453. Berberine &ots=iOgj97O9Gr&sig=XQh0UdzzXN3zgCJcH-H8KhwBN5k” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://books.google.com/books?hl%3Den%26lr%3Dlang_en%26id%3DpqfE9vWjvbEC%26oi%3Dfnd%26pg%3DPA388%26dq%3D%2BBerberine %26ots%3DiOgj97O9Gr%26sig%3DXQh0UdzzXN3zgCJcH-H8KhwBN5k&source=gmail&ust=1581476879652000&usg=AFQjCNEr1Xwie8NTCLyfw42Jf0N-mQPH5A”>Effects of Berberine on the action potential and the delayed rectifier potassium channel in isolated cardiac preparations and ventricular myocytes of guinea pigs
2454. Effects of Berberine on the activity of glucokinase and the gene expression in cultured hepG2 cells
2455. Effects of Berberine on the apoptosis of NIT-1 cells induced by high glucose and saturated fatty acids [J]
2456. Effects of Berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study
2457. Effects of Berberine on the clinical, metabolic and reproductive features of obese polycystic ovary syndrome women
2458. Effects of Berberine on the Expression of Caspase-3 Gene in Human Cervical Cancer Hela Cell
2459. Effects of Berberine on the Expression of GPVI on Platelets of Diabetes Rats [J]
2460. Effects of Berberine on the expression of hepatocyte nuclear factors mRNA in HepG2 cells [J]
2461. Effects of Berberine on the expression of LDLR in human liver cell strain Bel-7402
2462. Effects of Berberine on the expression of vascular endothelial growth factor in HepG2 cells
2463. Berberine -on-the-expressions-of-nrf2-and-ho1-in-endothelial-cells-of-diabetic-rat.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://www.biomedres.info/biomedical-research/effects-of-Berberine -on-the-expressions-of-nrf2-and-ho1-in-endothelial-cells-of-diabetic-rat.pdf&source=gmail&ust=1581476879653000&usg=AFQjCNFOM62BzFCKJmEiS9pmAqsqF9y3Bg”>Effects of Berberine on the expressions of NRF2 and HO-1 in endothelial cells of diabetic rat
2464. Effects of Berberine on the growth and immune performance in response to ammonia stress and high-fat dietary in blunt snout bream Megalobrama amblycephala
2465. Effects of Berberine on the growth performance, antioxidative capacity and immune response to lipopolysaccharide challenge in broilers
2466. Effects of Berberine on the Intractable Heart Failure [J]
2467. Effects of Berberine on the levels of DTH and several important cytokines in the mice induced by DNFB
2468. Effects of Berberine on the pancreatic beta cell apoptosis in rats with insulin resistance
2469. Effects of Berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism
2470. Effects of Berberine on the photosynthetic pigments compositions and ultrastructure of Cyanobacterium Microcystis aeruginosa
2471. Effects of Berberine on the prevention of left ventricular remodeling after acute myocardial infarction
2472. Effects of Berberine on the proliferation and differentiation of HL-60 cells
2473. Effects of Berberine on the proliferation and the protein expression of Bcl-2, Bax on human gastric carcinoma SGC-7901 cells
2474. Effects of Berberine on the proliferation of diabetes mellitus rats vascular smooth muscle cells
2475. Effects of Berberine on the secretion of cytokines and expression of genes involved in cell cycle regulation in THP-1 monocytic cell line
2476. Effects of Berberine on the serum cystatin C levels and urine albumin/creatine ratio in patients with type 2 diabetes mellitus
2477. Effects of Berberine on the transport of P-gp substrates across Caco-2 and L-MDR1 cell monolayers
2478. Effects of Berberine on the vascular smooth muscle cell proliferation, rat carotid artery balloon-injury model and PTEN expression
2479. Effects of Berberine on tumor growth and intestinal permeability in HCT116 tumor-bearing mice using polyamines as targets
2480. Effects of Berberine on ventricular fibrillation threshold and action potentials in rabbit myocardium in vivo
2481. Effects of Berberine on β-secretase activity in a rabbit model of Alzheimer’s disease
2482. Effects of Berberine pretreatment on degree and incubation period of epileptic seizure in mice with penicillin-induced epilepsy
2483. Effects of Berberine , a plant alkaloid, on the growth of anaerobic protozoa in axenic culture.
2484. Effects of Berberine , Chelerythrine, and Sanguinarine on Proliferation in Four Human Immortalized Cell Lines
2485. Effects of Berberine , curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells—Power of …
2486. Effects of Berberine , glaucine, stephaglabrine, and sanguirythrine on neuromuscular transmission
2487. Effects of Berberine , palmatine and total alkaloids from Rhizoma coptidis on cholinergic nerve
2488. Effects of Berberine -evodiamine compatibility on expressions of intestinal ACAT2, ApoB48 and NPC1L1 in hypercholesterolemic rat
2489. Effects of berberis vulgaris fruit extracts and its active component Berberine on morphine dependence hypnosis and locomotor activity in mice
2490. Effects of Berberis vulgaris fruit extracts and its active component, Berberine , on morphine dependence, hypnosis and locomotor activity in mice
2491. Effects of chemical enhancers on the in vitro percutaneous absorption and amount retained in skin of baicalin and Berberine hydrochloride in compound Jiaoxuanling …
2492. Effects of chlorpromazine, Berberine and verapamil on Escherichia coli heat-labile enterotoxin-induced intestinal hypersecretion in rabbit ileal loops
2493. Effects of Cinnamon and Coptis in different compatibility proportion on content of Berberine in Jiaotai Bolus
2494. Effects of cinnamon granules on pharmacokinetics of Berberine in Rhizoma Coptidis granules in healthy male volunteers
2495. Effects of coadministration of Berberine chloride with cyclosporin on liver microsomal cytochrome P450 isoenzyme and mdr1 in rats
2496. Effects of Coadministration of Berberine Hydrochloride with Cyclosporine A on Liver Microsomal Drug Metabolizing Enzymes in Mice
2497. Effects of Complex of Astragalus Polysaccharids and Berberine on Egg Quality
2498. Effects of crude drugs and Berberine hydrochloride on the activities of fungi
2499. Effects of curcumin, Berberine and its compatibility on mRNA expression of glucose and lipid metabolismrelated genes in db/db mice
2500. Effects of decoction on transferring rate of Berberine hydrochloride in Jiawei Ermiaofang [J]
2501. Effects of different concentrations of Berberine on 3T3-L1 adipocyte glycometabolism and inflammatory cytokine expression
2502. Effects of different dose Berberine on hemodynamic parameters and [Ca2+] i of cardiac myocytes of diastolic heart failure rat model
2503. Effects of Different Processing Methods on Berberine Hydrochloride Content of Rhizoma Coptidis [J]
2504. Effects of emodin and Berberine on insulin resistance HepG2 cells [J]
2505. Effects of Evodiae Fructus on targeted distribution of Berberine in rats
2506. Effects of evodiamine and Berberine hydrochloride on cell apoptosis and expression of hTERT-mRNA of human colorectal cancer cell line HT-29 [J]
2507. Effects of evodiamine and Berberine hydrochloride on telomerase activity of human colorectal cancer cell line HT29
2508. Effects of Exenatide combinated with Berberine therapy on early phase insulin secretion in the patients with new onset type 2 diabetes mellitus
2509. Effects of ginseng total saponins with Berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure
2510. Effects of ginseng total saponins with Berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure.
2511. Effects of ginsenoside and Berberine on secretion of immunosuppressive cytokines in lung carcinoma cell line PG
2512. Effects of hypo-and hyperthermia, Berberine and the combination of Berberine with hyperthermia on osteosarcoma cells
2513. Effects of isoquinoline alkaloid Berberine on lipid peroxidation, antioxidant defense system, and liver damage induced by lead acetate in rats
2514. Effects of low retention enema with compound Berberine decoction on anal sinusitis
2515. Effects of Media Environment on the Fluorescence Spectra of Berberine
2516. Effects of Medicinal Herbs on Contraction Rate of Cultured Cardiomyocyte. Possible Mechanisms Involved in the Chronotropic Effects of Hawthorn and Berberine in Neonatal Murine Cardiomyocyte
2517. Effects of multiple washing on cotton fabrics containing Berberine microcapsules with anti-Staphylococcus aureus activity
2518. Effects of neutral sulfate Berberine on LPS-induced cardiomyocyte TNF-α secretion, abnormal calcium cycling, and cardiac dysfunction in rats
2519. Effects of neutral sulfate Berberine on LPS-induced cardiomyocyte TNF-α secretion, abnormal calcium cycling, and cardiac dysfunction in rats1
2520. Effects of oral administration of Berberine on distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats
2521. Effects of pH Value and Heat Treatment on the Antimicrobial Activity of Berberine
2522. Effects of Phosphate, Precursor and Exogenous Berberine on the Production of Alkaloid in Plant Cell Cultures
2523. Effects of probiotics, oligosaccharides, and Berberine combinationson growth performance of pigs
2524. Effects of rapeseed meal, terramycin, Berberine hydrochloride and andrographolide on thyroid function in fattening swine
2525. Effects of Resveratrol, Berberine and Their Combinations on Reactive Oxygen Species, Survival and Apoptosis in Human Squamous Carcinoma (SCC-25) Cells
2526. Effects of Simplex Component of Chinese Medicine Berberine and Ligustrazine on Production of Nitric Oxide of Porcine Oocyte in vitro Maturation [J]
2527. EFFECTS OF TEMPERATURE AND MOBILE PHASE COMPOSITION ON THE INTERACTION BETWEEN Berberine AND IMMOBILIZED β2-ADRENOCEPTOR BY …
2528. Effects of the complex prescription of metformin and Berberine on blood glucose and other indexes of the diabetic rats [J]
2529. Effects of the major alkaloid of Hydrastis canadensis L., Berberine , on rabbit prostate strips
2530. Effects of the Traditional Chinese Medicine Berberine on antiatheroscloresis and antioxidant activities in hyperlipoidemic model rats
2531. Effects of three preparation technologies on the oral bioavailability of Berberine α-hydroxy β-decanoylethyl sulfonate
2532. Effects of type 2 diabetes mellitus on the pharmacokinetics of Berberine in rats
2533. Effects of ultramicro-pulverization on the geniposide and Berberine dissolubility of Huanglianjiedusan
2534. Effects of Various Elicitors on the Production of Berberine in Plant Cell Suspension Cultures of Thalicrtrum rugosum
2535. Effects of veratrine, Berberine , nicotine and atropine on developmental characteristics and survival of the dark-sided cutworm, Euxoa messoria (Lepidoptera …
2536. Effects of water stress on Berberine , jatrorrhizine and palmatine contents in amur corktree seedlings
2537. Effects of β-cyclodextrin on the intestinal absorption of Berberine hydrochloride, a P-glycoprotein substrate
2538. Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized …
2539. Efficacy and safety of Berberine for congestive heart failure
2540. Efficacy and safety of Berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
2541. Efficacy and safety of Berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
2542. Efficacy and Safety of Berberine in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis
2543. Efficacy and safety of Berberine in the treatment of type 2 diabetes with insulin resistance: Protocol for a systematic review
2544. Efficacy and tolerability of a nutraceutical combination (red yeast rice, policosanols, and Berberine ) in patients with low-moderate risk hypercholesterolemia: a …
2545. Efficacy of Berberine alone and in combination for the treatment of hyperlipidemia: a systematic review
2546. Efficacy of Berberine combined with ofloxacin on acute bacillary dysentery in infants and children by retentional enema treatment
2547. Efficacy of Berberine hydrochloride on biochemical parameters in Indian type 2 diabetic patients
2548. Efficacy of Berberine Hydrochloride Tablet in the Treatment of Non-alcoholic Fatty Liver Disease: A Me-ta-analysis
2549. Efficacy of Berberine in controlling foliar rice diseases
2550. Efficacy of Berberine in patients with non-alcoholic fatty liver disease
2551. Efficacy of Berberine in patients with type 2 diabetes mellitus
2552. Efficacy of Berberine , an antimicrobial plant alkaloid, as an endodontic irrigant against a mixed-culture biofilm in an in vitro tooth model
2553. Efficacy of Nutraceutical Combination of Monacolin K, Berberine , and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic …
2554. Electrochemical determination of Berberine at a multi-walled carbon nanotubes-modified glassy carbon electrode
2555. Electrochemical oxidation of Berberine and mass spectrometric identification of its oxidation products
2556. Electrochemical oxidation of Berberine and of its oxidation products at a glassy carbon electrode
2557. Electrochemical studies of Berberine and jatrorubine by pulse polarography
2558. Electropharmacological effects of Berberine on canine cardiac Purkinje fibres and ventricular muscle and atrial muscle of the rabbit.
2559. Electrophysiologic effects of Berberine on isolated sinoatrial and atrioventricular nodes of rabbit.
2560. Electrospun cellulose acetate/gelatin nanofibrous wound dressing containing Berberine for diabetic foot ulcer healing: in vitro and in vivo studies
2561. Elicitation, bioconversion and quantification of Berberine from Cissampelos pareira callus cultures
2562. Elicitor‐induced tyrosine decarboxylase in Berberine ‐synthesizing suspension cultures of Thalictrum rugosum
2563. Elimination of drug resistance plasmids from Shigella by norfloxacin and Berberine
2564. Elucidation of the signaling pathways that mediate Berberine -induced effects in cancer cells
2565. Encapsulation of Berberine in nano-sized PLGA synthesized by emulsification method
2566. Enhanced activity of strobilurin and fludioxonil by using Berberine and phenolic compounds to target fungal antioxidative stress response
2567. Enhanced anti-diabetic effect of Berberine combined with timosaponin B2 in Goto-Kakizaki rats, associated with increased variety and exposure of effective …
2568. Enhanced antimicrobial effect of Berberine in nanogel carriers with cationic surface functionality
2569. Enhanced circulating PCSK9 concentration by Berberine through SREBP-2 pathway in high fat diet-fed rats
2570. Enhanced DNA binding of 9-ω-amino alkyl ether analogs from the plant alkaloid Berberine
2571. Enhanced mineralization of antibiotic Berberine by the photoelectrochemical process in presence of chlorides and its optimization by response surface methodology
2572. Enhanced production of Berberine in In vitro regenerated cell of Tinospora cordifolia and its analysis through LCMS QToF
2573. Enhanced Production of Berberine Through Callus Culture of Tinospora cordifolia (Willd.) Miers ex Hook F. and Thoms.
2574. Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of Berberine chloride in rats
2575. Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of Berberine and evodiamine
2576. Enhancement of arsenic trioxide (As2O3)-mediated apoptosis using Berberine in human neuroblastoma SH-SY5Y cells
2577. Enhancement of Berberine Hypoglycemic Activity by Oligomeric Proanthocyanidins
2578. Enhancement of Berberine production by spermidine in Thalictrum minus cell suspension cultures
2579. Enhancement of Berberine production in suspension cultures of Coptis japonica by gibberellic acid treatment
2580. Enhancement of native fluorescence intensity of Berberine by (2-hydroxypropyl)-β-cyclodextrin in capillary electrophoresis coupled by laser-induced fluorescence …
2581. Enhancement of selectivity and sensitivity for Berberine determination by extraction-fluorophotometry
2582. Enhancement of sodium caprate on intestine absorption and antidiabetic action of Berberine
2583. Enhancing Effect of Berberine on Cyclosporine Against Skin Allograft Rejection in Mice [J]
2584. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of Berberine in rats
2585. Enhancing the antitumor activity of Berberine hydrochloride by solid lipid nanoparticle encapsulation
2586. Environmental impact of switching from the synthetic glucocorticoid prednisolone to the natural alkaloid Berberine
2587. Enzymatic extraction and dyeing ability of Berberine dyestuff from phellodenron [J]
2588. Enzymatic Synthesis of Chiral Amines using ω‐Transaminases, Amine Oxidases, and the Berberine Bridge Enzyme
2589. Enzyme-inducing effects of Berberine on cytochrome P450 1A2 in vitro and in vivo
2590. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis
2591. Equine Cutaneous Leishmaniasis: Treatment with Berberine Sulphate.
2592. Erratum to: Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation
2593. Estimation of Berberine in ayurvedic formulations containing Berberis aristata
2594. Berberine _in_Berberis_Extracts_by_RP-HPLC/links/0046351d4bf6f6e9c9000000.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Jaya_Raja_Kumar/publication/244989109_Estimation_of_Berberine _in_Berberis_Extracts_by_RP-HPLC/links/0046351d4bf6f6e9c9000000.pdf&source=gmail&ust=1581476879659000&usg=AFQjCNEBDO-_x3q8CK6f5bzX_WD41K_EGg”>Estimation of Berberine in berberis extracts by RP-HPLC
2595. Estimation of biomarkers Berberine and gallic acid in polyherbal formulation punarnavashtak kwath and its clinical study for hepatoprotective potential
2596. Eulipidemic effects of Berberine administered alone or in combination with other natural cholesterol-lowering agents
2597. Eur J Endocrinol: A clinical study on the short term effect of Berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary …
2598. Evaluation of a 13-hexyl-Berberine hydrochloride topical gel formulation
2599. EVALUATION OF ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY OF RUTIN AND Berberine
2600. Evaluation of anti-cholinesterase and anti-inflammation activities of Berberine derivatives
2601. Evaluation of Anticoagulant and Antithrombotic Activities of Berberine : A Focus on the Ameliorative Effect on Blood Hypercoagulation
2602. Evaluation of Berberine as a natural fungicide: biodegradation and antimicrobial mechanism
2603. Evaluation of Berberine as an Alternative to Antibiotics in Nursery Pig Diets
2604. Evaluation of Berberine chloride as a new antibacterial agent against gram-positive bacteria for medical textiles
2605. Evaluation of Berberine /bovine serum albumin nanoparticles for liver fibrosis therapy
2606. Evaluation of biotransformed Berberine derivatives as anti inflammatory drugs: An in silico study
2607. Evaluation of Carvedilol and Berberine on Thiol Related Pathways
2608. Evaluation of cytotoxicity effects of combination Nano-Curcumin and Berberine in breast cancer cell line
2609. Evaluation of HPLC and spectrophotometric methods for analysis of bioactive constituent Berberine in stem extracts of Coscinium fenestratum
2610. Evaluation of synergetic anticancer activity of Berberine and curcumin on different models of A549, Hep-G2, MCF-7, Jurkat, and K562 cell lines
2611. Evaluation of the alpha-adrenoceptor antagonistic action of Berberine in isolated organs.
2612. Evaluation of the antimicrobial mode of Berberine by LC/ESI-MS combined with principal component analysis
2613. Evaluation of the biological potencies of newly synthesized Berberine derivatives bearing benzothiazole moieties with substituted functionalities
2614. Evaluation of the effect of a plant alkaloid (Berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro.
2615. Evaluation of the serum sex hormones levels and alkaline phosphatase activity in rats’ testis after administering of Berberine in experimental varicocele
2616. Evaluation of vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of Berberine as an anticancer …
2617. Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing Berberine , hypaconitine and skimmianine on the …
2618. Examination of Berberine dye using GC-MS after selective degradation treatments
2619. Examination of the In Vitro Dissolution of Berberine in the Coptis Root Powder of Different Granule Diameters
2620. Excretion of Berberine and its metabolites in oral administration in rats
2621. Experimental And Calculated By The DFT Method Vibration Spectra Of Berberine
2622. Experimental and quantum-chemical study of nucleophilic substitution mechanism in Berberine
2623. Experimental study of Berberine anti macrophages apoptosis induced by Tg and Fuc
2624. Experimental Study of Berberine on Diabetes Mellitus Complicated with Systemically Candida Albicans Infection [J]
2625. Experimental study of the antitrachoma action of Berberine .
2626. Experimental study on anti-bacter ial, anti-inflammatory and analgesic activities of the mixture of mangiferin and Berberine
2627. Experimental Study on Hypoglycemic Effect of the Mixture of Mangiferin and Berberine [J]
2628. Experimental Study on Inhibition Effect of Berberine in Escherichia coil Gene Transcription
2629. Experimental Study on SD Rats with Insulin Resistance (IR) Induced by High Fat Diet Intervened by Berberine
2630. Experimental study on the insulin-sensitivity-increasing effect of Berberine in insulin resistant rat models
2631. Experiments on the origin and function of Berberine in Berberis Darwinii
2632. Exploring the active mechanism of Berberine against HCC by systematic pharmacology and experimental validation
2633. Exploring thermodynamic parameters and the binding energetic of Berberine chloride to bovine serum albumin (BSA): Spectroscopy, isothermal titration calorimetry …
2634. Expression of the TetA gene encoding TetA efflux protein in E. coli contributes to its increased bacterial resistance toward Berberine
2635. Extensive intestinal first-pass elimination and predominant hepatic distribution of Berberine explain its low plasma levels in rats
2636. Extracellular signal-regulated kinase–dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine Berberine
2637. Extract Berberine from Rhizoma coptidis [J]
2638. Extract Berberine hydrochloride by aqueous two-phase system
2639. Extraction and Determination of Hydrochloric Acid Berberine from Aleuritopteris Argentea (Gmel) Fee [J]
2640. Extraction and Etermination of Berberine Hydrochloride in Jiaweizuojin Pills
2641. Extraction and isolation of jatrorrhizine choride in the preparation of Berberine chloride
2642. Extraction and Purification of Berberine Using Ion Erchange Fiber by Orthogonal Method [J]
2643. Extraction Berberine Hydrochloride from Coptis by [Bmim] BF_4/EA-(NH_4) _2SO_4-H_2O Aqueous Two-Phase System
2644. Extraction in cholinium-based magnetic ionic liquid aqueous two-phase system for the determination of Berberine hydrochloride in Rhizoma coptidis
2645. Extraction kinetical deviations of Berberine alkaloids in Rhizoma Coptidis and Zuojin Formulae
2646. Extraction of Berberine and removal of cadmium from Coptis chinensis Franch.
2647. Extraction of Berberine by Liquid Surfactant Membrane from Liquor of Berberis Amurensis Rupr [J]
2648. Extraction of Berberine dye and its dyeing behavior on nylon 6 fabric
2649. Extraction of Berberine from Rhizoma Coptidis
2650. Extraction of Berberine from Rhizomacoptidis by improved method [J]
2651. Extraction of Berberine from rhizome of Coptis chinensis Franch using supercritical fluid extraction
2652. Extraction of Berberine hydrochloride from Mahonia bealei (Fort.) Carr
2653. Extraction of Berberine Hydrochloride from Phellodendron Bark [J]
2654. Extraction Process of Berberine Hydrochloride in the Bitter Melon Fruit
2655. Extraction Study of Berberine from Cortex Phellodendri by Ultrasonic Wave-Cellulase [J]
2656. Extraction-spectrophotometric determination of Berberine in crude drugs by the formation of a new ion associate
2657. Extraction-Spectrophotometric Determination of Berberine in Pharmaceutical Preparations with 2, 6-Dichlorophenolindophenol
2658. Fabrication of novel hydrogel with Berberine -enriched carboxymethylcellulose and hyaluronic acid as an anti-inflammatory barrier membrane
2659. Facilitating effects of Berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity
2660. Failure of Berberine to Inhibit Pig Heart Glutamic-Aspartic Transaminase
2661. Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially
2662. FeMoO4-graphene oxide photo-electro-catalyst for Berberine removal and hydrogen evolution
2663. Field Control Effects of 0.3% Matrine· Berberine · Flavone Aqueous Solution on Tomato Late Blight
2664. Field Trails on Tomato Virus Control with 0.3% Radix Sophorea Flavesentis-Berberine -Flavone Bacteriocide AS [J]
2665. First case of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) due to Berberine , an over-the-counter herbal glycemic control agent
2666. Five salts of Berberine
2667. Five solvates of a multicomponent pharmaceutical salt formed by Berberine and diclofenac
2668. Flow cytometric analysis of cellular Berberine contents in high-and low-producing cell lines of Coptis japonica obtained by repeated selection
2669. Flow Injection Analysis Determined Berberine by Fouorimetry
2670. Flowcytometric analysis of the effect of Berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells
2671. Flow-injection chemiluminescence determination of Berberine hydrochloride
2672. Fluconazole assists Berberine to kill fluconazole-resistant Candida albicans
2673. Fluconazole inhibits cellular ergosterol synthesis to confer synergism with Berberine against yeast cells
2674. Fluorescence Anisotropy Study on the Effect of Phellodendri Cortex’s Berberine on Regulation of the Function of DNA
2675. Fluorescence assay based on preconcentration by a self-ordered ring using Berberine as a model analyte
2676. Fluorescence characteristics of the interaction between cycle DNA plasmid pUC118 and ligand Berberine
2677. Fluorescence microscopy demonstration of mitochondria in tissue culture cells using Berberine
2678. Fluorescence of Berberine in microheterogeneous systems
2679. Fluorescence Quenching Study on the Interaction of Berberine Derivatives with Bovine Serum Arlbumin
2680. Fluorescence spectra studies on the interaction of Berberine with nucleic acid
2681. Fluorescence Spectral Study of Berberine -K2HgI4 Associated Particle System and its Analytical Application
2682. Fluorescence Spectrophotometric Determination of Berberine Hydrochloride Content in Two Medicaments [J]
2683. Fluorescence Study of Liver‐Alcohol‐Dehydrogenase Complexes with Berberine and Other Ligands
2684. Fluorescent Berberine binding as a marker of internal glycosaminoglycans sulfate in bovine oocytes and sperm cells
2685. Fluorescent Berberine binding as a marker of secretory activity in mast cells
2686. Fluorescent organic ion pairs based on Berberine : counter-ion effect on the formation of particles and on the uptake by colon cancer cells
2687. Fluorophotometric Determination of Berberine with Micellar Sensitization [J]
2688. Force degradation studies of bioactive Berberine and Tinospora cordifolia extract
2689. Force Degradation Study of Berberine Chloride by Using Stability Indicating HPLC Method
2690. Formation and conformation of baicalin–Berberine and wogonoside–Berberine complexes
2691. Formation rules of baicalin-Berberine complex
2692. Formulation and in vitro evaluation of Berberine containing liposome optimized by 32 full factorial designs
2693. Formulation Design and in vitro Evaluation of Berberine Hydrochloride self-microemulsion [J]
2694. Formulation design and in vitro evaluation of Berberine -loaded self-nanoemulsifying drug delivery system
2695. Formulation of Berberine hydrochloride and hydroxypropyl-β-cyclodextrin inclusion complex with enhanced dissolution and reduced bitterness
2696. Four Arabidopsis Berberine bridge enzyme‐like proteins are specific oxidases that inactivate the elicitor‐active oligogalacturonides
2697. FoxO proteins’ nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in Berberine -treated HepG2 cells
2698. Function of Berberine on porcine in vitro fertilization embryo development and differential expression analysis of microRNAs
2699. Functional cross-talking between differentially expressed and alternatively spliced genes in human liver cancer cells treated with Berberine
2700. Functional study of the upregulation of miRNA-27a and miRNA-27b in 3T3-L1 cells in response to Berberine
2701. Fungicidal and herbicidal activities of Berberine related alkaloids
2702. Fungistasis of Berberine and Chitosan and Preparation of Composite Membrane [J]
2703. Berberine &ots=UwjdxruGvs&sig=hDQRaIc9ztk0nRylrB8lNFQXRNg” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://books.google.com/books?hl%3Den%26lr%3Dlang_en%26id%3D0k6rBAAAQBAJ%26oi%3Dfnd%26pg%3DPA133%26dq%3D%2BBerberine %26ots%3DUwjdxruGvs%26sig%3DhDQRaIc9ztk0nRylrB8lNFQXRNg&source=gmail&ust=1581476879664000&usg=AFQjCNG9i8aXcbr1Spj-D2nyQLA-4q5FPQ”>Further insights into the bicovalent flavinylation of Berberine bridge enzyme
2704. Further Studies on Competition of Berberine with Pyridoxal Phosphate in the Tryptophanase System of Escherichia coli.
2705. GADD153 mediates Berberine -induced apoptosis in human cervical cancer Ca ski cells
2706. Galactinol Synthase Gene of Coptis japonica Is Involved in Berberine Tolerance
2707. Gastrointestinal distribution of Berberine hydrochloride colon-specific tablets taken orally by rats
2708. Generation of reactive oxygen species by a novel Berberine –bile acid analog mediates apoptosis in hepatocarcinoma SMMC-7721 cells
2709. Genetic evidence for inhibition of bacterial division protein FtsZ by Berberine
2710. Genetic toxicity of Berberine on mouse heart
2711. Genetic variants of LDLR and PCSK9 associated with variations in response to antihypercholesterolemic effects of Armolipid Plus with Berberine
2712. Genome-scale microRNA identify small RNA modulators of the effect of Berberine on pancreatic cancer cell growth
2713. Genomic screening for targets regulated by Berberine in breast cancer cells
2714. Genotoxicity of the isoquinoline alkaloid Berberine in prokaryotic and eukaryotic organisms
2715. Genus Berberis and Berberine HPLC: An Overview
2716. Giloy is a rich source of columbin, palmatine, Berberine , choline, tinosporic acid, tinosporal, jatrohizine, starch (positive starch test with iodine solution), protein, calcium, phosphorus and several others. This is also known as “Divine Herbs” due to their high medicinal value.
2717. Global gene expression of Berberine against Yersiniapestis in vitro
2718. Global transcriptional profiles of Staphylococcus aureus treated with Berberine chloride
2719. Glycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine Berberine
2720. Gold nanoparticle and Berberine entrapped into hydrogel matrix as drug delivery system
2721. Gold Nanoparticle associated to Berberine induces vasorelaxation and cytosolic Ca2+ decrease in rat aorta
2722. Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of Berberine via efflux pump inhibition
2723. Gram‐scale production of carrier‐free fluorescent Berberine microrods for selective liver cancer therapy
2724. Growth performance, innate immune responses and disease resistance of fingerling blunt snout bream, Megalobrama amblycephala adapted to different Berberine -dietary feeding modes
2725. Growth suppression of HER2-overexpressing breast cancer cells by Berberine via modulation of the HER2/PI3K/Akt signaling pathway
2726. Growth-suppressive effect of Berberine on endometrial carcinoma cells: Role of mitochondrial and PI3K/Akt pathway
2727. Guizhou Berberis Wilsonae. Var. Guhtzunica Root in the Determination of Berberine Hydrochloride
2728. Gut microbiota-mediated personalized treatment of hyperlipidemia using Berberine
2729. Gut microbiota-regulated pharmacokinetics of Berberine and active metabolites in beagle dogs after oral administration
2730. GW24-e1352 Berberine mitigated cardiac hypoxiareoxygenation injury by Suppressed Autophagy and Reduced Cell Death via inhibition of the activation of AMPK …
2731. GW24-e2332 Berberine alleviates mesenteric artery endothelial dysfunction by improving insulin sensitivity in type 2 diabetic rats
2732. GW25-e2190 Berberine decrease β-amyloid level in N2a-APP695 cells through PPAR-gamma-IDE signaling pathway
2733. GW25-e3180 Berberine attenuates cardiac dysfunction, fibrosis, inflammatory in diabetic cardiomyopathy
2734. GW25-e4414 Berberine improves coronary vasodilation and prevents endothelial apoptosis via activating Akt-eNOS in diabetic rats
2735. GW26-e2333 Berberine Abolished the Decrease of Action Potential Duration Induced by Acetylcholine for Rabbits Atrial Tissue and Myocytes
2736. GW26-e4763 Berberine Prevents Atherosclerosis In Apolipoprotein E Knock Out Mice
2737. GW28-e0423 Berberine inhibits cardiomyocytes inflammation induced by ischemia though down-regulating toll-like receptors
2738. GW28-e0988 Berberine attenuates cardiac fibrosis via downregulating IGF1R in diabetic rats
2739. Habitat‐Dependent Variations in Berberine Content of Berberis asiatica Roxb. ex. DC. in Kumaon, Western Himalaya
2740. Berberine _AND_SULODEXIDE_IN_CANCER_MINIREVIEW_TOMAS_KOLTAI/links/578122d208ae01f736e6b8af/HEPARANASE-Berberine -AND-SULODEXIDE-IN-CANCER-MINIREVIEW-TOMAS-KOLTAI.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Tomas_Koltai3/publication/305082492_HEPARANASE_Berberine _AND_SULODEXIDE_IN_CANCER_MINIREVIEW_TOMAS_KOLTAI/links/578122d208ae01f736e6b8af/HEPARANASE-Berberine -AND-SULODEXIDE-IN-CANCER-MINIREVIEW-TOMAS-KOLTAI.pdf&source=gmail&ust=1581476879666000&usg=AFQjCNH-rYZ_ZrC0tR3qZbTRWmDd90vxmA”>HEPARANASE, Berberine AND SULODEXIDE IN CANCER MINIREVIEW
2741. Hepatobiliary excretion of Berberine
2742. Hepatocyte nuclear factor 1α plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound Berberine
2743. Hepatoprotection of Berberine Against Hydrogen Peroxide‐induced Apoptosis by Upregulation of Sirtuin 1
2744. Hepatoprotective activity of Berberine is mediated by inhibition of TNF-α, COX-2, and iNOS expression in CCl4-intoxicated mice
2745. Hepatoprotective effect of Berberine against methotrexate induced liver toxicity in rats
2746. Hepatoprotective effects of Berberine on acetaminophen-induced hepatotoxicity in mice
2747. Hepatoprotective effects of Berberine on carbon tetrachloride-induced acute hepatotoxicity in rats
2748. Hepatoprotective effects of Berberine on liver fibrosis via activation of AMP-activated protein kinase
2749. Hepatoprotective properties and biotransformation of Berberine and berberrubine by cell suspension cultures of Dodonaea viscosa and Ocimum basilicum
2750. Hepatoprotective role of Berberine against paraquat-induced liver toxicity in rat
2751. HepG2 cell IR: Establishment of model and improvement by Berberine
2752. Herbicidal Spectrum, Absorption and Transportation, and Physiological Effect on Bidens pilosa of the Natural Alkaloid Berberine
2753. hERG1 is involved in the pathophysiological process and inhibited by Berberine in SKOV3 cells
2754. Heterologous expression of the plant proteins strictosidine synthase and Berberine bridge enzyme in insect cell culture
2755. Heterotropic Cooperativity for CYP3A4-Mediated 1′-Hydroxylation of Midazolam by Berberine : An In Silico Modeling and Simulation Study
2756. High Berberine -producing cultures of Coptis japonica cells
2757. High density culture of Coptis japonica cells increases Berberine production
2758. High-content analysis of chelidonine and Berberine from Iranian Chelidonium majus L. ecotypes in different ontogenetical stages using various methods of extraction
2759. High-Content Analysis of Chelidonine and Berberine from Iranian Chelidonium majus L. Ecotypes in Different Ontogenetical Stages Using Various Methods of …
2760. Highly efficient degradation of Berberine chloride form wastewater by a novel three-dimensional electrode photoelectrocatalytic system
2761. Highly selective fluorescent visual detection of perfluorooctane sulfonate via blue fluorescent carbon dots and Berberine chloride hydrate
2762. Highly selective, sensitive and fluorescent sensing of dimeric G-quadruplexes by a dimeric Berberine
2763. Highly sensitive fluorescence response to inclusion complex formation of Berberine alkaloid with cucurbit [7] uril
2764. High-performance capillary electrophoresis for determining the contents of Berberine , jatrorrhizine and palmatine in Gegenqinlian decoction.
2765. High‐performance liquid chromatography determination of hydrastine and Berberine in dietary supplements containing goldenseal
2766. Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie Berberine improvement of learning and memory in streptozotocin-diabetic rats
2767. Histamine (H1) Receptors, Cyclooxygenase Pathway and Nitric Oxide Formation Involved in Rat Tracheal Smooth Muscle Relaxant Effect of Berberine
2768. Histochemistry of Berberine of coptis chinensis franch. Rhizome
2769. Histological observation of direct pulp-capping with biomembrane of Berberine compound in minipigs
2770. HNF1α plays a critical role in PCSK9 gene transcription and regulation by a natural hypocholesterolemic compound Berberine
2771. Homology modeling and docking studies of Plasmodium falciparum telomerase reverse transcriptase with Berberine and some of its derivatives
2772. Hop rho iso-alpha acids, Berberine , vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial
2773. Hop rho iso-alpha acids, Berberine , vitamin D₃ and vitamin K₁ favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial
2774. Hormetic effect of Berberine attenuates the anticancer activity of chemotherapeutic agents
2775. Hormonal regulation of Berberine production in cell suspension cultures of Thalictrum minus
2776. HPCE Determination of Berberine Content in Coptidis Rhizoma [J]
2777. HPCE Determination of Berberine in Qingjing Capsules
2778. HPLC analysis of paeoniflorin, Berberine hydrochloride and glycyrrhizic acid in Weiyankang capsules [J]
2779. HPLC Determination of Berberine Chloride in Lianpu Shuangqing Tablet
2780. HPLC Determination of Berberine Hydrochloide in Qianlie Tong Tablet
2781. HPLC Determination of Berberine Hydrochloide in Qianlie Tong Tablet [J]
2782. HPLC determination of Berberine hydrochloride and palmatine hydrochloride in Zhibai Dihuang pills
2783. HPLC Determination of Berberine Hydrochloride Content in Yujinyinxie Pill
2784. HPLC determination of Berberine hydrochloride in compound Berberine [J]
2785. HPLC Determination of Berberine Hydrochloride in GuZhiNing Liniment
2786. HPLC determination of Berberine hydrochloride in Milinqing capsules [J]
2787. HPLC Determination of Berberine Hydrochloride in Shihu Yeguang Pills [J]
2788. HPLC Determination of Berberine Hydrochloridein Shibawei Hezi Liniaowan Capsulas
2789. HPLC Determination of Berberine in “Shaoshang Zhitong Ointment”
2790. HPLC determination of Berberine in medicinal herbs and a related traditional Chinese medicine
2791. HPLC determination of Berberine in plasma of patients with ischemic heart failure
2792. HPLC Determination of Content of Berberine Hydrochloride in the Baian Washing Lotion [J]
2793. HPLC determination of trimethoprim and Berberine sulfate in compound Berberine injection
2794. HPLC estimation of Berberine in Tinospora cordifolia and Tinospora sinensis
2795. HPLC Method for Measuring Berberine Bydrochloridein in Qingre Zhidai Granul
2796. HPLC quantitative analysis of Berberine absorpted with macroporous resin in Rhizoma Coptidis and its preparation zuo jin wan
2797. HPLC-dad determination of Berberine , chelerythrine and sanguinarine in the mexican prickly poppy (Argemone mexicana L. Papaveraceae), a medicinal …
2798. HPTLC ANALYSIS OF Berberine IN ARGEMONE MEXICANA L
2799. HPTLC analysis of Berberine in stem extracts of Fibraurea darshani
2800. HPTLC Determination of Synthetic Berberine Mixed in Fibrauretinum as Adulterant [J]
2801. HPTLC fingerprinting profile of marker compound (Berberine ) in roots of Berberis aristata DC
2802. HPTLC method development for Divya Arshkalp Vati containing marker compound Berberine
2803. HPTLC method for estimation of Berberine in ayurvedic formulations containing Berberis aristata by an acid dye method
2804. Human MDR1 and MRP1 recognize Berberine as their transport substrate
2805. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and Berberine to lung carcinoma
2806. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of Berberine chloride for an efficient suppression of Ehrlich ascites tumors
2807. Hybrid materials based on luminescent alkaloid Berberine and saponite
2808. Hydrophobic ring substitution on 9-O position of Berberine act as a selective fluorescent sensor for the recognition of bovine serum albumin
2809. Hypercrosslinked poly (styrene-co-divinylbenzene) resin as a specific polymeric adsorbent for purification of Berberine hydrochloride from aqueous solutions
2810. Hypoglycemic Activity of Berberine [J]
2811. Hypoglycemic and insulin-sensitizing effects of Berberine in high-fat diet-and streptozotocin-induced diabetic rats
2812. Hypoglycemic Pharmacodynamics and Clinical Efficacy of Berberine [J]
2813. Hypolipidemic Berberine Derivatives with a Reduced Aromatic Ring C
2814. Hypoxia-inducible factor 1 mediates the anti-apoptosis of Berberine in neurons during hypoxia/ischemia
2815. I. The alkaloids of corydalis cava. II. On the relation between the absorption spectra & the chemical structure of corydaline, Berberine , and other alkaloids
2816. Identification and characterization of Berberine in tinospora cordifolia by liquid chromatography Quadrupole time of flight mass spectrometry (LC MS/MS q-tof) and …
2817. Identification and characterization of bioactive compound Berberine in the Berberis vulgaris root extract using HR-LC-MS analysis
2818. Identification and quantitative determination of Berberine hydrochloride of Niaoyanqing tablet
2819. Identification and verification of potential therapeutic target genes in Berberine -treated zucker diabetic fatty rats through bioinformatics analysis
2820. Identification of a novel and potent inhibitor of phospholipase A2 in a medicinal plant: Crystal structure at 1.93 Å and Surface Plasmon Resonance analysis of phospholipase A2 complexed with Berberine
2821. Identification of actin as a direct proteomic target of Berberine using an affinity-based chemical probe and elucidation of its modulatory role in actin assembly
2822. Identification of Berberine as a direct thrombin inhibitor from traditional Chinese medicine through structural, functional and binding studies
2823. Identification of Berberine as a novel agonist of fatty acid receptor GPR40
2824. Identification of Berberine in ancient and historical textiles by surface‐enhanced Raman scattering
2825. Identification of Chief Effective Component of Jiawei Sanhuang Tablet with Thin-Layer Chromatography(TLC) and Determination of Content of Berberine in Jiawei Sanhuang Tablet with TLC Scanning
2826. Identification of Lianhuang Zhichuang suppository by TLC and determination of Berberine hydrochloride by HPLC [J]
2827. Identification of medicinal material for Jinji granules and determination of Berberine hydro-chloride [J]
2828. Identification of Molecular Target Proteins in Berberine ‐treated Cervix Adenocarcinoma HeLa Cells by Proteomic and Bioinformatic Analyses
2829. Identification of three sulfate-conjugated metabolites of Berberine chloride in healthy volunteers’ urine after oral administration.
2830. Berberine &ots=mXGr7uKgNG&sig=785jSEVDAAme8RjxqKmSxFQdfNc” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://books.google.com/books?hl%3Den%26lr%3Dlang_en%26id%3DfGHwCAAAQBAJ%26oi%3Dfnd%26pg%3DPA282%26dq%3D%2BBerberine %26ots%3DmXGr7uKgNG%26sig%3D785jSEVDAAme8RjxqKmSxFQdfNc&source=gmail&ust=1581476879669000&usg=AFQjCNEQORTD-acW8OFwT4gmYqnZabciww”>II. 7 Berberine : Production Through Plant (Thalictrum spp.) Cell Cultures
2831. Immunocytological localization of two enzymes involved in Berberine biosynthesis
2832. Immunoquantitative analysis for Berberine and its related compounds using monoclonal antibodies in herbal medicines
2833. Immunotoxicity induced in mice by subacute exposure to Berberine
2834. Impact of Berberine on broiler thiram-induced tibial cartilage dysplasia
2835. Impact of Berberine on human gut bacteria
2836. Impact of~(60) Co-γ irradiation on the active ingredient from Berberine
2837. Impact on absorption of Berberine and palmatine in different compatibilities of Wuji pill
2838. Impacts of Berberine on oxidized LDL-induced proliferation of human umbilical vein endothelial cells
2839. Impacts of Berberine on the growth, migration and radiosensitivity of breast cancer cells
2840. Impacts of multicomponent environment on intrinsic dissolution rate of Berberine in biopharmaceutics classification system of Chinese materia medica
2841. Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with Berberine …
2842. Improved methods for content determination of Berberine hydrochloride tablets
2843. Improved sample preparation method for content determination of Berberine in Renshen Zaizao pills
2844. Improved tablet disintegration and dissolution performance by incorporation of “baicalin-Berberine ” complex
2845. Improvement of anti-inflammatory and anti-angiogenic activity of Berberine by novel rapid dissolving nanoemulsifying technique
2846. Improvement of drug delivery using gold nanoparticle and Berberine associated to a new hydrogel system
2847. Improvement of extracting Berberine hydrochloride from cortex phallodendri [J]
2848. Improvement of Extracting Process of Berberine Hydrochlorlde in Cotex phallodendri [J]
2849. Improvement of intestinal transport, absorption and anti-diabetic efficacy of Berberine by using Gelucire44/14: In vitro, in situ and in vivo studies
2850. Improvement of light fastness of Berberine colorant by natural antioxidants
2851. Improvement of superoxide dismutase and catalase in streptozotocin–nicotinamide-induced type 2-diabetes in mice by Berberine and glibenclamide
2852. Improvement of the HPLC Determination of Berberine in Compound Berberine Tablets on ChP, 2000, Vol. I
2853. Improving solid-state properties of Berberine chloride through forming a salt cocrystal with citric acid
2854. In situ Berberine separation with immobilized adsorbent in cell suspension cultures ofThalictrum rugosum
2855. In situ intestinal absorption kinetics of Berberine and jatrorrhizine from extractive Rhizoma Coptidis in rats
2856. In situ thin layer chromatography-fourier transform-surface-enhanced Raman spectrum study on ingredients of Berberine
2857. In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii
2858. In vitro and in vivo activity of Berberine on the blood trypomastigote from Trypanosoma cruzi
2859. In vitro and in vivo antitumor efficacy of Berberine -nanostructured lipid carriers against H22 tumor
2860. In Vitro and in Vivo Antitumor Efficacy of Berberine -solid Lipid Nanoparticles Against H22 Tumor
2861. In Vitro Antibacterial Activities of Berberine Against the Five Mycoplasmal Species [J]
2862. In vitro antibacterial activity of allicin in combination with Berberine hydrochloride
2863. In vitro antibacterial effect of Berberine hydrochloride and enrofloxacin to fish pathogenic bacteria
2864. In vitro antifungal activity of the Berberine and its synergism with fluconazole
2865. In Vitro Anti-Helicobacter pylori Activity of Berberine and Barberry Extracts: A Preliminary Report
2866. In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid Berberine
2867. Berberine –solid-lipid-nanoparticles/10.1117/12.2209448.short” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.spiedigitallibrary.org/conference-proceedings-of-spie/9722/97221A/In-vitro-antitumor-efficacy-of-Berberine –solid-lipid-nanoparticles/10.1117/12.2209448.short&source=gmail&ust=1581476879671000&usg=AFQjCNEe6IlYE_VqEXPNCDB44g8qT4jQiw”>In vitro antitumor efficacy of Berberine : solid lipid nanoparticles against human HepG2, Huh7 and EC9706 cancer cell lines
2868. In vitro antiviral activity of a Berberine derivant HB-13 against herpes simplex virus
2869. In vitro biological assessment of berberis vulgaris and its active constituent, Berberine : antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer …
2870. In vitro characterization and inhibition of the interaction between ciprofloxacin and Berberine against multidrug-resistant Klebsiella pneumoniae
2871. In vitro cytotoxicity of Berberine against HeLa and L1210 cancer cell lines
2872. In vitro effect of some chemical compositions in Wuzhuyu on Berberine metabolism in rat liver microsomes
2873. Berberine -on-the-vitality-and-oxidative-profile-of-bovine-spermatozoa” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://publications.waset.org/10010794/in-vitro-effects-of-Berberine -on-the-vitality-and-oxidative-profile-of-bovine-spermatozoa&source=gmail&ust=1581476879672000&usg=AFQjCNFwPeX3VJy_HMGz0W7kAFjYGaccfg”>In vitro Effects of Berberine on the Vitality and Oxidative Profile of Bovine Spermatozoa
2874. In vitro effects of Berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis
2875. In vitro Effects of Berberine versus Sodium Hypochlorite on Dentin Flexural Strength
2876. In vitro Effects of the Traditional Chinese Medicine, Berberine , Matrine and Baicalin, on the Proliferation and Lipid Synthesis of Immortalized Human Sebocyte SZ95
2877. In vitro inhibitory effect of Berberis vulgaris (Berberidaceae) and its main component, Berberine against different Leishmania species
2878. In vitro regeneration and genetic transformation of the Berberine ‐producing plant, Thalictrum flavum ssp. glaucum
2879. In Vitro Research on the Effects of Berberine , Oleanolic Acid and Allitridi on Glucose Metabolism
2880. In vitro studies of antifibrotic and cytoprotective effects elicited by proto-Berberine alkaloids in human dermal fibroblasts
2881. In vitro studies of Berberine metabolism and its effect of enzyme induction on HepG2 cells
2882. In vitro studies on the multi-target anti-Alzheimer activities of Berberine -like alkaloids from Coptidis rhizoma
2883. In vitro study on the effects of trial denture cleansers with Berberine hydrochloride
2884. In Vitro Susceptibility of Berberine Combined with Antifungal Agents Against the Yeast Form of Talaromyces marneffei
2885. In vitro susceptibility testing of Candida albicans to Berberine hydrochdoride
2886. In vitro synergism between Berberine and miconazole against planktonic and biofilm Candida cultures
2887. In vivo and in vitro antiviral effects of Berberine on influenza virus
2888. In vivo and in vitro study on drug-drug interaction of lovastatin and Berberine from pharmacokinetic and HepG2 cell metabolism studies
2889. In vivo anti-apoptosis activity of novel Berberine -loaded chitosan nanoparticles effectively ameliorates osteoarthritis
2890. In vivo antibacterial activity of the compound Berberine gelatin
2891. In vivo anticoccidial activity of Berberine [18, 5, 6-dihydro-9, 10-dimethoxybenzo (g)-1, 3-benzodioxolo (5, 6-a) quinolizinium]–an isoquinoline alkaloid present in the …
2892. In vivo hemodynamic visualization of Berberine -induced effect on the cerebral cortex of a mouse by photoacoustic tomography
2893. In Vivo Interrelationship between Insulin Resistance and Interferon Gamma Production: Protective and Therapeutic Effect of Berberine
2894. In Vivo Small Intestinal Absorption of Berberine and Jatrorrhizine from Rhizoma coptidis Powder in Rats
2895. Inclusion complex formation of ionic liquids with 4-sulfonatocalixarenes studied by competitive binding of Berberine alkaloid fluorescent probe
2896. Inclusion complex formation of ionic liquids with cucurbit [7] uril studied by competitive binding of Berberine fluorescent probe
2897. Increase in action potential duration and inhibition of the delayed rectifier outward current IK by Berberine in cat ventricular myocytes.
2898. Increased Bioavailable Berberine Protects Against Myocardial Ischemia Reperfusion Injury Through Attenuation of NFκB and JNK Signaling Pathways
2899. Increased oxidative stress in cultured 3T3-L1 cells was attenuated by Berberine treatment
2900. Increased serotonergic neurotransmission is not responsible for the anticompulsive effect of Berberine in a murine model of obsessive–compulsive disorder
2901. Indirect determination of Berberine hydrochloride by atomic absorption spectrometry
2902. Indirect Determination of Berberine in Tabellae Berberine Hydrochloride by Atomic Emission Spectrometry
2903. Individual and combined effects of Berberine and santonin on spore germination of some fungi
2904. Induction of a specific methyltransferase activity regulating Berberine biosynthesis by cytokinin in Thalictrum minus cell cultures
2905. Induction of apoptosis by Berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-κB
2906. Induction of Berberine biosynthesis by cytokinins in Thalictrum minus cell suspension cultures
2907. Induction of G1 cell cycle arrest and apoptosis by Berberine in bladder cancer cells
2908. Induction of G2/M arrest by Berberine via activation of PI3K/Akt and p38 in human chondrosarcoma cell line
2909. Induction of interleukin‐12 production in mouse macrophages by Berberine , a benzodioxoloquinolizine alkaloid, deviates CD4+ T cells from a Th2 to a Th1 response
2910. Industrial production of shikonin and Berberine
2911. Influe of Berberine on T-cell mediated immunity
2912. Influence factors on in vitro release of Berberine hydrochloride from carboxymethyl konjac glucomannan pellets
2913. INFLUENCE OF Berberine AND SODIUM NITROPRUSSIDE ON THE ACTION OF SEVERAL AGONISTS IN THE AORTIC STRIPS OF RABBITS
2914. Influence of Berberine on cardiac function and plasma nitric oxide for chronic congestive heart failure secondary to ischemic or dilated cardiomyopathy
2915. Influence of Berberine on expression of hepatic X receptors and their target genes in liver of Chinese hamsters with type 2 diabetes mellitus [J]
2916. Influence of Berberine on left ventriculer remodeling in rats with hypertrophic cardiomyopathy induced by 2K1C
2917. Influence of Berberine on nerve conduction velocity in rats with type 2 diabetic neuropathy [J]
2918. Influence of Berberine on the blood pressure of rabbits
2919. Influence of Berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli.
2920. Influence of borneol on Berberine absorption in rat intestine
2921. Influence of compatibility on content of Berberine in Gegen Qinlian Decoction
2922. Influence of compatibility on content of Berberine in Maxingganshi decoction
2923. Influence of different extracting method on the content of Berberine in rhizoma coptis and antifungal performance
2924. Influence of Different Extraction Technologies on the Content of Berberine Hydrochloride in Miniaoning Granules
2925. Influence of drought stress on plant physiology and Berberine content of leaves in Phellodendron amurense seedlings.
2926. Influence of Environmental Factors on Production of Berberine Content in Berberis asiatica Roxb. ex DC in Kumaun West Himalaya, India
2927. Influence of Guizhi Fuling Pill Combined with Berberine on Polycystic Ovary Syndrome with Insulin Resistance
2928. Influence of Habitat Characteristics and Altitude on Berberine Content in Berberis jaeschkeana CK Schneid
2929. Influence of huanglian and Berberine on the erythrocytic osmotic fragilitas of experimental glucose-6-phosphate dehydrogenase deficiency in rats
2930. Influence of Ligustrazine and Berberine on Maturation of Porcine Oocytes in vitro [J]
2931. Influence of Mixed Decoction of Cortex Phellodendri, Radix Glycyrrhizae and Ramulus Loranthi on Ex-traction Rate of Berberine [J]
2932. Influence of penetration enhancer on transdermal permeation of Berberine hydrochloride in vitro [J]
2933. Influence of plasticizers on the physical performance and antimicrobial activity of a chitosan-Berberine composite membrane
2934. Influence of processing on the content of Berberine hydrochloride in Er Miao decoction
2935. Influence of quercetin, naringenin and Berberine on glucose transporters and insulin signalling molecules in brain of streptozotocin-induced diabetic rats
2936. Influence of various compatibilities on the content of baicalin and Berberine in Gegen Qinlian Decoction [J]
2937. Inherited cytoplasmic changes induced in yeasts by acriflavine and Berberine .
2938. Inhibit of Berberine combined with cyclophosphamide on Lewis pulmonary carcinoma in mice
2939. Inhibiting roles of Berberine in gut movement of rodents are related to activation of the endogenous opioid system
2940. Inhibition by Berberine and Cytosine Deaminase Enzyme Suicide Gene on Rectum Cancer Cells
2941. Inhibition by Berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells
2942. Inhibition Effect of Berberine Chloride Against Helminthosporium turcicum and Bipolaris maydis [J]
2943. Inhibition effect of Berberine on the corrosion of copper in acidic medium
2944. Inhibition of activator protein 1 activity by Berberine in human hepatoma cells
2945. Inhibition of autophagy by Berberine enhances the survival of H9C2 myocytes following hypoxia
2946. Inhibition of Berberine on growth of human nasopharyngeal carcinoma cells CNE-2 in vivo and in vitro
2947. Inhibition of Berberine on IKr, IKs and IK1 in thyroxine induced cardiomyopathic guinea pig ventricular myocytes.
2948. Inhibition of Berberine on organ anion transporters and its bidirectional trans-membrane transport
2949. Inhibition of Berberine on organ cation transporters
2950. Inhibition of biofilm formation and quorum sensing mediated phenotypes by Berberine in Pseudomonas aeruginosa and Salmonella typhimurium
2951. Inhibition of Candida rugosa Lipase by Berberine and Structurally Related Alkaloids, Evaluated by High-Performance Liquid Chromatography
2952. Inhibition of chemical carcinogenesis by Berberine in rats and mice
2953. Inhibition of cholinesterase activity and amyloid aggregation by Berberine -phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids
2954. Inhibition of compounding of gentamycin, sanhuangtang and Berberine to E. coli in vitro
2955. Inhibition of CYP1 by Berberine , palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling
2956. Inhibition of CYP450 1A and 3A by Berberine in crucian carp Carassius auratus gibelio
2957. Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of Berberine
2958. Inhibition of electrolyte transport in isolated guinea-pig ileum by Berberine
2959. Inhibition of endothelial microparticles-mediated oxidative stress by Berberine and its relation with endothelial function in humans
2960. Inhibition of H1N1 influenza A virus growth and induction of inflammatory mediators by the isoquinoline alkaloid Berberine and extracts of goldenseal (Hydrastis …
2961. Inhibition of human pregnancy plasma diamine oxidase with alkaloids of Argemone mexicana–Berberine and sanguinarine.
2962. Inhibition of in‐vitro lymphocyte transformation by the isoquinoline alkaloid Berberine
2963. INHIBITION OF LADH BY Berberine AND SOME RELATED ALKALOIDS
2964. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of Berberine
2965. Inhibition of M1 macrophage activation in adipose tissue by Berberine improves insulin resistance
2966. Inhibition of Mice Implanted Tumor by Berberine [J]
2967. Inhibition of Microbially-induced Inflammation by the Naturally Occurring Plant Compounds Tetra-O-methyl nordihydroguaiaretic acid (terameprocol) and Berberine
2968. Inhibition of migration and invasion by Berberine via inactivation of PI3K/Akt and p38 in human retinoblastoma cell line.
2969. Inhibition of oral streptococci growth induced by the complementary action of Berberine chloride and antibacterial compounds
2970. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of Berberine
2971. Inhibition of p38 mitogen-activated protein kinase potentiates the apoptotic effect of Berberine /tumor necrosis factor-related apoptosis-inducing ligand …
2972. Inhibition of pancreatic lipase by Berberine and dihydroBerberine : an investigation by docking simulation and experimental validation
2973. Inhibition of PCSK9 transcription by Berberine involves down-regulation of hepatic HNF1α protein expression through the ubiquitin-proteasome degradation pathway
2974. Inhibition of PCSK9 Transcription by Berberine Involves Down-regulation of HNF1 Protein Cellular Levels Through Ubiquitin-proteasome Pathway
2975. Inhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of Berberine in murine and human macrophages
2976. Inhibition of photosynthesis-related gene expression by Berberine in Microcystis aeruginosa.
2977. Inhibition of progression of erythroleukemia induced by Friend virus in BALB/c mice by natural products-Berberine , Curcumin and Picroliv.
2978. Inhibition of proprotein convertase subtilisin/kexin type 9: A novel mechanism of Berberine and 8-hydroxy dihydroBerberine against hyperlipidemia
2979. Inhibition of respiratory syncytial virus replication and virus-induced p38 kinase activity by Berberine
2980. Inhibition of retinoblastoma mRNA degradation through Poly (A) involved in the neuroprotective effect of Berberine against cerebral ischemia
2981. Inhibition of the respiratory chain by the alkaloids Berberine sulfate, alpinigenine, and tetrahydropalmatine
2982. Inhibition of thymocyte apoptosis by Berberine
2983. Inhibitive effects of Berberine hydrochloride on biofilm forming of Staphylococcus epidermidis [J]
2984. Inhibitory action of Berberine on glucose absorption
2985. Inhibitory Actions of Berberine on Growth and Arylamine N-Acetyltransferase Activity in Strains of Helicobacter Pylori from Peptic Ulcer Patients
2986. Inhibitory activity of Berberine on DNA strand cleavage induced by hydrogen peroxide and cytochrome c
2987. Inhibitory effect and transcriptional impact of Berberine and evodiamine on human white preadipocyte differentiation
2988. Inhibitory effect of Berberine from Coptidis rhizoma on melanin synthesis of murine malignant melanoma
2989. Inhibitory Effect of Berberine on Broiler P-glycoprotein Expression and Function: In Situ and In Vitro Studies
2990. Inhibitory effect of Berberine on differentiation of rat bone marrow mesenchymal stem cells to adipocytes
2991. Inhibitory effect of Berberine on Epstein-Barr DNA replication
2992. Inhibitory effect of Berberine on human skin squamous cell carcinoma A431 cells
2993. Inhibitory effect of Berberine on inflammation-induced dopaminergic neuron-degeneration [J]
2994. Inhibitory effect of Berberine on interleukin-2 secretion from PHA-treated lymphocytic Jurkat cells
2995. Inhibitory effect of Berberine on potassium channels in guinea pig ventricular myocytes
2996. Inhibitory effect of Berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver
2997. Inhibitory effect of Berberine on the activation and proliferation of T lymphocytes
2998. Inhibitory effect of Berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2
2999. Inhibitory effect of Berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma
3000. Inhibitory effect of Berberine on the motivational effects of ethanol in mice
3001. Inhibitory effect of Berberine on the TNF-α-induced Expression of IL-8 and MCP-1 is mediated through suppression of NF-κB activation in HT29 Human Colon …
3002. Inhibitory effect of Berberine on zeste homolog 2 (Ezh2) enhancement in human esophageal cell lines
3003. Inhibitory effect of Coptidis Rhizoma and Berberine on the proliferation of human esophageal cancer cell lines
3004. Inhibitory Effect of Panax notoginseng and Berberine on LPS-induced
3005. Inhibitory Effect of Sulbactum and Berberine on Extended-Spectrum β-Lactamases from E. colic in Fowl [J]
3006. Inhibitory Effect of Two Traditional Chinese Medicine Monomers, Berberine and Matrine, on the Quorum Sensing System of Antimicrobial-Resistant …
3007. Inhibitory effects of Berberine against morphine-induced locomotor sensitization and analgesic tolerance in mice
3008. Inhibitory Effects of Berberine Hydrochloride on Trichophyton mentagrophytes and the Underlying Mechanisms
3009. Inhibitory effects of Berberine on ATP-sensitive K+ channels in cardiac myocytes
3010. Inhibitory effects of Berberine on c fos expression and intracellular free calcium elevation induced by glutamate in dissociated brain cells of neonatal rats [J]
3011. Inhibitory Effects of Berberine on Chlamydia Pneumoniae Induced-Vascular Endothelial Cell Migration via PI3K [J]
3012. Inhibitory Effects of Berberine on growth of K562 cell
3013. Inhibitory effects of Berberine on IK1, IK, and HERG channels of cardiac myocytes
3014. Inhibitory effects of Berberine on IK1, IK, and HERG channels of cardiac myocytes.
3015. Inhibitory effects of Berberine on ion channels of rat hepatocytes
3016. Inhibitory effects of Berberine on lipopolysaccharide-induced inducible nitric oxide synthase and the high-mobility group box 1 release in macrophages
3017. Inhibitory effects of Berberine on proliferation and migration in rat aortic smooth muscle cells
3018. Inhibitory Effects of Berberine on Proliferation of Mouse Lymphoma Cells
3019. Inhibitory effects of Berberine on the activation and cell cycle progression of human peripheral lymphocytes
3020. Inhibitory effects of Berberine on the formation of cholesterol gallstone and its mechanism in rabbits
3021. Inhibitory effects of Berberine on the migratory and invasive abilities of cancer cells
3022. Inhibitory effects of Berberine on voltage-and calcium-activated potassium currents in human myeloma cells
3023. Inhibitory effects of Berberine -type alkaloids on elastase
3024. Inhibitory effects of Coptidis rhizoma and Berberine on cocaine-induced sensitization
3025. Inhibitory effects of emodin, baicalin, schizandrin and Berberine on hefA gene: Treatment of Helicobacter pylori-induced multidrug resistance
3026. Inhibitory effects of golden thread (Coptis chinensis) and Berberine on Microcystis aeruginosa
3027. Inhibitory effects of isoquinoline alkaloid Berberine on ischemia-induced apoptosis via activation of phosphoinositide 3-kinase/protein kinase B signaling …
3028. Inhibitory effects of Zoagumhwan water extract and Berberine on angiotensin II-induced monocyte chemoattractant protein (MCP)-1 expression and monocyte …
3029. Inhibitory effort of Berberine on pseudopod formation and the motility of CNE1 via Ezrin phosphoarylation
3030. Initial empirical study of human buccal mucosa fibroblasts inflammatory reaction after Berberine excitation.
3031. Berberine &ots=UwjdxruFDw&sig=iRxr0QL7OAPse7IR5X8i9D8cWhc” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://books.google.com/books?hl%3Den%26lr%3Dlang_en%26id%3D0k6rBAAAQBAJ%26oi%3Dfnd%26pg%3DPA157%26dq%3D%2BBerberine %26ots%3DUwjdxruFDw%26sig%3DiRxr0QL7OAPse7IR5X8i9D8cWhc&source=gmail&ust=1581476879681000&usg=AFQjCNHhgizHuTK_KySilk9pXgin7TEzuA”>Initiation of Solvent Isotope Effect Studies with Berberine Bridge Enzyme
3032. Innate Lymphoid Cells—A New Medium That Berberine Affect Glycolipid Metabolism
3033. Inotropic and chronotropic activity of Berberine on isolated guinea pig atria.
3034. In-silico bioprospecting of the enzymes involved in the biosynthetic pathway of the alkaloid Berberine and its distance study Through R
3035. Inspect the Content of Berberine and Baicalin in Sanhuang Tablets from Different Manufacturers [J]
3036. Insulin sensitizing and insulinotropic action of Berberine from Cortidis rhizoma
3037. Insulin-Dependent Type 2 Diabetes Treated with Berberine , Alpha-Lipoic Acid and a Ketogenic Diet: A Case Report
3038. Integration of microRNA–mRNA profiles and pathway analysis of plant isoquinoline alkaloid Berberine in sgc-7901 gastric cancers cells
3039. Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to Berberine
3040. Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with Berberine compounds
3041. Intensification of extracting Berberine by dual-frequency ultrasound
3042. Interaction Between Berberine and Human Gamma Globulin in Membrane Mimetic Environments
3043. Interaction between bovine serum albumin and Berberine chloride extracted from Chinese herbs of coptis chinensis franch
3044. Interaction between drugs and water-soluble polymers. VII. Binding of Berberine with bovine serum albumin
3045. Interaction between isopoly-tungstic acid and Berberine hydrochloride by resonance Rayleigh scattering spectrum
3046. Interaction between nucleic acids and Berberine sulfate
3047. Interaction between the plant alkaloid Berberine and fullerene C70: Experimental and quantum-chemical study
3048. Interaction mechanism between Berberine and the enzyme lysozyme
3049. Interaction of [HgX4] 2-with Berberine by Absorption and Resonance Rayleigh-Scattering Spectra and Their Analytical Applications
3050. Interaction of 9-O-(ω-amino) alkyl ether Berberine analogs with poly(dT)·poly(dA)*poly(dT) triplex and poly(dA)·poly(dT) duplex: a comparative study
3051. Interaction of anticancer herbal drug Berberine with DNA immobilized on the glassy carbon electrode
3052. Interaction of baicalin with Berberine for glucose uptake in 3T3-L1 adipocytes and HepG2 hepatocytes
3053. Interaction of Baicalin with Berberine for Intestinal Absorption in Rats [J]
3054. Interaction of Berberine chloride with deoxyribonucleic acids: evidence for base and sequence specificity.
3055. Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells
3056. Interaction of Berberine with human platelet α2 adrenoceptors
3057. Interaction of Berberine , palmatine, coralyne, and sanguinarine to quadruplex DNA: a comparative spectroscopic and calorimetric study
3058. INTERACTION OF DRUGS WITH DNA Ⅰ. Berberine AS LUMINESCENT SWITCHES FOR CALF THYMUS DNA AND EFFECTS OF pH
3059. Interaction of fluorescent Berberine alkyl derivatives with respiratory chain of rat liver mitochondria
3060. Interaction of herbal compounds with biological targets: A case study with Berberine
3061. Interaction of human serum albumin with Berberine hydrochloride by fluorescence method
3062. Interaction of Isoquinoline Alkaloids with an RNA Triplex: Structural and Thermodynamic Studies of Berberine , Palmatine, and Coralyne Binding to Poly(U).Poly(A)* …
3063. Interaction of liposomes with homologous series of fluorescent Berberine derivatives: new cationic probes for measuring membrane potential
3064. Interaction of plant alkaloid, Berberine , with zwitterionic and negatively charged phospholipid bilayers
3065. Interaction study between double-stranded DNA and Berberine using capillary zone electrophoresis
3066. Interactions of Berberine with poly (A) and tRNA
3067. Interactions of G-quadruplex DNA binding site with Berberine derivatives and construct a structure-based QSAR using docking descriptors
3068. Interpenetrating polymer network scaffold of sodium hyaluronate and sodium alginate combined with Berberine for osteochondral defect regeneration
3069. Interspecific differences among swallowtail larvae (Lepidoptera: Papilionidae) in susceptibility to aristolochic acids and Berberine
3070. Interventioal effect of Berberine liposome on impaired glucose tolerance accompanied with hyperlipemia
3071. Intervention effect of Berberine on expressions of TNF-alpha and receptor type I in Abeta25-35-induced inflammatory reaction in SH-SY5Y cell lines
3072. Intervention effect of Berberine on expressions of TNF-α and receptor type I in Aβ_ (25-35)-induced inflammatory reaction in SH-SY5Y cell lines
3073. Intervention Effect of Berberine on the Level of Serum IL-1?, Hs-CRP, Monocytes Infilitrating and the Expression of HSP-70 in Diet-induced Hyperlipidemic and Cpn …
3074. Intervention effect of Berberine on the level of serum IL-1β, Hs-CRP, monocytes infiltrating and the expression of HSP-70 in diet-induced hyperlipidemic and Cpn …
3075. Intervention Effect of Berberine on the Level of Serum Lipids, OX-LDL and Vascular Intimal Injury in Diet-induced Hyperlipidemic and Chlamydia Pneumoniae-infected …
3076. Intervention of Berberine on lipid deposition in liver cells of non-alcoholic fatty liver disease rats induced by high fat diet
3077. Intestinal absorption mechanisms of Berberine , palmatine, jateorhizine, and coptisine: involvement of P-glycoprotein
3078. Intestinal absorption of Berberine alone and in combinations by rats single pass intestinal perfusion in situ
3079. Intestinal absorption of Berberine and 8-hydroxy dihydroBerberine and their effects on sugar absorption in rat small intestine
3080. Intracellular compartmentation of two enzymes of Berberine biosynthesis in plant cell cultures
3081. INTRODUCTION OF A NEW DRUG DOSAGE FORM FOR Berberine
3082. Inverted binding due to a minor structural change in Berberine enhances its phospholipase A2 inhibitory effect
3083. Inverting the Regioselectivity of the Berberine Bridge Enzyme by Employing Customized Fluorine‐Containing Substrates
3084. Investigate the Effect of Berberine on Neuropeptide Y in Rats Colon Tissue and Plasma of Thyroid Hormone-Induced Diarrheic
3085. INVESTIGATING THE INTRACTION BETWEEN Berberine AND HUMAN TELOMER G-QUADRAPLEX DNA
3086. Investigating the possible role of Berberine on the metastatic behavior of esophageal cancer cells
3087. Investigation into the Mode of Antifungal Action of Berberine
3088. Investigation of differentially expressed proteins due to the inhibitory effects of Berberine in human liver cancer cell line HepG2
3089. Investigation of dose-dependent effects of Berberine against renal ischemia/reperfusion injury in experimental diabetic rats
3090. Investigation of In Vitro Antibacterial Effect of Berberine Sulfate with Colistin Sulfate
3091. Investigation of Interaction Models Between Berberine Hydrochloride and Cucurbit (N= 8) Uril Inclusion Complex
3092. Investigation of the interaction between Berberine and human serum albumin
3093. Investigation of the interaction between Berberine and nucleosomes in solution: Spectroscopic and equilibrium dialysis approach
3094. Investigation on binding interaction of Berberine chloride with bovine serum albumin immobilized onto chromatographic supports by frontal chromatography
3095. Investigation on intermolecular interaction between Berberine and β-cyclodextrin by 2D UV–Vis asynchronous spectra
3096. Investigation on the Interaction of Berberine with Human Serum Albumin by Equilibrium Dialysis [J]
3097. Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified Berberine chloride nanoparticles
3098. In-vitro Synergistic Effect of Metformin and Berberine on High Glucose-induced Lipogenesis
3099. In-vivo studies on the pharmacokinetics of Berberine on middle cerebral artery occlusion rat and sham-operated rat
3100. Involvement of AMP-activated protein kinase and Death Receptor 5 in TRAIL-Berberine -induced apoptosis of cancer cells
3101. Involvement of mitochondrial and B-RAF/ERK signaling pathways in Berberine -induced apoptosis in human melanoma cells
3102. Involvement of mitochondrial and survival signaling in Berberine -induced apoptosis in melanoma cells
3103. Involvement of p38 mitogen-activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by Berberine , a benzodioxoloquinolizine alkaloid
3104. Involvement of P-glycoprotein and multidrug and toxin extrusion protein 1 in hepatic and renal Berberine efflux in mice
3105. Involvement of reactive oxygen species and caspase-dependent pathway in Berberine -induced cell cycle arrest and apoptosis in C6 rat glioma cells
3106. Ionic mechanism responsible for prolongation of cardiac action-potential duration by Berberine
3107. IR absorption and surface-enhanced Raman spectra of the isoquinoline alkaloid Berberine
3108. Is Berberine Superior to Metformin in Management of Diabetes Mellitus and its Complications?
3109. Isolation and analysis of a gene bbe1 encoding the Berberine bridge enzyme from the California poppy Eschscholzia californica
3110. Isolation and Characterization of a Bacterial Strain Capable of Efficient Berberine Degradation
3111. ISOLATION AND CHARACTERIZATION OF Berberine HCl AND CYTOTOXIC EFFECT ON THE CELL LINE OF BREAST CANCER
3112. Berberine -from-the-calli-cultures-of-coscinium-fenestratum-l-an-endangered-medicinal-liana-of-western-ghat-india/” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.biotech-asia.org/vol6no1/isolation-and-characterization-of-enhanced-Berberine -from-the-calli-cultures-of-coscinium-fenestratum-l-an-endangered-medicinal-liana-of-western-ghat-india/&source=gmail&ust=1581476879685000&usg=AFQjCNEbVAmPQ-nwCcfG3s-j6q7W6osczQ”>Isolation and Characterization of Enhanced Berberine From the Calli Cultures of Coscinium Fenestratum L. An Endangered Medicinal Liana of Western Ghat …
3113. Isolation and identification of Berberine and berberrubine metabolites by Berberine -utilizing bacterium Rhodococcus sp. strain BD7100
3114. Isolation and Identification of Berberine from Cell Cultures of Coptis chinensis [J]
3115. Isolation and identification of Berberine from cell cultures of Coptis chinensis.
3116. Isolation and identification of Berberine from endophytic fungi HL-Y-3
3117. Isolation and identification of producing endophytic fungi of Berberine from the plant Phellodendron amurense
3118. Isolation and identification of urinary metabolites of Berberine in rats and humans
3119. Isolation and Purification of Berberine in Cortex Phellodendri by Centrifugal Partition Chromatography
3120. Isolation of Berberine from Berberis aristata by an acid dye method and optimization of parameters
3121. Isolation of Berberine from Berberis vulgaris Linn. and standardization of aqueous extract by RP-HPLC.
3122. Isolation of Berberine from the Rhizome of $ Coptis $$ chinensis $ by Centrifugal Partition Chromatography
3123. Isolation of Berberine tannate using a chromatography activity-guided fractionation from root bark of Berberis hispanica Boiss. & Reut.
3124. Isolation of the alkaloids, Berberine and berbamine, from Mahonia swaseyi
3125. ISOLATION, MOLECULAR STRUCTURAL ANALYSIS OF Berberine ALKALOID IN MAHONIA LESCHENAULTII-A TODA MEDICINAL PLANT BY USING IR …
3126. Isolation, sequence, and bacterial expression of a cDNA for (S)-tetrahydroBerberine oxidase from cultured Berberine -producing Coptis japonica cells
3127. Isoquinoline alkaloid Berberine acts as an inhibitor of osteoclast differentiation
3128. Berberine -exerts-its-antineoplastic-activity-by-inducing-molecular-dna-damage-in-hela-cells-a-comet-assay-studys-0974-8369.1000223.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://biolmedonline.com/Articles/Vol7_1_2015/BM_Vol7_1_isoquinoline-alkaloid-Berberine -exerts-its-antineoplastic-activity-by-inducing-molecular-dna-damage-in-hela-cells-a-comet-assay-studys-0974-8369.1000223.pdf&source=gmail&ust=1581476879687000&usg=AFQjCNHqpRR-mLyckVosUnHht7kKqetANg”>Isoquinoline alkaloid Berberine exerts its antineoplastic activity by inducing molecular DNA damage in HeLa cells: A comet assay study
3129. Isoquinoline alkaloid Berberine inhibits IL-5-dependent growth of pro-B Y16 cells through arresting cell cycle at G1 phase and inducing mitochondria-dependent …
3130. Isotope effects suggest a stepwise mechanism for Berberine bridge enzyme
3131. iTRAQ-based pharmacoproteomics reveals potential targets of Berberine , a promising therapy for ulcerative colitis
3132. Janus nanocarrier-based co-delivery of doxorubicin and Berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence
3133. Kidney Injury in Type 2 Diabetic: The Role of Berberine Treatment
3134. Kinetic difference of Berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract
3135. Kinetic study of superheated water extraction of Berberine from Berberis vulgaris root
3136. Kinetics and thermodynamics of Berberine inclusion in cucurbit [7] uril
3137. Kinetics study on photocatalytic degradation of Berberine hydrochloride in Nano-TiO_2 suspension system
3138. Knockdown of Berberine bridge enzyme by RNAi accumulates (S)-reticuline and activates a silent pathway in cultured California poppy cells
3139. Label-free fluorescence DNA walker for protein analysis based on terminal protection and dual enzyme assisted cleavage induced G-quadruplex/Berberine …
3140. Label-free fluorescent aptasensor Berberine -based strategy for ultrasensitive detection of Hg2+ ion
3141. Label-free fluorescent aptasensor for potassium ion using structure-switching aptamers and Berberine
3142. Laboratory studies of Berberine used alone and in combination with 1, 3-bis (2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
3143. LC/MS determination of Berberine and palmatin in rats plasma after oral administration of extracts Rhizoma Coptidis and its pharmacokinetics study
3144. LC-MS/MS Rapid Determination of Berberine in Plasma
3145. LC-MS-based metabolomics analysis of Berberine treatment in ulcerative colitis rats
3146. Learning from Berberine : Treating chronic diseases through multiple targets
3147. Leishmania donovani: Amastigote inhibition and mode of actior of Berberine
3148. Lekou Granules in HPLC Determination of Berberine and its Preparation Process of the Dynamic Analysis
3149. Letrozole, Berberine , or a combination for infertility in Chinese women with polycystic ovary syndrome: a multicentre, randomised, double-blind, placebo-controlled …
3150. Letrozole, Berberine , or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a double-blind randomised controlled …
3151. Leukocytes from diabetic patients kill retinal endothelial cells: effects of Berberine
3152. Lipid profiling of the therapeutic effects of Berberine in patients with nonalcoholic fatty liver disease
3153. Lipid-based floating multiparticulate delivery system for bioavailability enhancement of Berberine hydrochloride
3154. Lipid-lowering effect of Berberine in human subjects and rats
3155. Liposome encapsulated Berberine treatment attenuates cardiac dysfunction after myocardial infarction
3156. Liposome-encapsulated Berberine treatment reduces adverse ventricle remodeling after myocardial infarction
3157. LIPOSOMES LOADED WITH Berberine HYDROCHLORIDE: DEVELOPMENT, OPTIMISATION AND IN VITRO CITOTOXICITY
3158. Liquid crystalline nanoreservoir releasing a highly skin-penetrating Berberine oleate complex for psoriasis management
3159. Liver-target nanotechnology facilitates Berberine to ameliorate cardio-metabolic diseases
3160. Long non‑coding RNA CASC2 enhances Berberine ‑induced cytotoxicity in colorectal cancer cells by silencing BCL2
3161. Berberine _Based.404.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/jhypertension/Fulltext/2011/06001/Long_Term_Effects_of_A_Berberine _Based.404.aspx&source=gmail&ust=1581476879689000&usg=AFQjCNEu_sojsPDzYY6gjJzQCMN6ythljA”>LONG-TERM EFFECTS OF A Berberine BASED NUTRACEUTICAL ON BODY WEIGHT AND INSULIN-SENSITIVITY IN NON DIABETIC HYPERLIPIDAEMIC …
3162. Long-term effects of nutraceuticals (Berberine , red yeast rice, policosanol) in elderly hypercholesterolemic patients
3163. LVII.—The conversion of Berberine into β-homochelidonine (α-allo cryptopine)
3164. LXV.—A study of some derivatives of Berberine closely allied to derivatives of cryptopine
3165. LXV.—On the relation between the absorption spectra and the chemical structure of corydaline, Berberine , and other alkaloids
3166. LXXI.—Contributions from the Laboratories of the Heriot Watt College, Edinburgh. On Berberine . Part II
3167. LXXXII.—Researches on pseudo-bases. Part II. Note on some Berberine derivatives and remarks on the mechanism of the condensation reactions of pseudo-bases
3168. Magnetic nanoparticles directed delivery of Berberine —a cytotoxic phytoceutical for tumor control
3169. Make the Berberine extraction and separation experiment into comprehensive experiment
3170. MAPK pathways are involved in the inhibitory effect of Berberine hydrochloride on gastric cancer MGC 803 cell proliferation and IL-8 secretion in vitro and in …
3171. Mathematical Model for Adsorption of Berberine on Encapsulated Adsorbent
3172. MDM2 inhibition-mediated autophagy contributes to the pro-apoptotic effect of Berberine in p53-null leukemic cells
3173. Measurement of Berberine Hydrochloride Content of Guilin Watermelon Frost by UV Spectrometry [J]
3174. Measurement of unbound pravastatin in rat blood and bile on the perspective of hepatobiliary excretion and its interaction with cyclosporin A and Berberine
3175. Mechanical Deoppilation with Guide Wire Combined with Medical Macrogol Berberine Solution for the Treatment of Infertility Due to Fallopian Tube Obstruction
3176. Mechanism and pharmacological rescue of Berberine -induced hERG channel deficiency
3177. Mechanism and pharmacological rescue of Berberine -induced hERG channel deficiency [Corrigendum]
3178. Mechanism Guided Discovery of New Therapeutics Agents for Type 2 Diabetes from Berberine
3179. Mechanism of action of Berberine on Vibrio cholerae and vibrio cholerae biotype eltor.
3180. Mechanism of Berberine in the Regulation of CYP3A4 and P-gp via PXR Signaling Pathway
3181. Mechanism of Berberine regulating glucose and lipid metabolism studied with RT PCR array
3182. Mechanism of Berberine -mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates
3183. Mechanism of Electro-Coagulation with Al/Fe Periodically Reversing Treating Berberine Pharmaceutical Wastewater
3184. Mechanism of radiosensitization effect of Berberine on human nasopharyngeal carcinoma in hypoxia
3185. Mechanism of the aortic relaxation induced by low concentrations of Berberine
3186. Mechanism of UV‐driven Photoelectrocatalytic Degradation of Berberine Chloride Form Using the ESR Spin‐trapping Method
3187. Mechanism of vasodilatory effect of Berberine in rat mesenteric artery
3188. Mechanisms for protection of Berberine against LPS-induced acute lung injury in mice
3189. Mechanisms involved in the cytotoxic effects of Berberine on human colon cancer HCT-8 cells
3190. Mechanisms of Berberine (natural yellow 18)–induced mitochondrial dysfunction: Interaction with the adenine nucleotide translocator
3191. Mechanisms underlying the protection of Berberine against liver injury induced by lipopolysaccharide in mice
3192. Mechanistic studies on the growth inhibitory effects of Berberine on human osteosarcoma cells
3193. Media influence on the enhancement of the fluorescence of Berberine hydrochloride
3194. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of Berberine in lung cancer cells
3195. Membrane of Candida albicans as a target of Berberine
3196. Mercury-induced neurotoxicity and neuroprotective effects of Berberine
3197. Mesophase formation in binary mixtures of Berberine and glacial acetic acid
3198. Meta-analysis of the effect and safety of Berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
3199. Metabolic and cardiovascular effects of Berberine : from preclinical evidences to clinical trial results
3200. Metabolic characterization and pathway analysis of Berberine protects against prostate cancer
3201. Metabolic effect of Berberine –silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials
3202. Metabolic effects of Berberine on liver phosphatidate phosphohydrolase in rats fed on high lipogenic diet: an additional mechanism for the hypolipidemic effects of Berberine
3203. Metabolic profile associated with glucose and cholesterol lowering effects of Berberine in Sprague–Dawley rats
3204. Metabolic profiling analysis of Berberine , palmatine, jatrorrhizine, coptisine and epiBerberine in zebrafish by ultra-high performance liquid chromatography coupled …
3205. Metabolism: Efficacy of Berberine in patients with type 2 diabetes mellitus
3206. Metabolites identification of Berberine in rats using ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry
3207. Metabolomics profiling to investigate the pharmacologic mechanisms of Berberine for the treatment of high-fat diet-induced nonalcoholic steatohepatitis
3208. Metabolomics study of type 2 diabetes mellitus and the antidiabetic effect of Berberine in zucker diabetic fatty rats using Uplc‐ESI‐Hdms
3209. Metformin and Berberine prevent olanzapine-induced weight gain in rats
3210. Metformin and Berberine , two versatile drugs in treatment of common metabolic diseases
3211. Metformin in contrast to Berberine reversed arsenic‐induced oxidative stress in mitochondria from rat pancreas probably via Sirt3‐dependent pathway
3212. Methods of Double Wavelengths Fusion and HPLC to Determine Berberine Hydrochloride and Atractylodin in Ermiao Pill
3213. Methylglyoxal and insulin resistance in Berberine -treated type 2 diabetic patients
3214. Microarray expression profiling and Raman spectroscopy reveal anti-fatty liver action of Berberine in a diet-induced larval zebrafish model
3215. Microarray expression profiling of Yersinia pestis in response to Berberine
3216. Microbial Extraction of Berberine from Phellodendron for Simultaneous Product Purification and Waste Resource Utilization
3217. Microbial limit test of Berberine hydrochloride ointment
3218. Microbiota transplantation reveals beneficial impact of Berberine on hepatotoxicity by improving gut homeostasis
3219. Microcalorimetric investigation of effect of Berberine alkaloids from Coptis chinensis Franch on intestinal diagnostic flora growth
3220. Microcalorimetric investigation of the effect of Berberine alkaloids from Coptis chinensis Franch on Staphylococcus aureus growth
3221. Microcalorimetric investigation of the toxic action of Berberine on Tetrahymena thermophila BF5
3222. Micropropagation, Berberine content and antitumor activity of Jeffersonia dubia (Maxim.) Benth et Hook
3223. Micropropagation, isolation and characterization of Berberine from leaves of Naravelia zeylanica (L.) DC
3224. MicroRNA-21-3p, a Berberine -induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth
3225. microRNA-21-mediated inhibition of mast cell degranulation involved in the protective effect of Berberine on 2, 4-dinitrofluorobenzene-induced allergic contact …
3226. Microwave accelerated extraction and capillary electrophoresis analysis of Berberine from the cortices of Phellodendron wilsonii and Phellodendron amurense
3227. Microwave Aqueous Synthesis of Mesoporous Carbons for Highly Effective Adsorption of Berberine Hydrochloride and Matrine
3228. Microwave assisted extraction of Berberine from Mahonia bealei
3229. Mild Hyperthermia (39 C) Attenuates Berberine Chloride Cytotoxicity against Osteosarcoma Cells
3230. Mitochondria and NMDA receptor-dependent toxicity of Berberine sensitizes neurons to glutamate and rotenone injury
3231. Mitochondria play an important role in the cell proliferation suppressing activity of Berberine
3232. Mitochondrial membrane potential played crucial roles in the accumulation of Berberine in HepG2 cells
3233. Mitochondrial protein cyclophilin-D-mediated programmed necrosis attributes to Berberine -induced cytotoxicity in cultured prostate cancer cells
3234. Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted Berberine derivative for cancer treatment by inducing mitochondrial apoptosis …
3235. Mitochondrially targeted effects of Berberine [Natural Yellow 18, 5, 6-dihydro-9, 10-dimethoxybenzo (g)-1, 3-benzodioxolo (5, 6-a) quinolizinium] on K1735-M2 mouse …
3236. Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-Berberine conjugate for synergetic cancer treatment with enhanced …
3237. Mitophagy confers the nephroprotective effect of Berberine in hyperglycemic NRK-52E cells via Sirt1-FoxO3a-Bnip3 axis
3238. Berberine _on_lipid_metabolism__.10.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/co-lipidology/Fulltext/2017/06000/Mode_of_action_of_Berberine _on_lipid_metabolism__.10.aspx&source=gmail&ust=1581476879694000&usg=AFQjCNGAYvNv5hGtfZDDDdqxrVjtxv9OHA”>Mode of action of Berberine on lipid metabolism: a new–old phytochemical with clinical applications?
3239. Mode of binding of the cytotoxic alkaloid Berberine with the double helix oligonucleotide d (AAGAATTCTT) 2
3240. Modification to the functional status of the hemostatic system with the use of Berberine sulfate
3241. Modified Berberine and protoBerberine s from Enantia chlorantha as potential inhibitors of Trypanosoma brucei.
3242. Modulating gut microbiota as an anti-diabetic mechanism of Berberine
3243. Modulation action of Berberine on NO-cGMP signal pathway in isolated corpus cavernosum smooth muscle
3244. Modulation of adenylate cyclase signaling in association with MKK3/6 stabilization under combination of SAC and Berberine to reduce HepG2 cell survivability
3245. Modulation of apoptosis by Berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells
3246. Modulation of benzylisoquinoline alkaloid biosynthesis by overexpression Berberine bridge enzyme in Macleaya cordata
3247. Modulation of Berberine bridge enzyme levels in transgenic root cultures of California poppy alters the accumulation of benzophenanthridine alkaloids
3248. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting Berberine liposomes
3249. Modulation of glucagon-like peptide-1 release by Berberine : in vivo and in vitro studies
3250. Modulation of gut microbiota by Berberine and decocted Coptis chinensis Franch. in a high-fat diet-induced metabolic syndrome rat model
3251. Modulation of gut microbiota by Berberine and metformin during the treatment of high-fat diet-induced obesity in rats
3252. Modulation of gut microbiota by Berberine improves steatohepatitis in high-fat diet-fed BALB/C mice
3253. Modulation of gut microbiota with Berberine improves nonalcoholic steatohepatitis in mice
3254. Modulation of microbiota-gut-brain axis by Berberine resulting in improved metabolic status in high-fat diet-fed rats
3255. Modulation of Radioresponse by an Isoquinoline Alkaloid Berberine in Cultured HeLa Cells Exposed to Different Doses of γ–Radiation
3256. Modulation of the expression of folate cycle enzymes and polyamine metabolism by Berberine in cisplatin-sensitive and-resistant human ovarian cancer cells
3257. Modulations of cytochrome P450 expression in diabetic mice by Berberine
3258. Modulatory effect of Berberine on adipose tissue PPARγ, adipocytokines and oxidative stress in high fat diet/streptozotocin-induced diabetic rats
3259. Modulatory Effects of Berberine Chloride on Lipid Profile, Oxidant Status and Insulin Signaling Molecules in Streptozotocin Induced Diabetic Rats
3260. Molecular and crystal structures of three Berberine derivatives
3261. Molecular basis of inhibitory activities of Berberine against pathogenic enzymes in Alzheimer’s disease
3262. Molecular characterization of Berberine bridge enzyme genes from opium poppy
3263. Molecular characterization of carnitine palmitoyltransferase IA in Megalobrama amblycephala and effects on its expression of feeding status and dietary lipid and Berberine
3264. Molecular characterization of microtubule-associated protein 1-light chain 3B in Megalobrama amblycephala fed with high fat/Berberine diets
3265. Molecular cloning, expression, and induction of Berberine bridge enzyme, an enzyme essential to the formation of benzophenanthridine alkaloids in the response of …
3266. Molecular determinants of response of tumor cells to Berberine
3267. Molecular encapsulation of Berberine by a modified β-cyclodextrin and binding of host: guest complex to G-quadruplex DNA
3268. Molecular mechanism for Berberine to improve insulin resistance in 3T3-L1 adipocytes
3269. Molecular mechanism of Berberine improving insulin resistance induced by high glucose in 3T3-L1 adipocytes through targeting NF-κB p65 [J]
3270. Molecular mechanism of Berberine in improving insulin resistance induced by free fatty acid through inhibiting nuclear trascription factor-kappaB p65 in 3T3-L1 …
3271. Molecular mechanism of Berberine on improving insulin resistance of 3T3-L1 adipocytes induced by high glucose through IKKβ Ser 181 phosphorylation [J]
3272. Molecular mechanisms of action of herbal antifungal alkaloid Berberine , in Candida albicans
3273. Molecular Modeling on Berberine Derivatives toward BuChE: An Integrated Study with Quantitative Structure–Activity Relationships Models, Molecular Docking, and …
3274. Molecular modeling, dynamics simulations, and binding efficiency of Berberine derivatives: A new group of RAF inhibitors for cancer treatment
3275. Molecular modelling of Berberine derivatives as inhibitors of human smoothened receptor and hedgehog signalling pathway using a newly developed algorithm on …
3276. Molecular spectroscopy evidence of Berberine binding to DNA: comparative binding and thermodynamic profile of intercalation
3277. Molecular structure of an ancient folk medicine: Berberine hydrogen sulfate
3278. MONITOR THE BLOOD-DRUG CONCENTRATION OF Berberine BY MICELLA FLUOROMETRY
3279. Monitoring and kinetic parameter estimation for the binding process of Berberine hydrochloride to bovine serum albumin with piezoelectric quartz crystal impedance …
3280. Monodisperse microparticles loaded with the self-assembled Berberine -phospholipid complex-based phytosomes for improving oral bioavailability and enhancing …
3281. Mordant dyeing of modified acrylic fabric with Berberine
3282. Morphological Changes of Trichophytosis rubrum Treated by Berberine hydrochloride [J]
3283. Morphological changes of Trichophytosis rubrum treated by Berberine hydrochloride.
3284. MPB, a novel Berberine derivative, enhances lysosomal and bactericidal properties via TGF-β–activated kinase 1-dependent activation of the transcription factor EB
3285. Multicomponent therapeutics of Berberine alkaloids
3286. Multipath effects of Berberine on peach brown rot fungus Monilinia fructicola
3287. Multiple effects of Berberine derivatives on colon cancer cells
3288. Mutagenesis of a Berberine -producing endophytic fungus
3289. Myelosuppression and Nephrotoxicity Induced by Cisplatin in Female Rats: The Role of Berberine Nanoparticles
3290. Myocardial hypertrophy is improved with Berberine treatment via long non‐coding RNA MIAT‐mediated autophagy
3291. Myocardial salvaging effects of Berberine in experimental diabetes co-existing with myocardial infarction
3292. NACHT, LRR and PYD domains-containing protein 3 inflammasome is activated and inhibited by Berberine via toll-like receptor 4/myeloid differentiation …
3293. Nandina domestica (Heavenly Bamboo): In Vitro Culture and the Production of Jatrorrhizine, Berberine , and Other Alkaloids
3294. Nandinine, a derivative of Berberine , inhibits inflammation and reduces insulin resistance in adipocytes via regulation of AMP-kinase activity
3295. NANO ENCAPSULATION OF Berberine AND COLLAGEN
3296. Nano strategies for Berberine delivery, a natural alkaloid of Berberis
3297. Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics
3298. Nanoemulsion Improves Hypoglycemic Efficacy of Berberine by Overcoming its Gastrointestinal Challenge
3299. NANOENCAPSULATION OF Berberine INTO LYOTROPIC LIQUID CRYSTALLINE MESOPHASES TO ENHANCE ANTICANCER ACTIVITY
3300. Nanostructured electrochemical DNA biosensors for detection of the effect of Berberine on DNA from cancer cells
3301. Narrowbore high performance liquid chromatography of Berberine and palmatine in crude drugs and pharmaceuticals with ion-pair extraction using cobalt thiocyanate …
3302. Natural Alkaloid Berberine Activity against Pseudomonas aeruginosa MexXY-Mediated Aminoglycoside Resistance: In Silico and in Vitro Studies
3303. Natural and synthetic G-quadruplex interactive Berberine derivatives
3304. Natural aromatic compounds as scaffolds to develop selective G-Quadruplex ligands: from previously reported Berberine derivatives to new palmatine analogues
3305. Natural Berberine -Based Chinese Herb Medicine Assembled Nanostructures with Modified Antibacterial Application
3306. Natural deep eutectic solvents (NADES) to enhance Berberine absorption: an in vivo pharmacokinetic study
3307. NATURAL PLANT PRODUCT Berberine /CISPLATIN BASED RADIOTHERAPY FOR CERVICAL CANCER: THE NEW AND EFFECTIVE METHOD TO TREAT …
3308. Natural products Berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin
3309. Naturally occurring proteinaceous nanoparticles in Coptidis Rhizoma extract act as concentration-dependent carriers that facilitate Berberine absorption
3310. Near Infrared Diffuse Reflection Optical Spectra Combined with PCR Rapid Determination Content of Berberine Hydrochloride in Berberis Heteropoda Cortex
3311. Neuronal activities of Berberine in Schistosoma mansoni-infected mice
3312. Neuropharmacological and pharmacokinetic properties of Berberine : a review of recent research
3313. Neuroprotection of early and short-time applying Berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB …
3314. Neuroprotective effect of Berberine against environmental heavy metals-induced neurotoxicity and Alzheimer’s-like disease in rats
3315. Neuroprotective effect of Berberine against learning and memory deficits in diffuse axonal injury
3316. Neuroprotective effect of Berberine agonist against impairment of learning and memory skills in severe traumatic brain injury via Sirt1/p38 MAPK expression
3317. Neuroprotective effect of Berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia
3318. Neuroprotective effect of Berberine is mediated by MAPK signaling pathway in experimental diabetic neuropathy in rats
3319. Neuroprotective effects of Berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
3320. Neuroprotective effects of Berberine in neurodegeneration model rats induced by ibotenic acid
3321. Neuroprotective effects of Berberine on recognition memory impairment, oxidative stress, and damage to the purinergic system in rats submitted to …
3322. Neuroprotective effects of Berberine on stroke models in vitro and in vivo
3323. Neurotoxic effects of Berberine on long-term l-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
3324. Neurotoxicity induced by Berberine in cultured cortical and cerebellar granule neurons of rat
3325. Neutral sulfate Berberine modulates cytokine secretion and increases survival in endotoxemic mice1
3326. New 13-pyridinealkyl Berberine analogues intercalate to DNA and induce apoptosis in HepG2 and MCF-7 cells through ROS mediated p53 dependent pathway …
3327. New aspects of Saccharomyces cerevisiae as a novel carrier for Berberine
3328. New Clinical Application of Berberine
3329. New Oral Delivery System to Improve Absorption of Berberine : Likely Interaction of Cationized Chitosan with PG-P Pump.
3330. New progress inhypoglycemic mechanism and clinical application of Berberine
3331. New Synthetic Approach to the Berberine Alkaloids
3332. Berberine .htm” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://www.itmonline.org/arts/Berberine .htm&source=gmail&ust=1581476879700000&usg=AFQjCNFRLpjZTLuMhNnoCaNWpaA7qwSenA”>New uses of Berberine
3333. NLRP3 inflammasome as a target of Berberine in experimental murine liver injury: interference with P2X7 signalling
3334. NMR studies on antitumor drug candidates, Berberine and berberrubine
3335. Non-antibiotic anti-diarrhoeal drugs: factors affecting oral bioavailability of Berberine and loperamide in intestinal tissue
3336. Nonaqueous capillary electrophoresis coupled with laser‐induced native fluorescence detection for the analysis of Berberine , palmatine, and jatrorrhizine in Chinese …
3337. Non-coding RNAs and Berberine : a new mechanism of its anti-diabetic activities
3338. Nonoxynol-9 Berberine plural gel has little effect on expression of SLPI, SP-D and lactoferrin in mice’s vagina
3339. Nootropic Effect of Berberine in Colchicines Induced Experimental Alzheimer’s Disease Model: Effect on Cholinergic Neurotransmission
3340. NOTE ON THE ESTIMATION OF Berberine .
3341. Note on the use of Berberine tannate (BertamixND) for increasing the productivity of meat yielding in pig breeding in Vietnam
3342. Notes on Berberine Sulphate in Oriental Sore
3343. Notes on the Treatment of Oriental Sore with Berberine Acid Sulphate
3344. Novel Berberine derivatives: Design, synthesis, antimicrobial effects, and molecular docking studies
3345. Novel Berberine triazoles: synthesis, antimicrobial evaluation and competitive interactions with metal ions to human serum albumin
3346. Novel Berberine -based derivatives with potent hypoglycemic activity
3347. Novel carbohydrate modified Berberine derivatives: synthesis and in vitro anti-diabetic investigation
3348. Novel cremochylomicrons for improved oral bioavailability of the antineoplastic phytomedicine Berberine chloride: Optimization and pharmacokinetics
3349. Novel drug delivery approaches for improving therapeutic applications of Berberine
3350. Novel effect of Berberine on thermoregulation in mice model induced by hot and cold environmental stimulation
3351. Novel mitochondria-targeted antioxidants: plastoquinone conjugated with cationic plant alkaloids Berberine and palmatine
3352. Novel mitochondria-targeted compounds composed of natural constituents: conjugates of plant alkaloids Berberine and palmatine with plastoquinone
3353. Novel Nanoparticles Berberine Chloride Oral Delivery Approaches Targeting PCSK9
3354. Novel potential artificial MRSA DNA intercalators: synthesis and biological evaluation of Berberine -derived thiazolidinediones
3355. Novel role of Berberine in LOX1-mediated endothelial dysfunction
3356. Novel salt cocrystal of chrysin with Berberine : Preparation, characterization, and oral bioavailability
3357. Novel skin penetrating Berberine oleate complex capitalizing on hydrophobic ion pairing approach
3358. Novel triazolyl Berberine derivatives prepared via CuAAC click chemistry: synthesis, anticancer activity and structure-activity relationships
3359. Nubia and the Berberine
3360. Nuclear magnetic resonance spectral analysis and molecular properties of Berberine
3361. Nutr Metab Cardiovasc Dis: effects of a nutraceutical combination (Berberine , red yeast rice and policosanols) on lipid levels and endothelial function randomized …
3362. Nutraceutical combination (red yeast rice, Berberine and policosanols) improves aortic stiffness in low-moderate risk hypercholesterolemic patients
3363. Nutraceutical pill containing Berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial …
3364. Nutritional supplementation of hop rho iso-alpha acids, Berberine , vitamin D3, and vitamin K1 produces a favorable bone biomarker profile supporting healthy bone …
3365. Observation of bending, cracking and jumping phenomena on cooling and heating of tetrahydrate Berberine chloride crystals
3366. Observation of Berberine ion-transmission and ultrashort wave on chronic prostatitis
3367. Observation of Clinical Effect of Berberine Combined with Birid Triple viable in Treatment of Diarrhea Predominant Irritable Bowel Syndrome [J]
3368. Observation of therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and Flupentixol and Melitracen tablets
3369. Observation of therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and lived combined B. Subtilis and E. Faecium …
3370. Observation on Effect of Berberine and Potassium Magnesium Aspartate for Treating Chronic Pulmonary Heart Disease Complicated by Arrhythmia in 60 Cases
3371. Of Berberine and puerarin on dexamethasone-induced insulin resistance in porcine ovarian thecal cells
3372. O-hexadecyl-dextran entrapped Berberine nanoparticles abrogate high glucose stress induced apoptosis in primary rat hepatocytes
3373. On Berberine -treating simulated sewage through periodically alternating electrocoagulation [J]
3374. On the mechanism of antidepressant-like action of Berberine chloride
3375. On the mechanism of Berberine –INF55 (5-Nitro-2-phenylindole) hybrid antibacterials
3376. On the mechanism of vasodilating action of Berberine : possible role of inositol lipid signaling system.
3377. ON THE OCCURRENCE OF Berberine IN XANTHORRHIZA APIIFOLIA.
3378. Oncosis-like cell death is induced by Berberine through ERK1/2-mediated impairment of mitochondrial aerobic respiration in gliomas
3379. One new Berberine from the branches and leaves of Polyalthia obliqua Hook.f. & Thomson
3380. On-line concentration by head-column field amplified sample injection for the analysis of Berberine , palmatine and jatrorrhizine in herbal medicine by flow injection …
3381. Berberine .pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://healthmatrixstore.com/uploads/3/4/9/8/34984218/optialaBerberine .pdf&source=gmail&ust=1581476879704000&usg=AFQjCNENg6kUVykk301BdUo1pMhw1P9i7g”>Opti ALA/Berberine
3382. Optical fiber sensor for Berberine based on fluorescence quenching of 2-(4-diphenylyl)-6-phenylbenzoxazole
3383. Optical sensor for Berberine utilizing its intrinsic fluorescence enhanced by the formation of inclusion complex with butylated-β-cyclodextrin
3384. Optimization and Determination of Berberine and Baicalin in Wanshi Niuhuang Qingxin Wan by High Performance Liquid Chromatography
3385. Optimization and preparation of Berberine hydrochloride liposomes using Box-Behnken design methodology
3386. Optimization for the production of liposomal Berberine with the comparison of antihepatoma effects, and the apoptotic pathways of Berberine solution or liposomal Berberine on HepG2 cells
3387. Optimization of a novel mucoadhesive drug deliver system with ion-exchange resin core loaded with Berberine hydrochloride using central composite design …
3388. Optimization of Enzyme-alkali Method Extraction Process of Berberine from Cortex Phellodendri by Orthogonal Experiments
3389. Optimization of ex vivo permeability characteristics of Berberine in presence of quercetin using 32 full factorial design
3390. Optimization of Extraction Conditions of Berberine in Rhizoma Coptidis with Orthogonal Test [J]
3391. Optimization of Extraction Process for Berberine Hydrochloride in Rhizoma Copotidis by Orthogonal Experiment
3392. Optimization of Extraction Technology for Berberine in Cortex Phellodendri and Its Inhibition Effect on Plant Pathogen
3393. Optimization of Fermentation Conditions of a Mutagenized Berberine -Producing Strain
3394. Optimization of floating pellet containing Berberine hydrochloride formulation by central composite design-response surface methodology
3395. Optimization of mesoporous carbons for efficient adsorption of Berberine hydrochloride from aqueous solutions
3396. Optimization of oleic acid-, induced insulin resistance HepG2 cell model and anti-hyperglycemic effect of Berberine , baicalin, puerarin and liquiritin
3397. Optimization of Preparation Technology of Berberine -β-Cyclodextrin Inclusion Complex by Central Composite Design and Response Surface Method [J]
3398. Optimization of Salting-out Extraction of Berberine from Huanglian by Orthogonal Experiment [J]
3399. Optimization of the extraction process in Berberine hydrochloride from Coptis Chinensis Franch. by the genetic algorithm
3400. Optimization of the percotion processes on Berberine hydrochloride in Coptis Chinensis Franch by orthogonal design [J]
3401. Optimization of the process of Berberine liposome preparation using supercritical CO_2
3402. Optimization of thermosensitive in situ gel system containing Berberine hydrochloride for ocular use
3403. Optimization of β-cyclodextrin grafting on wool fibers improved by plasma treatment and assessment of antibacterial activity of Berberine finished fabric
3404. Optimizing manufacture of liposomal Berberine with evaluation of its antihepatoma effects in a murine xenograft model
3405. Orally administered Berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-γ and subsequent expression of HGF …
3406. Orally administered Berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal FXR signaling pathway
3407. Orengedokuto and Berberine improve indomethacin-induced small intestinal injury via adenosine
3408. Organic anion-transporting polypeptides contribute to the hepatic uptake of Berberine
3409. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and Berberine
3410. Organic cation transporter-mediated drug–drug interaction potential between Berberine and metformin
3411. Oriental Sore treated by Berberine Sulphate. An Analysis of Fifty Cases.
3412. Oxidation of monolignols by members of the Berberine bridge enzyme family suggests a role in plant cell wall metabolism
3413. Oxidative damage and antioxidant responses in Microcystis aeruginosa exposed to the allelochemical Berberine isolated from golden thread
3414. Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of Berberine in rats
3415. OxyBerberine , a novel gut microbiota-mediated metabolite of Berberine , possesses superior anti-colitis effect: impact on intestinal epithelial barrier, gut microbiota …
3416. P-010 Berberine inhibits the migration and invasion depending on HNF4αvia Wnt/beta-catenin pathway in gastric cancer
3417. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by Berberine
3418. p53 cooperates Berberine ‐induced growth inhibition and apoptosis of non‐small cell human lung cancer cells in vitro and tumor xenograft growth in vivo
3419. p53, Bcl-2 and cox-2 are involved in Berberine hydrochloride-induced apoptosis of HeLa229 cells
3420. Palmatine and Berberine isolation artifacts
3421. Parmacokinetics of bacalin and Berberine Gonglao Quhuo tablets in rats
3422. Participation of an active transport system in Berberine -secreting cultured cells of Thalictrum minus
3423. Patterns of accumulation of Berberine alkaloid and chemical profiling of natural populations of Coscinium fenestratum (Menispermaceae) in the Central Western Ghats …
3424. PEG–lipid–PLGA hybrid nanoparticles loaded with Berberine –phospholipid complex to facilitate the oral delivery efficiency
3425. Percutaneous penetration of [sup 3] H-Huangbai extracts and H [sup 3]-Berberine
3426. Percutaneous penetration of 3H-Huangbai extracts and H3-Berberine
3427. Performance and modeling of a pilot-scale up-flow anaerobic sludge blanket (UASB) treating pharmaceutical wastewater containing Berberine
3428. P‐glycoprotein–mediated transport of Berberine across Caco‐2 cell monolayers
3429. Pharmacodynamics Research Progress of Berberine and the Derivatives
3430. Pharmacodynamics Study of Tablet of Complex Prescription Rhizoma Coptidis to Lower Glucose (复方黄连降糖片) and Berberine on Sugar-lipid Metabolism [J]
3431. Pharmacokinetic and NMR metabolomics approach to evaluate therapeutic effect of Berberine and Coptidis Rhizoma for sepsis
3432. Pharmacokinetic and pharmacodynamic characteristics of Berberine and jateorhizine in Coptidis Rhizoma powder and their monomeric compounds in type 2 diabetic …
3433. Pharmacokinetic comparison of Berberine in rat plasma after oral administration of Berberine hydrochloride in normal and post inflammation irritable bowel syndrome …
3434. Pharmacokinetic comparisons of Berberine and palmatine in normal and metabolic syndrome rats
3435. Pharmacokinetic difference of Berberine between normal and chronic visceral hypersensitivity irritable bowel syndrome rats and its mechanism
3436. Pharmacokinetic interaction between tacrolimus and Berberine in a child with idiopathic nephrotic syndrome
3437. Pharmacokinetic interactions and tolerability of Berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy …
3438. Pharmacokinetic interactions between metformin and Berberine in rats: Role of oral administration sequences and microbiota
3439. Pharmacokinetic studies of novel Berberine derivatives with ultra-performance liquid chromatography–tandem mass spectrometry
3440. Pharmacokinetic Study of 9-O-glucosyl-Berberine in Rats
3441. Pharmacokinetic study of Berberine from rasont and implication of lysergol for its bioavailability enhancement
3442. Pharmacokinetic Study of Berberine Hydrochloride in Chickens
3443. Pharmacokinetic study of Berberine hydrochloride of cortex phellodendri in rat plasma [J]
3444. Pharmacokinetic study of Berberine in ultramicro-pulverised powder of Huanglian jiedusan in rabbits
3445. Pharmacokinetic Study of Berberine in Ultramicro-Pulverised Powder of Huanglian jiedusan in Rabbits [J]
3446. Pharmacokinetic study on Berberine in the extract of rhizoma coptidis-radix aucklandiae drug-pair in rats
3447. Pharmacokinetic study on compatibility of Berberine and citrus aurantium extract in rats
3448. Pharmacokinetics and relative bioavailability study of Berberine hydrochloride phytosome in rabbits
3449. Pharmacokinetics Comparison of Berberine in Gengenqinlian Decoction Between Normal Rats and Diabetic Rats [J]
3450. Pharmacokinetics of Berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry
3451. Pharmacokinetics of Berberine chloride after a single and multiple oral dose in Beagle dogs [J]
3452. Pharmacokinetics of Berberine in Puerariae and Scutellariae and Coptidis Decoction in Vivo of Dog
3453. Pharmacokinetics of Berberine in Puerariae and Scutellariae and Coptidis Decoction in Vivo of Dog [J]
3454. Pharmacokinetics of Berberine in Rat Thalamus After Intravenous Administration of Coptidis Rhizoma Extract
3455. Berberine -bioactive-compound/103/00004483″ target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://insights.ovid.com/allergy-clinical-immunology/jaci/2014/02/001/pharmacokinetics-Berberine -bioactive-compound/103/00004483&source=gmail&ust=1581476879711000&usg=AFQjCNFt4LTuFm8CI8dkNgAnMkvx9Keq8g”>Pharmacokinetics Of Berberine , a Bioactive Compound In Butanol Purified Food Allergy Herbal Formula-2
3456. Pharmacokinetics of cyclosporin A coadministrated with Berberine in Chinese healthy volunteers
3457. Pharmacokinetics of Palmatine and Berberine of Yulian Cataplasm [J]
3458. Pharmacokinetics of synergistic effect of coadministration of cyclosporin A with Berberine hydrochloride in renal transplantation recipients
3459. Pharmacokinetics studied on Berberine hydrochloride acted by rhizoma coptidis-fructus evodiae herbal couple in acute gastric ulcer rats
3460. Pharmacokinetics study on Berberine hydrochloride in rats administered with Coptidis rhizoma-Evodiae fructus
3461. Pharmacologic preconditioning with Berberine attenuating ischemia-induced apoptosis and promoting autophagy in neuron
3462. Pharmacological Action of Berberine .
3463. Pharmacological actions of Berberine on the central nervous system
3464. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent Berberine
3465. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, Berberine
3466. Pharmacological Effect of Berberine Chloride in Propyl Thiouracil Induced Thyroidal Dysfunction-A Time Bound Study in Female Rats
3467. Pharmacological effects of Berberine and its derivatives: a patent update
3468. Pharmacological Effects of Berberine and Palmatine on the Prostatic and Urethral Smooth Muscle of the Rabbit.
3469. Pharmacological effects of Berberine on mood disorders
3470. Pharmacological effects of Berberine on the longitudinal muscle of the guinea-pig isolated ileum.
3471. Pharmacological evaluation of Berberine against nimesulide induced hepatoxicity
3472. PHARMACOLOGICAL EVALUATION OF HEPATIC PROFILE OF NIMESULIDE ALONG WITH Berberine
3473. Pharmacological investigations of Berberine sulphate
3474. Pharmacological studies on antidiarrheal effects of a preparation containing Berberine and geranii herba
3475. Pharmacological studies on antidiarrheal effects of Berberine and geranii herba
3476. Pharmacological/Biological effects of Berberine
3477. Pharmacologically relevant concentrations of Berberine transiently stimulate dihydrotestosterone-inducible androgen receptor-mediated luciferase activity in …
3478. Pharmacophore optimization of Berberine as HER2 inhibitor
3479. Phellodendri and a Total of Extract Atractylodes of Phellodendri in Berberine Rate of Extraction Experiments [J]
3480. Phellodendron amurense (Cork Tree): In Vitro Culture, Micropropagation, and the Production of Berberine
3481. Phellodendron amurense and its major alkaloid compound, Berberine ameliorates scopolamine-induced neuronal impairment and memory dysfunction in rats
3482. Phenanthroline-linked Berberine dimer and fluorophore-tagged DNA conjugate for the selective detection of microRNA-185: Experimental and molecular docking …
3483. Phenol oxidation and biosynthesis. Part VIII. Investigations on the biosynthesis of Berberine and protopine
3484. Photochemical and phototoxic activity of Berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells
3485. Photochemistry and Photocytotoxicity of Alkaloids from Goldenseal (Hydrastis canadensis L.) 1. Berberine
3486. Photodynamic effect of Berberine sulfate on the growth rate of Allium cepa roots
3487. Photodynamic Therapy Enhanced the Antitumor Effects of Berberine on HeLa Cells
3488. Photometric Determination of Berberine Hydrochloride in Drugs Based on Its Reaction with Nanogold [J]
3489. Photophysical and calorimetric studies on the binding of 9-O-substituted analogs of the plant alkaloid Berberine to double stranded poly (A)
3490. Photostabilization of biocontrol agents by Berberine
3491. Physicochemical characterization of Berberine chloride: a perspective in the development of a solution dosage form for oral delivery
3492. Physicochemical properties of Berberine and palmatine upon binding to DNA
3493. Physiological effects of Berberine
3494. Physiology of Berberine production in suspension-cultured plant cell lines of Thalictrum.
3495. PI3K p55γ promoter activity enhancement is involved in the anti-apoptotic effect of Berberine against cerebral ischemia–reperfusion
3496. PICTET AND GAMS’Berberine SYNTHESIS
3497. Pilot study on the additive effects of Berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control
3498. Pilot-scale treatment of pharmaceutical Berberine wastewater by Fenton oxidation
3499. Pioglitazone-induced bone loss in diabetic rats and its amelioration by Berberine : A portrait of molecular crosstalk
3500. PL-03 Harnessing multidrug resistance gene expression for effective antifungal strategies by a natural product Berberine
3501. Plasma and hippocampal pharmacokinetics of Berberine after intravenous or intranasal administration in rats
3502. Plasmodium DNA fluoresces with Berberine : a novel approach for diagnosis of malarial parasites
3503. Podoplanin mediates the renoprotective effect of Berberine on diabetic kidney disease in mice
3504. Polarographic determination of Berberine in the presence of H2O2 in medicinal plants
3505. Polyethylene glycol 400 (PEG400) affects the systemic exposure of oral drugs based on multiple mechanisms: Taking Berberine as an example
3506. Polygonum cuspidatum, compared with baicalin and Berberine , inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 …
3507. Polypharmacology of Berberine based on multi-target binding motifs
3508. Porphyrin dimer as neutral ionophore for a Berberine -sensitive potentiometric sensor
3509. Porphyrin–metalloporphyrin composite based optical fiber sensor for the determination of Berberine
3510. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of Berberine chloride
3511. Possible role of P-glycoprotein in the neuroprotective mechanism of Berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction
3512. Possible therapeutic potential of Berberine in diabetic osteopathy
3513. Possible therapeutic potential of Berberine in the treatment of STZ plus HFD-induced diabetic osteoporosis
3514. Potent antiprotozoal activity of a novel semi-synthetic Berberine derivative
3515. Potent in vitro synergism of fluconazole and Berberine chloride against clinical isolates of Candida albicans resistant to fluconazole
3516. Potent in vitro synergism of fusidic acid (FA) and Berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)
3517. Potential antibacterial activity of Berberine against multi drug resistant enterovirulent Escherichia coli isolated from yaks (Poephagus grunniens) with haemorrhagic …
3518. Potential antimutagenic activity of Berberine , a constituent of Mahonia aquifolium
3519. Potential benefits of Berberine in the management of perimenopausal syndrome
3520. Potential cerebral perfusion agents. Synthesis and evaluation of Berberine analogues
3521. Potential compounds for oral cancer treatment: resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, Berberine , pterostilbene, deguelin, andrographolide …
3522. Potential cytotoxic and anti-metastatic effects of Berberine on gynaecological cancers with drug-associated resistance
3523. Potential of Berberine to enhance antimicrobial activity of commonly used antibiotics for dairy cow mastitis caused by multiple drug-resistant Staphylococcus …
3524. Potential Prophylactic Effect of Berberine against Rat Colon Carcinoma Induce by 1, 2-Dimethyl Hydrazine
3525. Precipitation reaction between Berberine and rheinic acid by capillary electrophoresis
3526. Pre-clinical toxicity of a combination of Berberine and 5-aminosalicylic acid in mice
3527. Precursor-directed biosynthesis of non-natural Berberine and galanthamine analogues
3528. Prediction of the selectivity coefficients of a Berberine selective electrode using artificial neural networks
3529. Predictive QSAR modeling study on Berberine derivatives with hypolipidemic activity
3530. Preferential induction of CYP1A1 over CYP1B1 in human breast cancer MCF-7 cells after exposure to Berberine
3531. PRELIMINARY INVESTIGATION OF Berberine ON THE FUNCTION OF SINO-ATRIAL NODE (SAN)
3532. Preliminary investigation of the effect of Berberine -oryzanol on intestinal mircoflora in the type Ⅱ diabetes
3533. Preliminary Investigation of the effect of the Intestinal mircoflora in the type Ⅱ diabetes by Berberine and Oryzanol
3534. Preliminary studies of Berberine and its semi-synthetic derivatives as a promising class of multi-target anti-parkinson agents
3535. Preliminary Study of Production Traditional Medicinal Ointments for Closed Soft Tissue Injury——Experimental Study of Extraction Process about Berberine …
3536. Preliminary study on application of some dosage methods of Berberine chloride in raw material and berberin tablets
3537. Preliminary Study on Effects of Berberine on Experimental Autoimmune Encephalomyelitis in Lewis Rats [J]
3538. Preliminary study on RC membrane permeability and mechanism of seven traditional Chinese medicine alkaloids such as Berberine
3539. Prelimitary study of 18F Berberine derivatives as a potential cardiac PET imaging agent
3540. Preparation and adsorption behavior of Berberine hydrochloride imprinted polymers by using silica gel as sacrificed support material
3541. Preparation and adsorption characteristics of rosin-based polymer microspheres for Berberine hydrochloride and separation of total alkaloids from coptidis rhizoma
3542. Preparation and Antibacterial of Berberine Complexes with Rare Earth
3543. Preparation and Application of DNA Fluorescence Capillary Biosensor Labelled with Berberine [J]
3544. Preparation and characteristics of Berberine polylactic acid microspheres [J]
3545. Preparation and characterization of Berberine Hydrochloride and Trimethoprim Chitosan/SBE7-β-CD microspheres
3546. Preparation and Characterization of Berberine Hydrochloride Ternary Complexes
3547. Preparation and Characterization of Erythrocyte Membrane-Camouflaged Berberine Hydrochloride-Loaded Gelatin Nanoparticles
3548. Preparation and Determination of Release of Berberine Sustained-release Tablets Containing Chitosan in Vitro
3549. Preparation and evaluation of a microemulsion for oral delivery of Berberine
3550. Preparation and evaluation of antidiabetic agents of Berberine organic acid salts for enhancing the bioavailability
3551. Preparation and evaluation of Berberine alginate beads for stomach-specific delivery
3552. Preparation and evaluation of Berberine -Cl imprinted polymers by using silica-gel as sacrificed materials [J]
3553. Preparation and evaluation of chitosan-coated alginate/gelatin sustained releasing microspheres containing Berberine hydrochloride in vitro
3554. Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of Berberine hydrochloride
3555. Preparation and in vitro characterization of Berberine hydrochloride–self-emulsifying microsphere by membrane emulsification technology
3556. Preparation and in vitro evaluation of self-assembled beads drug delivery system of Berberine hydrochloride
3557. Preparation and in vitro-in vivo evaluation of intestinal retention pellets of Berberine chloride to enhance hypoglycemic and lipid-lowing efficacy
3558. Preparation and Medical Efficacy of Germicidal Emulsion of Rare Earths Berberine Complex
3559. Preparation and optimization of a drug delivery system based on Berberine chloride-immobilized MgAl hydrotalcite
3560. Preparation and physicochemical characteristics of Berberine hydrochloric nanoemulsion
3561. Preparation and Property of Berberine Hydrochloride Bioadhesive-coated Tablets
3562. Preparation and Quality Control of Berberine Hydrochloride Colon-specific Enteric-coated Tablets
3563. Preparation and Quality Evaluation of Berberine Hydrochloride Liposomes [J]
3564. Preparation and quality evaluation of Berberine hydrochloride sustained-release pellets
3565. Preparation and release characteristics of Berberine calcium alginate gel beads
3566. Preparation and release characteristics of Berberine chitosan nanoparticles in vitro
3567. Preparation and release in vitro of Berberine tannate colon-specific coated tablets [J]
3568. Preparation and sustained release in vitro of Berberine loaded in different carrier-system fibers [J]
3569. Preparation and the Berberine hydrochloride release behavior in vitro of β-cyclodextrin polymer microspheres
3570. Preparation and the dissolution research of the dispersible tablet of Berberine hydrochloride and paeonol
3571. Preparation characterization and antitumor activity in vitro of Berberine hydrochloride polymeric micelles
3572. Preparation of a stir bar with molecularly imprinted polymer and its application in analysis of Berberine hydrochloride in cortex phellodendri chinensis by HPLC
3573. Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of Berberine
3574. Preparation of Berberine Hydrochloride Liposomes by a New pH Gradient Method [J]
3575. Preparation of Berberine hydrochloride long-circulating liposomes by ionophore A23187-mediated ZnSO4 gradient method
3576. Preparation of Berberine Hydrochloride Microcapsules for Taste Masking by Fluidized Bed Coating
3577. Preparation of Berberine Hydrochloride Poloxamer 188 Solid Dispersion
3578. Preparation of Berberine hydrochloride prolipsomes and study of its physicochemical properties
3579. Preparation of Berberine hydrochloride-resinates sustained microcapsules by intra-liquid desiccation
3580. Preparation of Berberine -loaded Chitosan Microspheres and Their Fungistasis [J]
3581. Preparation of Berberine -montmorillonite-metolachlor formulations from hydrophobic/hydrophilic mixtures
3582. Preparation of Colon Controlled Release Pellets of Berberine Hydrochloride
3583. Preparation of enzyme-controlled colon-positioning tablets of Berberine Hydrochloride [J]
3584. Preparation of Free Berberine and Characterization of Its Solution Properties
3585. Preparation of gastroretentive floating tablets of Berberine hydrochloride [J]
3586. Preparation of micropipette tip-based molecularly imprinted monolith for selective micro-solid phase extraction of Berberine in plasma and urine samples
3587. Preparation of oral Berberine bisulfate liposomes
3588. Preparation of porous biodegradable chitosan/Berberine hydrochloride composite xerogel and its antibacterial and hemostatic properties
3589. PREPARATION OF PVC MEMBRANE Berberine SELECTIVE ELECTRODE
3590. Preparation of thermosensitive in situ gel containing Berberine hydrochloride for ophthalmic use and pharmacokinetics in aqueous humors of rabbit eyes [J]
3591. Preparation, characterization and in vivo studies of amorphous solid dispersion of Berberine with hydrogenated phosphatidylcholine
3592. Preparation, Crystal Structures, and Oral Bioavailability of Two Cocrystals of Emodin with Berberine Chloride
3593. Preparation, pharmacokinetics and tumour‐suppressive activity of Berberine liposomes
3594. Preparation, Quality and Safety Evaluation of Berberine Nanoemulsion for Oral Application [J]
3595. Prescription screening of Berberine Hydrochloride transdermal absorption ointment
3596. Pressurized hot water extraction of Berberine , baicalein and glycyrrhizin in medicinal plants
3597. Pressurized liquid extraction and multiple, ultrasonically-assisted extractions of hydrastine and Berberine from goldenseal (Hydrastis canadensis) with subsequent …
3598. Pressurized liquid extraction of Berberine and aristolochic acids in medicinal plants
3599. Pretreatment of rats with increased bioavailable Berberine attenuates cerebral ischemia-reperfusion injury via down regulation of adenosine-5′ monophosphate …
3600. Pretreatment with a combination of ligustrazine and Berberine improves cardiac function in rats with coronary microembolization
3601. Berberine _and_Yohimbine_Protects.16.aspx” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://journals.lww.com/shockjournal/Fulltext/2011/03000/Pretreatment_with_Berberine _and_Yohimbine_Protects.16.aspx&source=gmail&ust=1581476879723000&usg=AFQjCNGtFd-wlv9rccXPpq835VHqSK8bEw”>Pretreatment with Berberine and yohimbine protects against LPS-induced myocardial dysfunction via inhibition of cardiac I-κBα phosphorylation and apoptosis in mice
3602. Pre-treatment with Berberine enhances effect of 5-fluorouracil and cisplatin in HEP2 laryngeal cancer cell line.
3603. Prevention effect of emodin and Berberine on insulin resistance in HepG2 cells [J]
3604. Prevention of acute heart allograft rejection by Berberine combined with cyclosporine A in rats
3605. Prevention of HIV protease inhibitor-induced inflammatory response and ER stress by Berberine in macrophages
3606. Preventive and curative effects of Berberine on experimental colon cancer in rats and its relationship to expression of peroxisome proliferator-activated receptor γ
3607. Preventive and Therapeutic Roles of Berberine in Gastrointestinal Cancers
3608. Preventive effect of Berberine against DMBA-induced breast cancer in female Sprague Dawley rats
3609. Preventive effect of Coptis chinensis and Berberine on intestinal injury in rats challenged with lipopolysaccharides
3610. Preventive effects of Berberine on experimental colon cancer and relationship with cyclooxygenase-2 expression
3611. Preventive effects of Berberine on glucocorticoid-induced osteoporosis in rats
3612. Preventive use of Berberine in inhibition of lead-induced renal injury in rats
3613. Primary study on fluro [19F] Berberine derivative for human hepatocellular carcinoma targetting in vitro
3614. Probiotics Plus Berberine as an Anti-Diabetic Regimen in Patients with Type 2 Diabetes, Particularly in the Elderly: A Multicentre Randomised Controlled Trial
3615. Process‐induced phase transformation of Berberine chloride hydrates
3616. Production and investigation of sustained Berberine pellet drug release system
3617. Production of Berberine in cultured cells of Coptis japonica
3618. Production of Berberine in immobilized plant cell culture ofThalictrum rugosum
3619. Production of singlet oxygen by sanguinarine and Berberine
3620. Profiling of Traditional Chinese Medicine Compound Berberine as Anticancer Agent in Melanoma
3621. Progress about Clinical Application of Berberine [J]
3622. Progress in pharmacological effects and clinical applications of Berberine
3623. Progress in the Study of Berberine Biosynthetic Enzymes of Coptis [J]
3624. Progress of Berberine for treatment of type 2 diabetes
3625. Proliferation effects of Berberine on rat neural stem cells induced by hydrogen peroxide
3626. Protecting effect of Berberine for gut mucosal barrier during early phase of sepsis by cecal ligation and puncture in rat [J]
3627. Protection and mechanism of Berberine against chronic brain injury induced by aluminumoverload in rats
3628. Protection by and anti‐oxidant mechanism of Berberine against rat liver fibrosis induced by multiple hepatotoxic factors
3629. Protection Effect of Berberine Ischemia-Reperfusion for Renal Tubular Epithelial Cell of Rats
3630. Protection Mechanism of Berberine against Liver Injury Induced by Isoniazid in Mice
3631. Protection of Berberine in NIDDM rat brain [J]
3632. Protection of Berberine on intestinal mucosa following autologous orthotropic liver transplantation and its correlationship with p-AMPK activation and p-mTOR …
3633. Protection of cholinergic and antioxidant system contributes to the effect of Berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes
3634. Protective effcts of Berberine on cerebral ischemia in mice and rats [J]
3635. Protective effect of Berberine against cardiac ischemia/reperfusion injury by inhibiting apoptosis through the activation of Smad7
3636. Protective Effect of Berberine Against Cerebral Ischemic “Insult” in Rats
3637. Protective effect of Berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling
3638. Protective effect of Berberine against oxidative stress-induced apoptosis in rat bone marrow-derived mesenchymal stem cells
3639. Berberine _chloride_on_Plasmodium_chabaudi-induced_hepatic_tissue_injury_in_mice/links/55dd917108ae591b309ae309.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Mohamed_Dkhil/publication/276452261_Protective_effect_of_Berberine _chloride_on_Plasmodium_chabaudi-induced_hepatic_tissue_injury_in_mice/links/55dd917108ae591b309ae309.pdf&source=gmail&ust=1581476879726000&usg=AFQjCNGZ7WebIfI8L2pkABrIBetVqkn0gw”>Protective effect of Berberine chloride
3640. Protective effect of Berberine chloride on Plasmodium chabaudi-induced hepatic tissue injury in mice
3641. Protective effect of Berberine on aconite‑induced myocardial injury and the associated mechanisms
3642. Protective effect of Berberine on acute cardiomyopathy associated with doxorubicin treatment
3643. Protective Effect of Berberine on Acute Hypoxia Induced by Sodium Nitrite in Mice
3644. Protective effect of Berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver
3645. Protective effect of Berberine on aortic endothelial dysfunction in diabetic rats
3646. Protective Effect of Berberine on Atherosclerotic Injury [J]
3647. Protective effect of Berberine on beta cells in streptozotocin-and high-carbohydrate/high-fat diet-induced diabetic rats
3648. Protective effect of Berberine on cardiac hypertrophy induced by L-thyroxine in rats
3649. Protective effect of Berberine on cardiac myocyte injured by ischemia-reperfusion
3650. Protective Effect of Berberine on CCl_4-induced Acute Liver Injury in Mice
3651. Protective effect of Berberine on CCl4 induced acute liver injury in mice
3652. Protective effect of Berberine on cyclophosphamide‐induced haemorrhagic cystitis in rats
3653. Protective effect of Berberine on doxorubicin‑induced acute hepatorenal toxicity in rats
3654. Protective effect of Berberine on expression pattern of apoptotic, cell proliferative, inflammatory and angiogenic markers during 7, 12-dimethylbenz (a) …
3655. Protective effect of Berberine on high glucose and hypoxia-induced apoptosis via the modulation of HIF-1α in renal tubular epithelial cells
3656. PROTECTIVE EFFECT OF Berberine ON IMMUNOEXPRESSION PATTERN OF P53 AND BCL-2 IN 7,12-DIMETHYLBENZ [A] ANTHRACENE-INDUCED SKIN …
3657. Protective effect of Berberine on injury of sciatic nerve in diabetes rats [J]
3658. Protective effect of Berberine on isolated perfused heart in heart failure
3659. Protective effect of Berberine on oleic acid-induced injury in human aortic endothelial cells via AMPK-eNOS activation.
3660. Protective effect of Berberine on PPARs and P-TEFb expression in CA3 region of diabetic rat hippocampus
3661. Protective effect of Berberine on rat hippocampus against cerebral ischemia
3662. Protective effect of Berberine on renal fibrosis caused by diabetic nephropathy
3663. Protective effect of Berberine on serum glucose levels in non-obese diabetic mice
3664. Protective effect of Berberine on the intestinal caecum in chicks with Eimeria tenella
3665. Protective effect of Berberine pretreatment in hepatic ischemia/reperfusion injury of rat
3666. Protective effect of Berberine , an isoquinoline alkaloid ameliorates ethanol-induced oxidative stress and memory dysfunction in rats
3667. Protective effect of isoquinoline alkaloid Berberine on spontaneous inflammation in the spleen, liver and kidney of non-obese diabetic mice through downregulating …
3668. Protective effect of surface-modified Berberine nanoparticles against LPS-induced neurodegenerative changes: a preclinical study
3669. Berberine -against-amyloid-beta/4/01300535″ target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://insights.ovid.com/neural-regeneration-research/nrgr/2011/01/030/protective-effects-Berberine -against-amyloid-beta/4/01300535&source=gmail&ust=1581476879729000&usg=AFQjCNEvB-9d22snlIzAH2YbKK2X7F9ETg”>Protective effects of Berberine against amyloid beta-induced toxicity in cultured rat cortical neurons**★
3670. Protective effects of Berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin
3671. Protective effects of Berberine against exhaustion exercise induced myocardial injury in rats
3672. Protective effects of Berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells
3673. Protective effects of Berberine and phentolamine on myocardial reoxygenation damage.
3674. Protective effects of Berberine hydrochloride on DSS-induced ulcerative colitis in rats
3675. Protective effects of Berberine in an experimental rat osteoarthritis model
3676. Protective effects of Berberine on aortic endothelial function in type 2 diabetic rats
3677. Protective effects of Berberine on cerebral ischemia in mice and r ats
3678. Protective Effects of Berberine on Cerebral Ischemia in Mice and Rats [J]
3679. Protective effects of Berberine on doxorubicin-induced hepatotoxicity in mice
3680. Protective effects of Berberine on doxorubicin-induced nephrotoxicity in mice
3681. Protective effects of Berberine on early renal hyperfiltration in diabetic rats
3682. Protective effects of Berberine on experimental myocardial infarction in rats
3683. Protective effects of Berberine on high fat-induced kidney damage by increasing serum adiponectin and promoting insulin sensitivity
3684. Protective effects of Berberine on intestinal ischemia and reperfusion injury in rats
3685. Protective effects of Berberine on isoproterenol-induced acute myocardial ischemia in rats through regulating HMGB1-TLR4 axis
3686. Protective Effects of Berberine on Myocardial Ischemia Reperfusion Injury in Rats
3687. Protective Effects of Berberine on Myocardium Suffered from Acute Ischemia [J]
3688. Protective effects of Berberine on neuronal injury in cultured cortical neurons in rats
3689. Protective effects of Berberine on oxygen-glucose deprivation/reperfusion on oligodendrocyte cell line (OLN-93)
3690. Protective effects of Berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung …
3691. Protective effects of Berberine on renal injury in streptozotocin (STZ)-induced diabetic mice
3692. Protective effects of Berberine on spontaneous ventricular fibrillation in dogs after myocardial infarction
3693. Protective mechanisms of Berberine against experimental autoimmune myocarditis in a rat model
3694. Protective role of Berberine and Coptischinensis extract on T2MD rats and associated islet Rin‑5f cells
3695. Protective role of Berberine chloride on blood components in streptozotocin induced diabetic rats
3696. Protective role of Berberine in isoprenaline-induced cardiac fibrosis in rats
3697. Protective role of Berberine on ulcerative colitis through modulating enteric glial cells–intestinal epithelial cells–immune cells interactions
3698. Protein kinase C is involved in the neuroprotective effect of Berberine against intrastriatal injection of quinolinic acid‐induced biochemical alteration in mice
3699. Proteomic Analysis Reveals a Synergistic Mechanism of Fluconazole and Berberine against Fluconazole-Resistant Candida albicans: Endogenous ROS …
3700. Proteomic and redox-proteomic analysis of Berberine -induced cytotoxicity in breast cancer cells
3701. Proteomic profiling of the neurons in mice with depressive-like behavior induced by corticosterone and the regulation of Berberine : pivotal sites of oxidative …
3702. ProtoBerberine Alkaloids Berberine , Palmatine, and Coralyne Binding to Poly (dT)⋅(Poly (dA)⋅ Poly (dT)) Triplex: Comparative Structural Aspects and Energetics …
3703. Protonated forms of poly [d (GC)] and poly (dG). poly (dC) and their interaction with Berberine
3704. Protonated structures of naturally occurring deoxyribonucleic acids and their interaction with Berberine
3705. Protoscolecidal effect of Berberis vulgaris root extract and its main compound, Berberine in cystic echinococcosis
3706. Provenance variations in Berberine content of Phellodendron amurense, a rare and endangered medicinal plant grown in Northeast China
3707. Pulsatilla and Different Ratios of Berberine Dissolution of the Active Ingredient and the Next Dose-effect Relationship
3708. Purification and characterization of the Berberine bridge enzyme from Berberis beaniana cell cultures
3709. Q8, a Berberine derivative, increases osteoblastic differentiation and function through Runx2 and Osterix
3710. Qualitative Identification and Content Determination of Berberine Hydrochloride in Huangjin Paste
3711. Quantification of Berberine in Berberis vulgaris L. Root Extract and Its Curative and Prophylactic Role in Cisplatin-Induced In Vivo Toxicity and In Vitro Cytotoxicity
3712. Quantification of Berberine in different Berberis species and their commercial samples from herbal drug markets of India through HPTLC
3713. Quantification of Berberine in Macleaya cordata
3714. Quantitation of Berberine chloride in human urine by use of selected ion monitoring in the field desorption mode
3715. Quantitative analysis of Berberine hydrochloride in traditional Chinese medicine Kangfushu soft capsules by high performance liquid chromatography
3716. Quantitative analysis of Berberine in an Ayurvedic formulation-Rasayanachurna by UV spectrophotometry
3717. Quantitative analysis of Berberine in Argemone mexicana Linn.(Papaveraceae) using HPLC and HPTLC.
3718. Quantitative analysis of Berberine in Berberis aristata fruits and in a traditional anti-inflammatory unani formulation by use of a validated HPLC method
3719. Quantitative analysis of Berberine in processed coptis by near-infrared diffuse reflectance spectroscopy
3720. Quantitative analysis of Berberine in urine samples by chemical ionization mass fragmentography
3721. Quantitative analysis of the anti-inflammatory activity of orengedokuto II: Berberine is responsible for the inhibition of NO production
3722. Quantitative Determination of Berberine Hydrochloride and Palmatin Hydrochloride in Mongolia Medicine ShaRiGa-4 by TLCF [J]
3723. Quantitative determination of Berberine hydrochloride in San-Huang tablets by HPLC-MS/MS [J]
3724. Quantitative Determination of Berberine Hydrochloride of Mongolian Medicine Sambucus Williamsii Hance by Spectrophotometry [J]
3725. Quantitative determination of Berberine hydrochloride of Tianshen capsule by HPLC
3726. Quantitative Determination of Berberine Hydrochloride, Phellodendrine and Timosaponin BⅡ in Common Anemarrhena Rhizome and Amur Corktree Bark Extraction …
3727. Quantitative Determination of Berberine in Marketed Herbal Formulations by TLC Densitometry and their Hypoglycemic Effect
3728. Quantitative Determination of Berberine in Qingwei Huanglian Pills by HPCE [J]
3729. Quantitative Determination of the Content of Berberine Hydrochloride in the Shirebi by TLCF [J]
3730. Quantitative determination of total alkaloids and Berberine in five medicinal Berberis plants
3731. Quantitative evaluation of Berberine subcellular distribution and cellular accumulation in non-small cell lung cancer cells by UPLC–MS/MS
3732. QUANTITATIVE METHOD STUDY ON TRANSPORT MECHANISM OF PUERARIN, Berberine HYDROCHLORIDE AND PAEONIFLORIN
3733. Quantitative study of Berberine Hydrochloride in Powdered Traditional Chinese Medicine
3734. Berberine _IN_HOMEOPATHIC_FORMULATION_CONTAINING_Berberis_vulgaris_L_BY_UV/links/5566f98608aec22682ffae7b.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Ramadoss_Karthikeyan/publication/277309586_QUANTITATIVE_ANALYSIS_OF_Berberine _IN_HOMEOPATHIC_FORMULATION_CONTAINING_Berberis_vulgaris_L_BY_UV/links/5566f98608aec22682ffae7b.pdf&source=gmail&ust=1581476879734000&usg=AFQjCNGMpVQyl19wa5TxLTGr1FbYsw_Nkw”>Quantitive analysis of Berberine in homeopathic formulation containing Berberis vulgaris L. by uv
3735. Quantitive determination of Berberine hydrochloride by proton nuclear magnetic resonance spectroscopy with internal standard method [J]
3736. Quantum chemical and nuclear magnetic resonance spectral studies on molecular properties and electronic structure of Berberine and berberrubine
3737. Quenching effect of l-tyrosine on peroxyoxalate chemiluminescence of Berberine as the fluorophore
3738. Quinacrine and Berberine as Antiviral Agents against Dengue and Zika Fever: In Silico Approach
3739. Quinolino-benzo-[5, 6]-dihydroisoquindolium compounds derived from Berberine : a new class of highly selective ligands for G-quadruplex DNA in c-myc oncogene
3740. Radioiodination, biodistribution and pharmacokinetics of Berberine in mice
3741. Radiolysis and photolysis studies on active transient species of Berberine
3742. Radiolysis of Berberine or palmatine in aqueous solution
3743. Radiosensitivity of Berberine on hypoxia esophageal cancer cells
3744. Radiosensitization effects of Berberine on human breast cancer cells
3745. Radiosensitizing effect of Berberine on nude mice transplanted with LNCaP cells of prostate cancer
3746. Radiosynthesis and Biological Evaluation of a Novel Berberine Derivative for Cardiac PET Imaging
3747. Radiosynthesis of novel 18F Berberine derivatives as potential tumor imaging agent
3748. Rajesh Suman (2017) Dipeptidyl Peptidase IV Inhibitory Activity of Berberine and Mangiferin: An In Silico Approach
3749. Raman spectra of Berberine : experimental and quantum-mechanical interpretation by the DFT method
3750. Raman spectrum spectral imaging revealing the molecular mechanism of Berberine -induced Jurkat cell apoptosis and the receptor-mediated Berberine delivery …
3751. Randomized Controlled Trial of Berberine Sulfate Therapy for Diarrhea Due to Enterotoxigenic Escherichia coli and Vibrio cholerae
3752. Randomized controlled trial of letrozole, Berberine , or a combination for infertility in the polycystic ovary syndrome
3753. Rapid and nondestructive detection of Berberine hydrochloride in tablets using optical fiber sensing with integrating sphere reflection
3754. Rapid and visual detection of Berberine hydrochloride based on a water‐soluble pyrene derivative
3755. Rapid Capillary Electrophoretic Analysis of Berberine in the Stem Extracts of Coscinium fenestratum (Gaertn.) Colebr.
3756. Rapid Content Petermination of Berberine Hydrochloride in Berberis Heteropoda Skin by Near Infrared Diffuse Reflection Optical Spectra Combined with Partial Least …
3757. Rapid determination of Berberine in baidai pill by non-aqueous capillary electrophoresis
3758. Rapid determination of Berberine in Tianshen capsule by nonaqueous capillary electrophoresis
3759. Rapid Identification of Berberine Metabolites in Rat Plasma by UHPLC-Q-TOF-MS
3760. Rat mesenchymal stem cells differentiate into neuron-like cells induced by Berberine in vitro
3761. Ratiometric delivery of doxorubicin and Berberine by liposome enables superior therapeutic index than DoxilⓇ
3762. Rational design of Berberine -based FtsZ inhibitors with broad-spectrum antibacterial activity
3763. Rationale and problems for use of coptis and Berberine in cancer chemoprevention
3764. Reaction of protoBerberine -type alkaloids. Part 12. A facile method for regiospecific oxygenation and excited oxidative ring-cleavage of Berberine alkaloids
3765. Reactive epidermal hyperplasia to?-sitosterol and Berberine moist exposed burn ointment (MEBO): A case report.
3766. Recent advances in nucleic acid binding aspects of Berberine analogs and implications for drug design
3767. Recent clinical advances with Berberine
3768. Recognition of human telomeric G‐quadruplex DNA by Berberine analogs: effect of substitution at the 9 and 13 positions of the isoquinoline moiety
3769. Recognition of molecularly imprinted polymers for a quaternary alkaloid of Berberine
3770. Berberine _Practical_Strategy_for_Promoting_Vascular_and_Metabolic_Health/links/55ec9def08ae65b6389f3cc3.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/James_Dinicolantonio/publication/281342988_Red_Yeast_Rice_Plus_Berberine _Practical_Strategy_for_Promoting_Vascular_and_Metabolic_Health/links/55ec9def08ae65b6389f3cc3.pdf&source=gmail&ust=1581476879737000&usg=AFQjCNFj4mnxFfP4Qif5QRia6y8LJT41nA”>Red yeast rice plus Berberine : practical strategy for promoting vascular and metabolic health
3771. Redox regulation in health and disease—Therapeutic potential of Berberine
3772. Reduced system exposures of total rhein and baicalin after combinatory oral administration of rhein, baicalin and Berberine to beagle dogs and rats
3773. Reducing Effects of Aerobic Exercise Training Combined with Berberine Chloride Supplementation on the Apoptotic Markers of Kidney in Streptozotocin …
3774. Reducing the inhibitory effect of cigarette smoke on the activity of oral peroxidase by the addition of Berberine in cigarette filter
3775. Reduction of Apolipoprotein E-rich HDL Levels with Berberine Stimulates Reverse Cholesterol Transport in Hyperlipidemic Hamsters Treated with CETP Inhibitor …
3776. Re-evaluation of the Effect of Non-prescription Drug Berberine on Antidiarrhea [J]
3777. Regulation Effect of Berberine on the Inhibition of Hexokinase Ⅱ in Breast Cancer Cells Glycolysis
3778. Regulation of akt/foxo3a/skp2 axis is critically involved in Berberine -induced cell cycle arrest in hepatocellular carcinoma cells
3779. Regulation of Berberine and dioscin in expression of glucose metabolism molecular in trophoblast cells.
3780. Regulation of cell signaling pathways by Berberine in different cancers: searching for missing pieces of an incomplete jig-saw puzzle for an effective cancer therapy
3781. Regulation of GSK-3 activity by curcumin, Berberine and resveratrol: potential effects on multiple diseases
3782. Regulation of hepatic cholesterol biosynthesis by Berberine during hyperhomocysteinemia
3783. Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound Berberine
3784. Regulations of Berberine on gene expression of BMP4 transcriptional pathways to improve visceral white adipose tissues insulin resistance in type 2 diabetic …
3785. Regulative effect of Berberine on glucocorticoid-induced dyslipidemia
3786. Regulatory effect of Berberine on unbalanced expressions of renal tissue TGF-beta1/SnoN and smad signaling pathway in rats with early diabetic nephropathy
3787. Regulatory effects of Berberine on microRNome in cancer and other conditions
3788. Regulatory effects of the combination of Berberine and ginsenoside Rb1 on high-fat diet-induced nonalcoholic fatty liver disease via AMPK pathway and improved …
3789. Relationship Between Metabolic Disorders and Breast Cancer Incidence and Outcomes. Is There a Preventive and Therapeutic Role for Berberine ?
3790. Relationship between the clinical effects of Berberine on severe congestive heart failure and its concentration in plasma studied by HPLC
3791. Relationship of Berberine -producing capability between Thalictrum plants and their tissue cultures
3792. Relative Inhibitory Activity of Berberine -Type Alkaloids against 12-ο-Tetradecanoylphorbol-13-acetate-Induced Inflammation in Mice
3793. Relaxant action mechanism of Berberine identified as the active principle of Argemone ochroleuca Sweet in guinea‐pig tracheal smooth muscle
3794. Relaxant action of Berberine , palmatine and total alkaloids from Rhizoma Coptidis on rat gastric fundus
3795. Relaxant Effect of Berberine on Isolated Rabbit Corpus Cavernosum
3796. Relaxant effects of Berberine on the rat fundus.
3797. Relaxation of corpus cavernosum and raised intracavernous pressure by Berberine in rabbit
3798. Release and crystallization of Berberine in the liquid medium of Thalictrum minus cell suspension cultures
3799. Release behavior and kinetic evaluation of Berberine hydrochloride from ethyl cellulose/chitosan microspheres
3800. Release Behavior of Berberine Encapsulated by Complex Microsphere Based on Alginate and Soy Protein Isolate
3801. Release of Berberine and its crystallization in liquid medium of cell suspension cultures of Coscinium fenestratum (Gaertn.) Colebr.
3802. Renal protection of Berberine and its mechanism in type II diabetic rats [J]
3803. Renal vectorial transport of Berberine mediated by organic cation transporter 2 (OCT2) and multidrug and toxin extrusion proteins 1 (MATE1) in rats
3804. Reno-protective effect of Berberine
3805. Renoprotective Effect of Berberine on Kidney Injury of Type 2 Diabetic Rat Model via Upregulating Smad7
3806. Renoprotective effect of Berberine on streptozotocin-induced diabetic nephropathy rats
3807. Renoprotective effects of Berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats
3808. Renoprotective effects of Berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color …
3809. Renoprotective effects of Berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats
3810. Repeated administration of Berberine inhibits cytochromes P450 in humans
3811. Requirement for Ergosterol in Berberine tolerance underlies synergism of Fluconazole and Berberine against fluconazole-resistant Candida albicans isolates
3812. Research Advance on Lowering of Blood Lipid Function of Berberine [J]
3813. Research development of extraction technology of Berberine in Coptis chinensis Franchb.
3814. Research of antiviral mechanisms of action of Berberine derivate HB-13 against herpes simplex virus type 2 [J]
3815. Research of Berberine to proliferation and apoptotic mechanism of human ovarian cancer cell line SKOV3
3816. Research of in vitro Dissolution of Berberine Solid Preparation Based on Biological Activity
3817. Research on anti-inflammatory activity of Berberine [J]
3818. RESEARCH ON BACTERIOSTAT EFFECT AND TOXICITY OF A KIND OF ANTI-BACTERIA GEL WITH Berberine TANNATE
3819. Research on Method of Microwave Extraction of Berberine in Coptis Chinensis
3820. Research on Methods of MAE and Salting-out for Extracting Berberine [J]
3821. Research on New Clinical Application Progress of Berberine
3822. Berberine &ots=9gFjPCC08V&sig=ZTAYYV36mxHj-tB805GEl6mIXew” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://books.google.com/books?hl%3Den%26lr%3Dlang_en%26id%3Dfa-NAgAAQBAJ%26oi%3Dfnd%26pg%3DPA235%26dq%3D%2BBerberine %26ots%3D9gFjPCC08V%26sig%3DZTAYYV36mxHj-tB805GEl6mIXew&source=gmail&ust=1581476879741000&usg=AFQjCNELoUVvVGo_decoJwVCJtGNAQfpdA”>Research on the best degradation condition of treating Berberine hydrochloride wastewater with the cooperation of microwave and activated carbon
3823. Research on the Effect of Berberine on the Function of Endothelial Vessels, IL-6 and TNF-a in Newly Diagnosed Patients with Type 2 Diabetes Mellitus
3824. Research on the effective improvement of hyperlipidemia by Berberine
3825. Research on the progress of Berberine determination
3826. Research on therapeutic effect and hemorrheology change of Berberine in new diagnosed patients with type 2 diabetes combining nonalcoholic fatty liver disease
3827. Research progress and mechanism of Berberine in respiratory diseases
3828. Research progress in analysis methods and pharmacological effects of Berberine
3829. Research progress of Berberine in treatment of diabetic kidney disease
3830. Research progress of relationship between diabetes and intestinal epithelial tight junction barrier and intervetion of Berberine
3831. Research progress on application of Berberine in nursing care of diabetes patients
3832. Research progress on Berberine with a special focus on its oral bioavailability
3833. Resistance of Berberine on Lung Inflammatory Injury in Mice with Viral Pneumonia Caused by Influenza Virus
3834. Resolution of Liver Fibrosis by Isoquinoline Alkaloid Berberine in CCl4-Intoxicated Mice Is Mediated by Suppression of Oxidative Stress and Upregulation of MMP-2 …
3835. Resonance driven regioselective demethylation of Berberine . Microwave assisted synthesis of berberrubine and its assessment as fluorescent chemosensor for …
3836. Resonance Rayleigh scattering for the determination of Berberine in tablet form with some acidic xanthene fluorescent dyes
3837. Resonance Rayleigh scattering spectra of Berberine -tetraphenylboron association nanoparticle and its analytical application
3838. Resonance Rayleigh scattering study on the interaction of gold nanoparticles with Berberine hydrochloride and its analytical application
3839. Response of Escherichia coli to Prolonged Berberine Exposure
3840. Response surface methodology optimization of formulation using supercritical CO 2 to prepare Berberine liposome
3841. Restoration of GLP-1 secretion by Berberine is associated with protection of colon enterocytes from mitochondrial overheating in diet-induced obese mice
3842. RETRACTED: Berberine inhibits growth, induces G1arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki–Cdk-cyclin cascade …
3843. RETRACTED: Berberine , an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E2and …
3844. Retraction: Berberine Improves Kidney Function in Diabetic Mice via AMPK Activation
3845. Reversal of cholera toxin-induced secretion in rat ileum by luminal Berberine
3846. Reversed-phase ion pair high performance liquid chromatography in determination of Berberine and palmatine in Phellodendron chinense Schneid. and its granules
3847. Review on the Mechanism of Berberine Reducing Blood Lipid
3848. Review on the Studies of Chemical Synthesis and Pharmacological of Berberine Derivative [J]
3849. Rhizoma Coptidis and Berberine as a natural drug to combat aging and aging-related diseases via anti-oxidation and AMPK activation
3850. Rhizoma coptidis and Berberine -induced activation of murine microglia N9 cells
3851. RNA binding small molecules: studies on t-RNA binding by cytotoxic plant alkaloids Berberine , palmatine and the comparison to ethidium
3852. RNA targeting by small molecule alkaloids: studies on the binding of Berberine and palmatine to polyribonucleotides and comparison to ethidium
3853. RNA-binding potential of protoBerberine alkaloids: spectroscopic and calorimetric studies on the binding of Berberine , palmatine, and coralyne to protonated RNA …
3854. Role of 13-(di) phenylalkyl Berberine derivatives in the modulation of the activity of human topoisomerase IB
3855. Berberine _against_arsenic_induced_oxidative_damage_in_isolated_rat_liver_mitochondria/links/570de50c08ae3199889bcce2.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Mohsen_Rezaei6/publication/301226871_Role_of_Berberine _against_arsenic_induced_oxidative_damage_in_isolated_rat_liver_mitochondria/links/570de50c08ae3199889bcce2.pdf&source=gmail&ust=1581476879743000&usg=AFQjCNG2AnPV3P7qzp6MmUtj9mqaxaOOQQ”>Role of Berberine against arsenic induced oxidative damage in isolated rat liver mitochondria
3856. Role of Berberine as an adjuvant response modifier during tumour therapy in mice
3857. Role of Berberine in Alzheimer’s disease
3858. Role of Berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice
3859. Role of Berberine in anti-bacterial as a high-affinity LPS antagonist binding to TLR4/MD-2 receptor
3860. Role of Berberine in Diabetic Adult Male Rats
3861. Role of Berberine in fibronectin expression via S1P2-MAPK signaling pathway in diabetic nephropathy [J]
3862. Berberine _on_molecular_markers_involved_in_migration_of_esophageal_cancer_cells/links/566f052d08ae4bef4061f646.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.researchgate.net/profile/Mohammad_Amir_Mishan/publication/286904577_Role_of_Berberine _on_molecular_markers_involved_in_migration_of_esophageal_cancer_cells/links/566f052d08ae4bef4061f646.pdf&source=gmail&ust=1581476879744000&usg=AFQjCNEJ-V4AIT2_UGh4qB4n4R_y3sxGNQ”>Role of Berberine on molecular markers involved in migration of esophageal cancer cells
3863. Role of Berberine on schistosomiasis-inducted oxidative stress and damage in spleen of mice
3864. Role of JAK2 in the Pathogenesis of Diabetic Erectile Dysfunction and an Intervention With Berberine
3865. Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by Berberine in human HepG2 cells
3866. Role of malic acid in solubilizing excess Berberine accumulating in vacuoles of Coptis japonica
3867. Roles of nitric oxide in protective effect of Berberine in ethanol-induced gastric ulcer mice
3868. Rosin‐based molecularly imprinted polymers as the stationary phase in high‐performance liquid chromatography for selective separation of Berberine hydrochloride
3869. RP—HPLC Determination of Berberine Hydrochloride in Biling Weitong Granules [J]
3870. RP-HPLC Determination of Berberine Hydrochloride in Fukang Cleaning Solution [J]
3871. RP-HPLC Determination of Berberine Hydrochloride in Shirebi Tablets
3872. RP-HPLC determination of Berberine in cortex Phellodendri
3873. RP-HPLC Determination of Berberine in Cortex Phellodendri [J]
3874. RP-HPLC determination of Berberine , plmatine and jatrorrhizine in Huangbo [J]
3875. RP-HPLC determination of paeoniflorin, baicalin, palmatine hydrochloride and Berberine hydrochloride in Kuntai Capsules [J]
3876. RP-HPLC Determination of Palmatine Hydrochloride and Berberine Hydrochloride in the Preparation of Fu Yan Xiao Lotion
3877. RP-HPLC Determination of Palmatine Hydrochloride and Berberine Hydrochloride in the Preparation of Fu Yan Xiao Lotion [J]
3878. RP-HPLC determination of the Berberine type alkaloids from the Rhizoma coptidis
3879. RP-HPLC Determination of the Content of Berberine Hydrochloride and Related Compounds
3880. SAC and Berberine Mediated Repression of Reactive Species and Hepatoprotection After DEN + CCl4 Exposure
3881. Safety and Effectiveness of Berberine Hydrochloride as Quality Indexes of Rhizoma Coptidis Chinensis in Clinical Medication
3882. Safety profile for evaluation of Berberine in sprague-dawley rats: effects on renal, liver and myelopoietic functions
3883. Screening of enhancers for permeation of Berberine in ruyi patcher in vitro
3884. Screening of Enhancers for Permeation of Berberine in Ruyi Patcher in Vitro [J]
3885. Selection and analysis of DNA aptamers to Berberine to develop a label-free light-up fluorescent probe
3886. Selection of high Berberine yielding phellodendron insulare nak. lines and the antimicrobial activity of their extracts
3887. Selective Adsorption of Berberine Hydrochloride Using Molecularly Imprinted Polymers with Modified Rosin as Cross-linker.
3888. Selective extraction of Berberine from Cortex Phellodendri using polydopamine‐coated magnetic nanoparticles
3889. Selective inhibition of MAPKK Wis1 in the stress-activated MAPK cascade of Schizosaccharomyces pombe by novel Berberine derivatives
3890. Selective Interactions with Various G-Quadruplex DNA Forming Sequences by Berberine and Palmatine Analogues
3891. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid Berberine
3892. Selective sensing of silver ion using Berberine , a naturally occurring plant alkaloid
3893. Selectivity of an indolyl Berberine derivative for tetrameric G‐quadruplex DNA
3894. Selectivity on different G-quadruplex DNA of Berberine derivatives in vitro results in their preferential to related pathway in tumor cells
3895. Selenium-coated nanostructured lipid carriers used for oral delivery of Berberine to accomplish a synergic hypoglycemic effect
3896. Self-Assemblies Based on Traditional Medicine Berberine and Cinnamic Acid for Adhesion-induced Inhibiting Multidrug-Resistant Staphylococcus aureus
3897. Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of Berberine
3898. Semi-quantitative analysis on the content of Berberine hydrochloride in compound Berberine tablets with the fluorescence spectral imaging method
3899. Sensitization of Candida albicans to terbinafine by Berberine and berberrubine
3900. Sensory evaluation of the taste of Berberine hydrochloride using an Electronic Tongue
3901. Separation and Beneficiation of Berberine Hydrochloride byAqueous Two Phase from Phellodendri Amurensis Cortex
3902. Separation and characterization of cytokinin-inducible (S)-tetrahydroBerberine oxidases controlling Berberine biosynthesis in Thalictrum minus cell cultures
3903. Separation and purification of Berberine by ion-exchange fiber
3904. Separation of Berberine hydrochloride and tetrahydropalmatine and their quantitative analysis with thin layer chromatography involved with ionic liquids
3905. Separation of choline from Coptidis Rhizoma and impact on glucose metabolism of Berberine in HepG2 cells
3906. Sequential inclusion of two Berberine cations in cucurbit [8] uril cavity: kinetic and thermodynamic studies
3907. Set9, NF-κB, and microRNA-21 mediate Berberine -induced apoptosis of human multiple myeloma cells
3908. Shining a light on LAMP assays’ A comparison of LAMP visualization methods including the novel use of Berberine
3909. Short Communication Selective extraction of Berberine and palmatine from Huangbai powder
3910. Short term effects of Berberine on T2DM resistance to external insulin [J]
3911. Sieving characteristics of cytokine-and peroxide-induced epithelial barrier leak: Inhibition by Berberine
3912. Signal pathways, diseases, and functions associated with the miR‐19a/92a cluster and the use of Berberine to modulate the expression of this cluster in multiple …
3913. Significant feeding deterrent of Berberine from Tali kuning (Tinospora dissitiflora Diels) against two subterranean termites Coptotermes formosanus Shiraki and …
3914. Significant fluorescence enhancement by supramolecular complex formation between Berberine chloride and cucurbit (n= 7) uril and its analytical application
3915. Significant pharmacokinetic differences of Berberine are attributable to variations in gut microbiota between Africans and Chinese
3916. Silver nanoparticles exhibit the dose-dependent anti-proliferative effect against human squamous carcinoma cells attenuated in the presence of Berberine
3917. Simple and sensitive fluorescence sensor for detection of potassium ion in the presence of high concentration of sodium ion using Berberine –G-quadruplex complex …
3918. Simultaneous Analysis of Puerarin, Baicalin and Berberine Hydrochloride in Gegen Qinlian Pill by HPLC [J]
3919. Simultaneous determiantion of baicalin and Berberine hydrochloride contents in Qinlian Jiedu capsules by HPLC [J]
3920. Simultaneous determiantion of baicalin and Berberine hydrochloride contents in Shuanghuang Xiaoyan tablets by HPLC [J]
3921. Simultaneous Determinat ion of Berberine hydrochloride, palmtine hydrochloride and jatrorrhizine hydrochloride in Xianglian pill by HPLC [J]
3922. Simultaneous Determination of 4-Amino Salicylic Acid and Berberine Hydrochlorie In You Sai Qing by Ultravidet Spectrophotometry
3923. Simultaneous determination of aloe-emodin, rhein, emodin, physcion, chrysophanol, baicalin, wogonin, Berberine hydrochloride in Yiqing granules by HPLC [J]
3924. Simultaneous determination of anemoside B4, phellodendrine, Berberine , palmatine, obakunone, esculin, esculetin in rat plasma by UPLC–ESI–MS/MS and its …
3925. Simultaneous Determination of Baicalin and Berberine Hydrochloride in Fufangkangkui Suspension by HPLC.
3926. Simultaneous determination of baicalin and Berberine hydrochloride in Huanglian Jiedu San for animals by HPLC [J]
3927. Simultaneous determination of baicalin and Berberine hydrochloride in Huanglian Jiedu San for animals by HPLC.
3928. Simultaneous Determination of Baicalin and Berberine Hydrochloride in Huanglian Yanggan Pills by HPLC [J]
3929. Simultaneous Determination of Baicalin and Berberine Hydrochloride in Qinlian Capsule by HPLC
3930. Simultaneous determination of baicalin, baicalein, wogonin, Berberine , palmatine and jatrorrhizine in rat plasma by liquid chromatography–tandem mass spectrometry …
3931. Simultaneous determination of baicalin, baicalein, wogonoside, wogonin, scutellarin, Berberine , coptisine, ginsenoside Rb1 and ginsenoside Re of Banxia xiexin …
3932. Simultaneous determination of baicalin, rhein and Berberine in rat plasma by column-switching high-performance liquid chromatography
3933. Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, Berberine , coptisine, palmatine, jateorrhizine and glycyrrhizin in Kampo medicines by ion …
3934. Simultaneous determination of baicalina, Chrysophanol, Berberine Hydrochloride in the SanYuXiaoZhong Ointment by HPLC [J]
3935. Simultaneous Determination of Berberine and Evodiamine in Dog Plasma by LC-ESI-MS Method and Its Application to Pharmacokinetics
3936. Simultaneous Determination of Berberine and Palmatine in “Huong Lien Hoan” by HPLC
3937. Simultaneous Determination of Berberine and Palmatine in Rabbit Plasma by LC-MS–MS and Its Application in Pharmacokinetic Study After Oral Administration of …
3938. Simultaneous determination of Berberine and palmatine in rat plasma by HPLC–ESI-MS after oral administration of traditional Chinese medicinal preparation Huang …
3939. Simultaneous determination of Berberine and phenolsulfonphthalein in the solution of in situ intestinal loop by HPLC [J]
3940. Simultaneous Determination of Berberine and Salvianolic Acid B in Fuyankang Enema by HPLC
3941. Simultaneous Determination of Berberine and Salvianolic Acid B in Fuyankang Enema by HPLC [J]
3942. Simultaneous determination of Berberine and β-sitosterol in the leaf extracts of Naravelia zeylanica by analytical methods and their in vitro Anti diabetic activity
3943. Simultaneous Determination of Berberine Curcumin and Emodin in Ruyi Jinhuang Power by HPLC [J]
3944. Simultaneous determination of Berberine hydrochloride and atractylodin in Simiao pills by RP-HPLC [J]
3945. Simultaneous Determination of Berberine Hydrochloride and Baicalin in Mingmushangqing Tablets by HPLC [J]
3946. Simultaneous determination of Berberine hydrochloride and palmatine hydrochloride in Cortex Phellodendri chinensis by capillary electrophoresis
3947. Simultaneous determination of Berberine hydrochloride and phellodendrine in Ermiao Wan by HPLC
3948. Simultaneous Determination of Berberine Hydrochloride, Jatrorrhizine Hydrochloride and Palmatine Hydrochloride in Huanglian Shangqing Tablet by RP-HPLC
3949. Simultaneous determination of Berberine hydrochloride, palmatine hydrochloride and rhaponticin in Sanhuang Tablets by RP-HPLC [J]
3950. Simultaneous Determination of Berberine Hydrochloride, Phellodendrine Hydrochloride and Matrine in Qingfei Yihuo Pills by Capillary Electrophoresis Method
3951. Simultaneous determination of Berberine in rat blood, liver and bile using microdialysis coupled to high-performance liquid chromatography
3952. Simultaneous determination of Berberine , matrine and oxymatrine in traditional Chinese medicines by using nonaqueous capillary electrophoresis
3953. Simultaneous Determination of Berberine , Neomangiferin and Mangiferin in Huangbai-Zhimu Decoction by UPLC [J]
3954. Simultaneous determination of Berberine , palmatine and coptisine in crude drugs and oriental pharmaceutical preparations by ion-pair high-performance liquid …
3955. Simultaneous determination of Berberine , palmatine and jatrorrhizine by liquid chromatography–tandem mass spectrometry in rat plasma and its application in a …
3956. Simultaneous determination of Berberine , palmatine, matrine, catechin and baicalin in Funing Shuan by micellar electrokinetic capillary chromatography-electrospray …
3957. Simultaneous Determination of Catechin and Berberine Hydrochloride in Zhuhuang Chuihou Powder by HPLC [J]
3958. Simultaneous Determination of Chlorogenic acid, Polydatin and Berberine Hydrochloride in Tangshang Mixtures by HPLC [J]
3959. Simultaneous Determination of Ciprofloxacin Hydrochloride and Berberine Hydrochloride by HPLC
3960. Simultaneous Determination of Content of Baicalin and Berberine Hydrochloride in Sijisanhuang Tablets [J]
3961. Simultaneous determination of contents of Berberine hydrochloride and quercetin in Migan granules by HPLC
3962. Simultaneous determination of Curcumin and Berberine in their Pure Form and from the Combined Extracts of Curcuma Longa and Berberis aristata
3963. Simultaneous Determination of Four Berberine -type Alkaloids in Coptis Chinensis Franch Using RP-HPLC
3964. Simultaneous determination of geniposide and Berberine hydrochloride in Zhizijinhua Wan by high performance liquid chromatography [J]
3965. Simultaneous determination of geniposide, baicalin and Berberine hydrochloride in Angong Niuhuang pill by RP-HPLC
3966. Simultaneous determination of geniposide, baicalin and Berberine hydrochloride in Daochi Pills by multiple wavelength RP-HPLC [J]
3967. Simultaneous determination of geniposide, paeoniflorin, baicalin, Berberine hydrochloride and emodin in Huanglian Shuangqing pills by HPLC
3968. Simultaneous determination of gentiopicrosid and Berberine hydrochloride in Shiwei Longdanhua Keli by HPLC
3969. Simultaneous Determination of Jatrorrhizine, EpiBerberine , Coptisine, Palmatine and Berberine Hydrochloride in Purification Parts of’Sanrelun’Compound Decoction …
3970. Simultaneous Determination of Jatrorrhizine, Palmatine and Berberine in Mahonia duclouxiana Gagnep. by HPLC [J]
3971. Simultaneous determination of jatrorrhizine, palmatine, Berberine , and obacunone in Phellodendri Amurensis Cortex by RP-HPLC
3972. Simultaneous determination of mangiferin, Berberine hydrochloride and paeonol in Zhibo Bawei Oral Solution by HPLC [J]
3973. Simultaneous determination of matrine and Berberine in fruits, vegetables, and soil using ultra-performance liquid chromatography/tandem mass spectrometry
3974. Simultaneous determination of paeoniflorin, baicalin, palmatine and Berberine in Qinlian Tablet by reversed phase high performance liquid chromatography [J]
3975. Simultaneous Determination of Paeoniflorin, Salvianolic Acid B and Berberine in Fuyankang Pills by HPLC [J]
3976. Simultaneous determination of palmatine and Berberine using cucurbit [7] uril as mobile phase additive by HPLC
3977. Simultaneous Determination of Palmatine Hydrochloride and Berberine Hydrochloride in Jinji Tablets by HPLC [J]
3978. Simultaneous Determination of Palmatine Hydrochloride, Berberine Hydrochloride and Paeonolin in Compound Yishen Soft Capsules by RP-HPLC
3979. Simultaneous determination of plasma mangiferin and Berberine in rat plasma by LC/MS/MS
3980. Simultaneous Determination of Puerarin, Liquiritin, Baicalin and Berberine Hydrochloride in Gegenqinlian Micropills by RP-HPLC [J]
3981. Simultaneous Determination of Tetrahydropalmatine, Dehydrocorydaline, Berberine and Palmatine in Dog Plasma by LC-MS/MS: Application to Pharmacokinetic …
3982. Simultaneous determination of tetrandrine, fangchinoline and Berberine hydrochloride in Fengtongan Capsule by RP-HPLC [J]
3983. Simultaneous Determination of the Content of Baicalin and Berberine Hydrochloride in Sanhuang Tablets by HPLC [J]
3984. Simultaneous Determination of the Content of Berberine Hydrochloride, Baicalin and Osthole in Jinchan Zhiyang Capsules by HPLC
3985. Simultaneous determination of the contents of chloromycetin and Berberine hydrochloride in chloromycetin and Berberine ointment by RP-HPLC method [J]
3986. Simultaneous determination on the contents of Berberine hydrochloride, jatrorrhizine hydrochloride and palmatine hydrochloride in Pulsatill Decoction by RP-HPLC
3987. Simultaneous Effects of Aerobic Training and Berberine Chloride on Plasma Glucose, IL-6 and TNF-α in Type 1 Diabetic Male Wistar Rats
3988. Simultaneous fluorescence light-up and selective multicolor nucleobase recognition based on sequence-dependent strong binding of Berberine to DNA abasic site
3989. Berberine -and-curcumin-in-igruhadhoomadi-churnai-3503.html?view=mobile” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=http://www.ijpsonline.com/articles/simultaneous-hptlc-estimation-of-Berberine -and-curcumin-in-igruhadhoomadi-churnai-3503.html?view%3Dmobile&source=gmail&ust=1581476879754000&usg=AFQjCNGYcXh2VwtYgNwtxisbYkrBOcM_Rw”>Simultaneous HPTLC Estimation of Berberine and Curcumin in Gruhadhoomadi Churna
3990. Simultaneous quantification of Berberine and lysergol by HPLC‐UV: evidence that lysergol enhances the oral bioavailability of Berberine in rats
3991. Simultaneous Quantification of Berberine Hydrochloride and Fibrauretine Tablets in Rat Urine, Feces, Bile and Plasma by HPLC/DAD.
3992. Simultaneous Quantification of Pharmacological Markers Quercetin and Berberine Using High-Performance Thin-Layer Chromatography (HPTLC) and High …
3993. Simultaneous Quantitative Analysis of Berberine and Other Alkaloids in Powdered Phellodendron Bark
3994. Simultaneous spectrophotometric determination of furazolidone and Berberine in tablet form
3995. Simutaneous Determination the Contents of Baicalin and Berberine in Siji Sanhuang soft Capsules by RPHPLC
3996. Smiles rearrangements in a series of Berberine analogues containing a secondary acetamide fragment
3997. Sodium caprate augments the hypoglycemic effect of Berberine via AMPK in inhibiting hepatic gluconeogenesis
3998. Solid dispersion of Berberine hydrochloride and Eudragit® S100: formulation, physicochemical characterization and cytotoxicity evaluation
3999. Solid dispersion of Berberine –phospholipid complex/TPGS 1000/SiO2: preparation, characterization and in vivo studies
4000. Solid molar volumes of interest to supercritical extraction at 298 K: atropine, Berberine hydrochloride hydrate, brucine dihydrate, capsaicin, ergotamine tartrate …
4001. Solubility and oil-water partition coefficient of puerarin, baicalin and Berberine hydrochloride in Gegenqinlian formula
4002. Solubility of Berberine chloride in various solvents
4003. Solution and Solid‐State Analysis of Binding of 13‐Substituted Berberine Analogues to Human Telomeric G‐quadruplexes
4004. Solvent effect on the UV/Vis absorption and fluorescence spectroscopic properties of Berberine
4005. Solvent extraction of Berberine hydrochloride and palmatine hydrochloride in Cortex Phellodendri
4006. Solvent extraction–spectrophotometric determination of Berberine and benzethonium in drugs with tetrabromophenolphthalein ethyl ester by batchwise and flow …
4007. Somaclonal variation in the Berberine -producing capability of a culture strain of Thalictrum minus
4008. Some observations on the effect of Berberine against trichomoniasis in Burmese women
4009. Some Toxicological, Hematological, Biochemical, and Reproductive Effects of Berberine In Male Rats.
4010. SONODYNAMIC EFFECT OF Berberine ON MACROPHAGES
4011. Specific differences in tolerance to exogenous Berberine among plant cell cultures
4012. Specifically targeting mixed-type dimeric G-quadruplexes using Berberine dimers
4013. Berberine -complex-interaction-with-living-cells-for-nanoparticle-mediated-drug-delivery” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://cyberleninka.ru/article/n/spectral-analysis-of-nanodiamond-Berberine -complex-interaction-with-living-cells-for-nanoparticle-mediated-drug-delivery&source=gmail&ust=1581476879756000&usg=AFQjCNF3_0zhtpev3mQogrSlbNYpMN7pZw”>Spectral analysis of nanodiamond-Berberine complex interaction with living cells for nanoparticle mediated drug delivery
4014. Spectral characteristics of silver nanoparticles in polyacrylamide matrix in the presence of Berberine molecules
4015. Spectrofluorimetric determination of Berberine in oriental pharmaceutical preparations by flow-injection analysis coupled with liquid-liquid extraction
4016. Spectrofluorometric determination of Berberine using a novel Au nanocluster with large Stokes shift
4017. Spectrofluorometric determination of DNA and RNA with Berberine
4018. Spectrophotometric Analytical Application of the Berberine -I~ 3^-Association Particle System
4019. Spectrophotometric determination of Berberine chloride in pharmaceutical preparations
4020. Spectrophotometric Determination of Berberine Sulfate Injection
4021. Spectrophotometric determination of content of Berberine hydrochloride tablet by complex ion pair extraction
4022. Spectrophotometry analysis of Berberine chloride in xianglian jiaowan
4023. Spectroscopic and binding properties of Berberine to DNA and its application to DNA detection
4024. Spectroscopic and calorimetric studies on the binding of alkaloids Berberine , palmatine and coralyne to double stranded RNA polynucleotides
4025. Spectroscopic and thermodynamic studies on the binding of sanguinarine and Berberine to triple and double helical DNA and RNA structures
4026. Spectroscopic Investigation of Interaction between Berberine Chloride and Bovine Serum Albumin
4027. Spectroscopic investigation on the sonodynamic damage to proteins in the presence of Berberine in vitro
4028. Spectroscopic, molecular modeling, and NMR-spectroscopic investigation of the binding mode of the natural alkaloids Berberine and sanguinarine to human telomeric …
4029. Spontaneous formation of fluorescent nanofibers and reticulated solid from Berberine palmitate: a new example of aggregation-induced emission enhancement in …
4030. Square-wave voltammetry of Berberine
4031. Stability-indicating validated HPLC method for analysis of Berberine hydrochloride and trimethoprim in pharmaceutical dosage form
4032. Stage specificity of Plasmodium falciparum telomerase and its inhibition by Berberine
4033. Staining Effect of Fluorochrome Berberine Hydrochloride on Nucleic Acid in Gels [J]
4034. Standardization of Biomarkers Gallic Acid and Berberine in Polyherbal Formulation Entoban Capsules by High-Performance Thin-Layer Chromatography …
4035. Start-up performance of hybrid ABR-aerobic granulation reactor for Berberine wastewater treatment
4036. Statistical method of experimentation for the analysis and optimization of Berberine finishing of cellulose fiber
4037. Stereochemistry of enzymic formation of the Berberine bridge in protoBerberine alkaloids
4038. Stimulation of Berberine production inThalictrum rugosum suspension cultures in response to addition of cupric sulfate
4039. Stimulation of Berberine secretion and growth in cell cultures of Thalictrum minus
4040. Structural and biochemical characterization of a monolignol oxidoreductase from A. thaliana implies a link between the Berberine bridge enzyme-like family and cell …
4041. Structural and mechanistic studies reveal the functional role of bicovalent flavinylation in Berberine bridge enzyme
4042. Structural changes of gut microbiota during Berberine -mediated prevention of obesity and insulin resistance in high-fat diet-fed rats
4043. Structural modification of Berberine alkaloid and their hypoglycemic activity
4044. Structural modification of Berberine alkaloids in relation to cytotoxic activity in vitro
4045. Structural Optimization of Berberine as a Synergist to Restore Antifungal Activity of Fluconazole against Drug‐Resistant Candida albicans
4046. Structure of a Berberine bridge enzyme-like enzyme with an active site specific to the plant family Brassicaceae
4047. Structure-activity relationship of Berberine and derivatives acting as antifungal compounds
4048. Structure-activity relationship of Berberine derivatives for their glucose-lowering activities
4049. Structure–activity studies of some Berberine analogs as inhibitors of Toxoplasma gondii
4050. Studies on Berberine derivatives and related alkaloids. VII. On the biosynthesis of protopine
4051. Studies on Berberine derivatives and related alkaloids. VII. On the biosynthesis of protopine.
4052. Studies on Berberine hydrochlodride in different partsif cortex phellodendron chinese
4053. Studies on dyeing with natural dyes: Part II—Dyeing of Berberine on acrylic fibre
4054. Studies on in Vitro and in Vivo Release of Berberine Hydrochloride from Carboxymethyl Konjac Glucomannan Pellets of Colonic Targeting Delivery
4055. Studies on in vivo release of Berberine hydrochloride from carboxymethyl konjac glucomannan pellets in rats
4056. STUDIES ON MUTAGENICITY OF Berberine TRANSDERMAL FORMULATION BY THE MARROW CELL MICRONUCLEUS IN MICE
4057. Studies on Percutaneous Absorption in Vitro of Berberine in Ruyijinhuang Strapping
4058. Studies on preparation and bioactivities of Berberine mixtural formulation [J]
4059. Studies on preparation and in vitro release of Berberine sulphate multivesicular liposomes
4060. Studies on Preparation of Berberine Microencapsulation
4061. Studies on preventive and curative effects of Berberine on chemical-induced hepatotoxicity in rodents
4062. Studies on the antinephritic effect of plant components (4): reduction of protein excretion by Berberine and coptisine in rats with original-type anti-GBM nephritis
4063. Studies on the Bioavailability of Berberine Preparations (II): Antibacterial Activity and Bioavailability of Coprecipitate of Coptidis Rhizoma and Glycyrrhizae Radix
4064. Studies on the Cultivation Trial of Coptis japonica in Korea and Its Berberine Contents
4065. Studies on the Dissolubility of Berberine Hydrochloride Microcapsule [J]
4066. Studies on the Dual Cytotoxicity and Antioxidant Properties of Berberis vulgaris Extracts and Its Main Constituent Berberine
4067. Studies on the Dyeing and Functional Properties of Modified Berberine for a Variety of Fabrics
4068. Studies on the Extracting Technology of Berberine [J]
4069. Studies on the Extracting Technology of Berberine from Jiechangan Enteric-coated Tablets
4070. Studies on the hypoglycemic effect of Coptis chinensis and Berberine
4071. Studies on the Interaction Between Berberine and K_2PtCl_4, KAuCl_4 with Different Molar Ratios
4072. Studies on the Method for the Determination of Berberine Hydrochloride
4073. Studies on the non-covalent binding between Berberine and human serum albumin by electrospray ion trap mass spectrometry
4074. Studies on the pharmaceutical quality evaluation of crude drug preparations used in orient medicine” kampoo”. II. Precipitation reaction of Berberine and glycyrrhizin in …
4075. Studies on the Pharmaceutical Quality Evaluation of Crude Drug Preparations used in Orient Medicine”Kampoo”. II. Precipitation Reaction of Berberine and Glycyrrhizin in Aqueous Solution
4076. Studies on the preparation technology of Berberine bisulfate liposomes [J]
4077. Studies on the quantitative analysis of constituents in crude drugs by thin-layer chromatography. I. studies on the quantitative analysis of Berberine in Coptis Japonica …
4078. STUDIES ON THE RULE OF NET SUBSTANCE ACCUMULATION AND THE Berberine CONTENT VARIATIONS IN THE RHIZOMES OF COPTIS CHINENSIS …
4079. Studies on the seasonal variation of Berberine contents in Berberis koreana
4080. Studies on the Spectra of ProtoBerberine Alkaloids. I. Absorption Spectrum of Berberine
4081. Studies on the Syntheses of Heterocyclic Compounds. DXXV. Syntheses of Berberine and Related Compounds. III. Dealkylation of N-Substituted Protoberberinium …
4082. Studies on the syntheses of heterocyclic compounds. Part CCCII. Alternative total syntheses of (±)-nandinine,(±)-canadine, and Berberine iodide
4083. Studies on Tissue Distributionm Fluorescent Properties, and Iodination of the Plant Alkaloid, Berberine
4084. Studies on α-, β-, and γ-cyclodextrin inclusion complexes of isoquinoline alkaloids Berberine , palmatine and coralyne
4085. STUDY AND OPTIMIZATION OF Berberine EXTRACTION CONDITIONS FROM BARBERRY ROOT BY SUPERCRITICAL CARBON DIOXIDE
4086. Study in the effects of Berberine on inhibiting HT-29 human colon cancer cell proliferation induced by deoxycholic acid
4087. STUDY OF Berberine EFFECTS ON ALPHA 1 AND BETA ADRENOCEPTORS WITH RADIOLIGAND BINDING ASSAY
4088. Study of Berberine effects on alpha 2-adrenoceptor of rabbit platelet with radioligand binding assay
4089. Study of Berberine on Attenuating PM2. 5-Induced Vascular Endothelial Cells Injury by ERK1/2 Signal Pathway
4090. Study of Berberine on the 125I particle in radiosensitization and its effects of angiogenesis on nude mice hepatocellular carcinoma
4091. Study of Dissolubility and Partition Coefficient of Berberine Hydrochloride [J]
4092. Study of interaction between Berberine and ofloxacia
4093. Study of interaction of Berberine with DNA in the presence of β-cyclodextrin
4094. Study of intestinal absorption changes of compatible Berberine hydrochloride with puerarin [J]
4095. Study of ion-activated in situ gel system containing Berberine hydrochloride for ocular use
4096. Study of Microwave-Assisted Extraction and Spectrophotometry on Berberine from Phellodendron Amurense Rupr
4097. Study of nuclear factor‐2 erythroid related factor‐2 activator, Berberine , in paclitaxel induced peripheral neuropathy pain model in rats
4098. Study of the Effect of Consciousness Energy Healing Treatment on the Natural Product Berberine Chloride
4099. Study of the effects and mechanisms of Berberine on slow-response action potentials
4100. Study of the effects in vitro of Berberine combined with bortezomib on multiple myeloma cell line U266 cells
4101. Study of the Interaction between Berberine and Trypsin.
4102. Study of the interactions of Berberine and daunorubicin with DNA using alternating penalty trilinear decomposition algorithm combined with excitation–emission matrix …
4103. Study on 2-cell Embryos in vitro Culture and Effect of Embryo Transfer of Mice by Adding Chinese Medicine Berberine into Culture Medium
4104. Study on absorption of Berberine of different concentrations and purities in rat’s intestine [J]
4105. Study on adsorptive separation of Berberine alkaloids in coptis Japonica makino by molecular dynamics simulation
4106. Study on antifungal activities of glycosides of white peony root and Berberine against oral Candidas
4107. Study on application of internal electrolysis to treat Berberine wastewater [J]
4108. Study on Aqueous Extraction of Berberine From Coptis Chinensis Franch [J]
4109. Study on Berberine and β-cyclodextrin inclusion compound [J]
4110. STUDY ON Berberine ION SELECTIVE ELECTRODE [J]
4111. Study on Berberine /β-cyclodextrin inclusion complex and its thermodynamic properties [J]
4112. Study on determination method for entrapment efficiency of Berberine hydrochloride proliposomes [J]
4113. Study on Differences Between the Concentrations of Berberine Hydrochloride, Chlorogenic Acid, Baicalin and in Rabbit Body Fluid Their Minimal Inhibitory …
4114. Study on differential expression of genes associated with metabolism by cDNA microarry in rat liver treated with Berberine chloride
4115. Study on effect of Berberine on modulating lipid and CPT IA gene expression
4116. Study on effect of Berberine on modulating lipid and CPTⅠA gene expression [J]
4117. Study on effects of baicalin, Berberine and Astragalus polysaccharides and their combinative effects on aldose reductase in vitro
4118. Study on effects of Berberine of amyloid proein of serum β in blood and brain of diabetic rats
4119. Study on electrophysiological properties of neurons from a rat cortex model under the influence of the phytoalkaloid compound Berberine
4120. Study on Extract Technology of Berberine Hydrochloride in Caulis Mahoniae by Orthogonal Design [J]
4121. Study on Extraction of Berberine from Coptis chinensis by Polysorbate-80
4122. Study on extraction of Berberine hydrochloride and preparation condition of dropping pills [J]
4123. Study on extraction of Berberine in rhizoma of Coptis chinensis Franch by different solvents and different extracting ways [J]
4124. Study on Extraction Process for Berberine of Kuolougenwan with Orthogonal Design [J]
4125. Study on Extraction Process of Berberine [J]
4126. Study on extraction technology of Berberine by enzymatic hydrolysis [J]
4127. Study on extraction technology of Berberine from Phellodendron amurense Rupr. by supercritical CO2.
4128. Study on extraction technology of Berberine from Rhizoma coptidis by the method of orthogonal-test optimization
4129. Study on formation technology of Berberine Hydrochloride Dropping Pills [J]
4130. Study on HPLC determination Berberine hydrochlodride content of cortex phellodendron Chinese by different drugs-processing methods [J]
4131. Study on inhibitory effects of Berberine hydrochloride nano-emulsion on Microcystis aeruginosa.
4132. Study on interaction between plasmid DNA and Berberine derivatives with aliphatic chain by fluorescence analysis
4133. Study on membrane injury mechanism of total alkaloids and Berberine from Coptidis Rhizoma on Aeromonas hydrophila
4134. Study on Micro-arc Oxidation-Silica-Berberine Composite Bio-coating of Magnesium Alloy
4135. Study on Microwave Irradiation of Berberine from Rhizoma Coptidis
4136. Study on Pharmacoeconomics of Ciclosporin A Combined with Berberine chloride
4137. Study on pharmacokinetic interaction between γ-oryzanol and Berberine
4138. Study on Photocatalytic Elimination of Berberine Hydrochloride by Nano TiO_2
4139. Study on Plastics Transdermal Absorption of Berberine Hydrochloride of Complex Prescription Coptis chinensis
4140. Study on preparation and controlled release characteristics of colon controlled release pellets of Berberine hydrochloride in vitro [J]
4141. Study on preparation of Berberine hydrochloride liposome
4142. Study on Preparation of Berberine Hydrochloride Liposomes [J]
4143. Study on preparation of Berberine microemulsion and its absorption in intestine
4144. Study on Preparation of Compound Berberine Dispersible Tablets
4145. Study on property of biopharmaceutics classification system of Berberine in Huanglian decoction
4146. Study on Release Characteristics of Compound Berberine Hydrochloride Colon Specific Tablets in Rats
4147. Study on Release Characteristics of pH-and Enzyme-Controlled Tablets of Berberine Hydrochloride for Colon-Specific Delivery in Rats
4148. Study on release mechanism of Berberine hydrochloride-loaded carboxymethyl konjac glucomannan pellets for colonic delivery
4149. Study on separation and purification of Berberine in Coptis chinensis by macroporous adsorption resin [J]
4150. Study on Smashing Tissue Extraction Technology of Berberine Hydrochloride from Cortex Phellodendri [J]
4151. Study on spectral properties of the associated particle of Berberine -PHLO and its analytical application
4152. Study on the ameliorative effect of S Allyl Cysteine and Berberine against hepatocarcinoma
4153. Study on the anti-bacterial function of Berberine in vivo of mice
4154. Study on the Contents of Berberine Hydrochloride and Ferulic Acid in Different Compatibility about Qingwei San
4155. Study on the degradation behavior of Berberine dye and Berberine dyed silk using hydrogen peroxide/UV/oxygen treatment
4156. Study on the determination method of dissolution rate of Berberine hydrochloride in Danning Dispersible Tablets.
4157. Study on the Determination Method of Relative Substance in Berberine Hydrochloride and Its Tablets [J]
4158. Study on the determination of Berberine Calamine Lotion Berberine hydrochloride
4159. Study on the Effect of Berberine in Human Cervical Cancer Hela Cells in Vitro
4160. Study on the Effect of Berberine in Human Cervical Cancer Hela Cells in Vitro [J]
4161. Study on the effect of coptis coadministrated with cassia on liver metabolic activities of Berberine in rats and its mechanism
4162. Study on the effects of Berberine on colon carcinoma in vitro
4163. Study on the electrochemical behavior of the anticancer herbal drug Berberine and its analytical application
4164. Study on the Extraction of Berberine from Coptis chinensis by Microwave [J]
4165. Study on the Extraction Process of Herbal Pair Puerarin-Berberine by Plackett-Burman Design and Box-Behnken Response Surface Methodology
4166. Study on the HPLC determination method of Berberine Hydrochloride in Sanhuang tablets
4167. Study on the inclusion interactions of Berberine hydrochloride and cucurbit [7] by spectrofluorimetry
4168. STUDY ON THE INFLUENCE OF HOST TREE ON THE QUALITY OF PARASITIC LORANTHUS BY DETERMINING Berberine
4169. Study on the Interaction between Berberine Chloride Dihydrate and Bovine Serum Albumin in the Presence of Cu (Ⅱ) or Ni (Ⅱ)[J]
4170. Study on the interaction of Berberine with nucleic acids in the presence of silver nanoparticles, and the fluorometric determination of nucleic acids
4171. Study on the interaction of β-cyclodextrin and Berberine hydrochloride and its analytical application
4172. Study on the interactions of Berberine displace other drug from their plasma proteins binding sites [J]
4173. Study on the Method of Determination the Content of Berberine Hydrochloride
4174. Study on the optimal extraction process for Berberine in rhizoma of the Coptis chinensis Franch
4175. Study on the optimal ultrasonic extraction process for Berberine from rhizome coptidis [J]
4176. Study on the Pharmacokinetics of Berberine [J]
4177. Study on the pharmacokinetics of Berberine after oral administration in human being
4178. Study on the Pharmacokinetics of Berberine in Rabbits
4179. Study on the pharmacokinetics of Berberine in single dosage and coadministration with oryzanol in rabbits and healthy volunteers
4180. Study on the precipitation reaction between baicalin and Berberine by HPLC
4181. Study on the Preparation of Colon-specific Delivery System for pH and Time-controlled Coated Tablets of Berberine Hydrochloride and Its in Vitro Release [J]
4182. Study on the Preparation Process of Berberine Hydrochloride Liposomes by Orthogonal Design [J]
4183. Study on the protecting function of Berberine on the invasion of Streptococcus pneumoniae to A549 cells in vitro
4184. Study on the protective Effects of Berberine on myocardial injury of type 2 diabetic rats [J]
4185. Study on the quick determination of Berberine hydrochloride in Guilin watermelon forst [J]
4186. Study on the quick determination of Berberine hydrochloride in Guilin watermelon frost
4187. Study on the release behaviors of Berberine hydrochloride based on sandwich nanostructure and shape memory effect
4188. Study on the resonance light scattering spectrum of Berberine –cetyltrimethylammonium bromide system and the determination of nucleic acids at nanogram levels
4189. Study on the tissue distribution of Berberine from Rhizoma Coptidis and compatibility with Rhizoma Coptidis and Cortex Cinnamomi in rats
4190. Study on Tumor Associated and Immune Associated Gene Differential Expression by cDNA Microarray in Rat Liver Treated with Coadministration of Berberine with …
4191. Study progress of Berberine for treating cardiovascular disease
4192. Study Progress of Berberine in treating Cardiovascular Disease [J]
4193. Study the effect of Berberine on the telomerase activity of human nasopharyngeal carcinoma (NPC) CNE-2
4194. Berberine _Boiled_with_Water_an20190905-15115-goo2yt.pdf” target=”_blank” rel=”noopener” data-saferedirecturl=”https://www.google.com/url?hl=en&q=https://www.academia.edu/download/60494717/499_Subchronic_Effect_of_Yellow_Root__Arcangelisia_Flava__L__Merr.__Containing_Berberine _Boiled_with_Water_an20190905-15115-goo2yt.pdf&source=gmail&ust=1581476879770000&usg=AFQjCNGxF8K9K2oOrCwlNZhlFq60L257JQ”>Subchronic Effect of Yellow Root (Arcangelisia Flava (L) Merr.) Containing Berberine Boiled With Water and Brackish Water On Hematological, Blood …
4195. Sulfonato-β-cyclodextrin mediated supramolecular nanoparticle for controlled release of Berberine
4196. Sulphate of Berberine as Diagnostic and Therapeutic Means in Latent Malaria.
4197. Superb-selective chemodosimetric signaling of sulfide in the absence and in the presence of CT-DNA and imaging in living cells by a plant alkaloid Berberine …
4198. Supplementary Materials: Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
4199. Supplementary Observations on the Chemistry of the Alkaloids of Berberine Series. II. The Ultraviolet Absorption Spectra of Berberine s and Related Compounds
4200. Supporting Information Assessing the impact on aqueous solubility of Berberine Chloride via co-crystallization with different stoichiometric ratios of Pyromellitic …
4201. Suppression of beta-naphthoflavone induced CYP1A expression and lipid-peroxidation by Berberine
4202. Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by Berberine
4203. Suppression of oxLDL‐Induced MMP‐9 and EMMPRIN Expression by Berberine via Inhibition of NF‐κB Activation in Human THP‐1 Macrophages
4204. Suppressive effect of Berberine on experimental dextran sulfate sodium-induced colitis
4205. Suppressive effects of Berberine on atherosclerosis via downregulating visfatin expression and attenuating visfatin-induced endothelial dysfunction
4206. Supramolecular complex binding to G-quadruplex DNA: Berberine encapsulated by a planar side arm–tethered β-cyclodextrin
4207. Supramolecular interaction of ethylenediamine linked β-cyclodextrin dimer and Berberine hydrochloride by spectrofluorimetry and its analytical application
4208. Surface Enhanced Raman Spectroscopy Study of Berberine Based on BSA-Coated Silver Nanowires
4209. Susceptibility Test by Berberine Hydrochloride Combined with Antifungal Agents Against Trichophyton Rubrum in Vitro
4210. Sustained antibacterial activity of Berberine hydrochloride loaded supramolecular organoclay networks with hydrogen-bonding junctions
4211. Sustained antidiabetic effects of a Berberine -containing Chinese herbal medicine through regulation of hepatic gene expression
4212. Sustained release effects of Berberine -loaded chitosan microspheres on in vitro chondrocyte culture
4213. Sweet Berberine
4214. Symbol Berberine suppresses COX-2 mRNA and protein expression in human peripheral blood mononuclear cells: c-JUN terminal kinase pathway*☆
4215. Symbol Preparation and controlled release of Berberine magnetic gelatin drug microsphere
4216. SymbolEffects of Berberine on expression of hepatic peroxisome proliferator-activated receptors and its target genes in type 2 diabetic Chinese hamsters
4217. Symmetric drug-related intertriginous and flexural exanthema due to a Berberine extract, an herbal supplement for diabetes therapy
4218. Synchronous scanning first and second derivative spectrofluorimetric determination of the alkaloid Berberine
4219. Synergic inhibition of Berberine with carbendazim against Monilinia fructicola [J]
4220. Synergistic activity of Berberine with azithromycin against Pseudomonas aeruginosa isolated from patients with cystic fibrosis of lung in vitro and in vivo
4221. Synergistic anti-cancer effects of galangin and Berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells
4222. Synergistic anticancer effects of nanocarrier loaded with Berberine and miR-122
4223. Synergistic antifungal activity of Berberine derivative B-7b and fluconazole
4224. Synergistic Antimicrobial Activity of Berberine Hydrochloride, Baicalein and Borneol against Candida Albicans
4225. SYNERGISTIC ANTINEOPLASTIC ACTIVITY OF Berberine AND DOXORUBICIN ON A CHEMICALLY INDUCED HEPATOCELLULAR CARCINOMA IN …
4226. Synergistic approach for treatment of chicken coccidiosis using Berberine –A plant natural product
4227. Synergistic chemopreventive effects of curcumin and Berberine on human breast cancer cells through induction of apoptosis and autophagic cell death
4228. Synergistic Corrosion inhibition effects of coptis extract/Berberine and thiourea on the corrosion of mild steel in carbon dioxide saturated brine solution
4229. Synergistic effect of Berberine and HMQ1611 impairs cell proliferation and migration by regulating Wnt signaling pathway in hepatocellular carcinoma
4230. Synergistic effect of Berberine and pentoxifylline in attenuation of acute kidney injury
4231. Synergistic Effect of TPD7 and Berberine against Leukemia Jurkat Cell Growth through Regulating Ephrin‐B2 Signaling
4232. Synergistic inhibition on acetylcholinesterase by the combination of Berberine and palmatine originally isolated from Chinese medicinal herbs
4233. Synergistic Inhibitory Effect of Berberine and d-Limonene on Human Gastric Carcinoma Cell Line MGC803
4234. Synergistic tumor-killing effect of radiation and Berberine combined treatment in lung cancer: the contribution of autophagic cell death
4235. Synergy among thymol, eugenol, Berberine , cinnamaldehyde and streptomycin against planktonic and biofilm‐associated food‐borne pathogens
4236. Synergy in a medicinal plant: antimicrobial action of Berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor
4237. Synergy of 2-deoxy-d-glucose combined with Berberine in inducing the lysosome/autophagy and transglutaminase activation-facilitated apoptosis
4238. Synergy of theophylline reduces necrotic effect of Berberine , induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 …
4239. Synthesis and activity evaluation of 9-O-substituted Berberine derivatives containing polyamine chain as highly selective telomeric G-quadruplex stabilizing ligands
4240. Synthesis and anticancer activity of 9-O-pyrazole alkyl substituted Berberine derivatives
4241. Synthesis and anticancer activity of a novel series of 9-O-substituted Berberine derivatives: A lipophilic substitute role
4242. Synthesis and anticancer activity of novel 9, 13-disubstituted Berberine derivatives
4243. Synthesis and Anticancer Activity of Novel 9-O-Substituted Berberine Derivatives
4244. Synthesis and antifungal activity of a novel series of 13-(4-isopropylbenzyl) Berberine derivatives
4245. Synthesis and antihyperlipidemic efficiency of Berberine -based HMG-CoA reductase inhibitor
4246. Synthesis and anti-inflammatory effects of a series of novel 9-O-substituted Berberine derivatives
4247. Synthesis and Antimalarial Evaluation of [1, 2, 3]‐Triazole‐Tethered Sulfonamide‐Berberine Hybrids
4248. Synthesis and antitubercular activity of Berberine derivatives
4249. Synthesis and bioactive evaluation of novel hybrids of metronidazole and Berberine as new type of antimicrobial agents and their transportation behavior by human …
4250. Synthesis and biological evaluation of 8-substituted Berberine derivatives as novel anti-mycobacterial agents
4251. Synthesis and biological evaluation of a new series of Berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase
4252. Synthesis and biological evaluation of Berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor
4253. Synthesis and biological evaluation of Berberine derivatives
4254. Synthesis and Biological Evaluation of Berberine Derivatives as a New Class of Broad-Spectrum Antiviral Agents against Coxsackievirus B
4255. Synthesis and biological evaluation of Berberine derivatives as IBS modulator
4256. Synthesis and biological evaluation of Berberine derivatives bearing 4-aryl-1-piperazine moieties
4257. Synthesis and biological evaluation of Berberine –thiophenyl hybrids as multi-functional agents: Inhibition of acetylcholinesterase, butyrylcholinesterase, and Aβ …
4258. Synthesis and biological evaluation of new Berberine derivatives as cancer immunotherapy agents through targeting IDO1
4259. Synthesis and cytotoxicity evaluation of 13-n-alkyl Berberine and palmatine analogues as anticancer agents
4260. Synthesis and evaluation of 9-O-substituted Berberine derivatives containing aza-aromatic terminal group as highly selective telomeric G-quadruplex stabilizing …
4261. Synthesis and evaluation of antioxidant and cytotoxicity of the N-Mannich base of Berberine bearing benzothiazole moieties
4262. Synthesis and evaluation of Berberine derivatives and analogs as potential antiacetylcholinesterase and antioxidant agents
4263. Synthesis and evaluation of novel 12-aryl Berberine analogues with hypoxia-inducible factor-1 inhibitory activity
4264. Synthesis and evolution of Berberine derivatives as a new class of antiviral agents against enterovirus 71 through the MEK/ERK pathway and autophagy
4265. Synthesis and hypoglycemic activity of 9-O-(lipophilic group substituted) Berberine derivatives
4266. Synthesis and identification of novel Berberine derivatives as potent inhibitors against TNF-α-induced NF-κB activation
4267. Synthesis and Release Properties on Berberine Hydrochloride of P (AA-co-DMAA)/SA Interpenetrating Polymer Networks Hydrogels
4268. Synthesis and spectroscopic studies of Berberine immobilized modified cellulose material
4269. Synthesis and structure–activity relationship of Berberine analogues in LDLR up-regulation and AMPK activation
4270. Synthesis and structure–activity relationships of Berberine analogues as a novel class of low-density-lipoprotein receptor up-regulators
4271. Synthesis of 13-(substituted benzyl) Berberine and Berberrubine Derivatives [J]
4272. Synthesis of 13-(substituted benzyl) Berberine and berberrubine derivatives as antifungal agents
4273. Synthesis of 13-substituted derivatives of Berberine : Aggregation-induced emission enhancement and pH sensitive property
4274. Synthesis of 8-alkyl-13-bromo-Berberine hydrochloride derivatives and their effect on proliferation of human HepG2 cell line
4275. Synthesis of 9-O-glycosyl-Berberine derivatives and bioavailability evaluation
4276. Synthesis of 9-substituted Berberine derivatives with microwave irradiation
4277. Synthesis of 9-substituted derivatives of Berberine as anti-HIV agents
4278. Synthesis of a Naturally Occurring Plant Alkaloid Berberine Analogue and Its Application in Nanomolar Selective Detection of Hydrazine in Free and DNA‐Binding …
4279. Synthesis of a water-soluble 2, 2′-biphen [4] arene and its efficient complexation and sensitive fluorescence enhancement towards palmatine and Berberine
4280. Synthesis of Berberine hydrochloride encapsulated into β-cyclodextrin polymer microspheres and its behavior of drug release
4281. Synthesis of Berberine loaded polymeric nanoparticles by central composite design
4282. Synthesis of Berberine —Efflux Pump Inhibitor Hybrid Antibacterials
4283. Synthesis of Berberine -piperazine conjugates as potential antioxidant and cytotoxic agents
4284. Synthesis of columbamine from Berberine
4285. Synthesis of glycosylated porphyrins as neutral ionophores for a Berberine -sensitive electrode
4286. Synthesis of linked Berberine dimers and their remarkably enhanced DNA-binding affinities
4287. Synthesis of Mannich base derivatives of Berberine and evaluation of their anticancer and antioxidant effects
4288. Synthesis of new 13-diphenylalkyl analogues of Berberine and elucidation of their base pair specificity and energetics of DNA binding
4289. Synthesis of N-Mannich bases of Berberine linking piperazine moieties revealing anticancer and antioxidant effects
4290. Synthesis of novel 9-ON-aryl/aryl–alkyl amino carbonyl methyl substituted Berberine analogs and evaluation of DNA binding aspects
4291. Synthesis of piperazine based N-Mannich bases of Berberine and their antioxidant and anticancer evaluations
4292. Synthesis of the hydrophobic–hydrophilic macroporous poly divinylbenzene/poly (sodium acrylate) IPN resin and adsorption performance for Berberine
4293. Synthesis, anticancer activities, antimicrobial activities and bioavailability of Berberine -bile acid analogues
4294. Synthesis, antioxidant and anticancer screenings of Berberine –indole conjugates
4295. Synthesis, biological evaluation and molecular modeling of novel triazole-containing Berberine derivatives as acetylcholinesterase and β-amyloid aggregation …
4296. Synthesis, biological evaluation of 9-N-substituted Berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase …
4297. Synthesis, biological evaluation, and molecular modeling of Berberine derivatives as potent acetylcholinesterase inhibitors
4298. Synthesis, characterization and potent DNA-cleaving activity of copper (II)-complexed Berberine carboxylate
4299. Synthesis, Characterization, and Biological Evaluations of 1, 3, 5-Triazine Derivatives of Metformin Cyclization with Berberine and Magnolol in the Presence of Sodium …
4300. Synthesis, cytotoxicity, and DNA-binding property of Berberine derivatives
4301. Synthesis, DNA-binding affinities, and binding mode of Berberine dimers
4302. Synthesizing a Berberine Derivative and Evaluating Antimicrobial Activity To Reinforce with Students the Potential Significance of Small Chemical Structure Changes …
4303. Systematic analysis of Berberine -induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a∼ 125b cluster function by seed …
4304. Systematic development of optimized nanostructured systems of galantamine and Berberine with improved biopharmaceutical attributes
4305. Systems pharmacology to investigate the interaction of Berberine and other drugs in treating polycystic ovary syndrome
4306. Target Animal Safety and Residual Study for Berberine and other Phytogenic Compounds in Broiler Chickens
4307. Targeting Human Telomeric G-Quadruplex DNA by Berberine Analogs: A Comparative Biophysical Investigation
4308. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with Berberine for treatment of colorectal cancer
4309. Targets and mechanisms of Berberine , a natural drug with potential to treat cancer with special focus on breast cancer
4310. TATA boxes in gene transcription and poly (A) tails in mRNA stability: New perspective on the effects of Berberine
4311. Technological Processes Combination of Three-Dimensional-Electrode and Iron-Carbon Micro-Electrolysis Method for Berberine Wastewater Treatment [J]
4312. Technology and Mechanism for Extracting Berberine from Rhizoma coptidis by Two Steps of Releasing and Inner Ebullition
4313. Technology effect of different menstruum on extraction rate of Berberine chloride from Berberis tsienii Ying
4314. Ten Pharmacological effects of Berberine [J]
4315. Testing the Relative Content of Berberine of Cortex Phellodendri Chinensis In Vivo by Multispectral Imaging Method
4316. Tetrandrine potentiates the hypoglycemic efficacy of Berberine by inhibiting P-glycoprotein function
4317. TGF-β1-induced EMT is suppressed by Berberine in triple negative breast cancers
4318. The 9-position in Berberine analogs is an important determinant of DNA topoisomerase II inhibition
4319. The action of Berberine on mammalian hearts
4320. The advance in research of Berberine [J]
4321. The advance on antimicrobial effect of Berberine .
4322. The alkaloid Berberine from Coscinium fenestratum is an inhibitor of phytopathogenic organisms
4323. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest
4324. The alkaloid Berberine isolated from Coscinium fenestratum is an inhibitor of phytopathogenic fungi
4325. The ameliorating effect of Berberine -rich fraction against gossypol-induced testicular inflammation and oxidative stress
4326. The ameliorative effect of Berberine and coenzyme Q10 in an ovalbumin-induced allergic rhinitis model
4327. THE AMELIORAVTIVE EFFECT OF Berberine ON THE MILD PANCREATIC DAMAGES INDUCED BY RENAL ISCHEMIA/REPERFUSION INJURY IN RAT
4328. The anti-atherogenic effects of Berberine on foam cell formation are mediated through the upregulation of sirtuin 1
4329. The antibacterial mechanism of Berberine against Actinobacillus pleuropneumoniae
4330. THE ANTIBACTERIAL MECHANISM OF BERBERIS——Ⅰ. THE INHIBITION OF RESPIRATION OF DYSENTERY BACILLI BY BERBERIS AND Berberine
4331. The anticonvulsant and antioxidant effects of Berberine in kainate-induced temporal lobe epilepsy in rats
4332. The anti-diabetic effects and pharmacokinetic profiles of Berberine in mice treated with Jiao-Tai-Wan and its compatibility
4333. The anti-diarrhea mechanisms of Berberine in diarrhea disease
4334. The antifeeding effect experiment of Berberine chloride against Pieris rapae Linnaeus and Plutella xylostella L.
4335. The antihyperglycaemic activity of Berberine arises from a decrease of glucose absorption
4336. The antihypertensive effect of the Berberine derivative 6-protoBerberine in spontaneously hypertensive rats
4337. The anti-inflammatory potential of Berberine in vitro and in vivo
4338. The antimalarial activity of Berberine and some synthetic analogues
4339. The antioxidant protective effect of Berberine on myocardial ischemia/Reperfusion injury in rabbits [J]
4340. The anti-platelet-rich-plasma-clot-retraction effect of Berberine and its mechanism
4341. The antiviral alkaloid Berberine ameliorates neuropathic pain in rats with peripheral nerve injury
4342. The antiviral alkaloid Berberine reduces chikungunya virus-induced mitogen-activated protein kinase signaling
4343. The assisting effect of Berberine on urokinase and streptokinase induced thrombolysis
4344. The auxiliary determination of the binding site of Berberine binding to human serum albumin by surface-enhanced Raman scattering
4345. The Berberine bridge forming enzyme in tetrahydroprotoBerberine biosynthesis
4346. The Biochemical Effects of Berberine on Hyperlipidemia and Insulin Resistance in Rats Fed High Fat Diet.
4347. The biosynthesis of hydrastine and Berberine
4348. The Characteristics of Aerobic Granules Cultivated with the Effluent from an Anaerobic Baffled Reactor for Berberine Wastewater Treatment
4349. The clinical efficacy of Berberine in treatment of type 2 diabetes mellitus
4350. The clinical observation on Berberine treating nasopharyngeal carcinoma patients with leukopenia caused by radiotherapy and chemiotherapy
4351. The combination of Berberine and irradiation enhances anti‐cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells
4352. The combinational effect of vincristine and Berberine on growth inhibition and apoptosis induction in hepatoma cells
4353. The Combined Effect of the Send Oil from Zanthoxylum bungeanum Maxim and Berberine on Treatment of Thermal Burn
4354. The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Aβ25–35 Induced Neuronal Injury Through Regulating the Expression …
4355. The compound of mangiferin-Berberine salt has potent activities in modulating lipid and glucose metabolisms in HepG2 cells
4356. The Content Determination of Berberine Hydrochloride in Modified Pulsatilla Granule by RP-HPLC [J]
4357. The conversion of Berberine into (.+-.)-. alpha.-and (.+-.)-. beta.-hydrastine
4358. The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of Berberine in LPS-stimulated macrophages and endotoxin …
4359. The crystal structure of Berberine -bridge-forming enzyme (BBE) from California poppy
4360. The crystal structure of human telomeric DNA complexed with Berberine : an interesting case of stacked ligand to G-tetrad ratio higher than 1: 1
4361. The curative effect of Berberine nanoparticles and cisplatin combination therapies against hepatocarcinogenesis-induced by n-nitroso-diethylamine in male rat
4362. The design and synthesis of a novel compound of Berberine and baicalein that inhibits the efficacy of lipid accumulation in 3T3-L1 adipocytes
4363. The detection of active component of Berberine hydrochloride in Acne Lotion
4364. The determination of Berberine by Ion-pair extraction-titration, with tetrabromophenolphthalein ethyl ester as the indicator
4365. The Determination of Berberine Hydrochloride in Fukezhidai Capsules with HPLC [J]
4366. The determination of Berberine hydrochloride in fuzhiqing ointments by HPLC
4367. the Determination of Berberine Hydrochloride in Shangkejingushui by HPLC
4368. The Determination of Berberine , Jatrorrhizine and Palmatine in Qing Wei Huang Lian Tablet [J]
4369. The DNA influence on spectral properties of the Berberine , chelidonine and sanguinarine alkaloids
4370. The dynamics of mast cell secretion studied by vital Berberine staining
4371. The Effect and Mechanism of Berberine on Preventing Atherosclerosis
4372. The Effect of Anti-atherosclerosis of Berberine and Its Mechanism [J]
4373. The effect of Berberine administration of evaluation of the functional state of rat liver after ligation of common bile duct
4374. The effect of Berberine administration to rats on the functional state of liver after common bile duct ligation
4375. The Effect of Berberine Chloride on Escherichia coli and Its Metabolites Using Kirby Bauer and Tissue Culture Methods
4376. The effect of Berberine chloride on experimental colitis in rats in vivo and in vitro
4377. THE EFFECT OF Berberine CHLORIDE ON HIPPOCAMPUS OXIDATIVE STRESS OF STREPTOZOTOCIN-DIABETIC RATS
4378. THE EFFECT OF Berberine HYDROCHLORIDE ON COGNITIVE DYSFUNCTION IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
4379. The effect of Berberine hydrochloride on Enterococcus faecalis biofilm formation and dispersion in vitro
4380. THE EFFECT OF Berberine HYDROCHLORIDE ON MOTOR FUNCTION IMPAIRMENT IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
4381. The effect of Berberine in inhibition of proliferation and induction of apoptosis of gastric cancer cell MGC-803
4382. The effect of Berberine in inhibition of proliferation and induction of apoptosis of gastric cancer cell MGC-803 [J]
4383. The effect of Berberine in sterilizing infective root canal of deciduous teeth
4384. The effect of Berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cells
4385. The effect of Berberine nanomicelles on hepatic cirrhosis in bile duct-ligated rats
4386. The effect of Berberine on ameliorating chronic inflammatory pain and depression
4387. The effect of Berberine on angiotensin of carotid artery atherosclerosis in rabbit
4388. THE EFFECT OF Berberine ON ARRHYTHMIA CAUSED BY STRETCH OF ISOLATED MYOCARDIAL INFARCTED HEARTS IN RATS
4389. The effect of Berberine on arrhythmia caused by stretch of myocardium, in vitro, of rats after myocardial ischemia
4390. The effect of Berberine on bilirubin excretion in the rat
4391. The effect of Berberine on cell proliferation, cell cycle and CD44V6 expression in gastric cancer cell
4392. The effect of Berberine on delayed neuronal death in CA_1 in rat exposed to cerebral ischemia [J]
4393. The effect of Berberine on human umbilical vascular endothelial cells proliferation induced by HeLa Cell
4394. The effect of Berberine on hydroxyl free radical of the experimental type 2 diabetes rats
4395. The effect of Berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized …
4396. THE EFFECT OF Berberine ON PATIENTS WITH PSORIASIS
4397. The Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A Meta-Analysis and Systematic Review
4398. The Effect of Berberine on Reproduction and Metabolism in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Control …
4399. THE EFFECT Of Berberine ON SOD AND MDA IN THE SERUM OF DIABETES RATS WITH [J]
4400. THE EFFECT Of Berberine ON THE ACTIVITY OF SOD IN MYOCARDIUM AND KIDNEY IN EXPERIMENTAL DIABETIC RATS
4401. The effect of Berberine on the angiotensin Ⅱ receptor type 1 in the prevention of carotid artery atherosclerosis in rabbits
4402. The effect of Berberine on the expression of matrix metalloproteinase-13 and ADAMTS-5 in articular cartilage in a rabbit model of osteoarthritis
4403. The effect of Berberine on the in vitro proliferation and cell–cycle distribution of the mouse lymphocytes
4404. The effect of Berberine on the pharmacokinetics of oral enrofloxain in broilers.
4405. The effect of Berberine on the secondary structure of human serum albumin
4406. The effect of Berberine on the thickness of intima and chemoattaction of macrophage cell in rabbit [J]
4407. The Effect of Berberine on the Transcriptome and Proteome of E. coli
4408. The effect of Berberine on the VCAM-1 and NF-κB in rabbits with carotid artery atherosclerosis
4409. The effect of Berberine on xanthine oxidase activity in the serum and the renal tissue of experimental type 2 diabetic rats [J]
4410. The effect of Berberine preparation on diarrheal symptoms due to Linac irradiation
4411. The effect of Berberine treatment on the reversibility of the development of mouse zygotes and gametes, and on the fertilization and subsequent development
4412. The effect of different compatibility proportion of Berberine and total matrines on UC model rats
4413. The effect of different shadings on the content of Berberine in different age coptis [J]
4414. The effect of ERK signaling cascade pathways on the inhibition of Berberine on lipopolysaccharide induced COX-2 expression
4415. The Effect of Hwangryunhaedok-tang and its Major Component Coptidis Rhizoma, Berberine on Nicotine Addiction in Rats
4416. THE EFFECT OF ISOQUINOLINE ALKALOIDS, Berberine , PALMATINE AND CORALYNE ON THE FREQUENCY OF X-RAY–INDUCED MICRONUCLEI IN …
4417. The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of Berberine
4418. The Effect of N-acetylcysteine and Berberine on Pulmonary Fibrosis Induced by Bleomycin
4419. The effect of oxidation on Berberine -mediated CYP1 inhibition: oxidation behavior and metabolite-mediated inhibition
4420. The effect of the intervention of Berberine in ACM rats
4421. The effects and mechanism of action on Berberine to Atherosclerosis in rats [J]
4422. The effects and mechanisms of Berberine on proliferation of papillary thyroid cancer K1 cells induced by high glucose
4423. The Effects of Active Ingredients of Barberry Root (Berberine ) on Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients
4424. The Effects of Berberine and Nitroxl (HNO) on the Glucose Uptake in L929 Fibroblast Cells
4425. The effects of Berberine and palmatine on efflux pumps inhibition with different gene patterns in Pseudomonas aeruginosa isolated from burn infections
4426. The effects of Berberine and taurine on PAI-1 mRNA expression in epiploon adipose tissue of high fat rats model of insulin resistance (IR)
4427. The effects of Berberine chloride on platelet activation of mice with dextransulphate sodium-induced colitis [J]
4428. The effects of Berberine combination with calcium gluconate on sick sinus syndrome [J]
4429. The effects of Berberine combining with atorvastatin on blood choksterol level and carotid atherosclerotic plaques in patients with acute cerebral infarction
4430. The effects of Berberine on a murine model of multiple sclerosis and the SPHK1/S1P signaling pathway
4431. The effects of Berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials
4432. The Effects of Berberine on Concanavalin A-Induced Autoimmune Hepatitis (AIH) in Mice and the Adenosine 5′-Monophosphate (AMP)-Activated Protein …
4433. The effects of Berberine on glucose metabolism in adipocyte
4434. The effects of Berberine on growth of Immorto-Min colonic epithelial cell line
4435. The effects of Berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet
4436. The Effects of Berberine on Influenza A virus, Influenza A virus-induced Inflammation and the Lipopolysaccharide-induced Synthesis of Prostaglandin E2.
4437. The effects of Berberine on inhibiting glycation-oxidative stress and down-regulating inflammatory cytokines in metabolic syndrome and hypertensive rats with …
4438. The effects of Berberine on p38MAPK pathway and COX-2 mRNA expression
4439. The effects of Berberine on reactive oxygen species production in human neutrophils and in cell-free assays
4440. The effects of Berberine on reducing blood glucose and lipid in metabolic symptom and hypertensive rats with ventricular remodeling
4441. The Effects of Berberine on the Gut Microbiota in Apc min/+ Mice Fed with a High Fat Diet
4442. The effects of Berberine on the magnitude of the acute inflammatory response induced by Escherichia coli lipopolysaccharide in broiler chickens
4443. The effects of Berberine on the pharmacokinetics of ciclosporin A in healthy volunteers.
4444. The Effects of Conjugated Linoleic Acid and Berberine Supplementation on Markers of Allopurinol Activated Oxidative Stress in Broiler Chickens
4445. The Effects of Conjugated Linoleic Acid and Berberine Supplementation on Markers of Oxidative Stress in Broiler Chickens
4446. The Effects of Different Desicating Methods on the Content of Berberine in Rhizoma Coptidis
4447. The effects of Forsythia suspensa extract and Berberine on growth performance, immunity, antioxidant activities, and intestinal microbiota in broilers under high stocking density
4448. The effects of insulin and Berberine on the osseointegration of titanium implant in type H diabetic rats
4449. The Effects of Preparing Procedure for Crude Herbs on the Berberine Content in Yuhuanglian [J]
4450. The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides
4451. The enhancement of cardiotoxicity that results from inhibiton of CYP 3A4 activity and hERG channel by Berberine in combination with statins
4452. The enhancement of combination of Berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1
4453. The evaluation of pro-cognitive and antiamnestic properties of Berberine and magnoflorine isolated from barberry species by centrifugal partition chromatography …
4454. The examination of Berberine excited state by laser flash photolysis
4455. The Experimental Research on Contact Dermatitis Treated by Berberine Flocculant [J]
4456. The experimental study on the acute and the local toxicity of compound Berberine hydrosulphate clyster
4457. The external antimicrobial of the oregano oil with Berberine for colibacillosis (ESBLs) in chicken
4458. The extraction methods of Berberine from Coptis chinensis
4459. The Extraction of a Natural Dye Berberine and Evaluation of its Corrosion Inhibition properties for P110SS Steel
4460. The family of Berberine bridge enzyme-like enzymes: A treasure-trove of oxidative reactions
4461. The first 13-vinyl derivatives of Berberine : synthesis and antimicrobial activity
4462. The fluorescent reaction between Berberine and DNA and the fluorometry of DNA
4463. The Fluorescent Staining of Heparin in Mast Cells Using Berberine Sulfate: Compatibility with Paraformaldehyde or o-Phthalaldehyde Induced Fluorescence and …
4464. The gut microbiota modulator Berberine ameliorates collagen-induced arthritis in rats by facilitating the generation of butyrate and adjusting the intestinal hypoxia and …
4465. The Hypoglycemic Effects on the Mixture of Balsam Pear Saponins and Berberine in Type-Ⅱ Diabetic Mice [J]
4466. The Hypoglycemic Pharmacodynamic and Clinical Study by Berberine [J]
4467. The impact of Berberine on insulin resistance and cytokines in patients with schizophrenia
4468. The impact of Keap1/Nrf2, P38MAPK/NF-κB and Bax/Bcl2/caspase-3 signaling pathways in the protective effects of Berberine against methotrexate-induced …
4469. The Improving Effect and Mechanism of Berberine on Lung Vascular Permeability of Mice with Viral Pneumonia Caused by Influenza Virus
4470. The In Vitro Inhibition of Human CYP1A2, CYP2D6 and CYP3A4 by Tetrahydropalmatine, Neferine and Berberine
4471. The In vitro/vivo Evaluation of Prepared Gastric Floating Tablets of Berberine Hydrochloride
4472. The inflammasome pathway as a target of Berberine in experimental steatohepatitis and acetaminophen toxicity
4473. The influence of Berberine on co-stimulatory molecule expression and T cell activation
4474. The influence of Berberine preconditioning on cardiac function of rats with myocardial ischemia-reperfusion injury
4475. The influence of clay surface modification with Berberine on the sorption of anthocyanins
4476. THE INFLUENCE OF COMBINED USE OF SULFATHIAZOLE AND ANTIBIOTICS OR Berberine ON THE DEVELOPMENT OF DRUGFASTNESS OF SHIGELLA …
4477. The influence of deoxyribonucleic acid on ultraviolet and visible light absoption of Berberine
4478. The inhibit effect of Berberine on human colon cell line cyclooxygenase-2
4479. The inhibition of inflammatory molecule expression on 3T3-L1 adipocytes by Berberine is not mediated by leptin signaling
4480. The inhibitory effect of Berberine on COX-2 expression in human colon cancer cells
4481. The inhibitory effect of Berberine on Streptococcus mutans in vitro
4482. The interaction of Berberine and human serum albumin
4483. The interactions between Berberine and ethidium bromide with DNA [J]
4484. The investigation of the preventive effects of Coenzyme Q10 and Berberine for tourniquet induced ischemia-reperfusion injury on skeletal muscle in rat hindlimb
4485. The involvement of multidrug and toxin extrusion protein 1 in the distribution and excretion of Berberine
4486. The involvement of P‐glycoprotein in Berberine absorption
4487. The isoquinoline alkaloid Berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity.
4488. The lncRNA Malat1 functions as a ceRNA to contribute to Berberine -mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation
4489. The Many Benefits of Berberine
4490. The Mechanism of Berberine on Preventing Carotid Atherosclerosis in Rabbits
4491. The mechanism of guanine specific photooxidation in the presence of Berberine and palmatine: activation of photosensitized singlet oxygen generation through DNA …
4492. The mechanisms of ROS-photogeneration by Berberine , a natural isoquinoline alkaloid
4493. The metabolism of Berberine and its contribution to the pharmacological effects
4494. The microenvironment of DNA switches the activity of singlet oxygen generation photosensitized by Berberine and palmatine
4495. The natural alkaloid Berberine targets multiple pathways to induce cell death in cultured human colon cancer cells
4496. The natural compound Berberine positively affects macrophage functions involved in atherogenesis
4497. The natural compound Berberine positively modulates macrophage functions involved in atherogenesis
4498. The natural product Berberine is a human prolyl oligopeptidase inhibitor
4499. The neuroprotective effects of Berberine against amyloid β-protein-induced apoptosis in primary cultured hippocampal neurons via mitochondria-related caspase …
4500. The new method for extracting Berberine from coptis
4501. The new progress improving insulin resistance of Berberine [J]
4502. The norcoclaurine pathway is operative in Berberine biosynthesis in Coptis japonica
4503. The Observation of the Curative Effect of Berberine Together with Glibenclcrmide for Curing Diabetes [J]
4504. The optimized preparative method of Berberine hydrochloride nanoliposome and its in vivo cytotoxicity
4505. The pathogenesis of diabetes mellitus by oxidative stress and inflammation: its inhibition by Berberine
4506. The pharmacoeconomic study of coadministration of cyclosporin A with Berberine hydrochloride
4507. The possible role of Berberine in ameliorating doxorubicin-induced cardiomyopathy in adult male albino rat: a histological and immunohistochemical study
4508. The potential effect of Berberine in mercury-induced hepatorenal toxicity in albino rats
4509. The potential mechanisms of Berberine in the treatment of nonalcoholic fatty liver disease
4510. The potential role for Berberine , an alkaloid dietary supplement, in mitigating the subclinical pathology and delaying onset of rheumatoid arthritis
4511. The preconditioning of Berberine suppresses hydrogen peroxide-induced premature senescence via regulation of Sirtuin 1
4512. The preparation and antibacterial activity in vitro of Berberine hydrochloric nanometer microemulsion
4513. The preparation and clinical application of compound Berberine hydrosulphate clyster
4514. The Preparation of Oral Berberine Bisulfate Liposomes [J]
4515. The preparation of tritiated Berberine
4516. The preparation, characterization, anti-ultraviolet and antimicrobial activity of gelatin film incorporated with Berberine -HP-β-CD
4517. The Preventive And Therapeutic Effect Of Coptidis Rhizoma And Berberine In Cancer
4518. The progress of hypoglycemic mechanism of Berberine .
4519. The promotion function of Berberine for osteogenic differentiation of human periodontal ligament stem cells via ERK-FOS pathway mediated by EGFR
4520. The protecting effects of Berberine on the hypertensive renal impairment in rats fed by enriched high fat-salt-fructose diet [J]
4521. The protection of resveratrol and its combination with glibenclamide, but not Berberine on the diabetic hearts against reperfusion-induced arrhythmias: the role of …
4522. The protective effect of Berberine against lipopolysaccharide-induced abortion by modulation of inflammatory/immune responses
4523. The protective effect of Berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune …
4524. The protective effect of Berberine combined with captopril preconditioning on myocardium ischemia/reperfusion injury in rats
4525. The protective effect of Berberine hydrochloride on LPS‑induced osteoclastogenesis through inhibiting TRAF6‑Ca2+‑calcineurin‑NFATcl signaling pathway
4526. The Protective Effect of Berberine on Cultured Myocardial Cells During Anoxia [J]
4527. The protective effect of Berberine on β-cell lipoapoptosis
4528. The protective effect of Berberine with different doses on the myocardial infarction in rats
4529. The protective effect of coenzyme Q10 and Berberine on sperm parameters, with and without varicocelectomy in rats with surgically induced varicoceles
4530. The protective effects of Berberine and Hesperidin on inflammatory factor-stimulating cardiac fibroblasts.
4531. The Protective Effects of Berberine Preconditioning on Myocardial Ischemia Reperfusion Injury in Rats
4532. The Qualitative and Quantitative Analysis of Berberine [J]
4533. The renoprotective effects of Berberine via the EP4-Gαs-cAMP signaling pathway in different stages of diabetes in rats
4534. The role and mechanism of Berberine on coronary arteries
4535. The role of Berberine in the multi-target treatment of senile dementia
4536. The Role of Berberine in the Prevention of HIF-1α Activation to Alleviate Adipose Tissue Fibrosis in High-Fat-Diet-Induced Obese Mice
4537. The role of cyclooxygenase-2 in Berberine induced apoptosis and inhibited cell migration of human gastric adenocarcinoma RF-1 and RF-48 cell lines
4538. The role of ethylene in Berberine production byThalictrum minus cell suspension cultures
4539. The role of phytohormone on the production of Berberine in the calli cultures of an endangered medicinal plant, turmeric (Coscinium fenestratum l.)
4540. The role of ROS and p38 MAP kinase in Berberine -induced apoptosis on human hepatoma HepG2 cells
4541. The Selection of High-yield Strains of Berberine with Complex Mutagenesis of Laser and Ultraviolet Rays
4542. The Separation Optimization of Berberine in Anting-Anting Plants (Acalypha Indica Linn) using High Performance Liquid Chromatography (HPLC)
4543. The simultaneous determination of Berberine , palmatine, coptisine, epiBerberine and jatrorrhizine in rat plasma by LC-MS/MS and a pharmacokinetic comparison after …
4544. The single Berberine bridge enzyme homolog of Physcomitrella patens is a cellobiose oxidase
4545. The Speedy Recovery of a Case of Kala-Azar by Intravenous Injection of Sodium Antimony Tartrate with Sodium Cinnamate and Berberine Hydrochloride.
4546. The Stability and Anti-inflammatory Effects of Berberine /Heparin/Chitosan Nanoparticles
4547. The structure-dependent electric release and enhanced oxidation of drug in graphene oxide-based nanocarrier loaded with anticancer herbal drug Berberine
4548. The Studies of Berberine Extracted by Salting-Out Process [J]
4549. The Studies of Extraction Process of Berberine Hydrochloride in Coptis Chinensis Franch.[J]
4550. The study apoptosis of human gastric carcinoma BGC-823 cell induced by Berberine
4551. The study of absorption kinetics of Berberine based on portal vein in rat, and the influence of verapamil and borneol to its absorption ability by uhplc method
4552. The study of the effect and mechanism of Berberine on the carotid atherosclerotic plaque
4553. The study of the effects of Berberine on reperfusion-induced arrhythmias and on modulating calcium in rat
4554. The Study of the Interactions of Berberine with Bovine Serum Albumin and Bovine Hemoglobin
4555. The study on mechanism of emodin and Berberine improving the insulin resistance in HepG2 cells [J]
4556. The synergistic antitumor effects of Berberine alpha-hydroxy-beta-decanoylethyl sulfonate with hydroxycamptothecine and its effect on topoisomerase
4557. The synergistic effects of Berberine hydrochloride and fluconazol on drug-resistant Candida albicans: An experimental study
4558. The synergy of Berberine chloride and totarol against Staphylococcus aureus grown in planktonic and biofilm cultures
4559. The synthesis and antistaphylococcal activity of 9, 13-disubstituted Berberine derivatives
4560. THE SYNTHESIS OF TETRAHYDROPALMATINE ANALOGUES Ⅰ.ESTERIFICATION AND ALKYLATION OF DEMETHYLATED TETRAHYDROPALMATINE AND DEMETHYLENEDIOXYLATED Berberine
4561. The therapeutic effect of Berberine in the treatment of nonalcoholic fatty liver disease: a meta-analysis
4562. The therapeutic effect of Berberine on TNBS induced mice colitis [J]
4563. The therapeutic effects of Berberine extract on ulcerative colitis in mice
4564. The therapeutic effects of combination of simvastatin with Berberine on the patients with hyperlipemia
4565. The therapeutic potential of Berberine against the altered intrinsic properties of the CA1 neurons induced by Aβ neurotoxicity
4566. The therapeutic potential of Berberine chloride hydrate against harmaline-induced motor impairments in a rat model of tremor
4567. The Therapeutic Potential of Berberis darwinii Stem-Bark: Quantification of Berberine and In Vitro Evidence for Alzheimer’s Disease Therapy
4568. The traditional uses and pharmacological effects of different parts Berberis Vulgaris (Berberine ) in Iran
4569. The treatment of Oriental sore with Berberine acid Sulphate
4570. The uptake and transport behavior of Berberine in Coptidis Rhizoma extract through rat primary cultured cortical neurons
4571. The use of Berberine for women with polycystic ovary syndrome undergoing IVF treatment
4572. The use of novel and unique biofield energy healing treatment for the improvement of poorly bioavailable compound, Berberine in male Sprague Dawley rats
4573. Themes: Title: Amelirative Effect of Berberine on the Functional Damages of Testis in the Ischemic Acute Renal Failure in Rat.
4574. Themes: Title: Berberine Ameliorates Pulmonary Injury Induced by Ischemic Acute Renal Failure In Rat.
4575. Themes: Title: Berberine Ameliorates Renal Ischemia/reperfusion Injury in Rats.
4576. Themes: Title: Berberine Improves Liver Injury Following Renal Ischemia/Reperfusion in Rats.
4577. Themes: Title: Effect of Berberine on glutamate-induced cytotoxicity in PC12 and N2A cells
4578. Themes: Title: Effects of Berberine chloride on synaptic plasticity in STZ induced diabetic rats.
4579. Themes: Title: The Amelioravtive Effect of Berberine on the Mild Pancreatic Damages Induced by Renal Ischemia/Reperfusion Injury In Rat.
4580. Therapeutic and biological activities of Berberine : The involvement of Nrf2 signaling pathway
4581. THERAPEUTIC AND PROPHYLACTIC EFFECTS OF CO-Berberine ON ACUTE ENTERITIS AT HIGH ALTITUDE
4582. Therapeutic Effect of Berberine Combined with Diformin for Women with Polycystic Ovary Syndrome and Insulin Resistance
4583. Therapeutic effect of Berberine on 60 patients with non-insulin dependent diabetes mellitus and experimental research
4584. Therapeutic effect of Berberine on Huntington’s disease transgenic mouse model
4585. Therapeutic effect of Berberine on renal ischemia-reperfusion injury in rats and its effect on Bax and Bcl-2
4586. Therapeutic effect of Berberine on TDP-43-related pathogenesis in FTLD and ALS
4587. Therapeutic Effect of Berberine Recipe on ICR Mouse Model of Type 2 Diabetes
4588. Therapeutic effect of ulinastatin and Berberine on burn sepsis in rats
4589. Therapeutic effects of Berberine capsule on patients with mild hyperlipidemia
4590. Therapeutic Effects of Coptidis Rhizoma and Berberine in Streptozotocin-induced Diabetic Rats
4591. Therapeutic efficacy of Berberine in treatment of diarrhea caused by metformin hydrochloride: a report of 19 cases
4592. Therapeutic efficacy of combined Berberine and Glipizide on type 2 diabete
4593. Therapeutic Potential and Mechanisms of Berberine in Cardiovascular Disease
4594. Therapeutic potential and recent delivery systems of Berberine : A wonder molecule
4595. Therapeutic value of Berberine for digestive tract diseases
4596. Thermal analysis of β-cyclodextrin/Berberine chloride inclusion compounds
4597. Thermal behavior and thermodynamic properties of Berberine hydrochloride
4598. Thermodynamic and kinetic studies of adsorption of Berberine on silk
4599. Thermodynamic study on the effects of β-cyclodextrin inclusion with Berberine
4600. Thermodynamics of the interaction of Berberine with DNA
4601. THU0078 Berberine ameliorates bone erosions in collagen-induced arthritis rat models via suppressing the expression of il-17a
4602. Tissue distribution of Berberine and its metabolites after oral administration in rats
4603. TLC densitometric fingerprint development and validation of Berberine as markers in poly-herbal Unani formulations
4604. TLC identification of migan tablet and determination of Berberine hydrochloride [J]
4605. TNFα-induced and Berberine -antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFκB signaling
4606. To Determine Content of Berberine in Complex Prescription Lianshao Tablet by HPLC
4607. To determine the Effect of Berberine on 6-OHDA induced memory impairment in Parkinson’s disease in rodents
4608. To Determine the Serum Consentration of Berberine in Rabbits in RP-HPLC [J]
4609. Tobacco nectarin V is a flavin-containing Berberine bridge enzyme-like protein with glucose oxidase activity
4610. Total Synthesis and Evaluation of B‐Homo Palmatine and Berberine Derivatives as p300 Histone Acetyltransferase Inhibitors
4611. Toxicological effects of Berberine and sanguinarine
4612. Toxicology effects of Berberis vulgaris (barberry) and its active constituent, Berberine : a review
4613. Traditional human taste panel and taste sensors methods for bitter taste masking research on combined bitterness suppressants of Berberine hydrochloride
4614. Transcriptional profile of the Shigella flexneri response to an alkaloid: Berberine
4615. Transfer of cationic antibacterial agents Berberine , palmatine, and benzalkonium through bimolecular planar phospholipid film and Staphylococcus aureus membrane
4616. Transformation of opium poppy (Papaver somniferumL.) with antisense Berberine bridge enzyme gene (anti-bbe) via somatic embryogenesis results in an altered …
4617. Transforming Berberine into its intestine-absorbable form by the gut microbiota
4618. Transgenic and mutation-based suppression of a Berberine bridge enzyme-like (BBL) gene family reduces alkaloid content in field-grown tobacco
4619. Transport and uptake characteristics of a new derivative of Berberine (CPU-86017) by human intestinal epithelial cell line: Caco-2
4620. Transportation of Berberine into HepG2, HeLa and SY5Y cells: a correlation to its anti-cancer effect
4621. Treatment effects of ischemic stroke by Berberine , baicalin, and jasminoidin from Huang-Lian-Jie-Du-Decoction (HLJDD) explored by an integrated metabolomics …
4622. Treatment of Berberine hydrochloride pharmaceutical wastewater by O3/UV/H2O2 advanced oxidation process
4623. Treatment of Berberine hydrochloride pharmaceutical wastewater by pulse electro-coagulation.
4624. Treatment of Berberine hydrochloride wastewater by pulse electrocoagulation process [J]
4625. Treatment of Berberine hydrochloride wastewater by using pulse electro-coagulation process with Fe electrode
4626. Treatment of Berberine pharmaceutical wastewater by O3/UV synergetic oxidation.
4627. Treatment of Berberine pharmaceutical wastewater with O_3 oxidation process
4628. Treatment of Berberine with indium
4629. Treatment of chloroquine-resistant malaria using pyrimethamine in combination with Berberine , tetracycline or cotrimoxazole.
4630. Treatment of Diabetes Ⅱ and IR with Berberine Hydrochloride Combined with Intensified Life Interference [J]
4631. Treatment of Malaria by combining Berberine by Mouth with Oral or Intramuscular Quinidine.
4632. Treatment of refractory Berberine wastewater with anaerobic baffled reactor (ABR).
4633. Treatment of simulated Berberine wastewater by electrochemical process with Pt/Ti anode
4634. Treatment of simulated Berberine wastewater in electrochemical process
4635. Treatment of synthetic Berberine wastewater in a hybrid upflow anaerobic sludge blanket reactor (UASB)-membrane bioreactor (MBR) system.
4636. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid Berberine
4637. Tree Turmeric (Dar-e-Hald)., A Berberine Containing Unani Medicinal Herb of Pakistan
4638. Trial of Berberine as an antisecretory drug in human cholera
4639. Trial-producing of Berberine hydrochloride suppository and determining of its blood concentration and availability
4640. Trimetazidine combined with Berberine on endothelial function of patients with coronary heart disease combined with primary hypertension
4641. Tumor control by hypoxia-specific chemotargeting of iron-oxide nanoparticle–Berberine complexes in a mouse model
4642. Tumor suppressor Berberine binds VASP to inhibit cell migration in basal-like breast cancer
4643. Two cocrystals of Berberine chloride with myricetin and dihydromyricetin: Crystal structures, characterization and anti-tumor activities
4644. Two flavonols from Artemisa annua which potentiate the activity of Berberine and norfloxacin against a resistant strain of Staphylococcus aureus
4645. Two stage cultures for the production of Berberine in cell suspension cultures of Thalictrum rugosum
4646. Two telomerase-targeting Pt (II) complexes of jatrorrhizine and Berberine derivatives induce apoptosis in human bladder tumor cells
4647. Two-stage culture for producing Berberine by cell suspension and shoot cultures of Berberis buxifolia Lam
4648. Ultrasonic extraction process of Berberine from rhizome coptidis and mathematic simulation [J]
4649. Ultrasonic-assisted extraction of Berberine from Caulis Mahonia [J]
4650. Uncertainty Evaluation of Berberine Hydrochloride in Cortex Phellodendri by HPLC [J]
4651. Uncoupling protein‐2 mediates the protective action of Berberine against oxidative stress in rat insulinoma INS‐1 E cells and in diabetic mouse islets
4652. Understanding the ultrastructural aspects of Berberine -induced skin-darkening activity in the toad, Bufo melanostictus, melanophores
4653. Unveiling the mode of interaction of Berberine alkaloid in different supramolecular confined environments: interplay of surface charge between nano-confined charged …
4654. Update on Berberine in nonalcoholic Fatty liver disease
4655. Update on the benefits and mechanisms of action of the bioactive vegetal alkaloid Berberine on lipid metabolism and homeostasis
4656. UPLC simultaneous determination of Berberine hydrochloride and palmatine hydrochloride in Coptis
4657. UPLC-Q-TOFMS/MS analysis of Berberine and gut microbiota transformed metabolites.
4658. Upregulating Reverse Cholesterol Transport With Cholesteryl Ester Transfer Protein Inhibition Requires Combination With the LDL-Lowering Drug Berberine in Dyslipidemic Hamsters
4659. Up‐regulation of multidrug resistance transporter expression by Berberine in human and murine hepatoma cells
4660. Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine
4661. Uptake and levels of the antibiotic Berberine in individual dormant and germinating Clostridium difficile and Bacillus cereus spores as measured by laser tweezers …
4662. Uptake of and resistance to the antibiotic Berberine by individual dormant, germinating and outgrowing Bacillus spores as monitored by laser tweezers …
4663. Uptake of and Resistance to the Antibiotic Berberine by Individual Dormant, Germinating and Outgrowing Spores as Monitored by Laser Tweezers Raman …
4664. Use of Berberine in treatment of giardiasis
4665. Use of frontal chromatography to measure the binding interaction of Berberine chloride with bovine serum albumin
4666. Use of HPHT autoclave to determine corrosion inhibition by Berberine extract on carbon steels in 3.5% NaCl solution saturated with CO2
4667. USE OF THE FLUORESCENCE MICROSCOPE TO DEMONSTRATE THE STORAGE OF Berberine IN CHONDRIOSOME EQUIVALENTS OF BACTERIA IN VIVO
4668. Usefulness of Berberine (an Alkaloid from Berberis aristata) in the Treatment of Cholera (Experimental).
4669. Utilisation of in vitro cultures of Tinospora cordifolia Miers (chittamrithu) for Berberine
4670. Utilization of Protopine and Related Alkaloids. III. Acid Catalyzed Cyclization of AnhydromethylBerberine . The Revised Structures for Hydroxyisoanhydrodihydromethyl–Berberine and IsoanhydromethylBerberine
4671. Utilization of Protopine and Related Alkaloids. VI. Transformation of Berberine to 10b-Methylhexahydrobenzo [c] phenanthridine Derivative
4672. Vacuole-localized Berberine bridge enzyme-like proteins are required for a late step of nicotine biosynthesis in tobacco
4673. Validated HPLC-UV method for the determination of Berberine in raw herb Daruharidra (Berberis aristata DC), its extract, and in commercially marketed …
4674. Validated UPLC–MS/MS method for simultaneous determination of simvastatin, simvastatin hydroxy acid and Berberine in rat plasma: Application to the drug–drug pharmacokinetic interaction study of simvastatin combined with Berberine after oral administration in rats
4675. Validation of a liquid chromatography–tandem mass spectrometric assay for the quantitative determination of hydrastine and Berberine in human serum
4676. Vanadium compounds induced damage of human umbilical vein endothelial cells and the protective effect of Berberine
4677. Variability in Potency Among Commercial Preparations of Berberine
4678. Variation of Berberine content in coscinium fenestratum stem in Thailand Market
4679. Variations on the Berberine Hydrochloride Content of Berberis tsienii Populations from Different Altitudes of Liu panshui
4680. Vasorelaxant and antiproliferative effects of Berberine
4681. Vectorial transport of the plant alkaloid Berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux …
4682. Ventricular tachyarrhythmias treated with Berberine
4683. Verapamil augments the neuroprotectant action of Berberine in rat model of transient global cerebral ischemia
4684. Versatile methods for synthesizing organic acid salts of quaternary Berberine -type alkaloids as anti-ulcerative colitis agents
4685. Vibrational spectra of Berberine and their interpretation by means of DFT quantum-mechanical calculations
4686. Vibrational Spectra of Berberine Organic Compound and Their Interpretation by Means of DFT Quantum-mechanical Calculations
4687. Visible light in-duced photocatalytic degradation of the antibiotic Berberine with CdS-TiO2 in suspension
4688. Visible-light photocatalytic fuel cell with Z-scheme g-C3N4/Fe0/TiO2 anode and WO3 cathode efficiently degrades Berberine chloride and stably generates electricity
4689. Visual colorimetric detection of Berberine hydrochloride with silver nanoparticles
4690. White-light-emitting single MOF sensor based array for Berberine homologues discrimination
4691. Whole-cell patch clamp measurements and Berberine inhibition of hyperpolarization-activated inward current in rabbit sinoatrial node cells.
4692. Xiangsha Weiling Pills Berberine Trimethoprim Treatment of Chronic Ulcerative Colitis 80 Case
4693. XII. On the occurrence of Berberine in the columba wood of Ceylon, the menispermum fenestratum of botanists
4694. XII.—On Berberine .(Part I.)
4695. XLIII.—On Berberine —contributions to its history and revision of its formula
4696. X-Ray diffraction analyses of the natural isoquinoline alkaloids Berberine and Sanguinarine complexed with double helix DNA d (CGTACG)
4697. XV.—The relationship of corydaline to Berberine . Berberidic acid
4698. XVI.—On the preparation of Berberine from coscinium fenestratum
4699. XXXIII.—Strychnine, Berberine , and allied alkaloids
4700. Yohimbine enhances protection of Berberine against LPS-induced mouse lethality through multiple mechanisms
4701. Zhongguo Zhong Yao Za Zhi: effect of Berberine on pharmacokinetics of digoxin after oral administration to rats.[Article in Chinese]
4702. γ‐Cyclodextrin as Inhibitor of the Precipitation Reaction between Berberine and Glycyrrhizin in Decoctions of Natural Medicines: Interaction Studies of Cyclodextrins with …